CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: monomethoxybenzene
Accession: CHEBI:25235
browse the term
Definition: Compounds containing a benzene skeleton substituted with one methoxy group.
Synonyms: related_synonym: monomethoxybenzenes
G
Hnf1a
HNF1 homeobox A
decreases expression
ISO
isolariciresinol results in decreased expression of HNF1A mRNA
CTD
PMID:35755389
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:41,645,587...41,672,104
G
Ldlr
low density lipoprotein receptor
decreases expression
ISO
isolariciresinol results in decreased expression of LDLR protein
CTD
PMID:35755389
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
decreases expression
ISO
isolariciresinol results in decreased expression of PCSK9 mRNA; isolariciresinol results in decreased expression of PCSK9 protein
CTD
PMID:35755389
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:121,211,278...121,233,688
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
isolariciresinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:21191767
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
isolariciresinol results in decreased expression of SREBF1 mRNA
CTD
PMID:35755389
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
decreases expression
ISO
isolariciresinol results in decreased expression of SREBF2 mRNA
CTD
PMID:35755389
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:113,663,202...113,720,848
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions decreases expression
ISO
[loliolide co-treated with pinoresinol] results in decreased expression of ACACA protein pinoresinol results in decreased expression of ACACA protein
CTD
PMID:31610126
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Fasn
fatty acid synthase
multiple interactions decreases expression
ISO
[loliolide co-treated with pinoresinol] results in decreased expression of FASN protein pinoresinol results in decreased expression of FASN protein
CTD
PMID:31610126
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
multiple interactions
ISO
pinoresinol results in increased ubiquitination of and results in increased degradation of and results in decreased expression of NR1H2 protein
CTD
PMID:31610126
NCBI chr 1:104,178,483...104,183,863
Ensembl chr 1:95,041,967...95,047,377
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions
ISO
pinoresinol results in increased ubiquitination of and results in increased degradation of and results in decreased expression of NR1H3 protein
CTD
PMID:31610126
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
pinoresinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:21191767
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression multiple interactions
ISO
pinoresinol results in decreased expression of SREBF1 protein [loliolide co-treated with pinoresinol] results in decreased expression of SREBF1 protein
CTD
PMID:31610126
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Tnf
tumor necrosis factor
decreases secretion
ISO
pinoresinol results in decreased secretion of TNF protein
CTD
PMID:29740324
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
yakuchinone-A results in increased expression of BAX mRNA; yakuchinone-A results in increased expression of BAX protein
CTD
PMID:24070160
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
yakuchinone-A results in decreased expression of BCL2 mRNA; yakuchinone-A results in decreased expression of BCL2 protein
CTD
PMID:24070160
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Il17a
interleukin 17A
multiple interactions
ISO
yakuchinone-A inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IL17A protein]
CTD
PMID:31001353
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA]; yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]
CTD
PMID:12086399
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Odc1
ornithine decarboxylase 1
multiple interactions
ISO
yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein]; yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ODC1 mRNA]
CTD
PMID:10517978 PMID:12201673
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:40,329,964...40,336,440
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
yakuchinone-A results in increased cleavage of PARP1 protein
CTD
PMID:24070160
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Ptgs1
prostaglandin-endoperoxide synthase 1
multiple interactions
ISO
yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS1 protein]
CTD
PMID:12086399
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]
CTD
PMID:12201673
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Sik3
SIK family kinase 3
multiple interactions
ISO
yakuchinone-A inhibits the reaction [Bucladesine results in increased phosphorylation of SIK3 protein]
CTD
PMID:38164184
NCBI chr 8:55,208,969...55,419,138
Ensembl chr 8:46,311,989...46,522,444
G
Tnf
tumor necrosis factor
multiple interactions
ISO
yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of TNF protein] yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF mRNA]; yakuchinone-A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]
CTD
PMID:10517978 PMID:12086399 PMID:12201673
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation
ISO
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of AKT1 protein]
CTD
PMID:38521250
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of BAX protein
CTD
PMID:38521250
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of BCL2 protein
CTD
PMID:38521250
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases cleavage multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP3 protein Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP3 protein]
CTD
PMID:38521250
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases cleavage
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP9 protein
CTD
PMID:38521250
Ensembl chr 5:154,109,046...154,126,626
G
Ccnb1
cyclin B1
increases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CCNB1 protein
CTD
PMID:38521250
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Cdc25c
cell division cycle 25C
increases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CDC25C protein
CTD
PMID:38521250
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,335,834...26,356,185
G
Cdk1
cyclin-dependent kinase 1
increases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CDK1 protein
CTD
PMID:38521250
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of CDKN1A protein
CTD
PMID:38521250
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of CDKN1B protein
CTD
PMID:38521250
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cycs
cytochrome c, somatic
increases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CYCS protein
CTD
PMID:38521250
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]
CTD
PMID:31029725
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA] 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA; 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein
CTD
PMID:31029725
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Il1b
interleukin 1 beta
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]
CTD
PMID:31029725
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions increases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA]
CTD
PMID:31029725
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased lipidation of and results in increased localization of MAP1LC3B protein; Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased lipidation of and results in increased localization of MAP1LC3B protein]
CTD
PMID:38521250
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]
CTD
PMID:31029725
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]
CTD
PMID:31029725
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased phosphorylation of MAPK8 protein 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]
CTD
PMID:31029725
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mtor
mechanistic target of rapamycin kinase
decreases phosphorylation multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of MTOR protein Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of MTOR protein]
CTD
PMID:38521250
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein]
CTD
PMID:31029725
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of and affects the stability of NFKBIA protein]
CTD
PMID:31029725
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
increases expression multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA]
CTD
PMID:31029725
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]
CTD
PMID:31029725
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of PARP1 protein]
CTD
PMID:38521250
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions decreases phosphorylation
ISO
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of PIK3R1 protein]
CTD
PMID:38521250
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Sqstm1
sequestosome 1
increases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of SQSTM1 protein
CTD
PMID:38521250
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Tnf
tumor necrosis factor
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA]
CTD
PMID:31029725
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
2-nitroanisole results in increased expression of ALDH1A1 protein
CTD
PMID:33211169
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Cd44
CD44 molecule
increases expression
EXP
2-nitroanisole results in increased expression of CD44 protein
CTD
PMID:33211169
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases metabolic processing increases oxidation increases expression
ISO EXP
CYP1A1 protein results in increased metabolism of 2-nitroanisole CYP1A1 protein results in increased oxidation of 2-nitroanisole 2-nitroanisole results in increased expression of CYP1A1
CTD
PMID:11409192 PMID:15144223 PMID:17159769 PMID:21218109
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
EXP
2-nitroanisole results in increased expression of CYP1A2; 2-nitroanisole results in increased expression of CYP1A2 protein
CTD
PMID:11409192 PMID:16601807
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases oxidation
EXP
CYP2B2 protein results in increased oxidation of 2-nitroanisole
CTD
PMID:21218109
NCBI chr 1:90,722,243...90,736,272
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases oxidation increases metabolic processing
ISO
CYP2B6 protein results in increased oxidation of 2-nitroanisole CYP2B6 protein results in increased metabolism of 2-nitroanisole
CTD
PMID:15144223 PMID:17159769 PMID:21218109
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases oxidation
EXP ISO
CYP2C6 protein results in increased oxidation of 2-nitroanisole CYP2C19 protein results in increased oxidation of 2-nitroanisole
CTD
PMID:21218109
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d2
cytochrome P450, family 2, subfamily d, polypeptide 2
increases oxidation
EXP
CYP2D2 protein results in increased oxidation of 2-nitroanisole
CTD
PMID:21218109
NCBI chr 7:115,815,212...115,819,281
Ensembl chr 7:113,935,138...113,939,209
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases metabolic processing increases oxidation
ISO EXP
CYP2E1 protein results in increased metabolism of 2-nitroanisole CYP2E1 protein results in increased oxidation of 2-nitroanisole
CTD
PMID:15144223 PMID:17159769 PMID:21218109
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
H2ax
H2A.X variant histone
increases expression
EXP
2-nitroanisole results in increased expression of H2AX protein
CTD
PMID:26338220
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Krt14
keratin 14
increases expression
EXP
2-nitroanisole results in increased expression of KRT14 protein
CTD
PMID:33211169
NCBI chr10:85,638,182...85,642,450
Ensembl chr10:85,066,802...85,171,799
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
2-nitroanisole results in increased expression of NQO1
CTD
PMID:11409192
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Xdh
xanthine dehydrogenase
increases reduction
ISO
XDH protein results in increased reduction of 2-nitroanisole
CTD
PMID:14729594
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Taar1
trace-amine-associated receptor 1
increases activity multiple interactions
ISO
3-methoxytyramine results in increased activity of TAAR1 protein [3-methoxytyramine results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:19725810
NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084
G
Vdr
vitamin D receptor
multiple interactions increases abundance
ISO
Calcitriol promotes the reaction [VDR protein results in increased abundance of 3-methoxytyramine]
CTD
PMID:27450565
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
G
Hmox1
heme oxygenase 1
increases expression
ISO
4-acetylanisole results in increased expression of HMOX1 mRNA
CTD
PMID:26244607
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Taar1
trace-amine-associated receptor 1
increases activity multiple interactions
ISO
3-hydroxy-4-methoxyphenethylamine results in increased activity of TAAR1 protein [3-hydroxy-4-methoxyphenethylamine results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:19725810
NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions increases expression
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [shogaol results in increased expression of ADIPOQ mRNA]; shogaol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein]
CTD
PMID:18577375
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
shogaol metabolite results in increased expression of AKR1B10 protein; shogaol results in increased expression of AKR1B10 mRNA; shogaol results in increased expression of AKR1B10 protein
CTD
PMID:25148906
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akt1
AKT serine/threonine kinase 1
multiple interactions affects phosphorylation
ISO
shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] shogaol affects the phosphorylation of AKT1 protein AKT activator SC79 affects the reaction [shogaol affects the phosphorylation of AKT1 protein]
CTD
PMID:18683823 PMID:36341865
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
increases expression multiple interactions affects folding
ISO
shogaol results in increased expression of BAX protein shogaol promotes the reaction [BAX protein binds to BAX protein binds to BAX protein]; shogaol promotes the reaction [BAX protein binds to BAX protein] shogaol affects the folding of BAX protein
CTD
PMID:18384088 PMID:25619640
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
shogaol results in decreased expression of BCL2 protein
CTD
PMID:18384088
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
shogaol results in decreased expression of BCL2L1 protein
CTD
PMID:18384088
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bdnf
brain-derived neurotrophic factor
multiple interactions increases expression
ISO
[shogaol co-treated with Hydrogen Peroxide] results in increased expression of BDNF mRNA; [shogaol co-treated with Hydrogen Peroxide] results in increased expression of BDNF protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BDNF mRNA] [shogaol results in increased expression of BDNF protein] which results in increased expression of CHAT protein; [shogaol results in increased expression of BDNF protein] which results in increased expression of SLC5A7 protein
CTD
PMID:22381256
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Casp3
caspase 3
multiple interactions
ISO
[shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein]; shogaol results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:18384088 PMID:25619640
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
ISO
shogaol results in increased cleavage of and results in increased activity of CASP9 protein
CTD
PMID:18384088
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
decreases expression
ISO
shogaol results in decreased expression of CAT mRNA; shogaol results in decreased expression of CAT protein
CTD
PMID:36341865
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cdh1
cadherin 1
increases expression multiple interactions
ISO
shogaol results in increased expression of CDH1 mRNA; shogaol results in increased expression of CDH1 protein ferrostatin-1 inhibits the reaction [shogaol results in increased expression of CDH1 protein]
CTD
PMID:36341865
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
G
Cdh2
cadherin 2
decreases expression affects expression
ISO
shogaol results in decreased expression of CDH2 protein shogaol affects the expression of CDH2 mRNA
CTD
PMID:36341865
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:7,776,704...7,990,167
G
Cflar
CASP8 and FADD-like apoptosis regulator
multiple interactions decreases expression
ISO
Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [shogaol results in decreased expression of CFLAR protein modified form]; CFLAR protein modified form inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; shogaol promotes the reaction [Cycloheximide results in decreased expression of CFLAR protein modified form]; shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]
CTD
PMID:25619640
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
G
Chat
choline O-acetyltransferase
multiple interactions increases expression
ISO
[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of CHAT protein]; staurosporine aglycone inhibits the reaction [[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein] [shogaol results in increased expression of BDNF protein] which results in increased expression of CHAT protein; shogaol results in increased expression of CHAT protein
CTD
PMID:22381256
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,657,362...7,717,093
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased expression of CHUK protein]
CTD
PMID:23899529
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
G
Ctnnb1
catenin beta 1
decreases expression
ISO
shogaol results in decreased expression of CTNNB1 mRNA; shogaol results in decreased expression of CTNNB1 protein
CTD
PMID:27645308
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [shogaol results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [shogaol results in increased expression of DDIT3 protein] shogaol results in increased expression of DDIT3 mRNA; shogaol results in increased expression of DDIT3 protein
CTD
PMID:18384088
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Dffa
DNA fragmentation factor subunit alpha
increases degradation
ISO
shogaol results in increased degradation of DFFA protein
CTD
PMID:18384088
NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:159,540,715...159,553,633
G
Fabp4
fatty acid binding protein 4
multiple interactions increases expression
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [shogaol results in increased expression of FABP4 mRNA]
CTD
PMID:18577375
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578
G
Fas
Fas cell surface death receptor
increases expression
ISO
shogaol results in increased expression of FAS protein
CTD
PMID:18384088
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
increases expression
ISO
shogaol results in increased expression of FASLG protein
CTD
PMID:18384088
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Flt1
Fms related receptor tyrosine kinase 1
decreases expression
ISO
shogaol results in decreased expression of FLT1 protein
CTD
PMID:36341865
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
G
Ftl1
ferritin light chain 1
increases expression
ISO
shogaol metabolite results in increased expression of FTL protein; shogaol results in increased expression of FTL mRNA; shogaol results in increased expression of FTL protein
CTD
PMID:25148906
NCBI chr 1:105,072,858...105,074,705
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions
ISO
shogaol metabolite results in increased expression of GCLC protein; shogaol results in increased expression of GCLC protein shogaol results in increased expression of GCLC mRNA NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of GCLC mRNA]
CTD
PMID:25148906
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
shogaol metabolite results in increased expression of GCLM protein; shogaol results in increased expression of GCLM protein
CTD
PMID:25148906
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gdf15
growth differentiation factor 15
increases expression
ISO
shogaol results in increased expression of GDF15 mRNA
CTD
PMID:25148906
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Gpx4
glutathione peroxidase 4
decreases expression multiple interactions
ISO
shogaol results in decreased expression of GPX4 mRNA; shogaol results in decreased expression of GPX4 protein ferrostatin-1 inhibits the reaction [shogaol results in decreased expression of GPX4 protein]
CTD
PMID:36341865
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:9,650,185...9,652,982
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions
ISO
shogaol results in increased expression of and results in increased phosphorylation of GSK3B protein
CTD
PMID:27645308
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
H2ax
H2A.X variant histone
multiple interactions
ISO
shogaol analog inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AX protein]
CTD
PMID:23899529
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite results in increased expression of HMOX1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol results in increased expression of HMOX1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite results in increased expression of HMOX1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol results in increased expression of HMOX1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite results in increased expression of HMOX1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol results in increased expression of HMOX1 protein] shogaol analog results in increased expression of HMOX1 protein; shogaol results in increased expression of HMOX1 protein KEAP1 protein affects the reaction [shogaol analog results in increased expression of HMOX1 protein]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of HMOX1 protein] shogaol analog results in increased expression of HMOX1 protein; shogaol metabolite results in increased expression of HMOX1 protein; shogaol results in increased expression of HMOX1 mRNA; shogaol results in increased expression of HMOX1 protein
CTD
PMID:23899529 PMID:25148906 PMID:36341865
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased expression of IKBKB protein]
CTD
PMID:23899529
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il1b
interleukin 1 beta
multiple interactions
ISO
shogaol inhibits the reaction [IL1B protein results in increased expression of PTGES protein]
CTD
PMID:27645308
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions increases alkylation decreases expression
ISO
KEAP1 protein affects the reaction [shogaol analog results in increased expression of HMOX1 protein]; KEAP1 protein affects the reaction [shogaol analog results in increased expression of NFE2L2 protein]; KEAP1 protein affects the reaction [shogaol analog results in increased expression of NQO1 protein] shogaol results in increased alkylation of KEAP1 protein shogaol metabolite results in decreased expression of KEAP1 protein; shogaol results in decreased expression of KEAP1 protein
CTD
PMID:23899529 PMID:25148906
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases phosphorylation
ISO
shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] shogaol results in decreased phosphorylation of MAPK1 protein
CTD
PMID:18683823 PMID:36341865
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation
ISO
shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] shogaol results in decreased phosphorylation of MAPK3 protein
CTD
PMID:18683823 PMID:36341865
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mmp2
matrix metallopeptidase 2
affects expression multiple interactions decreases expression
ISO
shogaol affects the expression of MMP2 mRNA AKT activator SC79 inhibits the reaction [shogaol results in decreased expression of MMP2 protein]
CTD
PMID:36341865
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression
ISO
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]; shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] shogaol results in decreased expression of MMP9 mRNA; shogaol results in decreased expression of MMP9 protein
CTD
PMID:23899529 PMID:36341865
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mt1
metallothionein 1
multiple interactions increases expression
ISO
NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 mRNA]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 protein] shogaol results in increased expression of MT1 mRNA; shogaol results in increased expression of MT1 protein
CTD
PMID:25148906
NCBI chr19:10,831,959...10,832,975
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression affects localization multiple interactions
ISO
shogaol analog results in increased expression of NFE2L2 protein shogaol affects the localization of NFE2L2 protein KEAP1 protein affects the reaction [shogaol analog results in increased expression of NFE2L2 protein]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of GCLC mRNA]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of HMOX1 protein]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 mRNA]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 protein] shogaol affects the localization of NFE2L2 protein; shogaol metabolite affects the localization of NFE2L2 protein; shogaol metabolite affects the localization of NFE2L2 protein modified form 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein]; shogaol metabolite results in increased expression of and results in increased phosphorylation of NFE2L2 protein; shogaol results in increased expression of and results in increased phosphorylation of NFE2L2 protein
CTD
PMID:23899529 PMID:25148906
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
shogaol inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; shogaol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:18683823
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased expression of NFKBIA protein] shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:18683823 PMID:23899529
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; shogaol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]
CTD
PMID:18683823 PMID:23899529
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions increases expression
ISO
KEAP1 protein affects the reaction [shogaol analog results in increased expression of NQO1 protein]
CTD
PMID:23899529
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; CFLAR protein modified form inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]
CTD
PMID:18384088 PMID:25619640
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pparg
peroxisome proliferator-activated receptor gamma
increases activity
ISO
shogaol results in increased activity of PPARG protein
CTD
PMID:18577375
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ptges
prostaglandin E synthase
multiple interactions decreases expression
ISO
shogaol inhibits the reaction [IL1B protein results in increased expression of PTGES protein] shogaol results in decreased expression of PTGES mRNA
CTD
PMID:27645308
NCBI chr 3:34,575,643...34,586,987
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; shogaol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]
CTD
PMID:18683823 PMID:23899529
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
shogaol inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; shogaol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein] shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RELA protein]
CTD
PMID:18683823 PMID:23899529
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Slc5a7
solute carrier family 5 member 7
multiple interactions increases expression
ISO
[shogaol co-treated with Hydrogen Peroxide] results in increased expression of SLC5A7 protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC5A7 protein]; staurosporine aglycone inhibits the reaction [[shogaol co-treated with Hydrogen Peroxide] results in increased expression of SLC5A7 protein] [shogaol results in increased expression of BDNF protein] which results in increased expression of SLC5A7 protein; shogaol results in increased expression of SLC5A7 protein
CTD
PMID:22381256
NCBI chr 9:7,922,693...7,953,509
Ensembl chr 9:7,595,444...7,626,258
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
shogaol results in decreased expression of SLC7A11 mRNA; shogaol results in decreased expression of SLC7A11 protein
CTD
PMID:36341865
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Sod2
superoxide dismutase 2
decreases expression
ISO
shogaol results in decreased expression of SOD2 mRNA; shogaol results in decreased expression of SOD2 protein
CTD
PMID:36341865
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Tnf
tumor necrosis factor
multiple interactions
ISO
shogaol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein]
CTD
PMID:18577375
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
multiple interactions increases response to substance
ISO
[shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; CFLAR protein modified form inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]; shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] shogaol results in increased susceptibility to TNFSF10 protein
CTD
PMID:25619640
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
G
Vim
vimentin
decreases expression multiple interactions
ISO
shogaol results in decreased expression of VIM mRNA; shogaol results in decreased expression of VIM protein ferrostatin-1 inhibits the reaction [shogaol results in decreased expression of VIM protein]
CTD
PMID:36341865
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects response to substance
EXP
ABCB1 protein affects the susceptibility to aliskiren
CTD
PMID:24388840
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Agt
angiotensinogen
multiple interactions decreases expression
EXP ISO
aliskiren inhibits the reaction [Indomethacin results in increased expression of AGT protein] aliskiren inhibits the reaction [microcystin RR results in increased expression of AGT protein] aliskiren results in decreased expression of AGT protein modified form
CTD
PMID:18829990 PMID:27645307 PMID:28330766
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
multiple interactions
EXP
[Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of CAMK2D protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of CAMK2D protein]
CTD
PMID:26982530
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:215,024,004...215,286,178
G
Casp3
caspase 3
multiple interactions
EXP
[Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]
CTD
PMID:26982530
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Ckm
creatine kinase, M-type
multiple interactions
EXP
[Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of CKM protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of CKM protein]
CTD
PMID:26982530
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
ISO
aliskiren results in decreased activity of CYP1A1 protein
CTD
PMID:33814510
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Il1b
interleukin 1 beta
multiple interactions
EXP
aliskiren inhibits the reaction [Indomethacin results in increased expression of IL1B mRNA]
CTD
PMID:27645307
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Ptgs1
prostaglandin-endoperoxide synthase 1
multiple interactions
EXP
aliskiren inhibits the reaction [Indomethacin results in increased expression of PTGS1 mRNA]
CTD
PMID:27645307
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
aliskiren inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA]
CTD
PMID:27645307
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ren
renin
multiple interactions decreases activity
ISO EXP
[aliskiren co-treated with Atenolol] results in decreased activity of REN protein [aliskiren co-treated with Carvedilol] inhibits the reaction [Isoproterenol results in increased activity of REN protein]; aliskiren inhibits the reaction [Indomethacin results in increased expression of REN protein]; aliskiren inhibits the reaction [Isoproterenol results in increased activity of REN protein] aliskiren results in decreased activity of REN protein
CTD
PMID:18957387 PMID:26982530 PMID:27645307
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
Tnf
tumor necrosis factor
multiple interactions
EXP
aliskiren inhibits the reaction [Indomethacin results in increased expression of TNF mRNA]
CTD
PMID:27645307
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
anethole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
CTD
PMID:29191726
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation
ISO
anethole results in decreased phosphorylation of AKT1 protein
CTD
PMID:21212515
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of BAX mRNA]
CTD
PMID:35430261 PMID:39029857
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of BCL2 mRNA]
CTD
PMID:35430261 PMID:39029857
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP3 protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein]; anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP9 protein]
CTD
PMID:35430261 PMID:39029857
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; anethole inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cst3
cystatin C
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of CST3 protein]
CTD
PMID:39029857
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
anethole inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD
PMID:29191726
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Esr1
estrogen receptor 1
affects binding multiple interactions
ISO EXP
anethole metabolite binds to ESR1 protein anethole analog binds to ESR1 protein anethole metabolite inhibits the reaction [Estradiol binds to ESR1 protein]
CTD
PMID:12818366 PMID:27420082
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Ggt1
gamma-glutamyltransferase 1
decreases activity
EXP
anethole analog results in decreased activity of GGT1 protein
CTD
PMID:20171274
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442
G
Gsta2
glutathione S-transferase alpha 2
increases expression
EXP
anethole results in increased expression of GSTA2 protein
CTD
PMID:8406240
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798
G
Havcr1
hepatitis A virus cellular receptor 1
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of HAVCR1 protein]
CTD
PMID:39029857
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
anethole promotes the reaction [Isoproterenol results in increased expression of HMOX1 mRNA]; anethole promotes the reaction [Isoproterenol results in increased expression of HMOX1 protein]
CTD
PMID:35430261
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
decreases activity
ISO
anethole results in decreased activity of IKBKB protein
CTD
PMID:10871845
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il1b
interleukin 1 beta
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
multiple interactions
ISO
anethole inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; anethole inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein]
CTD
PMID:16531003
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of IL6 protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
EXP
anethole inhibits the reaction [Isoproterenol results in increased expression of KEAP1 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of KEAP1 protein]
CTD
PMID:35430261
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Lcn2
lipocalin 2
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of LCN2 protein]
CTD
PMID:39029857
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
anethole inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein]
CTD
PMID:10871845
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
anethole results in decreased phosphorylation of MAPK1 protein
CTD
PMID:21212515
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
ISO
anethole results in decreased phosphorylation of MAPK3 protein
CTD
PMID:21212515
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
anethole inhibits the reaction [TNF protein results in increased activity of MAPK8 protein]
CTD
PMID:10871845
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mmp2
matrix metallopeptidase 2
decreases expression decreases activity
ISO
anethole results in decreased expression of MMP2 mRNA anethole results in decreased activity of MMP2 protein
CTD
PMID:21212515
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
decreases activity decreases expression
ISO
anethole results in decreased activity of MMP9 protein anethole results in decreased expression of MMP9 mRNA
CTD
PMID:21212515
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of MYD88 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of MYD88 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of MYD88 protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 mRNA]; anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 protein]
CTD
PMID:35430261
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO EXP
anethole inhibits the reaction [Ceramides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Hydrogen Peroxide results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] anethole inhibits the reaction [Doxorubicin results in increased expression of NFKB1 mRNA]
CTD
PMID:10871845 PMID:39029857
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions decreases degradation
ISO
anethole inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; anethole inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] anethole results in decreased degradation of NFKBIA protein
CTD
PMID:10871845 PMID:21212515
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
anethole inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein]
CTD
PMID:10871845
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Plau
plasminogen activator, urokinase
decreases expression
ISO
anethole results in decreased expression of PLAU mRNA
CTD
PMID:21212515
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO EXP
anethole inhibits the reaction [Ceramides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Hydrogen Peroxide results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] anethole inhibits the reaction [Isoproterenol results in increased expression of RELA protein]
CTD
PMID:10871845 PMID:35430261
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
anethole results in increased expression of TIMP1 mRNA
CTD
PMID:21212515
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Tlr4
toll-like receptor 4
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of TLR4 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of TLR4 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of TLR4 protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein]; anethole inhibits the reaction [TNF protein results in increased activity of MAPK8 protein]; anethole inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein]; anethole inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; anethole inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] anethole inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of TNF protein]
CTD
PMID:10871845 PMID:35430261 PMID:39029857
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnni3
troponin I3, cardiac type
multiple interactions
EXP
anethole inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]
CTD
PMID:35430261
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
G
Casp8
caspase 8
increases activity
ISO
BI 2536 results in increased activity of CASP8 protein
CTD
PMID:24403256
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Notch1
notch receptor 1
multiple interactions
ISO
BI 2536 inhibits the reaction [Arsenic Trioxide results in decreased expression of NOTCH1 protein]; BI 2536 inhibits the reaction [Nocodazole results in decreased expression of NOTCH1 protein]
CTD
PMID:31597699
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Plk1
polo-like kinase 1
decreases activity multiple interactions
ISO
BI 2536 results in decreased activity of PLK1 protein BI 2536 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of PLK1 protein]
CTD
PMID:24748653 PMID:31597699
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:176,716,420...176,726,400
G
Cd69
Cd69 molecule
decreases localization
ISO
capsiate analog results in decreased localization of CD69 protein
CTD
PMID:12115659
NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:162,725,446...162,733,542
G
Icam1
intercellular adhesion molecule 1
decreases localization
ISO
capsiate analog results in decreased localization of ICAM1 protein
CTD
PMID:12115659
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Igf1
insulin-like growth factor 1
increases expression
ISO
capsiate results in increased expression of IGF1 protein
CTD
PMID:17307377
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
multiple interactions
ISO
capsiate analog inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased activity of IKBKG protein]
CTD
PMID:12115659
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:152,216,596...152,239,499
G
Il2ra
interleukin 2 receptor subunit alpha
decreases localization
ISO
capsiate analog results in decreased localization of IL2RA protein
CTD
PMID:12115659
NCBI chr17:71,759,802...71,808,475
Ensembl chr17:66,849,974...66,898,697
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
capsiate analog inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased degradation of NFKBIA protein]
CTD
PMID:12115659
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Ucp3
uncoupling protein 3
decreases expression
EXP
capsiate results in decreased expression of UCP3 mRNA
CTD
PMID:17264228
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:154,815,777...154,828,762
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
ISO
coniferaldehyde results in increased expression of ABCC2 mRNA
CTD
PMID:26275128
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression
ISO
coniferaldehyde results in increased expression of ABCC3 mRNA
CTD
PMID:26275128
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
G
Akr1c1
aldo-keto reductase family 1, member C1
multiple interactions increases expression
ISO
NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of AKR1C1 protein] coniferaldehyde results in increased expression of AKR1C1 mRNA; coniferaldehyde results in increased expression of AKR1C1 protein
CTD
PMID:26275128
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
coniferaldehyde results in increased expression of AKR1C2 mRNA; coniferaldehyde results in increased expression of AKR1C2 protein
CTD
PMID:26275128
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
coniferaldehyde results in increased expression of AKR1C3 mRNA
CTD
PMID:26275128
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
coniferaldehyde results in increased expression of GCLC mRNA
CTD
PMID:26275128
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
coniferaldehyde results in increased expression of GCLM mRNA
CTD
PMID:26275128
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
coniferaldehyde results in increased expression of GSR mRNA coniferaldehyde results in increased expression of GSR protein
CTD
PMID:26275128
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; MAPK14 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; Ro 31-8220 inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] coniferaldehyde results in increased expression of HMOX1 mRNA; coniferaldehyde results in increased expression of HMOX1 protein
CTD
PMID:26275128
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Ifng
interferon gamma
multiple interactions
ISO
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein]
CTD
PMID:27378624
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Jak2
Janus kinase 2
multiple interactions
ISO
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of JAK2 protein]
CTD
PMID:27378624
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
ISO
MAPK14 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPK14 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]
CTD
PMID:26275128
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapkapk2
MAPK activated protein kinase 2
multiple interactions
ISO
MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]
CTD
PMID:26275128
NCBI chr13:45,066,027...45,112,326
Ensembl chr13:42,513,762...42,560,457
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
increases expression multiple interactions
ISO
coniferaldehyde results in increased expression of MUC5AC mRNA 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA]; A 967079 inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA]; coniferaldehyde results in increased expression of and results in increased secretion of MUC5AC protein; TWS 119 inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA]
CTD
PMID:31944254
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions increases expression
ISO
coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein; MAPK14 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of AKR1C1 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein] coniferaldehyde results in increased expression of NFE2L2 protein
CTD
PMID:26275128
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]
CTD
PMID:27378624
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
coniferaldehyde results in increased expression of NQO1 protein
CTD
PMID:26275128
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Pkn3
protein kinase N3
multiple interactions
ISO
PKN3 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]
CTD
PMID:26275128
NCBI chr 3:33,747,610...33,761,405
Ensembl chr 3:13,335,041...13,363,567
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of STAT1 protein modified form]; coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of STAT1 protein]
CTD
PMID:27378624
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Tnf
tumor necrosis factor
multiple interactions
ISO
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein]
CTD
PMID:27378624
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
increases activity
ISO
coniferaldehyde results in increased activity of TRPA1 protein
CTD
PMID:23541125
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:4,379,999...4,433,570
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
coniferaldehyde results in increased expression of TXNRD1 mRNA
CTD
PMID:26275128
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Ednra
endothelin receptor type A
multiple interactions
ISO
enrasentan binds to and results in decreased activity of EDNRA protein
CTD
PMID:16219361
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049
G
Ednrb
endothelin receptor type B
multiple interactions
ISO
enrasentan binds to and results in decreased activity of EDNRB protein
CTD
PMID:16219361
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
estragole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
CTD
PMID:29191726
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Casp3
caspase 3
increases expression
EXP
estragole results in increased expression of CASP3 protein modified form
CTD
PMID:29054680
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Ccna2
cyclin A2
increases expression
EXP
estragole results in increased expression of CCNA2 mRNA
CTD
PMID:29054680
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
increases expression multiple interactions
EXP ISO
estragole results in increased expression of CCNB1 mRNA flumequine promotes the reaction [estragole results in increased expression of CCNB1 mRNA]
CTD
PMID:29054680 PMID:31029721
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
increases expression
EXP
estragole results in increased expression of CCND1 protein
CTD
PMID:29054680
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
increases expression multiple interactions
EXP ISO
estragole results in increased expression of CCNE1 mRNA [flumequine co-treated with estragole] results in increased expression of CCNE1 mRNA
CTD
PMID:29054680 PMID:31029721
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Chek1
checkpoint kinase 1
increases expression
EXP
estragole results in increased expression of CHEK1 protein
CTD
PMID:29054680
NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:36,420,569...36,441,009
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
estragole inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD
PMID:29191726
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases hydroxylation increases response to substance multiple interactions increases expression
ISO
CYP1A2 protein results in increased hydroxylation of estragole CYP1A2 protein results in increased susceptibility to estragole [flumequine co-treated with estragole] results in increased expression of CYP1A2 mRNA estragole results in increased expression of CYP1A2 mRNA
CTD
PMID:19920071 PMID:31029721 PMID:32853702
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases hydroxylation
ISO
CYP2E1 protein results in increased hydroxylation of estragole
CTD
PMID:19920071
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Gsk3b
glycogen synthase kinase 3 beta
increases phosphorylation
EXP
estragole results in increased phosphorylation of GSK3B protein
CTD
PMID:29054680
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
H2ax
H2A.X variant histone
increases expression
EXP
estragole results in increased expression of H2AX protein modified form
CTD
PMID:29054680
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
EXP
estragole results in increased phosphorylation of MAPK1 protein
CTD
PMID:29054680
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
EXP
estragole results in increased phosphorylation of MAPK3 protein
CTD
PMID:29054680
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
EXP
estragole results in increased phosphorylation of MAPK8 protein
CTD
PMID:29054680
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
EXP
estragole results in increased phosphorylation of MAPK9 protein
CTD
PMID:29054680
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
G
Pcna
proliferating cell nuclear antigen
increases expression
EXP
estragole results in increased expression of PCNA protein
CTD
PMID:22576464 PMID:29054680
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
increases phosphorylation
EXP
estragole results in increased phosphorylation of PPP2CA protein
CTD
PMID:29054680
NCBI chr10:36,856,534...36,878,789
Ensembl chr10:36,358,101...36,377,862
G
Rad51
RAD51 recombinase
increases expression
EXP
estragole results in increased expression of RAD51 protein
CTD
PMID:29054680
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:106,100,381...106,125,035
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
increases phosphorylation
EXP
estragole results in increased phosphorylation of SRC protein
CTD
PMID:29054680
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[flumequine co-treated with estragole] results in increased expression of TNF mRNA
CTD
PMID:31029721
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
increases phosphorylation
EXP
estragole results in increased phosphorylation of TP53 protein
CTD
PMID:29054680
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
ISO
[flumequine co-treated with estragole] results in decreased expression of UGT1A1 mRNA
CTD
PMID:31029721
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Or5d18
olfactory receptor family 5 subfamily D member 18
multiple interactions
ISO
[ethyl vanillin binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; ethyl vanillin binds to and results in increased activity of OR5D18 protein
CTD
PMID:15716417
NCBI chr 3:93,972,754...93,973,695
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
ISO
ethyl vanillin results in increased activity of TRPV3 protein
CTD
PMID:16617338
NCBI chr10:58,382,054...58,413,657
Ensembl chr10:57,883,546...57,913,296
G
Abca6
ATP binding cassette subfamily A member 6
decreases expression
ISO
Eugenol results in decreased expression of ABCA6 mRNA
CTD
PMID:17374397
NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,142,966...95,211,530
G
Ache
acetylcholinesterase
multiple interactions
EXP
Eugenol inhibits the reaction [Chlorpyrifos results in decreased expression of ACHE protein]
CTD
PMID:32096903
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Ahr
aryl hydrocarbon receptor
multiple interactions increases activity affects localization
ISO
[Eugenol co-treated with acetyleugenol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [Eugenol co-treated with acetyleugenol] results in increased activity of AHR protein; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein]; Eugenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] Eugenol results in increased activity of AHR protein Eugenol affects the localization of AHR protein
CTD
PMID:17275817 PMID:22686307 PMID:29191726
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Ahrr
aryl-hydrocarbon receptor repressor
increases expression
ISO
Eugenol results in increased expression of AHRR mRNA
CTD
PMID:22686307
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:28,993,634...29,088,673
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
ISO
Eugenol results in increased expression of AKR1B1 mRNA
CTD
PMID:20566472
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Eugenol results in increased expression of AKR1B10 mRNA
CTD
PMID:20566472 PMID:26198647 PMID:30806763
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
Eugenol results in increased expression of AKR1C1 mRNA
CTD
PMID:20566472
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
Eugenol results in increased expression of AKR1C2 mRNA
CTD
PMID:26198647
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
Eugenol results in increased expression of AKR1C3 mRNA
CTD
PMID:20566472
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
G
Alb
albumin
multiple interactions
EXP
Eugenol inhibits the reaction [Streptozocin results in decreased expression of ALB protein]
CTD
PMID:38047382
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Alpl
alkaline phosphatase, biomineralization associated
increases expression
ISO
Eugenol results in increased expression of ALPL mRNA
CTD
PMID:22083529
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446
G
Apaf1
apoptotic peptidase activating factor 1
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of APAF1 protein]
CTD
PMID:20434464
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Ar
androgen receptor
multiple interactions
ISO
Eugenol binds to and results in decreased activity of AR protein
CTD
PMID:20226658
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Arhgap17
Rho GTPase activating protein 17
decreases expression
ISO
Eugenol results in decreased expression of ARHGAP17 mRNA
CTD
PMID:17374397
NCBI chr 1:187,238,675...187,328,093
Ensembl chr 1:177,807,583...177,896,854
G
Arl4c
ARF like GTPase 4C
increases expression
ISO
Eugenol results in increased expression of ARL4C mRNA
CTD
PMID:17374397
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
G
Atf3
activating transcription factor 3
increases expression
ISO
Eugenol results in increased expression of ATF3 mRNA
CTD
PMID:23999411
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
B2m
beta-2 microglobulin
increases expression
ISO
Eugenol results in increased expression of B2M mRNA
CTD
PMID:17936526
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:109,095,729...109,101,766
G
Bad
BCL2-associated agonist of cell death
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA]
CTD
PMID:20434464
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein] Eugenol results in increased expression of BAX mRNA
CTD
PMID:20434464 PMID:20537511
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of BCL2; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of BCL2 Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein] Eugenol results in decreased expression of BCL2 mRNA
CTD
PMID:20434464 PMID:20537511 PMID:21382956 PMID:21939359
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA]
CTD
PMID:20434464
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bclaf1
BCL2-associated transcription factor 1
decreases expression
ISO
Eugenol results in decreased expression of BCLAF1 mRNA
CTD
PMID:17374397
NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:15,070,894...15,148,832
G
Bdnf
brain-derived neurotrophic factor
increases expression
ISO
Eugenol results in increased expression of BDNF mRNA
CTD
PMID:15157811
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bid
BH3 interacting domain death agonist
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA]
CTD
PMID:20434464
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
G
Bmp6
bone morphogenetic protein 6
increases expression
ISO
Eugenol results in increased expression of BMP6 mRNA
CTD
PMID:17374397
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,318,569...26,470,365
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
ISO
Eugenol results in decreased expression of BUB1 mRNA
CTD
PMID:17374397
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:115,020,254...115,051,650
G
Calcrl
calcitonin receptor like receptor
increases expression
ISO
Eugenol results in increased expression of CALCRL mRNA
CTD
PMID:17374397
NCBI chr 3:89,835,071...89,932,616
Ensembl chr 3:69,430,120...69,525,910
G
Casp3
caspase 3
multiple interactions increases expression increases activity increases cleavage
ISO EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein] Eugenol results in increased expression of CASP3 mRNA Eugenol results in increased activity of CASP3 protein Eugenol inhibits the reaction [Chlorpyrifos results in increased expression of CASP3 protein]; Eugenol inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein] Eugenol results in increased expression of CASP3 protein modified form Eugenol results in increased cleavage of CASP3 protein
CTD
PMID:20434464 PMID:20537511 PMID:21656368 PMID:25455450 PMID:30518369 PMID:32096903 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases expression
ISO
Eugenol results in increased expression of CASP7 mRNA
CTD
PMID:30518369
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
multiple interactions increases expression increases activity
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] Eugenol results in increased expression of CASP9 mRNA Eugenol results in increased activity of CASP9 protein
CTD
PMID:20434464 PMID:25455450 PMID:30518369
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases expression decreases activity multiple interactions
ISO EXP
Eugenol results in increased expression of CAT mRNA Eugenol results in decreased activity of CAT protein Eugenol inhibits the reaction [Acetic Acid results in increased activity of CAT protein]; Eugenol inhibits the reaction [Chlorpyrifos results in decreased expression of CAT protein] CAT protein inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]
CTD
PMID:15576237 PMID:20566472 PMID:32096903 PMID:33245926 PMID:36007673
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl12
C-C motif chemokine ligand 12
increases expression
ISO
Eugenol results in increased expression of CCL13 mRNA
CTD
PMID:17936526
NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,070,230...67,071,780
G
Ccl19
C-C motif chemokine ligand 19
increases expression
ISO
Eugenol results in increased expression of CCL19 mRNA
CTD
PMID:17936526
NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:56,963,364...56,965,308
G
Ccl2
C-C motif chemokine ligand 2
increases expression increases secretion decreases expression
ISO
Eugenol results in increased expression of CCL2 mRNA Eugenol results in increased secretion of CCL2 protein Eugenol results in decreased expression of CCL2 mRNA
CTD
PMID:15585374 PMID:17374397 PMID:17936526 PMID:22245253
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
Eugenol results in increased expression of CCL20 mRNA
CTD
PMID:30806763
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
G
Ccl3
C-C motif chemokine ligand 3
increases expression increases secretion
ISO
Eugenol results in increased expression of CCL3 mRNA Eugenol results in increased secretion of CCL3 protein
CTD
PMID:15585374 PMID:23624239
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression increases secretion
ISO
Eugenol results in increased expression of CCL4 mRNA; Eugenol results in increased expression of CCL4 protein Eugenol results in increased secretion of CCL4 protein
CTD
PMID:15585374 PMID:18353026 PMID:30806763
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231
G
Ccnb1
cyclin B1
multiple interactions
EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCNB1 mRNA]
CTD
PMID:19851710
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
multiple interactions
EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA]
CTD
PMID:19851710
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccr2
C-C motif chemokine receptor 2
decreases expression
ISO
Eugenol results in decreased expression of CCR2 mRNA
CTD
PMID:17374397
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
increases expression
ISO
Eugenol results in increased expression of CCR5 mRNA
CTD
PMID:17936526 PMID:20713136
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Ccr7
C-C motif chemokine receptor 7
increases expression
ISO
Eugenol results in increased expression of CCR7 mRNA
CTD
PMID:17374397
NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,097,381...84,108,309
G
Cd24
CD24 molecule
decreases expression
ISO
Eugenol results in decreased expression of CD24 protein
CTD
PMID:31926151
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:47,073,512...47,079,662
G
Cd274
CD274 molecule
increases expression
ISO
Eugenol results in increased expression of CD274 protein
CTD
PMID:23624239
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:227,116,649...227,134,450
G
Cd36
CD36 molecule
decreases expression
ISO
Eugenol results in decreased expression of CD36 mRNA
CTD
PMID:17374397
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd44
CD44 molecule
decreases expression
ISO
Eugenol results in decreased expression of CD44 protein
CTD
PMID:31926151
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
G
Cd86
CD86 molecule
multiple interactions increases expression
ISO
[Dicumarol results in decreased activity of NQO1 protein] inhibits the reaction [Eugenol results in increased expression of CD86 protein]
CTD
PMID:12423654 PMID:20488241 PMID:21742781 PMID:23624239 PMID:30806763
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
Eugenol results in decreased expression of CDK6 protein
CTD
PMID:22686307
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO EXP
Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein]
CTD
PMID:19851710 PMID:20043298
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
Eugenol results in increased expression of CDKN1B protein
CTD
PMID:22686307
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cish
cytokine inducible SH2-containing protein
decreases expression
ISO
Eugenol results in decreased expression of CISH mRNA
CTD
PMID:15618236
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Clec4a3
C-type lectin domain family 4, member A3
decreases expression
ISO
Eugenol results in decreased expression of CLEC4A protein
CTD
PMID:23624239
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
G
Creb1
cAMP responsive element binding protein 1
affects expression
ISO
Eugenol affects the expression of CREB1 mRNA
CTD
PMID:20385217
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crem
cAMP responsive element modulator
increases expression
ISO
Eugenol results in increased expression of CREM mRNA
CTD
PMID:17374397
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:54,239,030...54,305,989
G
Ctnnb1
catenin beta 1
multiple interactions decreases expression
ISO
Eugenol results in decreased expression of and affects the phosphorylation of and affects the localization of CTNNB1 protein Eugenol results in decreased expression of CTNNB1 mRNA
CTD
PMID:31926151
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ctsl
cathepsin L
increases expression
ISO
Eugenol results in increased expression of CTSL mRNA
CTD
PMID:17374397
NCBI chr17:770,104...776,266
Ensembl chr17:764,309...770,548
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
ISO
Eugenol results in increased expression of CXCL1 mRNA
CTD
PMID:20713136
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression multiple interactions
ISO
Eugenol results in increased expression of CXCL1 mRNA Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA]
CTD
PMID:12963494 PMID:20713136
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
Eugenol results in increased expression of CXCR4 mRNA
CTD
PMID:20713136
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
G
Cycs
cytochrome c, somatic
multiple interactions
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS protein]
CTD
PMID:20434464
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression decreases expression decreases activity
ISO
[CYP1A1 protein co-treated with Copper] results in increased activity of Eugenol; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Eugenol inhibits the reaction [CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; Eugenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Eugenol results in increased expression of CYP1A1 mRNA Eugenol results in decreased expression of CYP1A1 mRNA Eugenol results in decreased activity of CYP1A1 protein
CTD
PMID:15576237 PMID:17275817 PMID:20713136 PMID:22686307 PMID:29191726
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol
CTD
PMID:15576237
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions decreases activity
ISO
Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Eugenol inhibits the reaction [CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene] Eugenol results in decreased activity of CYP1B1 protein
CTD
PMID:17275817
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
Eugenol results in decreased expression of CYP27A1 mRNA
CTD
PMID:20713136
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions increases metabolic processing
ISO
[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol; [CYP2D6 protein results in increased metabolism of Eugenol] which results in increased abundance of 2-hydroxychavicol; [Eugenol co-treated with Copper co-treated with CYP2D6 protein] results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine; bathocuproine inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]; CAT protein inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]; methional inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]
CTD
PMID:15576237
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP ISO
Eugenol inhibits the reaction [Thioacetamide results in increased expression of CYP2E1 protein] [CYP2E1 protein co-treated with Copper] results in increased activity of Eugenol
CTD
PMID:15576237 PMID:20036707
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Dkc1
dyskerin pseudouridine synthase 1
decreases expression
ISO
Eugenol results in decreased expression of DKC1 mRNA
CTD
PMID:17374397
NCBI chr X:157,751,651...157,757,796
G
Dlgap5
DLG associated protein 5
decreases expression
ISO
Eugenol results in decreased expression of DLGAP5 mRNA
CTD
PMID:17374397
NCBI chr15:23,113,678...23,144,281
Ensembl chr15:20,633,966...20,664,518
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
Eugenol results in increased expression of DNAJB4 mRNA
CTD
PMID:23999411 PMID:27965148
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:241,130,340...241,159,089
G
Dnase2
deoxyribonuclease 2, lysosomal
increases expression
ISO
Eugenol results in increased expression of DNASE2A mRNA
CTD
PMID:15618236
NCBI chr19:40,149,505...40,152,225
Ensembl chr19:23,244,664...23,247,376
G
Drd1
dopamine receptor D1
multiple interactions
EXP
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine binds to and results in increased activity of DRD1 protein] which results in increased susceptibility to Eugenol
CTD
PMID:9537685
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Eugenol results in increased expression of DUSP1 mRNA
CTD
PMID:30806763
NCBI chr10:17,184,853...17,187,646
G
E2f1
E2F transcription factor 1
decreases expression
ISO
Eugenol results in decreased expression of E2F1 mRNA; Eugenol results in decreased expression of E2F1 protein
CTD
PMID:15574415
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
E2f2
E2F transcription factor 2
decreases expression
ISO
Eugenol results in decreased expression of E2F2 mRNA; Eugenol results in decreased expression of E2F2 protein
CTD
PMID:15574415
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:148,399,642...148,421,217
G
E2f3
E2F transcription factor 3
decreases expression
ISO
Eugenol results in decreased expression of E2F3 mRNA; Eugenol results in decreased expression of E2F3 protein
CTD
PMID:15574415
NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,601,830...34,676,253
G
E2f4
E2F transcription factor 4
decreases expression
ISO
Eugenol results in decreased expression of E2F4 mRNA
CTD
PMID:15574415
NCBI chr19:50,084,335...50,091,731
Ensembl chr19:33,174,410...33,181,806
G
E2f5
E2F transcription factor 5
decreases expression
ISO
Eugenol results in decreased expression of E2F5 mRNA
CTD
PMID:15574415
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
G
E2f6
E2F transcription factor 6
increases expression
ISO
Eugenol results in increased expression of E2F6 mRNA
CTD
PMID:15574415
NCBI chr 6:39,592,224...39,608,685
Ensembl chr 6:39,592,228...39,608,683
G
Egfr
epidermal growth factor receptor
decreases expression increases expression
ISO
Eugenol results in decreased expression of EGFR protein Eugenol results in increased expression of EGFR mRNA
CTD
PMID:15618236
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
multiple interactions
ISO
[[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA
CTD
PMID:12767924
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
decreases expression
ISO
Eugenol results in decreased expression of EGR2 mRNA
CTD
PMID:17374397
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,051,277...21,055,562
G
Emb
embigin
decreases expression
ISO
Eugenol results in decreased expression of EMB mRNA
CTD
PMID:17374397
NCBI chr 2:50,803,468...50,858,001
Ensembl chr 2:49,069,087...49,125,050
G
Epcam
epithelial cell adhesion molecule
decreases expression
ISO
Eugenol results in decreased expression of EPCAM protein Eugenol results in decreased expression of EPCAM mRNA; Eugenol results in decreased expression of EPCAM protein
CTD
PMID:31926151
NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:6,878,237...6,896,127
G
Esr1
estrogen receptor 1
affects binding multiple interactions
ISO
Eugenol binds to ESR1 protein Eugenol inhibits the reaction [Estradiol binds to ESR1 protein]
CTD
PMID:12495555
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
affects binding multiple interactions
ISO
Eugenol binds to ESR2 protein Eugenol inhibits the reaction [Estradiol binds to ESR2 protein]
CTD
PMID:12495555
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
F13a1
coagulation factor XIII A1 chain
decreases expression
ISO
Eugenol results in decreased expression of F13A1 mRNA
CTD
PMID:17374397
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:27,815,702...27,992,700
G
Fasn
fatty acid synthase
decreases expression
ISO
Eugenol results in decreased expression of FASN mRNA
CTD
PMID:21870829
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fbxo9
f-box protein 9
decreases expression
ISO
Eugenol results in decreased expression of FBXO9 mRNA
CTD
PMID:17374397
NCBI chr 8:87,838,787...87,864,362
Ensembl chr 8:78,958,483...78,983,949
G
Fcgr2b
Fc gamma receptor 2B
increases expression
ISO
Eugenol results in increased expression of FCGR2B mRNA
CTD
PMID:17374397
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:83,193,163...83,207,778
G
Fech
ferrochelatase
increases expression
ISO
Eugenol results in increased expression of FECH mRNA
CTD
PMID:20566472
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:57,945,122...57,979,348
G
Ferry3
FERRY endosomal RAB5 effector complex subunit 3
decreases expression
ISO
Eugenol results in decreased expression of FERRY3 mRNA
CTD
PMID:17374397
NCBI chr 4:161,458,942...161,494,213
Ensembl chr 4:159,772,786...159,806,382
G
Flt1
Fms related receptor tyrosine kinase 1
multiple interactions
EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of FLT1 mRNA]
CTD
PMID:20434464
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
increases expression
ISO
Eugenol results in increased expression of FOSL2 mRNA
CTD
PMID:17374397
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:24,300,956...24,320,034
G
Ftl1
ferritin light chain 1
increases expression
ISO
Eugenol results in increased expression of FTL mRNA
CTD
PMID:20566472
NCBI chr 1:105,072,858...105,074,705
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
Eugenol results in increased expression of G6PD mRNA
CTD
PMID:20566472
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
multiple interactions
EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of GADD45A mRNA]
CTD
PMID:19851710
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
Eugenol results in increased expression of GADD45B mRNA
CTD
PMID:15618236
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:8,778,007...8,780,046
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Eugenol results in increased expression of GCLC mRNA
CTD
PMID:20566472 PMID:26198647 PMID:30806763
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Eugenol results in increased expression of GCLM mRNA
CTD
PMID:20566472 PMID:26198647 PMID:27965148 PMID:30806763
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gpat3
glycerol-3-phosphate acyltransferase 3
increases expression
ISO
Eugenol results in increased expression of GPAT3 mRNA
CTD
PMID:26198647
NCBI chr14:9,018,762...9,072,552
Ensembl chr14:8,714,373...8,766,490
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
Eugenol inhibits the reaction [Streptozocin results in increased expression of GPT protein]
CTD
PMID:38047382
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
Eugenol results in increased expression of GPX3 mRNA
CTD
PMID:20566472
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gsk3b
glycogen synthase kinase 3 beta
increases expression
ISO
Eugenol results in increased expression of GSK3B mRNA
CTD
PMID:17374397
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
Eugenol results in increased expression of GSR mRNA
CTD
PMID:20566472
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gsta1
glutathione S-transferase alpha 1
decreases activity
ISO
Eugenol analog results in decreased activity of GSTA1 protein
CTD
PMID:8620581
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:23,703,477...23,720,121
G
Gsta2
glutathione S-transferase alpha 2
increases expression decreases activity
EXP
Eugenol results in increased expression of GSTA2 protein Eugenol analog results in decreased activity of GSTA2 protein
CTD
PMID:8406240 PMID:8620581
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3
glutathione S-transferase alpha 3
decreases activity
EXP
Eugenol analog results in decreased activity of GSTA3 protein
CTD
PMID:8620581
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:23,658,574...23,684,240
G
Gstm1
glutathione S-transferase mu 1
decreases activity
ISO EXP
Eugenol analog results in decreased activity of GSTM1 protein
CTD
PMID:8620581
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
decreases activity
EXP
Eugenol analog results in decreased activity of GSTM2 protein
CTD
PMID:8620581
NCBI chr 2:198,312,179...198,316,962
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
decreases activity
ISO EXP
Eugenol analog results in decreased activity of GSTP1 protein
CTD
PMID:8620581
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Heatr5b
HEAT repeat containing 5B
decreases expression
ISO
Eugenol results in decreased expression of HEATR5B mRNA
CTD
PMID:17374397
NCBI chr 6:21,995,558...22,075,582
Ensembl chr 6:16,243,461...16,323,435
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
Eugenol results in increased expression of HIF1A mRNA
CTD
PMID:20713136
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
decreases expression
ISO
Eugenol results in decreased expression of HMGCR mRNA
CTD
PMID:21870829
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
increases expression
ISO
Eugenol results in increased expression of HMOX1 mRNA
CTD
PMID:20566472 PMID:20713136 PMID:23445166 PMID:26244607 PMID:30806763 PMID:31967339 More...
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A3
decreases expression
ISO
Eugenol results in decreased expression of HNRNPA3 mRNA
CTD
PMID:17374397
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
G
Hras
HRas proto-oncogene, GTPase
decreases expression
ISO
Eugenol results in decreased expression of HRAS protein
CTD
PMID:20537511
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Eugenol results in increased expression of HSPA6 mRNA
CTD
PMID:23999411
NCBI chr13:85,805,911...85,807,052
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
Eugenol results in increased expression of HSPH1 mRNA
CTD
PMID:23999411
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:5,390,922...5,410,224
G
Ibsp
integrin-binding sialoprotein
decreases expression
ISO
Eugenol results in decreased expression of IBSP mRNA; Eugenol results in decreased expression of IBSP protein
CTD
PMID:21706355
NCBI chr14:5,744,497...5,757,242
Ensembl chr14:5,439,829...5,452,693
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
Eugenol results in increased expression of ICAM1 mRNA; Eugenol results in increased expression of ICAM1 protein
CTD
PMID:30806763
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
Eugenol results in decreased expression of IDI1 mRNA
CTD
PMID:17374397
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:61,629,594...61,637,357
G
Ifng
interferon gamma
increases secretion multiple interactions
ISO
Eugenol results in increased secretion of IFNG protein [Methoxychlor co-treated with Eugenol] results in increased expression of IFNG protein; [Parathion co-treated with Eugenol] results in increased expression of IFNG protein
CTD
PMID:20920556 PMID:22245253
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of IKBKB protein]
CTD
PMID:19851710
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
multiple interactions
ISO
[Eugenol co-treated with Acetylcysteine] inhibits the reaction [Nicotine results in decreased secretion of IL10 protein]; Eugenol inhibits the reaction [Nicotine results in decreased expression of IL10 mRNA]
CTD
PMID:21237301
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il12a
interleukin 12A
multiple interactions
ISO
Eugenol inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]]
CTD
PMID:21237301
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:152,965,769...152,972,734
G
Il12b
interleukin 12B
multiple interactions
ISO
Eugenol inhibits the reaction [Nicotine results in increased expression of IL12B mRNA]; Eugenol inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]]
CTD
PMID:21237301
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
G
Il16
interleukin 16
multiple interactions increases secretion
ISO
Eugenol results in increased expression of and results in increased secretion of IL16 protein Eugenol results in increased secretion of IL16 protein
CTD
PMID:23624239 PMID:30806763
NCBI chr 1:147,026,852...147,127,177
Ensembl chr 1:137,617,944...137,718,130
G
Il18
interleukin 18
increases expression
ISO
Eugenol results in increased expression of IL18 protein
CTD
PMID:23063874
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
increases expression
ISO
Eugenol results in increased expression of IL1A mRNA
CTD
PMID:30806763 PMID:33715048
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions increases expression decreases expression
ISO
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of IL1B; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of IL1B; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Eugenol results in increased expression of IL1B mRNA Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Eugenol results in decreased expression of IL1B mRNA
CTD
PMID:12963494 PMID:17509409 PMID:20713136 PMID:21382956 PMID:21807015 PMID:21939359 More...
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
increases expression
ISO
Eugenol results in increased expression of IL1R2 mRNA
CTD
PMID:20713136 PMID:30806763
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:42,384,433...42,424,725
G
Il2
interleukin 2
increases expression increases secretion
ISO
Eugenol results in increased expression of IL2 protein Eugenol results in increased secretion of IL2 protein
CTD
PMID:22245253 PMID:22381623
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il4r
interleukin 4 receptor
increases expression
ISO
Eugenol results in increased expression of IL4RA protein
CTD
PMID:22381623
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
multiple interactions increases secretion increases expression
ISO EXP
Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein] Eugenol results in increased secretion of IL6 protein Eugenol inhibits the reaction [Thioacetamide results in increased activity of IL6 protein] Eugenol results in increased expression of IL6 mRNA
CTD
PMID:20036707 PMID:20043298 PMID:21870829 PMID:22245253
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Il7r
interleukin 7 receptor
increases expression
ISO
Eugenol results in increased expression of IL7R mRNA
CTD
PMID:20713136
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:58,454,217...58,477,757
G
Inhba
inhibin subunit beta A
decreases expression
ISO
Eugenol results in decreased expression of INHBA mRNA
CTD
PMID:15618236
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Ipcef1
interaction protein for cytohesin exchange factors 1
decreases expression
ISO
Eugenol results in decreased expression of IPCEF1 mRNA
CTD
PMID:17374397
NCBI chr 1:45,654,252...45,857,045
Ensembl chr 1:43,269,202...43,427,969
G
Itga6
integrin subunit alpha 6
increases expression
ISO
Eugenol results in increased expression of ITGA6 mRNA
CTD
PMID:17936526
NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:56,617,268...56,689,428
G
Itgb1
integrin subunit beta 1
increases expression
ISO
Eugenol results in increased expression of ITGB1 mRNA
CTD
PMID:17936526
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:56,705,171...56,753,195
G
Kcna5
potassium voltage-gated channel subfamily A member 5
decreases activity
ISO
Eugenol results in decreased activity of KCNA5 protein
CTD
PMID:17720863
NCBI chr 4:161,040,853...161,044,311
Ensembl chr 4:159,350,097...159,357,697
G
Kcnj2
potassium inwardly-rectifying channel, subfamily J, member 2
decreases expression
ISO
Eugenol results in decreased expression of KCNJ2 mRNA
CTD
PMID:17374397
NCBI chr10:96,560,225...96,570,788
Ensembl chr10:96,060,821...96,071,445
G
Kif23
kinesin family member 23
decreases expression
ISO
Eugenol results in decreased expression of KIF23 mRNA
CTD
PMID:17374397
NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:62,397,948...62,425,072
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Eugenol results in increased expression of MAFF mRNA
CTD
PMID:20566472
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression
ISO
Eugenol results in increased expression of MAFG mRNA
CTD
PMID:20566472
NCBI chr10:106,401,633...106,410,159
Ensembl chr10:105,903,237...105,912,026
G
Mafk
MAF bZIP transcription factor K
increases expression
ISO
Eugenol results in increased expression of MAFK mRNA
CTD
PMID:20566472
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Mcts1
MCTS1, re-initiation and release factor
decreases expression
ISO
Eugenol results in decreased expression of MCTS1 mRNA
CTD
PMID:17374397
NCBI chr X:122,215,602...122,228,101
Ensembl chr X:117,350,889...117,362,504
G
Me1
malic enzyme 1
increases expression
ISO
Eugenol results in increased expression of ME1 mRNA
CTD
PMID:20566472
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
G
Mgst1
microsomal glutathione S-transferase 1
increases expression
ISO
Eugenol results in increased expression of MGST1 mRNA
CTD
PMID:20566472
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:171,029,630...171,044,892
G
Mir146a
microRNA 146a
increases expression
ISO
Eugenol results in increased expression of MIR146A mRNA
CTD
PMID:37326882
NCBI chr10:28,349,996...28,350,090
Ensembl chr10:27,848,516...27,848,610
G
Mmp2
matrix metallopeptidase 2
multiple interactions decreases expression
EXP ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP2 mRNA] Eugenol results in decreased expression of MMP2 mRNA
CTD
PMID:20434464 PMID:30518369
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression
EXP ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA] Eugenol results in decreased expression of MMP9 mRNA
CTD
PMID:20434464 PMID:30518369
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
multiple interactions
EXP
Eugenol inhibits the reaction [Acetic Acid results in increased activity of MPO protein]; Eugenol inhibits the reaction [Thioacetamide results in increased activity of MPO protein]
CTD
PMID:20036707 PMID:33245926
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mrpl35
mitochondrial ribosomal protein L35
decreases expression
ISO
Eugenol results in decreased expression of MRPL35 mRNA
CTD
PMID:17374397
NCBI chr 4:105,424,076...105,431,844
Ensembl chr 4:103,865,812...103,880,887
G
Ms4a7
membrane spanning 4-domains A7
increases expression
ISO
Eugenol results in increased expression of MS4A7 mRNA
CTD
PMID:17374397
NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260
G
Mt3
metallothionein 3
increases expression
ISO
Eugenol results in increased expression of MT3 mRNA
CTD
PMID:15157811
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,848,755...10,850,158
G
Mtor
mechanistic target of rapamycin kinase
increases activity
EXP
Eugenol results in increased activity of MTOR protein
CTD
PMID:36007673
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Mxd1
max dimerization protein 1
increases expression
ISO
Eugenol results in increased expression of MXD1 mRNA
CTD
PMID:20713136
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Myb
MYB proto-oncogene, transcription factor
decreases expression
ISO
Eugenol results in decreased expression of MYB mRNA
CTD
PMID:17374397
NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:15,939,761...15,973,057
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein]
CTD
PMID:20537511
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
ISO
Eugenol results in increased expression of NAMPT mRNA
CTD
PMID:17374397
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:49,424,332...49,462,100
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects expression decreases expression multiple interactions
ISO
Eugenol affects the expression of NFE2L2 protein Eugenol results in decreased expression of NFE2L2 mRNA Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA]
CTD
PMID:17275817 PMID:31967339
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions affects expression
ISO EXP
Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol affects the expression of NFKB1 mRNA Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]
CTD
PMID:10871845 PMID:19851710 PMID:20385217
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKBIA protein modified form] Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:12963494 PMID:19851710 PMID:20043298
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein]; Eugenol inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA]; Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]
CTD
PMID:20043298 PMID:21237301
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
decreases expression
ISO
Eugenol results in decreased expression of NOTCH1 protein Eugenol results in decreased expression of NOTCH1 mRNA; Eugenol results in decreased expression of NOTCH1 protein
CTD
PMID:31926151
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression increases activity multiple interactions
ISO
Eugenol results in increased expression of NQO1 mRNA; Eugenol results in increased expression of NQO1 protein Eugenol results in increased activity of NQO1 protein [Dicumarol results in decreased activity of NQO1 protein] inhibits the reaction [Eugenol results in increased expression of CD86 protein]; Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA]
CTD
PMID:17275817 PMID:20566472 PMID:21742781
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression
ISO
Eugenol results in increased expression of NR1I2 mRNA
CTD
PMID:29933105
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
G
Nup88
nucleoporin 88
increases expression
ISO
Eugenol results in increased expression of NUP88 mRNA
CTD
PMID:17374397
NCBI chr10:55,667,903...55,692,249
Ensembl chr10:55,667,906...55,692,257
G
Or5d18
olfactory receptor family 5 subfamily D member 18
multiple interactions increases activity affects binding
ISO
[[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA; [Eugenol binds to and results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP; [Eugenol binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; [Eugenol binds to OR5D18 protein] which results in increased transport of Calcium; [Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP; Eugenol binds to and results in increased activity of OR5D18 protein; isomethyleugenol inhibits the reaction [[Eugenol binds to OR5D18 protein] which results in increased transport of Calcium]
CTD
PMID:12767924 PMID:14685265 PMID:15716417 PMID:19723634
NCBI chr 3:93,972,754...93,973,695
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
G
P2rx3
purinergic receptor P2X 3
multiple interactions
EXP
Eugenol inhibits the reaction [P2RX3 protein affects the activity of Adenosine Triphosphate]
CTD
PMID:19967073
NCBI chr 3:90,487,506...90,531,315
Ensembl chr 3:70,080,851...70,125,178
G
Paics
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
decreases expression
ISO
Eugenol results in decreased expression of PAICS mRNA
CTD
PMID:17374397
NCBI chr14:31,553,355...31,586,843
Ensembl chr14:31,173,541...31,232,635
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
Eugenol affects the reaction [Methylnitronitrosoguanidine affects the cleavage of PARP1 protein]
CTD
PMID:20434464
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO EXP
Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein]
CTD
PMID:19851710 PMID:20043298
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pde4b
phosphodiesterase 4B
increases expression
ISO
Eugenol results in increased expression of PDE4B mRNA
CTD
PMID:17374397
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pgd
phosphogluconate dehydrogenase
increases expression
ISO
Eugenol results in increased expression of PGD mRNA
CTD
PMID:20566472
NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:159,561,271...159,742,778
G
Picalm
phosphatidylinositol binding clathrin assembly protein
increases expression
ISO
Eugenol results in increased expression of PICALM mRNA
CTD
PMID:17374397
NCBI chr 1:153,468,982...153,550,086
Ensembl chr 1:144,056,721...144,137,557
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
EXP ISO
Eugenol results in increased expression of PIK3R1 mRNA
CTD
PMID:20724125 PMID:21870829
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Plat
plasminogen activator, tissue type
increases expression
ISO
Eugenol results in increased expression of PLAT mRNA
CTD
PMID:17374397
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
Eugenol results in increased expression of PMAIP1 mRNA
CTD
PMID:20713136
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:59,986,017...59,992,429
G
Pou5f1
POU class 5 homeobox 1
decreases expression
ISO
Eugenol results in decreased expression of POU5F1 protein Eugenol results in decreased expression of POU5F1 mRNA; Eugenol results in decreased expression of POU5F1 protein
CTD
PMID:31926151
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,223,129...3,227,891
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
Eugenol analog binds to and results in increased activity of PPARG protein Eugenol results in increased expression of PPARG mRNA bisphenol A diglycidyl ether inhibits the reaction [Eugenol analog binds to and results in increased activity of PPARG protein]; Eugenol analog binds to and results in increased activity of PPARG protein
CTD
PMID:20064974 PMID:21870829
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppbp
pro-platelet basic protein
multiple interactions increases expression
ISO
Eugenol results in increased expression of and results in increased secretion of PPBP protein Eugenol results in increased expression of PPBP mRNA
CTD
PMID:23624239
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
G
Prdx3
peroxiredoxin 3
decreases expression
ISO
Eugenol results in decreased expression of PRDX3 mRNA
CTD
PMID:17374397
NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:260,001,637...260,014,111
G
Ptger3
prostaglandin E receptor 3
decreases expression
ISO
Eugenol results in decreased expression of PTGER3 mRNA
CTD
PMID:17374397
NCBI chr 2:249,264,985...249,409,966
Ensembl chr 2:246,606,183...246,684,434
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
Eugenol results in increased expression of PTGR1 mRNA
CTD
PMID:20566472
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:73,784,009...73,802,666
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression decreases expression
ISO EXP
Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] Eugenol results in increased expression of PTGS2 mRNA Eugenol results in decreased expression of PTGS2 mRNA Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2] Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone]; Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased metabolism of Arachidonic Acid]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]
CTD
PMID:12757841 PMID:16101137 PMID:17509409 PMID:20036707 PMID:20043298 PMID:21807015 PMID:21939359 PMID:30806763 More...
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
Eugenol results in decreased expression of RB1 protein
CTD
PMID:22686307
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Reck
reversion-inducing-cysteine-rich protein with kazal motifs
multiple interactions
EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK protein]
CTD
PMID:20434464
NCBI chr 5:62,898,717...62,965,274
Ensembl chr 5:58,102,981...58,169,502
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO EXP
Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein]
CTD
PMID:10871845 PMID:19851710 PMID:20043298
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rgs1
regulator of G-protein signaling 1
increases expression
ISO
Eugenol results in increased expression of RGS1 mRNA
CTD
PMID:17374397 PMID:20713136
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Rpl27a
ribosomal protein L27A
increases expression
ISO
Eugenol results in increased expression of RPL27A mRNA
CTD
PMID:17374397
NCBI chr 1:163,539,732...163,542,771
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
ISO
Eugenol results in increased expression of RRM2B mRNA
CTD
PMID:21704725
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:69,078,291...69,108,633
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
Eugenol results in increased expression of SAT1 mRNA
CTD
PMID:17374397
NCBI chr X:44,008,089...44,011,376
Ensembl chr X:40,157,046...40,196,813
G
Sdc2
syndecan 2
increases expression
ISO
Eugenol results in increased expression of SDC2 mRNA
CTD
PMID:17374397
NCBI chr 7:66,012,405...66,125,101
Ensembl chr 7:64,127,110...64,241,081
G
Septin11
septin 11
decreases expression
ISO
Eugenol results in decreased expression of SEPTIN11 mRNA
CTD
PMID:17374397
NCBI chr14:15,119,760...15,275,222
Ensembl chr14:14,844,580...14,990,853
G
Serpinb3
serpin family B member 3
increases expression
ISO
Eugenol results in increased expression of SERPINB3 mRNA
CTD
PMID:30806763
NCBI chr13:23,788,758...23,795,298
Ensembl chr13:23,274,484...23,313,682
G
Slamf1
signaling lymphocytic activation molecule family member 1
decreases expression
ISO
Eugenol results in decreased expression of SLAMF1 mRNA
CTD
PMID:20713136
NCBI chr13:86,802,708...86,837,890
Ensembl chr13:84,270,316...84,305,497
G
Slc16a10
solute carrier family 16 member 10
increases expression
ISO
Eugenol results in increased expression of SLC16A10 mRNA
CTD
PMID:17374397
NCBI chr20:45,014,229...45,122,392
Ensembl chr20:43,459,709...43,567,839
G
Slc2a3
solute carrier family 2 member 3
increases expression
ISO
Eugenol results in increased expression of SLC2A3 mRNA
CTD
PMID:17374397
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472
G
Slc2a4
solute carrier family 2 member 4
increases expression
ISO EXP
Eugenol results in increased expression of SLC2A4 mRNA
CTD
PMID:20724125 PMID:21870829
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Eugenol results in increased expression of SLC7A11 mRNA
CTD
PMID:26198647 PMID:30806763
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Sod1
superoxide dismutase 1
increases expression decreases expression multiple interactions
ISO
Eugenol results in increased expression of SOD1 mRNA Eugenol results in decreased expression of SOD1 mRNA; Eugenol results in decreased expression of SOD1 protein Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA]; Glutathione promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA]
CTD
PMID:16101137 PMID:20566472
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases expression decreases expression multiple interactions
ISO
Eugenol results in increased expression of SOD2 mRNA Eugenol results in decreased expression of SOD2 mRNA; Eugenol results in decreased expression of SOD2 protein Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]; Glutathione promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]
CTD
PMID:16101137 PMID:20566472
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
increases expression
ISO
Eugenol results in increased expression of SOD3 mRNA
CTD
PMID:20566472
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Sqstm1
sequestosome 1
increases expression
ISO
Eugenol results in increased expression of SQSTM1 mRNA
CTD
PMID:26198647
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Eugenol results in increased expression of SRXN1 mRNA
CTD
PMID:20566472 PMID:26198647
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:140,599,608...140,628,448
G
Stat1
signal transducer and activator of transcription 1
decreases expression
ISO
Eugenol results in decreased expression of STAT1 mRNA
CTD
PMID:17374397
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Stat4
signal transducer and activator of transcription 4
increases expression
ISO
Eugenol results in increased expression of STAT4 mRNA
CTD
PMID:17374397
NCBI chr 9:56,964,617...57,080,523
Ensembl chr 9:49,419,340...49,588,540
G
Stat5b
signal transducer and activator of transcription 5B
increases expression
ISO
Eugenol results in increased expression of STAT5B mRNA
CTD
PMID:17374397
NCBI chr10:86,205,148...86,276,178
Ensembl chr10:85,705,670...85,775,668
G
Sult1c3
sulfotransferase family 1C member 3
increases sulfation
ISO
SULT1C1 protein results in increased sulfation of Eugenol
CTD
PMID:9560327
NCBI chr 9:7,548,839...7,594,299
Ensembl chr 9:7,221,578...7,267,030
G
Timp2
TIMP metallopeptidase inhibitor 2
multiple interactions
EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 protein]
CTD
PMID:20434464
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:103,531,505...103,590,611
G
Tlr4
toll-like receptor 4
increases expression
ISO
Eugenol results in increased expression of TLR4 mRNA
CTD
PMID:17936526
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions increases expression affects expression
ISO EXP
Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol results in increased expression of TNF mRNA Eugenol affects the expression of TNF mRNA Eugenol inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein]; Eugenol inhibits the reaction [Thioacetamide results in increased activity of TNF protein] [Methoxychlor co-treated with Eugenol] results in increased expression of TNF protein; [Parathion co-treated with Eugenol] results in increased expression of TNF protein; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Bacterial Toxins results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Eugenol inhibits the reaction [Nicotine results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [Nicotine results in increased secretion of TNF protein]
CTD
PMID:10871845 PMID:12963494 PMID:17509409 PMID:20036707 PMID:20043298 PMID:20385217 PMID:20639367 PMID:20920556 PMID:21237301 PMID:21807015 PMID:21870829 PMID:30806763 PMID:32096903 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
Eugenol results in increased expression of TNFAIP3 mRNA
CTD
PMID:20713136
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Eugenol results in increased expression of TNFAIP6 mRNA
CTD
PMID:17374397 PMID:20713136
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:36,502,188...36,521,649
G
Tp53
tumor protein p53
multiple interactions increases mutagenesis increases expression
EXP ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TP53 protein] Eugenol results in increased mutagenesis of TP53 gene Eugenol results in increased expression of TRP53 mRNA; Eugenol results in increased expression of TRP53 protein Eugenol promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]
CTD
PMID:15576237 PMID:19851710 PMID:20043298 PMID:20537511
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tp63
tumor protein p63
decreases expression
ISO
Eugenol results in decreased expression of TP63 mRNA
CTD
PMID:17936526
NCBI chr11:88,343,647...88,554,543
Ensembl chr11:74,838,859...75,049,398
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
multiple interactions increases activity
EXP
[2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide binds to and results in decreased activity of TRPA1 protein] which results in decreased susceptibility to Eugenol Eugenol results in increased activity of TRPA1 protein
CTD
PMID:22426238
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:4,379,999...4,433,570
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
multiple interactions increases activity
ISO EXP
Eugenol binds to and results in increased activity of TRPV3 protein [Eugenol binds to and results in increased activity of TRPV3 protein] which results in increased transport of Calcium; Eugenol binds to and results in increased activity of TRPV3 protein [Eugenol results in increased activity of TRPV3 protein] which results in increased transport of Calcium
CTD
PMID:16617338 PMID:20086034 PMID:21593771
NCBI chr10:58,382,054...58,413,657
Ensembl chr10:57,883,546...57,913,296
G
Txn2
thioredoxin 2
increases expression
ISO
Eugenol results in increased expression of TXN2 mRNA
CTD
PMID:20566472
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:109,496,761...109,510,359
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Eugenol results in increased expression of TXNRD1 mRNA
CTD
PMID:20566472 PMID:23445166
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
Eugenol results in increased expression of TXNRD2 mRNA
CTD
PMID:20566472
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:82,519,999...82,568,156
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
ISO
Eugenol results in increased expression of UGDH mRNA
CTD
PMID:16292757
NCBI chr14:43,202,480...43,226,002
Ensembl chr14:42,848,854...42,872,354
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of Eugenol
CTD
PMID:14557274
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
ISO
Eugenol results in increased expression of UGT1A6 mRNA
CTD
PMID:20566472
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of Eugenol
CTD
PMID:14557274
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases metabolic processing
ISO
UGT2B17 protein results in increased metabolism of Eugenol
CTD
PMID:8798464
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b15
UDP glucuronosyltransferase family 2 member B15
increases metabolic processing
EXP
UGT2B15 protein results in increased metabolism of Eugenol
CTD
PMID:7574722
NCBI chr14:21,122,866...21,138,450
Ensembl chr14:20,768,015...20,783,589
G
Vdr
vitamin D receptor
increases expression
ISO
Eugenol results in increased expression of VDR mRNA
CTD
PMID:17374397
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
G
Zbtb17
zinc finger and BTB domain containing 17
decreases expression
ISO
Eugenol results in decreased expression of ZBTB17 mRNA
CTD
PMID:17374397
NCBI chr 5:159,036,482...159,057,580
Ensembl chr 5:153,753,569...153,774,609
G
Mapt
microtubule-associated protein tau
multiple interactions
EXP
N-acetyl-N-formyl-5-methoxykynurenamine inhibits the reaction [Streptozocin results in increased phosphorylation of MAPT protein]
CTD
PMID:31833155
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
gingerol inhibits the reaction [ABCB1 protein results in increased transport of Digoxin]
CTD
PMID:18385293
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
gingerol inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA]; gingerol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein]
CTD
PMID:18577375 PMID:21851089
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
gingerol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of AKT1 protein]
CTD
PMID:27451028
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
gingerol results in increased expression of APAF1 mRNA; gingerol results in increased expression of APAF1 protein
CTD
PMID:19481070
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Apoe
apolipoprotein E
multiple interactions
ISO
gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BAX protein]; gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BCL2 protein]; gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CASP3 protein]; gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of RELA protein]; gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of TRP53 protein]
CTD
PMID:37121058
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Atf2
activating transcription factor 2
multiple interactions
ISO
gingerol inhibits the reaction [TNF protein results in increased phosphorylation of ATF2 protein]
CTD
PMID:18577375
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:58,718,332...58,795,236
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [gingerol results in increased expression of BAX protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of BAX protein] gingerol inhibits the reaction [hypoxia-reoxygenation increases expression of Bax protein in neural crest-derived cells] gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BAX protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of BAX protein]; gingerol inhibits the reaction [TNF protein results in increased expression of BAX protein] gingerol results in increased expression of BAX mRNA; gingerol results in increased expression of BAX protein
CTD RGD
PMID:18030663 PMID:19481070 PMID:25034532 PMID:28249781 PMID:37121058 PMID:34962339 More...
RGD:155882488
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO
gingerol results in decreased expression of BCL2 mRNA; gingerol results in decreased expression of BCL2 protein gingerol inhibits the reaction [hypoxia-reoxygenation decreases expression of Bcl2 protein in neural crest-derived cells] gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BCL2 protein]; gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]; gingerol inhibits the reaction [TNF protein results in decreased expression of BCL2 protein] [gingerol co-treated with Hydrogen Peroxide] results in increased expression of BCL2 protein; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BCL2 protein]; gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]
CTD RGD
PMID:18030663 PMID:19481070 PMID:25034532 PMID:27451028 PMID:28249781 PMID:37121058 PMID:34962339 More...
RGD:155882488
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
multiple interactions
ISO
gingerol inhibits the reaction [hypoxia-reoxygenation decreases expression of Bdnf protein in neural crest-derived cells]
RGD
PMID:34962339
RGD:155882488
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
multiple interactions
ISO
[gingerol co-treated with Hydrogen Peroxide] results in increased expression of BECN1 protein
CTD
PMID:27451028
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bid
BH3 interacting domain death agonist
multiple interactions decreases expression
ISO
Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BID protein]
CTD
PMID:25034532
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions decreases expression
ISO
Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BIRC5 protein]; gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein]
CTD
PMID:18030663 PMID:25034532
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Casp3
caspase 3
increases expression increases cleavage multiple interactions affects activity
ISO EXP
gingerol results in increased expression of CASP3 mRNA; gingerol results in increased expression of CASP3 protein gingerol results in increased cleavage of CASP3 protein gingerol inhibits the reaction [Chlorpyrifos results in increased activity of CASP3 protein] gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CASP3 protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased activity of CASP3 protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of CASP3 protein]; gingerol inhibits the reaction [TNF protein results in increased expression of CASP3 protein] gingerol affects the activity of CASP3 protein [TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of CASP3 protein]
CTD
PMID:17454143 PMID:18030663 PMID:19481070 PMID:25034532 PMID:28249781 PMID:28373059 PMID:28421826 PMID:37121058 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases cleavage affects activity
ISO
[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein] gingerol results in increased cleavage of CASP8 protein gingerol affects the activity of CASP8 protein
CTD
PMID:17454143 PMID:25034532 PMID:28249781
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases expression increases cleavage multiple interactions affects activity
ISO
gingerol results in increased expression of CASP9 mRNA; gingerol results in increased expression of CASP9 protein gingerol results in increased cleavage of CASP9 protein gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] gingerol affects the activity of CASP9 protein
CTD
PMID:17454143 PMID:18030663 PMID:19481070 PMID:28249781
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
ISO EXP
gingerol inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]; gingerol inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]; gingerol inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] gingerol inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein]
CTD
PMID:22285432 PMID:28373059 PMID:28421826 PMID:31004597
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccnb1
cyclin B1
decreases expression
ISO
gingerol results in decreased expression of CCNB1 mRNA; gingerol results in decreased expression of CCNB1 protein
CTD
PMID:28249781
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
multiple interactions increases expression decreases expression
ISO
[gingerol co-treated with Cycloheximide] results in increased degradation of CCND1 protein gingerol results in increased expression of CCND1 mRNA; gingerol results in increased expression of CCND1 protein gingerol results in decreased expression of CCND1 mRNA; gingerol results in decreased expression of CCND1 protein
CTD
PMID:18058799 PMID:26498061 PMID:28249781
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
decreases expression
ISO
gingerol results in decreased expression of CCNE1 mRNA; gingerol results in decreased expression of CCNE1 protein
CTD
PMID:28249781
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
gingerol results in decreased expression of CDK1 mRNA
CTD
PMID:28249781
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
gingerol results in decreased expression of CDK4 protein
CTD
PMID:18058799
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
gingerol results in decreased expression of CDKN1A mRNA
CTD
PMID:28249781
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
ISO
gingerol results in decreased expression of CDKN1B mRNA
CTD
PMID:28249781
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases expression multiple interactions
ISO
gingerol results in decreased expression of CEBPA mRNA; gingerol results in decreased expression of CEBPA protein GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA mRNA]; GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA protein]
CTD
PMID:26498061
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
G
Cflar
CASP8 and FADD-like apoptosis regulator
multiple interactions decreases expression
ISO
Acetylcysteine inhibits the reaction [gingerol results in decreased expression of CFLAR protein]
CTD
PMID:25034532
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
G
Chek2
checkpoint kinase 2
multiple interactions
ISO
gingerol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CHEK2 protein]
CTD
PMID:28988496
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:45,788,827...45,821,286
G
Ctnnb1
catenin beta 1
affects localization increases expression multiple interactions
ISO
gingerol affects the localization of CTNNB1 protein gingerol results in increased expression of CTNNB1 mRNA gingerol results in increased expression of and affects the localization of CTNNB1 protein gingerol promotes the reaction [IL1B protein results in increased expression of CTNNB1 protein]
CTD
PMID:18058799 PMID:26498061 PMID:27645308
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases response to substance
ISO
CYP2C19 mRNA results in increased susceptibility to gingerol
CTD
PMID:29555536
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
gingerol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]
CTD
PMID:18385293
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
gingerol results in increased expression of DUSP10 mRNA
CTD
PMID:17151092
NCBI chr13:98,145,317...98,183,304
Ensembl chr13:95,614,292...95,651,716
G
Dvl2
dishevelled segment polarity protein 2
increases expression
ISO
gingerol results in increased expression of DVL2 mRNA
CTD
PMID:26498061
NCBI chr10:55,222,245...55,231,506
Ensembl chr10:54,723,411...54,732,820
G
Fas
Fas cell surface death receptor
affects activity
ISO
gingerol affects the activity of FAS protein
CTD
PMID:17454143
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
decreases expression
ISO
gingerol results in decreased expression of FASN mRNA; gingerol results in decreased expression of FASN protein
CTD
PMID:26498061
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fn1
fibronectin 1
multiple interactions
ISO
gingerol inhibits the reaction [Glucose results in increased secretion of FN1 protein]
CTD
PMID:21829520
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
ISO
gingerol inhibits the reaction [Dextran Sulfate results in decreased expression of FSHB protein]
CTD
PMID:28421826
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
G
Gdf15
growth differentiation factor 15
increases expression multiple interactions
ISO
gingerol results in increased expression of GDF15 mRNA; gingerol results in increased expression of GDF15 protein GSK3B protein affects the reaction [gingerol results in increased expression of GDF15 protein]; PRKCE protein affects the reaction [gingerol results in increased expression of GDF15 protein]; Ro 31-8220 inhibits the reaction [gingerol results in increased expression of GDF15 protein]
CTD
PMID:18058799
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions increases response to substance increases phosphorylation increases expression
ISO
gingerol inhibits the reaction [IL1B protein results in increased expression of GSK3B protein]; gingerol inhibits the reaction [IL1B protein results in increased phosphorylation of GSK3B protein]; GSK3B protein affects the reaction [gingerol results in increased expression of GDF15 protein] GSK3B protein results in increased susceptibility to gingerol GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA mRNA]; GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA protein]; GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG mRNA]; GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG protein] gingerol results in increased phosphorylation of GSK3B protein gingerol results in increased expression of GSK3B protein
CTD
PMID:18058799 PMID:26498061 PMID:27645308
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
gingerol inhibits the reaction [Oxygen deficiency results in decreased expression of HIF1A mRNA]
CTD
PMID:21382473
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Htr3a
5-hydroxytryptamine receptor 3A
decreases activity
ISO
gingerol results in decreased activity of HTR3A protein
CTD
PMID:26456648
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Il1b
interleukin 1 beta
multiple interactions
ISO
gingerol inhibits the reaction [IL1B protein results in increased expression of GSK3B protein]; gingerol inhibits the reaction [IL1B protein results in increased phosphorylation of GSK3B protein]; gingerol promotes the reaction [IL1B protein results in increased expression of CTNNB1 protein] gingerol inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]
CTD
PMID:27645308 PMID:28421826 PMID:31004597
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
gingerol inhibits the reaction [sodium arsenite results in increased expression of IL6 mRNA]
CTD
PMID:22285432
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
ISO
gingerol inhibits the reaction [Dietary Fats results in increased expression of INS1 protein]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of INS1 protein]; gingerol inhibits the reaction [sodium arsenite results in decreased secretion of INS1 protein]
CTD
PMID:21851089 PMID:22285432
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Irs1
insulin receptor substrate 1
multiple interactions
ISO
gingerol inhibits the reaction [sodium arsenite results in decreased expression of IRS1 mRNA]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of IRS1 protein]
CTD
PMID:22285432
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
G
Irs2
insulin receptor substrate 2
multiple interactions
ISO
gingerol inhibits the reaction [sodium arsenite results in decreased expression of IRS2 mRNA]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of IRS2 protein]
CTD
PMID:22285432
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:78,485,045...78,512,482
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
gingerol inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein]
CTD
PMID:18577375
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Klkb1
kallikrein B1
multiple interactions decreases expression
ISO
gingerol inhibits the reaction [Testosterone results in increased expression of KLKB1 protein] gingerol results in decreased expression of KLKB1 protein
CTD
PMID:18030663
NCBI chr16:53,690,180...53,714,570
Ensembl chr16:46,958,707...46,982,053
G
Lats1
large tumor suppressor kinase 1
increases expression
ISO
gingerol results in increased expression of LATS1 protein
CTD
PMID:32926756
NCBI chr 1:3,980,801...4,014,029
Ensembl chr 1:2,160,411...2,193,640
G
Ldhc
lactate dehydrogenase C
multiple interactions
ISO
gingerol inhibits the reaction [Dextran Sulfate results in increased activity of LDHC protein]
CTD
PMID:28421826
NCBI chr 1:106,522,140...106,539,649
Ensembl chr 1:97,382,379...97,403,378
G
Lep
leptin
multiple interactions
ISO
gingerol inhibits the reaction [Dietary Fats results in increased expression of LEP mRNA]; gingerol inhibits the reaction [Dietary Fats results in increased expression of LEP protein]
CTD
PMID:21851089
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Lhb
luteinizing hormone subunit beta
multiple interactions
ISO
gingerol inhibits the reaction [Dextran Sulfate results in decreased expression of LHB protein]
CTD
PMID:28421826
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lrp6
LDL receptor related protein 6
increases expression
ISO
gingerol results in increased expression of LRP6 mRNA
CTD
PMID:26498061
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:167,270,353...167,400,497
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
ISO
[gingerol co-treated with Hydrogen Peroxide] results in increased expression of MAP1LC3B protein modified form
CTD
PMID:27451028
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map2k4
mitogen activated protein kinase kinase 4
multiple interactions
ISO
gingerol inhibits the reaction [TNF protein results in increased phosphorylation of MAP2K4 protein]
CTD
PMID:18577375
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,344,915...50,447,993
G
Mir210
microRNA 210
multiple interactions
ISO
gingerol inhibits the reaction [hypoxia-reoxygenation increases expression of Mir210 miRNA in neural crest-derived cells]
RGD
PMID:34962339
RGD:155882488
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:196,326,337...196,326,454
G
Mmp2
matrix metallopeptidase 2
decreases expression multiple interactions decreases activity
ISO
gingerol results in decreased expression of MMP2 mRNA; gingerol results in decreased expression of MMP2 protein gingerol inhibits the reaction [YAP1 protein results in increased expression of MMP2 protein] gingerol results in decreased activity of MMP2 protein
CTD
PMID:17683926 PMID:32926756
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
decreases expression decreases activity
ISO
gingerol results in decreased expression of MMP9 mRNA gingerol results in decreased activity of MMP9 protein
CTD
PMID:17683926
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
multiple interactions
EXP ISO
gingerol inhibits the reaction [Chlorpyrifos results in increased activity of MPO protein] gingerol inhibits the reaction [Benzo(a)pyrene results in increased activity of MPO protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]
CTD
PMID:28373059 PMID:28421826 PMID:31004597
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions decreases expression
ISO
gingerol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MTOR protein] gingerol results in decreased expression of MTOR protein modified form
CTD
PMID:27451028 PMID:28249781
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
gingerol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:18683823
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
gingerol affects the phosphorylation of and affects the activity of NFKBIA protein
CTD
PMID:17454143
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
gingerol inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein]; gingerol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; gingerol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]
CTD
PMID:18683823 PMID:31004597
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein]
CTD
PMID:25034532
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions decreases expression
ISO
gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein]; GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG mRNA]; GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG protein] gingerol results in decreased expression of PPARG mRNA; gingerol results in decreased expression of PPARG protein
CTD
PMID:22285432 PMID:26498061
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Prkce
protein kinase C, epsilon
multiple interactions
ISO
PRKCE protein affects the reaction [gingerol results in increased expression of GDF15 protein]
CTD
PMID:18058799
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Ptges
prostaglandin E synthase
decreases expression increases expression
ISO
gingerol results in decreased expression of PTGES protein gingerol results in increased expression of PTGES mRNA
CTD
PMID:27645308
NCBI chr 3:34,575,643...34,586,987
G
Ptgs2
prostaglandin-endoperoxide synthase 2
affects expression multiple interactions
ISO
gingerol affects the expression of PTGS2 mRNA; gingerol affects the expression of PTGS2 protein gingerol inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 protein]; gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]
CTD
PMID:17454143 PMID:18683823 PMID:31004597
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
gingerol results in decreased phosphorylation of RB1 protein
CTD
PMID:18058799
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
affects expression multiple interactions affects localization
ISO
gingerol affects the expression of RELA protein gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of RELA protein]; gingerol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; gingerol inhibits the reaction [TNF protein results in increased expression of RELA protein] gingerol affects the localization of RELA protein
CTD
PMID:17454143 PMID:18683823 PMID:37121058
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rps6kb1
ribosomal protein S6 kinase B1
decreases expression
ISO
gingerol results in decreased expression of RPS6KB1 protein modified form
CTD
PMID:28249781
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908
G
Slc2a4
solute carrier family 2 member 4
multiple interactions
ISO
gingerol inhibits the reaction [sodium arsenite results in decreased expression of SLC2A4 mRNA]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of SLC2A4 protein]
CTD
PMID:22285432
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
G
Snai1
snail family transcriptional repressor 1
multiple interactions
ISO
gingerol inhibits the reaction [Glucose results in increased expression of SNAI1 mRNA]
CTD
PMID:21829520
NCBI chr 3:176,667,476...176,671,965
Ensembl chr 3:156,248,485...156,252,969
G
Snai2
snail family transcriptional repressor 2
decreases expression multiple interactions
ISO
gingerol results in decreased expression of SNAI2 protein gingerol inhibits the reaction [YAP1 protein results in increased expression of SNAI2 protein]
CTD
PMID:32926756
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:86,181,909...86,186,200
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
gingerol inhibits the reaction [Oxygen deficiency results in decreased activity of SOD1 protein]; gingerol inhibits the reaction [Oxygen deficiency results in decreased expression of SOD1 mRNA]
CTD
PMID:21382473
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
gingerol inhibits the reaction [Oxygen deficiency results in decreased activity of SOD2 protein]; gingerol inhibits the reaction [Oxygen deficiency results in decreased expression of SOD2 mRNA]
CTD
PMID:21382473
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
gingerol inhibits the reaction [Benzo(a)pyrene results in increased expression of TNF protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; gingerol inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; gingerol inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; gingerol inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA]; gingerol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein]; gingerol inhibits the reaction [TNF protein results in decreased expression of BCL2 protein]; gingerol inhibits the reaction [TNF protein results in increased expression of BAX protein]; gingerol inhibits the reaction [TNF protein results in increased expression of CASP3 protein]; gingerol inhibits the reaction [TNF protein results in increased expression of RELA protein]; gingerol inhibits the reaction [TNF protein results in increased expression of TRP53 protein]; gingerol inhibits the reaction [TNF protein results in increased phosphorylation of ATF2 protein]; gingerol inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein]; gingerol inhibits the reaction [TNF protein results in increased phosphorylation of MAP2K4 protein] gingerol inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein]
CTD
PMID:18577375 PMID:21851089 PMID:22285432 PMID:28373059 PMID:28421826 PMID:31004597 PMID:37121058 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
multiple interactions increases response to substance
ISO
[gingerol results in increased expression of TP53 protein] which results in increased susceptibility to TNFSF10 protein; [TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein; [TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein; [TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein]; TP53 protein affects the reaction [gingerol results in increased susceptibility to TNFSF10 protein]
CTD
PMID:25034532
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
increases expression multiple interactions
ISO
gingerol results in increased expression of TP53 protein gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of TRP53 protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of TRP53 protein]; gingerol inhibits the reaction [TNF protein results in increased expression of TRP53 protein] [gingerol results in increased expression of TP53 protein] which results in increased susceptibility to TNFSF10 protein; [Testosterone co-treated with gingerol] results in increased expression of TP53 protein; gingerol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TP53 protein]; TP53 protein affects the reaction [gingerol results in increased expression of TNFRSF10B protein]; TP53 protein affects the reaction [gingerol results in increased susceptibility to TNFSF10 protein]
CTD
PMID:18030663 PMID:25034532 PMID:28988496 PMID:37121058
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Vim
vimentin
decreases expression multiple interactions
ISO
gingerol results in decreased expression of VIM protein gingerol inhibits the reaction [YAP1 protein results in increased expression of VIM protein]
CTD
PMID:32926756
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
gingerol results in decreased expression of XIAP protein
CTD
PMID:25034532
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Yap1
Yes1 associated transcriptional regulator
affects localization multiple interactions
ISO
gingerol affects the localization of YAP1 protein [gingerol co-treated with YAP1 protein] results in increased phosphorylation of YAP1 protein; gingerol inhibits the reaction [YAP1 protein results in increased expression of MMP2 protein]; gingerol inhibits the reaction [YAP1 protein results in increased expression of SNAI2 protein]; gingerol inhibits the reaction [YAP1 protein results in increased expression of VIM protein]; gingerol results in decreased expression of and results in increased phosphorylation of YAP1 protein
CTD
PMID:32926756
NCBI chr 8:13,380,551...13,451,640
Ensembl chr 8:5,095,722...5,167,010
G
Alb
albumin
affects binding
ISO
Guaiacol binds to ALB protein
CTD
PMID:11334365
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Car1
carbonic anhydrase 1
decreases activity
ISO
Guaiacol results in decreased activity of CA1 protein
CTD
PMID:19231207
NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:86,861,897...86,872,208
G
Car2
carbonic anhydrase 2
decreases activity
ISO
Guaiacol results in decreased activity of CA2 protein
CTD
PMID:19231207
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818
G
Comt
catechol-O-methyltransferase
multiple interactions
ISO
COMT mutant form inhibits the reaction [catechol results in increased abundance of Guaiacol]
CTD
PMID:24141029
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
Guaiacol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]
CTD
PMID:17465205
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Sult1c3
sulfotransferase family 1C member 3
increases sulfation
ISO
SULT1C1 protein results in increased sulfation of Guaiacol
CTD
PMID:9560327
NCBI chr 9:7,548,839...7,594,299
Ensembl chr 9:7,221,578...7,267,030
G
Aqp9
aquaporin 9
multiple interactions
ISO
AQP9 gene mutant form inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased abundance of Homovanillic Acid]
CTD
PMID:29566083
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:71,797,234...71,837,395
G
Comt
catechol-O-methyltransferase
multiple interactions
ISO EXP
[tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Homovanillic Acid
CTD
PMID:11793163 PMID:15190105 PMID:16012872
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Maob
monoamine oxidase B
multiple interactions
EXP
[Selegiline results in decreased activity of MAOB protein] which results in decreased abundance of Homovanillic Acid
CTD
PMID:16012872
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:5,907,266...6,011,003
G
Nos1
nitric oxide synthase 1
multiple interactions
ISO
NOS1 protein affects the reaction [Methamphetamine results in decreased abundance of Homovanillic Acid]
CTD
PMID:11085313
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases abundance
ISO
NR3C1 protein results in increased abundance of Homovanillic Acid
CTD
PMID:11226678
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Oprm1
opioid receptor, mu 1
multiple interactions
EXP
[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of Homovanillic Acid]
CTD
PMID:8884884
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Sct
secretin
increases abundance
ISO
SCT protein results in increased abundance of Homovanillic Acid
CTD
PMID:16168596
NCBI chr 1:205,812,435...205,813,246
Ensembl chr 1:196,382,856...196,383,658
G
Slc22a8
solute carrier family 22 member 8
multiple interactions
EXP
Homovanillic Acid inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:10224140
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:205,498,084...205,517,450
G
Tfam
transcription factor A, mitochondrial
decreases abundance
ISO
TFAM gene mutant form results in decreased abundance of Homovanillic Acid
CTD
PMID:28595911
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
G
Vdr
vitamin D receptor
multiple interactions increases abundance
ISO
Calcitriol promotes the reaction [VDR protein results in increased abundance of Homovanillic Acid]
CTD
PMID:27450565
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
G
Ahr
aryl hydrocarbon receptor
increases activity affects localization multiple interactions
ISO
isoeugenol results in increased activity of AHR protein isoeugenol affects the localization of AHR protein 3'-methoxy-4'-nitroflavone inhibits the reaction [isoeugenol results in increased activity of AHR protein]
CTD
PMID:16972787 PMID:22686307
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Ahrr
aryl-hydrocarbon receptor repressor
increases expression
ISO
isoeugenol results in increased expression of AHRR mRNA
CTD
PMID:22686307
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:28,993,634...29,088,673
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
ISO
isoeugenol results in increased expression of AKR1B1 mRNA
CTD
PMID:20566472
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
isoeugenol results in increased expression of AKR1B10 mRNA
CTD
PMID:20566472
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
isoeugenol results in increased expression of AKR1C1 mRNA
CTD
PMID:20566472
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression increases activity
ISO
isoeugenol results in increased expression of AKR1C2 mRNA isoeugenol results in increased activity of AKR1C2 promoter
CTD
PMID:20491607 PMID:21195160
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
isoeugenol results in increased expression of AKR1C3 mRNA
CTD
PMID:20566472
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
G
Ar
androgen receptor
affects binding
EXP
isoeugenol binds to AR protein
CTD
PMID:14565775
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Atf3
activating transcription factor 3
increases expression
ISO
isoeugenol results in increased expression of ATF3 mRNA
CTD
PMID:23999411
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Cat
catalase
increases expression
ISO
isoeugenol results in increased expression of CAT mRNA
CTD
PMID:20566472
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
decreases secretion
ISO
isoeugenol results in decreased secretion of CCL2 protein
CTD
PMID:20488241
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl27
C-C motif chemokine ligand 27
increases expression
ISO
isoeugenol results in increased expression of CCL27 mRNA
CTD
PMID:17936526
NCBI chr 5:61,737,261...61,744,375
Ensembl chr 5:56,941,402...56,948,506
G
Cd274
CD274 molecule
increases expression
ISO
isoeugenol results in increased expression of CD274 protein
CTD
PMID:20488241
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:227,116,649...227,134,450
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
isoeugenol results in decreased expression of CDK6 protein
CTD
PMID:22686307
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
isoeugenol results in increased expression of CDKN1B protein
CTD
PMID:22686307
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
isoeugenol results in increased expression of CXCL2 protein
CTD
PMID:23178550
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
isoeugenol results in increased expression of CYP1A1 mRNA
CTD
PMID:20491607 PMID:22686307
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
isoeugenol results in increased expression of DNAJB4 mRNA
CTD
PMID:23999411 PMID:27965148
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:241,130,340...241,159,089
G
Fech
ferrochelatase
increases expression
ISO
isoeugenol results in increased expression of FECH mRNA
CTD
PMID:20566472
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:57,945,122...57,979,348
G
Ftl1
ferritin light chain 1
increases expression
ISO
isoeugenol results in increased expression of FTL mRNA
CTD
PMID:20566472
NCBI chr 1:105,072,858...105,074,705
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
isoeugenol results in increased expression of G6PD mRNA
CTD
PMID:20566472
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
isoeugenol results in increased expression of GCLC mRNA
CTD
PMID:20566472
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
isoeugenol results in increased expression of GCLM mRNA
CTD
PMID:20566472 PMID:23999411 PMID:27965148
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
isoeugenol results in increased expression of GPX3 mRNA
CTD
PMID:20566472
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
isoeugenol results in increased expression of GSR mRNA
CTD
PMID:20566472
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
increases expression
ISO
isoeugenol results in increased expression of HMOX1 mRNA
CTD
PMID:20491607 PMID:20566472 PMID:23445166
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
isoeugenol results in increased expression of HSPA6 mRNA
CTD
PMID:23999411
NCBI chr13:85,805,911...85,807,052
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
isoeugenol results in increased expression of HSPH1 mRNA
CTD
PMID:23999411
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:5,390,922...5,410,224
G
Ifng
interferon gamma
increases secretion
ISO
isoeugenol results in increased secretion of IFNG protein
CTD
PMID:22245253
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Il18
interleukin 18
increases expression
ISO
isoeugenol results in increased expression of IL18 protein
CTD
PMID:23063874
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
increases expression
ISO
isoeugenol results in increased expression of IL1A protein
CTD
PMID:23178550
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il2
interleukin 2
multiple interactions increases secretion
ISO
isoeugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; isoeugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein] isoeugenol results in increased secretion of IL2 protein
CTD
PMID:17630204 PMID:22245253
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
increases secretion
ISO
isoeugenol results in increased secretion of IL6 protein
CTD
PMID:22245253
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
isoeugenol results in increased expression of MAFF mRNA
CTD
PMID:20491607 PMID:20566472
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression
ISO
isoeugenol results in increased expression of MAFG mRNA
CTD
PMID:20566472
NCBI chr10:106,401,633...106,410,159
Ensembl chr10:105,903,237...105,912,026
G
Mafk
MAF bZIP transcription factor K
increases expression
ISO
isoeugenol results in increased expression of MAFK mRNA
CTD
PMID:20566472
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; MAPK1 protein affects the reaction [isoeugenol affects the expression of NOS2]
CTD
PMID:17698059
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]; MAPK3 protein affects the reaction [isoeugenol affects the expression of NOS2]
CTD
PMID:17698059
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Me1
malic enzyme 1
increases expression
ISO
isoeugenol results in increased expression of ME1 mRNA
CTD
PMID:20566472
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
G
Mgst1
microsomal glutathione S-transferase 1
increases expression
ISO
isoeugenol results in increased expression of MGST1 mRNA
CTD
PMID:20566472
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:171,029,630...171,044,892
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:10871845
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; NFKBIA protein affects the reaction [isoeugenol affects the expression of NOS2]
CTD
PMID:17698059
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; isoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; MAPK1 protein affects the reaction [isoeugenol affects the expression of NOS2]; MAPK3 protein affects the reaction [isoeugenol affects the expression of NOS2]; NFKBIA protein affects the reaction [isoeugenol affects the expression of NOS2]
CTD
PMID:17698059
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
isoeugenol results in increased expression of NQO1 mRNA
CTD
PMID:20491607 PMID:20566472
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Or5d18
olfactory receptor family 5 subfamily D member 18
multiple interactions
ISO
isoeugenol binds to and results in decreased activity of OR5D18 protein; isoeugenol binds to and results in increased activity of OR5D18 protein
CTD
PMID:15574817 PMID:21142015
NCBI chr 3:93,972,754...93,973,695
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
G
Pgd
phosphogluconate dehydrogenase
increases expression
ISO
isoeugenol results in increased expression of PGD mRNA
CTD
PMID:20566472
NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:159,561,271...159,742,778
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
isoeugenol results in increased expression of PTGR1 mRNA
CTD
PMID:20566472
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:73,784,009...73,802,666
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
isoeugenol results in decreased expression of RB1 protein
CTD
PMID:22686307
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] isoeugenol inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]
CTD
PMID:10871845 PMID:17698059
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Socs3
suppressor of cytokine signaling 3
increases expression multiple interactions
ISO
isoeugenol results in increased expression of SOCS3 mRNA; isoeugenol results in increased expression of SOCS3 protein KT 5720 inhibits the reaction [isoeugenol results in increased expression of SOCS3 mRNA]
CTD
PMID:21969073
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Sod1
superoxide dismutase 1
increases expression
ISO
isoeugenol results in increased expression of SOD1 mRNA
CTD
PMID:20566472
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases expression
ISO
isoeugenol results in increased expression of SOD2 mRNA
CTD
PMID:20566472
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
increases expression
ISO
isoeugenol results in increased expression of SOD3 mRNA
CTD
PMID:20566472
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Srxn1
sulfiredoxin 1
increases expression
ISO
isoeugenol results in increased expression of SRXN1 mRNA
CTD
PMID:20566472
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:140,599,608...140,628,448
G
Tlr2
toll-like receptor 2
increases expression
ISO
isoeugenol results in increased expression of TLR2 mRNA
CTD
PMID:17936526
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tnf
tumor necrosis factor
multiple interactions increases secretion
ISO
isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] isoeugenol results in increased secretion of TNF protein
CTD
PMID:10871845 PMID:22245253
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Trim16
tripartite motif-containing 16
multiple interactions increases expression
ISO
[Indomethacin co-treated with isoeugenol] results in increased expression of TRIM16 mRNA isoeugenol results in increased expression of TRIM16 mRNA
CTD
PMID:21284934
NCBI chr10:47,985,235...48,008,242
Ensembl chr10:47,486,297...47,551,907
G
Txn2
thioredoxin 2
increases expression
ISO
isoeugenol results in increased expression of TXN2 mRNA
CTD
PMID:20566472
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:109,496,761...109,510,359
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
isoeugenol results in increased expression of TXNRD1 mRNA
CTD
PMID:20566472 PMID:23445166
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
isoeugenol results in increased expression of TXNRD2 mRNA
CTD
PMID:20566472
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:82,519,999...82,568,156
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
ISO
isoeugenol results in increased expression of UGT1A6 mRNA
CTD
PMID:20566472
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Zfp36
zinc finger protein 36
increases expression multiple interactions
ISO
isoeugenol results in increased expression of ZFP36 protein KT 5720 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein]; SB 203580 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein]
CTD
PMID:21969073
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564
G
Agt
angiotensinogen
multiple interactions
EXP
isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Hydrogen Peroxide]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Malondialdehyde]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein]
CTD
PMID:15607907
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Ccnd1
cyclin D1
decreases expression
ISO
isorhapontigenin results in decreased expression of CCND1 protein
CTD
PMID:37619952
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Cdh1
cadherin 1
multiple interactions
ISO
[sodium bichromate co-treated with isorhapontigenin] results in increased expression of CDH1 protein
CTD
PMID:37619952
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
G
Ctnnb1
catenin beta 1
multiple interactions
ISO
[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased localization of CTNNB1 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased phosphorylation of CTNNB1 protein
CTD
PMID:37619952
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Dnmt1
DNA methyltransferase 1
multiple interactions
ISO
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT1 protein
CTD
PMID:37619952
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
multiple interactions
ISO
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3A protein
CTD
PMID:37619952
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687
G
Dnmt3b
DNA methyltransferase 3 beta
multiple interactions
ISO
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3B protein
CTD
PMID:37619952
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
affects expression
EXP
isorhapontigenin affects the expression of FOS protein
CTD
PMID:15607907
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions
ISO
[sodium bichromate co-treated with isorhapontigenin] results in increased phosphorylation of GSK3B protein
CTD
PMID:37619952
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
affects activity
EXP
isorhapontigenin affects the activity of IKBKB protein
CTD
PMID:15607907
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
affects expression
EXP
isorhapontigenin affects the expression of JUN protein
CTD
PMID:15607907
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:15607907
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:15607907
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
EXP
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein]
CTD
PMID:15607907
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Meg3
maternally expressed 3
multiple interactions
ISO
isorhapontigenin inhibits the reaction [sodium bichromate results in decreased expression of MEG3]
CTD
PMID:37619952
NCBI chr 6:134,274,056...134,306,249
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
isorhapontigenin results in decreased expression of MKI67 protein
CTD
PMID:37619952
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
multiple interactions
ISO
[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of and results in decreased localization of NEDD9 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of NEDD9 mRNA
CTD
PMID:37619952
NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,282,326...23,468,019
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
isorhapontigenin affects the degradation of and affects the phosphorylation of NFKBIA protein
CTD
PMID:15607907
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Snai2
snail family transcriptional repressor 2
multiple interactions
ISO
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of SNAI2 protein
CTD
PMID:37619952
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:86,181,909...86,186,200
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions decreases expression
ISO
isosilybin inhibits the reaction [T0901317 results in increased expression of ACACA mRNA] isosilybin results in decreased expression of ACACA mRNA
CTD
PMID:36347319
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Acox1
acyl-CoA oxidase 1
increases expression
ISO
isosilybin results in increased expression of ACOX1 mRNA
CTD
PMID:36347319
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232
G
Cd36
CD36 molecule
multiple interactions
ISO
isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CD36 mRNA]
CTD
PMID:36347319
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions
ISO
isosilybin promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A mRNA]
CTD
PMID:36347319
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Fas
Fas cell surface death receptor
decreases expression multiple interactions
ISO
isosilybin results in decreased expression of FAS mRNA isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FAS protein]
CTD
PMID:36347319
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Mttp
microsomal triglyceride transfer protein
multiple interactions
ISO
isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of MTTP mRNA]; isosilybin inhibits the reaction [T0901317 results in decreased expression of MTTP mRNA]
CTD
PMID:36347319
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:226,613,090...226,654,239
G
Pnpla3
patatin-like phospholipase domain containing 3
decreases expression multiple interactions
ISO
isosilybin results in decreased expression of PNPLA3 mRNA isosilybin inhibits the reaction [T0901317 results in increased expression of PNPLA3 mRNA]
CTD
PMID:36347319
NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:115,293,538...115,314,077
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
ISO
isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein]
CTD
PMID:36347319
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression multiple interactions
ISO
isosilybin results in decreased expression of SREBF1 mRNA isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 protein]; isosilybin inhibits the reaction [T0901317 results in increased expression of SREBF1 mRNA]; isosilybin inhibits the reaction [T0901317 results in increased expression of SREBF1 protein]
CTD
PMID:36347319
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
KN 93 inhibits the reaction [Digoxin results in increased expression of ABCB1 protein]; KN 93 inhibits the reaction [Ouabain results in increased expression of ABCB1 protein]
CTD
PMID:19647009
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Aco1
aconitase 1
multiple interactions
EXP
KN 93 inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein]
CTD
PMID:25106854
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:55,259,827...55,316,391
G
Acp5
acid phosphatase 5, tartrate resistant
multiple interactions
ISO
KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]
CTD
PMID:32522522
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:20,663,985...20,667,929
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
KN 93 inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of AHR protein]
CTD
PMID:18089838
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Ahrr
aryl-hydrocarbon receptor repressor
multiple interactions
ISO
KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA]
CTD
PMID:18089838
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:28,993,634...29,088,673
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions
ISO
KN 93 inhibits the reaction [Cadmium Chloride affects the localization of AIFM1 protein]
CTD
PMID:18506790
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP ISO
KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein] KN 93 inhibits the reaction [rutacarpine results in increased phosphorylation of AKT1 protein]
CTD
PMID:19233221 PMID:21933187 PMID:28025122
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Atf4
activating transcription factor 4
multiple interactions
EXP
KN 93 inhibits the reaction [cadmium acetate results in increased expression of ATF4 protein]
CTD
PMID:29883672
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Atf6
activating transcription factor 6
increases expression multiple interactions
ISO
KN 93 results in increased expression of ATF6 protein KN 93 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]
CTD
PMID:37075931
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:82,930,034...83,107,177
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in increased expression of BAX mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of BAX protein]
CTD
PMID:34286406
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 mRNA]; KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 protein]
CTD
PMID:34286406
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in increased expression of CACNA1H mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]
CTD
PMID:34286406
NCBI chr10:14,894,630...14,952,317
Ensembl chr10:14,390,113...14,448,376
G
Calcr
calcitonin receptor
multiple interactions
ISO
KN 93 inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]
CTD
PMID:21869564
NCBI chr 4:32,615,955...32,691,075
Ensembl chr 4:31,661,273...31,736,392
G
Camk1
calcium/calmodulin-dependent protein kinase I
decreases activity
ISO
KN 93 results in decreased activity of CAMK1 protein
CTD
PMID:12193581
NCBI chr 4:148,036,843...148,047,675
Ensembl chr 4:146,481,196...146,492,081
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
multiple interactions
ISO EXP
[KN 93 co-treated with Losartan] inhibits the reaction [bisphenol A results in increased phosphorylation of CAMK2A protein]; KN 93 inhibits the reaction [bisphenol A results in increased phosphorylation of CAMK2A protein] KN 93 inhibits the reaction [rutacarpine results in increased phosphorylation of CAMK2A protein] KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of CAMK2A protein]; KN 93 inhibits the reaction [Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]]; KN 93 inhibits the reaction [Excitatory Amino Acid Agents promotes the reaction [CAMK2A protein binds to DRD3 protein]]; KN 93 inhibits the reaction [Ionomycin promotes the reaction [CAMK2A protein binds to DRD3 protein]]; KN 93 inhibits the reaction [Ionomycin promotes the reaction [CAMK2A protein modified form binds to DRD3 protein]]
CTD
PMID:19217379 PMID:21933187 PMID:25103225 PMID:28025122
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:54,378,784...54,438,994
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
multiple interactions
EXP
KN 93 inhibits the reaction [Cadmium affects the localization of CAMK2D protein]
CTD
PMID:22553113
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:215,024,004...215,286,178
G
Camk4
calcium/calmodulin-dependent protein kinase IV
multiple interactions
EXP
KN 93 inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of CAMK4 protein]
CTD
PMID:17973980
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
G
Casp12
caspase 12
multiple interactions
EXP
KN 93 inhibits the reaction [cadmium acetate results in increased cleavage of CASP12 protein]
CTD
PMID:29883672
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
multiple interactions
EXP ISO
KN 93 inhibits the reaction [cadmium acetate results in increased cleavage of CASP3 protein]; KN 93 inhibits the reaction [Methamphetamine results in increased cleavage of CASP3 protein]; KN 93 promotes the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein] KN 93 inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]] KN 93 inhibits the reaction [bisphenol A results in increased expression of and results in increased cleavage of CASP3 protein]; KN 93 inhibits the reaction [GW 7845 results in increased activity of CASP3 protein]; KN 93 inhibits the reaction [Vincristine results in increased cleavage of CASP3 protein]
CTD
PMID:19233221 PMID:20810541 PMID:26096086 PMID:26923100 PMID:28025122 PMID:29883672 PMID:34286406 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Ccl1
C-C motif chemokine ligand 1
multiple interactions
ISO
KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL1 mRNA]
CTD
PMID:18089838
NCBI chr10:67,625,962...67,628,740
Ensembl chr10:67,128,331...67,131,159
G
Ccnd1
cyclin D1
decreases expression
ISO
KN 93 results in decreased expression of CCND1 protein
CTD
PMID:15958590
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP
KN 93 inhibits the reaction [Capsaicin results in increased phosphorylation of CREB1 protein]; KN 93 inhibits the reaction [Nicotine results in increased phosphorylation of CREB1 protein]
CTD
PMID:15385614 PMID:15631885 PMID:21113126
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Csf1r
colony stimulating factor 1 receptor
multiple interactions
ISO
KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of NFATC1 protein]
CTD
PMID:32522522
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415
G
Cxcl12
C-X-C motif chemokine ligand 12
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in increased expression of CXCL12 mRNA]
CTD
PMID:34286406
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cycs
cytochrome c, somatic
multiple interactions
ISO
KN 93 inhibits the reaction [GW 7845 affects the localization of CYCS protein]
CTD
PMID:20810541
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
multiple interactions
ISO
KN 93 inhibits the reaction [Potassium results in increased expression of CYP11B2 mRNA]
CTD
PMID:12193581
NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:106,808,559...106,814,048
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO EXP
KN 93 inhibits the reaction [STO 609 results in increased activity of CYP1A1 protein]; KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]
CTD
PMID:18089838 PMID:18755850 PMID:23298284
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]
CTD
PMID:18089838
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions decreases expression
EXP ISO
KN 93 inhibits the reaction [cadmium acetate results in increased expression of DDIT3 protein] KN 93 results in decreased expression of DDIT3 protein
CTD
PMID:29883672 PMID:37075931
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Drd3
dopamine receptor D3
multiple interactions
EXP
KN 93 inhibits the reaction [Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]]; KN 93 inhibits the reaction [Excitatory Amino Acid Agents promotes the reaction [CAMK2A protein binds to DRD3 protein]]; KN 93 inhibits the reaction [Ionomycin promotes the reaction [CAMK2A protein binds to DRD3 protein]]; KN 93 inhibits the reaction [Ionomycin promotes the reaction [CAMK2A protein modified form binds to DRD3 protein]]; KN 93 inhibits the reaction [Ionomycin results in increased phosphorylation of DRD3 protein]
CTD
PMID:19217379
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596
G
Egfr
epidermal growth factor receptor
multiple interactions
EXP ISO
KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EGFR protein] KN 93 inhibits the reaction [carvacrol results in increased phosphorylation of EGFR protein]
CTD
PMID:19233221 PMID:32535744
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
EXP
KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein]
CTD
PMID:21933187
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:64,790,226...64,805,984
G
Foxo3
forkhead box O3
multiple interactions
ISO
KN 93 inhibits the reaction [Cadmium Chloride results in decreased activity of FOXO3 protein]; KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of FOXO3 protein]
CTD
PMID:23673518
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561
G
Gfap
glial fibrillary acidic protein
multiple interactions
EXP ISO
KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] KN 93 inhibits the reaction [Vincristine results in increased expression of GFAP protein]
CTD
PMID:21879721 PMID:34286406
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
G
Gja1
gap junction protein, alpha 1
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in increased expression of GJA1 mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of GJA1 protein]
CTD
PMID:34286406
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Gpx4
glutathione peroxidase 4
decreases expression
ISO
KN 93 results in decreased expression of GPX4 protein
CTD
PMID:37075931
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:9,650,185...9,652,982
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
multiple interactions
EXP
KN 93 inhibits the reaction [Capsaicin results in increased phosphorylation of GRIA1 protein]
CTD
PMID:12019337
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Hdac5
histone deacetylase 5
multiple interactions
ISO
KN 93 inhibits the reaction [Potassium Chloride results in increased phosphorylation of HDAC5 protein]
CTD
PMID:17988634
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,152,978...87,188,235
G
Hexb
hexosaminidase subunit beta
multiple interactions
EXP
KN 93 inhibits the reaction [Ionomycin results in increased secretion of HEXB protein]
CTD
PMID:14499669
NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:28,484,012...28,504,223
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
KN 93 inhibits the reaction [Digoxin affects the localization of HIF1A protein]; KN 93 inhibits the reaction [Digoxin results in increased phosphorylation of HIF1A protein]; KN 93 inhibits the reaction [Ouabain affects the localization of HIF1A protein]; KN 93 inhibits the reaction [Ouabain results in increased phosphorylation of HIF1A protein]
CTD
PMID:19647009
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
KN 93 inhibits the reaction [rutacarpine results in increased expression of HMOX1 mRNA]; KN 93 inhibits the reaction [rutacarpine results in increased expression of HMOX1 protein]
CTD
PMID:28025122
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
EXP
KN 93 inhibits the reaction [cadmium acetate results in increased expression of HSPA5 protein]
CTD
PMID:29883672
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Il1b
interleukin 1 beta
multiple interactions
ISO
KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B mRNA] KN 93 inhibits the reaction [Vincristine results in increased expression of IL1B mRNA]
CTD
PMID:18089838 PMID:34286406
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
multiple interactions
ISO
KN 93 inhibits the reaction [Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein]]
CTD
PMID:11809870
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in increased expression of IL6 mRNA]
CTD
PMID:34286406
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Itgb7
integrin subunit beta 7
multiple interactions
ISO
KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ITGB7 mRNA]
CTD
PMID:18089838
NCBI chr 7:135,225,962...135,243,522
Ensembl chr 7:133,347,960...133,364,876
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
multiple interactions
EXP
KN 93 inhibits the reaction [Phenylephrine results in increased activity of MAP3K5 protein]
CTD
PMID:15629441
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO EXP
KN 93 inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK1 protein]; KN 93 promotes the reaction [wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK1 protein]]; wortmannin promotes the reaction [KN 93 inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK1 protein]] KN 93 affects the reaction [Ptychodiscus brevis T2 toxin affects the phosphorylation of MAPK1 protein] KN 93 inhibits the reaction [cadmium acetate results in increased phosphorylation of MAPK1 protein]; KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein]; KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of MAPK1 protein]; KN 93 inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased phosphorylation of MAPK1 protein]
CTD
PMID:15086530 PMID:15355987 PMID:19233221 PMID:21879721 PMID:21933187 PMID:28181390 PMID:29883672 More...
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
EXP
KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK14 protein]
CTD
PMID:21933187
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO EXP
KN 93 inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK3 protein]; KN 93 promotes the reaction [wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK3 protein]]; wortmannin promotes the reaction [KN 93 inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK3 protein]] KN 93 affects the reaction [Ptychodiscus brevis T2 toxin affects the phosphorylation of MAPK3 protein] KN 93 inhibits the reaction [cadmium acetate results in increased phosphorylation of MAPK3 protein]; KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK3 protein]; KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of MAPK3 protein]; KN 93 inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased phosphorylation of MAPK3 protein]
CTD
PMID:15086530 PMID:15355987 PMID:19233221 PMID:21879721 PMID:21933187 PMID:28181390 PMID:29883672 More...
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
EXP
KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein]
CTD
PMID:21933187
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Myh7
myosin heavy chain 7
multiple interactions
EXP
Curcumin promotes the reaction [KN 93 inhibits the reaction [Caffeine results in increased expression of MYH7 mRNA]]; KN 93 inhibits the reaction [Caffeine results in increased expression of MYH7 mRNA]; KN 93 promotes the reaction [Curcumin inhibits the reaction [Caffeine results in increased expression of MYH7 mRNA]]
CTD
PMID:25093688
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:28,446,550...28,468,217
G
Nefl
neurofilament light chain
multiple interactions
EXP
KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein]
CTD
PMID:21879721
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
multiple interactions
EXP
KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFM protein]
CTD
PMID:21879721
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:42,360,454...42,365,755
G
Nfatc1
nuclear factor of activated T-cells 1
multiple interactions
ISO
KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of NFATC1 protein]
CTD
PMID:32522522
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:74,046,904...74,156,028
G
Nfatc2
nuclear factor of activated T-cells 2
decreases expression
ISO
KN 93 results in decreased expression of NFATC2 protein
CTD
PMID:37075931
NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:157,198,872...157,328,325
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
KN 93 inhibits the reaction [Phenylephrine results in increased degradation of NFKBIA protein]
CTD
PMID:15629441
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
KN 93 inhibits the reaction [Glyburide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]
CTD
PMID:27246103
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in increased expression of PTGS2 mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of PTGS2 protein]
CTD
PMID:34286406
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
KN 93 results in decreased phosphorylation of RB1 protein
CTD
PMID:15958590
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in increased phosphorylation of RELA protein]
CTD
PMID:34286406
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
EXP
KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]
CTD
PMID:21933187
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908
G
Slc7a11
solute carrier family 7 member 11
multiple interactions
ISO
KN 93 inhibits the reaction [Silicon Dioxide results in decreased expression of SLC7A11 protein]
CTD
PMID:37075931
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
EXP
KN 93 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of SRC protein]
CTD
PMID:19233221
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Tgfa
transforming growth factor alpha
multiple interactions
ISO
KN 93 inhibits the reaction [carvacrol results in increased secretion of TGFA protein]
CTD
PMID:32535744
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:118,618,269...118,700,894
G
Tnf
tumor necrosis factor
multiple interactions
ISO
KN 93 inhibits the reaction [Vincristine results in increased expression of TNF mRNA]
CTD
PMID:34286406
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf11
TNF superfamily member 11
multiple interactions
ISO
KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of NFATC1 protein]; KN 93 inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]
CTD
PMID:21869564 PMID:32522522
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
G
Vim
vimentin
multiple interactions
EXP
KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein]
CTD
PMID:21879721
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Wnt5a
Wnt family member 5A
multiple interactions
ISO
KN 93 inhibits the reaction [Silicon Dioxide results in increased expression of WNT5A protein]
CTD
PMID:37075931
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,697,032...3,718,234
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation
ISO
Ku 0063794 results in decreased phosphorylation of AKT1 protein
CTD
PMID:22885370
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
ISO
[Ku 0063794 co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] results in decreased phosphorylation of EIF4EBP1 protein; [Ku 0063794 co-treated with AZD 6244] results in decreased phosphorylation of EIF4EBP1 protein; [Ku 0063794 co-treated with mirdametinib] results in decreased phosphorylation of EIF4EBP1 protein; Ku 0063794 inhibits the reaction [dactolisib results in decreased phosphorylation of EIF4EBP1 protein]
CTD
PMID:22415236
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:64,790,226...64,805,984
G
Rps6
ribosomal protein S6
multiple interactions decreases phosphorylation
ISO
[Ku 0063794 co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] results in decreased phosphorylation of RPS6 protein Ku 0063794 results in decreased phosphorylation of RPS6 protein
CTD
PMID:22415236 PMID:22885370
NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases transport
ISO
methoxyfenozide inhibits the reaction [ABCB1 protein results in increased transport of Quinidine] ABCB1 protein results in increased transport of methoxyfenozide
CTD
PMID:26995013
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Slc5a5
solute carrier family 5 member 5
multiple interactions
EXP ISO
methoxyfenozide inhibits the reaction [SLC5A5 protein results in increased uptake of Iodides]
CTD
PMID:32065294
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,546,709...18,556,697
G
Drd2
dopamine receptor D2
affects response to substance affects binding multiple interactions
ISO EXP
DRD2 promoter polymorphism affects the susceptibility to nemonapride nemonapride binds to DRD2 protein Cinnarizine inhibits the reaction [nemonapride binds to DRD2 protein]; Flunarizine inhibits the reaction [nemonapride binds to DRD2 protein]
CTD
PMID:7503767 PMID:11505224
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd4
dopamine receptor D4
affects binding
ISO
nemonapride binds to DRD4 protein
CTD
PMID:31323226
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Akt1
AKT serine/threonine kinase 1
decreases expression
ISO
2-anisidine results in decreased expression of AKT1 mRNA
CTD
PMID:28089782
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Bcl10
BCL10, immune signaling adaptor
affects expression
ISO
2-anisidine affects the expression of BCL10 mRNA
CTD
PMID:28089782
NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:234,840,858...234,850,523
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
2-anisidine results in decreased expression of BCL2 mRNA
CTD
PMID:28089782
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl3
BCL3, transcription coactivator
affects expression
ISO
2-anisidine affects the expression of BCL3 mRNA
CTD
PMID:28089782
NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:79,471,369...79,485,607
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
2-anisidine results in decreased expression of BIRC5 mRNA
CTD
PMID:28089782
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Btrc
beta-transducin repeat containing E3 ubiquitin protein ligase
increases expression
ISO
2-anisidine results in increased expression of BTRC mRNA
CTD
PMID:28089782
NCBI chr 1:254,159,085...254,324,819
Ensembl chr 1:244,210,314...244,376,721
G
Card10
caspase recruitment domain family, member 10
decreases expression
ISO
2-anisidine results in decreased expression of CARD10 mRNA
CTD
PMID:28089782
NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:110,330,408...110,359,224
G
Card14
caspase recruitment domain family, member 14
decreases expression
ISO
2-anisidine results in decreased expression of CARD14 mRNA
CTD
PMID:28089782
NCBI chr10:105,064,941...105,100,132
Ensembl chr10:104,566,424...104,601,905
G
Ccl20
C-C motif chemokine ligand 20
affects expression
ISO
2-anisidine affects the expression of CCL20 mRNA
CTD
PMID:28089782
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
G
Ccl3
C-C motif chemokine ligand 3
increases expression
ISO
2-anisidine results in increased expression of CCL3 mRNA
CTD
PMID:28089782
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
2-anisidine results in increased expression of CCL5 mRNA
CTD
PMID:28089782
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Cd40
CD40 molecule
affects expression
ISO
2-anisidine affects the expression of CD40 mRNA
CTD
PMID:28089782
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd83
CD83 molecule
decreases expression
ISO
2-anisidine results in decreased expression of CD83 mRNA
CTD
PMID:28089782
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:20,887,309...20,907,083
G
Creb1
cAMP responsive element binding protein 1
affects expression
ISO
2-anisidine affects the expression of CREB1 mRNA
CTD
PMID:28089782
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crebbp
CREB binding protein
increases expression
ISO
2-anisidine results in increased expression of CREBBP mRNA
CTD
PMID:28089782
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Csf1
colony stimulating factor 1
increases expression
ISO
2-anisidine results in increased expression of CSF1 mRNA
CTD
PMID:28089782
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704
G
Csf3
colony stimulating factor 3
affects expression
ISO
2-anisidine affects the expression of CSF3 mRNA
CTD
PMID:28089782
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Cxcl1
C-X-C motif chemokine ligand 1
affects expression
ISO
2-anisidine affects the expression of CXCL1 mRNA
CTD
PMID:28089782
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
decreases expression
ISO
2-anisidine results in decreased expression of CXCL2 mRNA
CTD
PMID:28089782
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
affects expression
ISO
2-anisidine affects the expression of CXCL1 mRNA
CTD
PMID:28089782
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases oxidation increases expression
EXP ISO
CYP1A1 protein results in increased oxidation of 2-anisidine 2-anisidine results in increased expression of CYP1A1 mRNA 2-anisidine results in increased expression of CYP1A1; 2-anisidine results in increased expression of CYP1A1 protein
CTD
PMID:11409192 PMID:15828049 PMID:16601807 PMID:28089782
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression increases oxidation
EXP ISO
2-anisidine results in increased expression of CYP1A2 CYP1A2 protein results in increased oxidation of 2-anisidine
CTD
PMID:11409192 PMID:15828049
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases oxidation
EXP
CYP2B2 protein results in increased oxidation of 2-anisidine
CTD
PMID:16601807
NCBI chr 1:90,722,243...90,736,272
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases oxidation
ISO
CYP2B6 protein results in increased oxidation of 2-anisidine
CTD
PMID:15828049
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases oxidation
ISO
CYP2D6 protein results in increased oxidation of 2-anisidine
CTD
PMID:15828049
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases oxidation
ISO
CYP2E1 protein results in increased oxidation of 2-anisidine
CTD
PMID:15828049
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases oxidation
ISO
CYP3A4 protein results in increased oxidation of 2-anisidine
CTD
PMID:15828049
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Edaradd
EDAR associated via death domain
affects expression
ISO
2-anisidine affects the expression of EDARADD mRNA
CTD
PMID:28089782
NCBI chr17:92,850,791...92,894,808
Ensembl chr17:85,656,905...85,910,447
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
decreases expression
ISO
2-anisidine results in decreased expression of ENPP2 mRNA
CTD
PMID:28089782
NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:86,202,350...86,324,827
G
Fadd
Fas associated via death domain
affects expression
ISO
2-anisidine affects the expression of FADD mRNA
CTD
PMID:28089782
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Hmgb1
high mobility group box 1
increases expression
ISO
2-anisidine results in increased expression of HMGB1 protein
CTD
PMID:28089782
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
2-anisidine results in increased expression of HSPA6 mRNA
CTD
PMID:28089782
NCBI chr13:85,805,911...85,807,052
G
Icam1
intercellular adhesion molecule 1
affects expression
ISO
2-anisidine affects the expression of ICAM1 mRNA
CTD
PMID:28089782
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Ier3
immediate early response 3
affects expression
ISO
2-anisidine affects the expression of IER3 mRNA
CTD
PMID:28089782
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,928,378...2,929,583
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
affects expression
ISO
2-anisidine affects the expression of IKBKB mRNA
CTD
PMID:28089782
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
affects expression
ISO
2-anisidine affects the expression of IKBKG mRNA
CTD
PMID:28089782
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:152,216,596...152,239,499
G
Il12a
interleukin 12A
increases expression
ISO
2-anisidine results in increased expression of IL12A mRNA
CTD
PMID:28089782
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:152,965,769...152,972,734
G
Il1b
interleukin 1 beta
increases expression
ISO
2-anisidine results in increased expression of IL1B mRNA
CTD
PMID:28089782
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
increases expression
ISO
2-anisidine results in increased expression of IL1R1 mRNA
CTD
PMID:28089782
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:42,504,735...42,579,937
G
Il2
interleukin 2
increases expression
ISO
2-anisidine results in increased expression of IL2 mRNA
CTD
PMID:28089782
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il2ra
interleukin 2 receptor subunit alpha
decreases expression
ISO
2-anisidine results in decreased expression of IL2RA mRNA
CTD
PMID:28089782
NCBI chr17:71,759,802...71,808,475
Ensembl chr17:66,849,974...66,898,697
G
Il5
interleukin 5
increases expression
ISO
2-anisidine results in increased expression of IL5 mRNA
CTD
PMID:28089782
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
increases expression
ISO
2-anisidine results in increased expression of IL6 mRNA
CTD
PMID:28089782
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Irak1
interleukin-1 receptor-associated kinase 1
decreases expression
ISO
2-anisidine results in decreased expression of IRAK1 mRNA
CTD
PMID:28089782
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
G
Irak1bp1
interleukin-1 receptor-associated kinase 1 binding protein 1
decreases expression
ISO
2-anisidine results in decreased expression of IRAK1BP1 mRNA
CTD
PMID:28089782
NCBI chr 8:92,608,468...92,628,377
Ensembl chr 8:83,731,507...83,748,289
G
Irak2
interleukin-1 receptor-associated kinase 2
affects expression
ISO
2-anisidine affects the expression of IRAK2 mRNA
CTD
PMID:28089782
NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:146,786,100...146,842,602
G
Ltbr
lymphotoxin beta receptor
decreases expression
ISO
2-anisidine results in decreased expression of LTBR mRNA
CTD
PMID:28089782
NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:158,108,886...158,121,539
G
Malt1
MALT1 paracaspase
increases expression
ISO
2-anisidine results in increased expression of MALT1 mRNA
CTD
PMID:28089782
NCBI chr18:61,212,290...61,266,272
Ensembl chr18:58,942,299...58,994,260
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
decreases expression
ISO
2-anisidine results in decreased expression of MAP3K1 mRNA
CTD
PMID:28089782
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:43,350,098...43,414,463
G
Map3k14
mitogen-activated protein kinase kinase kinase 14
decreases expression
ISO
2-anisidine results in decreased expression of MAP3K14 mRNA
CTD
PMID:28089782
NCBI chr10:88,665,417...88,715,669
Ensembl chr10:88,165,351...88,215,523
G
Map3k7
mitogen activated protein kinase kinase kinase 7
decreases expression
ISO
2-anisidine results in decreased expression of MAP3K7 mRNA
CTD
PMID:28089782
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mpo
myeloperoxidase
multiple interactions
ISO
[[MPO protein co-treated with Hydrogen Peroxide co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased metabolism of 2-anisidine] which results in increased expression of MPO protein modified form; [MPO protein co-treated with Hydrogen Peroxide co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased metabolism of 2-anisidine
CTD
PMID:20199096
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
2-anisidine results in decreased expression of MYC mRNA
CTD
PMID:28089782
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Myd88
MYD88, innate immune signal transduction adaptor
decreases expression
ISO
2-anisidine results in decreased expression of MYD88 mRNA
CTD
PMID:28089782
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Nat1
N-acetyltransferase 1
increases activity
ISO
NAT1 protein results in increased activity of 2-anisidine
CTD
PMID:15450435
NCBI chr16:26,984,882...27,005,194
Ensembl chr16:22,208,194...22,238,520
G
Nat2
N-acetyltransferase 2
increases activity
ISO
NAT2 protein results in increased activity of 2-anisidine
CTD
PMID:15450435
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:22,208,194...22,238,520
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
2-anisidine results in decreased expression of NFKB1 mRNA
CTD
PMID:28089782
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
affects expression
ISO
2-anisidine affects the expression of NFKB2 mRNA
CTD
PMID:28089782
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbia
NFKB inhibitor alpha
affects expression
ISO
2-anisidine affects the expression of NFKBIA mRNA
CTD
PMID:28089782
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbib
NFKB inhibitor beta
affects expression
ISO
2-anisidine affects the expression of NFKBIB mRNA
CTD
PMID:28089782
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:84,046,295...84,053,862
G
Nfkbie
NFKB inhibitor epsilon
affects expression
ISO
2-anisidine affects the expression of NFKBIE mRNA
CTD
PMID:28089782
NCBI chr 9:22,941,037...22,947,872
Ensembl chr 9:15,436,941...15,450,437
G
Nkiras1
NFKB inhibitor interacting Ras-like 1
affects expression
ISO
2-anisidine affects the expression of NKIRAS1 mRNA
CTD
PMID:28089782
NCBI chr15:7,493,531...7,503,758
Ensembl chr15:7,493,531...7,503,854
G
Nkiras2
NFKB inhibitor interacting Ras-like 2
decreases expression
ISO
2-anisidine results in decreased expression of NKIRAS2 mRNA
CTD
PMID:28089782
NCBI chr10:85,554,704...85,562,072
Ensembl chr10:85,557,944...85,562,072
G
Nos2
nitric oxide synthase 2
increases expression
ISO
2-anisidine results in increased expression of NOS2 mRNA
CTD
PMID:28089782
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP ISO
2-anisidine results in increased expression of NQO1 2-anisidine results in increased expression of NQO1 mRNA
CTD
PMID:11409192 PMID:28089782
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Ptafr
platelet-activating factor receptor
affects expression
ISO
2-anisidine affects the expression of PTAFR mRNA
CTD
PMID:28089782
NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:144,765,976...144,795,251
G
Ptges
prostaglandin E synthase
increases expression
ISO
2-anisidine results in increased expression of PTGES mRNA
CTD
PMID:28089782
NCBI chr 3:34,575,643...34,586,987
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
2-anisidine results in increased expression of PTGS2 mRNA
CTD
PMID:28089782
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rel
REL proto-oncogene, NF-kB subunit
affects expression
ISO
2-anisidine affects the expression of REL mRNA
CTD
PMID:28089782
NCBI chr14:101,891,238...101,922,324
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
affects expression
ISO
2-anisidine affects the expression of RELA mRNA
CTD
PMID:28089782
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
decreases expression
ISO
2-anisidine results in decreased expression of RELB mRNA
CTD
PMID:28089782
NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:79,257,725...79,285,507
G
Ripk1
receptor interacting serine/threonine kinase 1
increases expression
ISO
2-anisidine results in increased expression of RIPK1 mRNA
CTD
PMID:28089782
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:30,839,650...30,871,824
G
Sele
selectin E
increases expression
ISO
2-anisidine results in increased expression of SELE mRNA
CTD
PMID:28089782
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
G
Stat1
signal transducer and activator of transcription 1
decreases expression
ISO
2-anisidine results in decreased expression of STAT1 mRNA
CTD
PMID:28089782
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Tab1
TGF-beta activated kinase 1/MAP3K7 binding protein 1
decreases expression
ISO
2-anisidine results in decreased expression of TAB1 mRNA
CTD
PMID:28089782
NCBI chr 7:113,556,157...113,587,351
Ensembl chr 7:111,686,371...111,707,058
G
Tbk1
TANK-binding kinase 1
decreases expression
ISO
2-anisidine results in decreased expression of TBK1 mRNA
CTD
PMID:28089782
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:57,077,830...57,110,892
G
Tlr1
toll-like receptor 1
increases expression
ISO
2-anisidine results in increased expression of TLR1 mRNA
CTD
PMID:28089782
NCBI chr14:43,737,761...43,750,389
Ensembl chr14:43,384,932...43,397,125
G
Tlr2
toll-like receptor 2
decreases expression
ISO
2-anisidine results in decreased expression of TLR2 mRNA
CTD
PMID:28089782
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
decreases expression
ISO
2-anisidine results in decreased expression of TLR3 mRNA
CTD
PMID:28089782
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
affects expression
ISO
2-anisidine affects the expression of TLR4 mRNA
CTD
PMID:28089782
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tlr6
toll-like receptor 6
decreases expression
ISO
2-anisidine results in decreased expression of TLR6 mRNA
CTD
PMID:28089782
NCBI chr14:43,715,809...43,727,019
Ensembl chr14:43,362,164...43,375,685
G
Tlr9
toll-like receptor 9
affects expression
ISO
2-anisidine affects the expression of TLR9 mRNA
CTD
PMID:28089782
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
affects expression
ISO
2-anisidine affects the expression of TNF mRNA
CTD
PMID:28089782
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
affects expression
ISO
2-anisidine affects the expression of TNFAIP3 mRNA
CTD
PMID:28089782
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
2-anisidine results in increased expression of TNFRSF10A mRNA
CTD
PMID:28089782
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf11a
TNF receptor superfamily member 11A
decreases expression
ISO
2-anisidine results in decreased expression of TNFRSF11A mRNA
CTD
PMID:28089782
NCBI chr13:22,442,930...22,501,257
Ensembl chr13:21,928,408...21,986,695
G
Tnfrsf1a
TNF receptor superfamily member 1A
decreases expression
ISO
2-anisidine results in decreased expression of TNFRSF1A mRNA
CTD
PMID:28089782
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnfsf11
TNF superfamily member 11
increases expression
ISO
2-anisidine results in increased expression of TNFSF11 mRNA
CTD
PMID:28089782
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
G
Tnfsf15
TNF superfamily member 15
decreases expression
ISO
2-anisidine results in decreased expression of TNFSF15 mRNA
CTD
PMID:28089782
NCBI chr 5:82,150,376...82,171,743
Ensembl chr 5:77,139,878...77,156,228
G
Tpo
thyroid peroxidase
decreases activity
EXP
2-anisidine results in decreased activity of TPO protein
CTD
PMID:26884060
NCBI chr 6:52,425,998...52,495,793
Ensembl chr 6:46,698,414...46,768,199
G
Tradd
TNFRSF1A-associated via death domain
decreases expression
ISO
2-anisidine results in decreased expression of TRADD mRNA
CTD
PMID:28089782
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:33,136,138...33,142,638
G
Traf2
Tnf receptor-associated factor 2
decreases expression
ISO
2-anisidine results in decreased expression of TRAF2 mRNA
CTD
PMID:28089782
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:8,341,951...8,366,538
G
Traf3
Tnf receptor-associated factor 3
decreases expression
ISO
2-anisidine results in decreased expression of TRAF3 mRNA
CTD
PMID:28089782
NCBI chr 6:136,025,097...136,128,363
Ensembl chr 6:130,206,484...130,305,481
G
Traf4
Tnf receptor associated factor 4
affects expression
ISO
2-anisidine affects the expression of TRAF4 mRNA
CTD
PMID:28089782
NCBI chr10:63,552,251...63,558,356
Ensembl chr10:63,054,181...63,060,284
G
Traf5
TNF receptor-associated factor 5
increases expression
ISO
2-anisidine results in increased expression of TRAF5 mRNA
CTD
PMID:28089782
NCBI chr13:106,100,921...106,149,724
Ensembl chr13:103,572,314...103,618,709
G
Vcam1
vascular cell adhesion molecule 1
decreases expression
ISO
2-anisidine results in decreased expression of VCAM1 mRNA
CTD
PMID:28089782
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Aass
aminoadipate-semialdehyde synthase
decreases expression
ISO
methyleugenol results in decreased expression of AASS mRNA
CTD
PMID:32234424
NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:51,606,462...51,663,136
G
Abat
4-aminobutyrate aminotransferase
decreases expression
ISO
methyleugenol results in decreased expression of ABAT mRNA
CTD
PMID:32234424
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:6,999,819...7,092,835
G
Abca1
ATP binding cassette subfamily A member 1
decreases expression
ISO
methyleugenol results in decreased expression of ABCA1 mRNA
CTD
PMID:32234424
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
G
Abca6
ATP binding cassette subfamily A member 6
decreases expression
ISO
methyleugenol results in decreased expression of ABCA6 mRNA
CTD
PMID:32234424
NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,142,966...95,211,530
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression
ISO
methyleugenol results in decreased expression of ABCB11 mRNA
CTD
PMID:32234424
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730
G
Abcb4
ATP binding cassette subfamily B member 4
decreases expression
ISO
methyleugenol results in decreased expression of ABCB4 mRNA
CTD
PMID:32234424
NCBI chr 4:26,106,895...26,164,440
Ensembl chr 4:25,151,953...25,209,202
G
Abcc6
ATP binding cassette subfamily C member 6
decreases expression
ISO
methyleugenol results in decreased expression of ABCC6 mRNA
CTD
PMID:32234424
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:96,447,251...96,501,464
G
Abcc9
ATP binding cassette subfamily C member 9
decreases expression
ISO
methyleugenol results in decreased expression of ABCC9 mRNA
CTD
PMID:32234424
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:175,532,547...175,655,356
G
Abcg5
ATP binding cassette subfamily G member 5
decreases expression
ISO
methyleugenol results in decreased expression of ABCG5 mRNA
CTD
PMID:32234424
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
decreases expression
ISO
methyleugenol results in decreased expression of ABCG8 mRNA
CTD
PMID:32234424
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:9,945,629...9,964,912
G
Abhd2
abhydrolase domain containing 2, acylglycerol lipase
decreases expression
ISO
methyleugenol results in decreased expression of ABHD2 mRNA
CTD
PMID:32234424
NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:133,217,375...133,299,061
G
Acaa1a
acetyl-CoA acyltransferase 1A
decreases expression
ISO
methyleugenol results in decreased expression of ACAA1 mRNA
CTD
PMID:32234424
NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:119,079,775...119,088,624
G
Acacb
acetyl-CoA carboxylase beta
decreases expression
ISO
methyleugenol results in decreased expression of ACACB mRNA
CTD
PMID:32234424
NCBI chr12:48,026,394...48,138,214
Ensembl chr12:42,366,548...42,457,655
G
Acat2
acetyl-CoA acetyltransferase 2
decreases expression
ISO
methyleugenol results in decreased expression of ACAT2 mRNA
CTD
PMID:32234424
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:47,695,788...47,752,821
G
Ache
acetylcholinesterase
increases expression
ISO
methyleugenol results in increased expression of ACHE mRNA
CTD
PMID:32234424
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Acmsd
aminocarboxymuconate semialdehyde decarboxylase
decreases expression
ISO
methyleugenol results in decreased expression of ACMSD mRNA
CTD
PMID:32234424
NCBI chr13:41,752,894...41,798,427
Ensembl chr13:39,200,314...39,245,209
G
Acot1
acyl-CoA thioesterase 1
decreases expression
ISO
methyleugenol results in decreased expression of ACOT1 mRNA
CTD
PMID:32234424
NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:103,636,041...103,644,163
G
Acot11
acyl-CoA thioesterase 11
decreases expression
ISO
methyleugenol results in decreased expression of ACOT11 mRNA
CTD
PMID:32234424
NCBI chr 5:121,523,833...121,581,699
Ensembl chr 5:121,527,435...121,581,538
G
Acot12
acyl-CoA thioesterase 12
decreases expression
ISO
methyleugenol results in decreased expression of ACOT12 mRNA
CTD
PMID:32234424
NCBI chr 2:24,721,648...24,763,686
Ensembl chr 2:22,986,626...23,027,536
G
Acox2
acyl-CoA oxidase 2
decreases expression
ISO
methyleugenol results in decreased expression of ACOX2 mRNA
CTD
PMID:32234424
NCBI chr15:19,090,820...19,122,392
Ensembl chr15:16,660,272...16,692,160
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
ISO
methyleugenol results in decreased expression of ACSL1 mRNA
CTD
PMID:32234424
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:45,755,254...45,821,541
G
Acsl4
acyl-CoA synthetase long-chain family member 4
decreases expression
ISO
methyleugenol results in decreased expression of ACSL4 mRNA
CTD
PMID:32234424
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:105,942,799...106,006,427
G
Acsl5
acyl-CoA synthetase long-chain family member 5
decreases expression
ISO
methyleugenol results in decreased expression of ACSL5 mRNA
CTD
PMID:32234424
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:254,292,521...254,336,607
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
decreases expression
ISO
methyleugenol results in decreased expression of ACSM2A mRNA
CTD
PMID:32234424
NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:173,916,368...173,955,116
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
decreases expression
ISO
methyleugenol results in decreased expression of ACSM3 mRNA
CTD
PMID:32234424
NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:174,133,288...174,160,184
G
Acsm5
acyl-CoA synthetase medium-chain family member 5
decreases expression
ISO
methyleugenol results in decreased expression of ACSM5 mRNA
CTD
PMID:32234424
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
G
Acss1
acyl-CoA synthetase short-chain family member 1
decreases expression
ISO
methyleugenol results in decreased expression of ACSS1 mRNA
CTD
PMID:32234424
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:139,450,383...139,500,325
G
Acss2
acyl-CoA synthetase short-chain family member 2
decreases expression
ISO
methyleugenol results in decreased expression of ACSS2 mRNA
CTD
PMID:32234424
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:144,004,336...144,059,675
G
Actl10
actin-like 10
increases expression
ISO
methyleugenol results in increased expression of ACTL10 mRNA
CTD
PMID:32234424
NCBI chr 3:143,057,061...143,058,561
Ensembl chr 3:143,057,402...143,058,442
G
Acyp2
acylphosphatase 2
decreases expression
ISO
methyleugenol results in decreased expression of ACYP2 mRNA
CTD
PMID:32234424
NCBI chr14:108,402,837...108,572,367
Ensembl chr14:104,201,895...104,371,386
G
Adam19
ADAM metallopeptidase domain 19
increases expression
ISO
methyleugenol results in increased expression of ADAM19 mRNA
CTD
PMID:32234424
NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,491,405...30,583,105
G
Adamts17
ADAM metallopeptidase with thrombospondin type 1 motif, 17
decreases expression
ISO
methyleugenol results in decreased expression of ADAMTS17 mRNA
CTD
PMID:32234424
NCBI chr 1:129,856,062...130,178,430
Ensembl chr 1:120,445,749...120,768,202
G
Adamts3
ADAM metallopeptidase with thrombospondin type 1, motif 3
decreases expression
ISO
methyleugenol results in decreased expression of ADAMTS3 mRNA
CTD
PMID:32234424
NCBI chr14:18,515,249...18,721,887
Ensembl chr14:18,231,165...18,435,556
G
Adamts6
ADAM metallopeptidase with thrombospondin type 1 motif, 6
decreases expression
ISO
methyleugenol results in decreased expression of ADAMTS6 mRNA
CTD
PMID:32234424
NCBI chr 2:37,155,260...37,367,077
Ensembl chr 2:35,421,510...35,633,298
G
Adamtsl3
ADAMTS-like 3
decreases expression
ISO
methyleugenol results in decreased expression of ADAMTSL3 mRNA
CTD
PMID:32234424
NCBI chr 1:145,698,004...146,006,195
Ensembl chr 1:136,288,793...136,596,986
G
Adarb2
adenosine deaminase RNA specific B2
decreases expression
ISO
methyleugenol results in decreased expression of ADARB2 mRNA
CTD
PMID:32234424
NCBI chr17:66,660,586...67,211,104
Ensembl chr17:61,756,067...62,300,831
G
Adcy5
adenylate cyclase 5
decreases expression
ISO
methyleugenol results in decreased expression of ADCY5 mRNA
CTD
PMID:32234424
NCBI chr11:78,976,861...79,123,343
Ensembl chr11:65,471,612...65,618,974
G
Adcy8
adenylate cyclase 8
decreases expression
ISO
methyleugenol results in decreased expression of ADCY8 mRNA
CTD
PMID:32234424
NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:96,417,324...96,665,911
G
Adgrf4
adhesion G protein-coupled receptor F4
increases expression
ISO
methyleugenol results in increased expression of ADGRF4 mRNA
CTD
PMID:32234424
NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217
G
Adgrg1
adhesion G protein-coupled receptor G1
increases expression
ISO
methyleugenol results in increased expression of ADGRG1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,003,975...10,041,108
G
Adgrg7
adhesion G protein-coupled receptor G7
decreases expression
ISO
methyleugenol results in decreased expression of ADGRG7 mRNA
CTD
PMID:32234424
NCBI chr11:57,282,904...57,345,417
Ensembl chr11:43,813,801...43,876,316
G
Adgrv1
adhesion G protein-coupled receptor V1
decreases expression
ISO
methyleugenol results in decreased expression of ADGRV1 mRNA
CTD
PMID:32234424
NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:11,331,442...11,911,688
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
decreases expression
ISO
methyleugenol results in decreased expression of ADH4 mRNA
CTD
PMID:32234424
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:226,947,466...226,987,591
G
Adh6
alcohol dehydrogenase 6 (class V)
decreases expression
ISO
methyleugenol results in decreased expression of ADH6 mRNA
CTD
PMID:32234424
NCBI chr 2:229,576,612...229,608,359
Ensembl chr 2:226,903,250...226,934,534
G
Adk
adenosine kinase
decreases expression
ISO
methyleugenol results in decreased expression of ADK mRNA
CTD
PMID:32234424
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,863,244...3,246,510
G
Adra1a
adrenoceptor alpha 1A
decreases expression
ISO
methyleugenol results in decreased expression of ADRA1A mRNA
CTD
PMID:32234424
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:40,832,534...40,927,500
G
Aff2
ALF transcription elongation factor 2
decreases expression
ISO
methyleugenol results in decreased expression of AFF2 mRNA
CTD
PMID:32234424
NCBI chr X:152,972,579...153,477,080
Ensembl chr X:147,928,407...148,429,995
G
Aff3
ALF transcription elongation factor 3
decreases expression
ISO
methyleugenol results in decreased expression of AFF3 mRNA
CTD
PMID:32234424
NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:40,404,375...40,857,247
G
Afg1l
AFG1 like ATPase
decreases expression
ISO
methyleugenol results in decreased expression of AFG1L mRNA
CTD
PMID:32234424
NCBI chr20:47,380,582...47,550,307
Ensembl chr20:45,798,349...45,967,906
G
Afm
afamin
decreases expression
ISO
methyleugenol results in decreased expression of AFM mRNA
CTD
PMID:32234424
NCBI chr14:17,815,194...17,848,042
Ensembl chr14:17,531,024...17,563,870
G
Agmo
alkylglycerol monooxygenase
decreases expression
ISO
methyleugenol results in decreased expression of AGMO mRNA
CTD
PMID:32234424
NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623
G
Agpat2
1-acylglycerol-3-phosphate O-acyltransferase 2
decreases expression
ISO
methyleugenol results in decreased expression of AGPAT2 mRNA
CTD
PMID:32234424
NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:9,416,843...9,428,371
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
increases expression
ISO
methyleugenol results in increased expression of AGR2 mRNA
CTD
PMID:32234424
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Agt
angiotensinogen
decreases expression
ISO
methyleugenol results in decreased expression of AGT mRNA
CTD
PMID:32234424
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Agxt
alanine--glyoxylate aminotransferase
decreases expression
ISO
methyleugenol results in decreased expression of AGXT mRNA
CTD
PMID:32234424
NCBI chr 9:101,122,793...101,132,746
Ensembl chr 9:93,675,384...93,685,336
G
Agxt2
alanine-glyoxylate aminotransferase 2
decreases expression
ISO
methyleugenol results in decreased expression of AGXT2 mRNA
CTD
PMID:32234424
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:59,336,283...59,377,926
G
Ahsg
alpha-2-HS-glycoprotein
decreases expression
ISO
methyleugenol results in decreased expression of AHSG mRNA
CTD
PMID:32234424
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:78,117,918...78,145,999
G
Aig1
androgen-induced 1
decreases expression
ISO
methyleugenol results in decreased expression of AIG1 mRNA
CTD
PMID:32234424
NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:8,046,430...8,269,084
G
Akap12
A-kinase anchoring protein 12
increases expression
ISO
methyleugenol results in increased expression of AKAP12 mRNA
CTD
PMID:32234424
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:40,730,123...40,819,886
G
Akap6
A-kinase anchoring protein 6
decreases expression
ISO
methyleugenol results in decreased expression of AKAP6 mRNA
CTD
PMID:32234424
NCBI chr 6:75,919,350...76,359,667
Ensembl chr 6:70,184,175...70,619,738
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
ISO
methyleugenol results in increased expression of AKR1B1 mRNA
CTD
PMID:32234424
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
methyleugenol results in increased expression of AKR1B10 mRNA
CTD
PMID:32234424
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akr1b8
aldo-keto reductase family 1, member B8
increases expression
ISO
methyleugenol results in increased expression of AKR1B15 mRNA
CTD
PMID:32234424
NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:62,997,161...63,010,097
G
Akr1d1
aldo-keto reductase family 1, member D1
decreases expression
ISO
methyleugenol results in decreased expression of AKR1D1 mRNA
CTD
PMID:32234424
NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:66,154,248...66,186,372
G
Akr7a3
aldo-keto reductase family 7 member A3
decreases expression
ISO
methyleugenol results in decreased expression of AKR7A3 mRNA
CTD
PMID:32234424
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:151,584,479...151,601,394
G
Alb
albumin
decreases expression
ISO
methyleugenol results in decreased expression of ALB mRNA
CTD
PMID:32234424
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
increases expression
ISO
methyleugenol results in increased expression of ALDH3A1 mRNA
CTD
PMID:32234424
NCBI chr10:46,392,464...46,402,151
Ensembl chr10:45,892,924...45,902,681
G
Aldh4a1
aldehyde dehydrogenase 4 family, member A1
decreases expression
ISO
methyleugenol results in decreased expression of ALDH4A1 mRNA
CTD
PMID:32234424
NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:151,830,701...151,925,345
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
ISO
methyleugenol results in decreased expression of ALDH6A1 mRNA
CTD
PMID:32234424
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:104,077,979...104,098,656
G
Aldh8a1
aldehyde dehydrogenase 8 family, member A1
decreases expression
ISO
methyleugenol results in decreased expression of ALDH8A1 mRNA
CTD
PMID:32234424
NCBI chr 1:18,003,507...18,022,952
Ensembl chr 1:16,183,940...16,203,385
G
Aldob
aldolase, fructose-bisphosphate B
decreases expression
ISO
methyleugenol results in decreased expression of ALDOB mRNA
CTD
PMID:32234424
NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:63,889,046...63,902,116
G
Alox5
arachidonate 5-lipoxygenase
increases expression
ISO
methyleugenol results in increased expression of ALOX5 mRNA
CTD
PMID:32234424
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Alpk2
alpha-kinase 2
increases expression
ISO
methyleugenol results in increased expression of ALPK2 mRNA
CTD
PMID:32234424
NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258
G
Ambp
alpha-1-microglobulin/bikunin precursor
decreases expression
ISO
methyleugenol results in decreased expression of AMBP mRNA
CTD
PMID:32234424
NCBI chr 5:81,583,621...81,593,938
Ensembl chr 5:76,568,094...76,578,331
G
Amotl1
angiomotin-like 1
decreases expression
ISO
methyleugenol results in decreased expression of AMOTL1 mRNA
CTD
PMID:32234424
NCBI chr 8:19,630,139...19,749,027
Ensembl chr 8:11,353,674...11,467,573
G
Ang
angiogenin
decreases expression
ISO
methyleugenol results in decreased expression of ANG mRNA
CTD
PMID:32234424
NCBI chr15:26,786,233...26,796,883
G
Angptl3
angiopoietin-like 3
decreases expression
ISO
methyleugenol results in decreased expression of ANGPTL3 mRNA
CTD
PMID:32234424
NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:113,703,012...113,709,957
G
Angptl8
angiopoietin-like 8
decreases expression
ISO
methyleugenol results in decreased expression of ANGPTL8 mRNA
CTD
PMID:32234424
NCBI chr 8:28,652,555...28,654,581
Ensembl chr 8:20,376,462...20,378,490
G
Ank1
ankyrin 1
increases expression
ISO
methyleugenol results in increased expression of ANK1 mRNA
CTD
PMID:32234424
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:68,877,504...69,054,759
G
Ank2
ankyrin 2
decreases expression
ISO
methyleugenol results in decreased expression of ANK2 mRNA
CTD
PMID:32234424
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:215,379,680...215,862,923
G
Ankrd1
ankyrin repeat domain 1
decreases expression
ISO
methyleugenol results in decreased expression of ANKRD1 mRNA
CTD
PMID:32234424
NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:233,815,851...233,834,919
G
Ankrd2
ankyrin repeat domain 2
decreases expression
ISO
methyleugenol results in decreased expression of ANKRD2 mRNA
CTD
PMID:32234424
NCBI chr 1:250,796,419...250,805,867
Ensembl chr 1:240,847,072...240,856,566
G
Anks1b
ankyrin repeat and sterile alpha motif domain containing 1B
decreases expression
ISO
methyleugenol results in decreased expression of ANKS1B mRNA
CTD
PMID:32234424
NCBI chr 7:26,200,649...27,366,552
Ensembl chr 7:24,312,843...25,477,693
G
Ano1
anoctamin 1
decreases expression
ISO
methyleugenol results in decreased expression of ANO1 mRNA
CTD
PMID:32234424
NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:199,751,439...199,900,069
G
Ano4
anoctamin 4
decreases expression
ISO
methyleugenol results in decreased expression of ANO4 mRNA
CTD
PMID:32234424
NCBI chr 7:23,329,015...23,738,423
Ensembl chr 7:23,329,070...23,738,434
G
Anxa10
annexin A10
decreases expression
ISO
methyleugenol results in decreased expression of ANXA10 mRNA
CTD
PMID:32234424
NCBI chr16:32,505,025...32,571,961
Ensembl chr16:27,738,712...27,805,648
G
Anxa3
annexin A3
increases expression
ISO
methyleugenol results in increased expression of ANXA3 mRNA
CTD
PMID:32234424
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:12,719,795...12,781,617
G
Aoc1
amine oxidase, copper containing 1
decreases expression
ISO
methyleugenol results in decreased expression of AOC1 mRNA
CTD
PMID:32234424
NCBI chr 4:79,143,126...79,162,705
Ensembl chr 4:77,812,260...77,831,840
G
Apba1
amyloid beta precursor protein binding family A member 1
decreases expression
ISO
methyleugenol results in decreased expression of APBA1 mRNA
CTD
PMID:32234424
NCBI chr 1:230,790,297...230,995,986
Ensembl chr 1:221,363,778...221,566,553
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
decreases expression
ISO
methyleugenol results in decreased expression of APBB1IP mRNA
CTD
PMID:32234424
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
G
Apcdd1l
APC down-regulated 1 like
increases expression
ISO
methyleugenol results in increased expression of APCDD1L mRNA
CTD
PMID:32234424
NCBI chr 3:183,000,504...183,076,628
Ensembl chr 3:162,582,252...162,658,073
G
Apcs
amyloid P component, serum
decreases expression
ISO
methyleugenol results in decreased expression of APCS mRNA
CTD
PMID:32234424
NCBI chr13:87,905,532...87,906,508
Ensembl chr13:85,373,220...85,374,298
G
Apmap
adipocyte plasma membrane associated protein
decreases expression
ISO
methyleugenol results in decreased expression of APMAP mRNA
CTD
PMID:32234424
NCBI chr 3:159,869,451...159,897,727
Ensembl chr 3:139,409,022...139,437,341
G
Apoa1
apolipoprotein A1
decreases expression
ISO
methyleugenol results in decreased expression of APOA1 mRNA
CTD
PMID:32234424
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Apoa4
apolipoprotein A4
decreases expression
ISO
methyleugenol results in decreased expression of APOA4 mRNA
CTD
PMID:32234424
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:46,539,082...46,541,469
G
Apoa5
apolipoprotein A5
decreases expression
ISO
methyleugenol results in decreased expression of APOA5 mRNA
CTD
PMID:32234424
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:46,561,229...46,563,816
G
Apoc3
apolipoprotein C3
decreases expression
ISO
methyleugenol results in decreased expression of APOC3 mRNA
CTD
PMID:32234424
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583
G
Apoh
apolipoprotein H
decreases expression
ISO
methyleugenol results in decreased expression of APOH mRNA
CTD
PMID:32234424
NCBI chr10:93,841,992...93,855,897
Ensembl chr10:93,310,977...93,356,329
G
Apom
apolipoprotein M
decreases expression
ISO
methyleugenol results in decreased expression of APOM mRNA
CTD
PMID:32234424
NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,688,413...3,693,550
G
Aqp4
aquaporin 4
decreases expression
ISO
methyleugenol results in decreased expression of AQP4 mRNA
CTD
PMID:32234424
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
Aqp9
aquaporin 9
decreases expression
ISO
methyleugenol results in decreased expression of AQP9 mRNA
CTD
PMID:32234424
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:71,797,234...71,837,395
G
Arb2a
ARB2 cotranscriptional regulator A
decreases expression
ISO
methyleugenol results in decreased expression of ARB2A mRNA
CTD
PMID:32234424
NCBI chr 2:7,553,873...8,018,183
Ensembl chr 2:7,553,891...8,018,162
G
Arg1
arginase 1
decreases expression
ISO
methyleugenol results in decreased expression of ARG1 mRNA
CTD
PMID:32234424
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:20,475,968...20,488,422
G
Arhgap6
Rho GTPase activating protein 6
decreases expression
ISO
methyleugenol results in decreased expression of ARHGAP6 mRNA
CTD
PMID:32234424
NCBI chr X:28,525,912...29,062,344
Ensembl chr X:24,953,464...25,488,663
G
Arhgef37
Rho guanine nucleotide exchange factor 37
increases expression
ISO
methyleugenol results in increased expression of ARHGEF37 mRNA
CTD
PMID:32234424
NCBI chr18:54,935,256...55,001,017
Ensembl chr18:54,949,110...55,000,669
G
Arl14
ARF like GTPase 14
increases expression
ISO
methyleugenol results in increased expression of ARL14 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 2:153,468,863...153,470,102
Ensembl chr 2:153,468,977...153,469,555
G
Arrb1
arrestin, beta 1
increases expression
ISO
methyleugenol results in increased expression of ARRB1 mRNA
CTD
PMID:32234424
NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:153,838,078...153,904,061
G
Arsb
arylsulfatase B
decreases expression
ISO
methyleugenol results in decreased expression of ARSB mRNA
CTD
PMID:32234424
NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:25,002,346...25,162,671
G
Art3
ADP-ribosyltransferase 3
decreases expression
ISO
methyleugenol results in decreased expression of ART3 mRNA
CTD
PMID:32234424
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
G
Arvcf
ARVCF, delta catenin family member
increases expression
ISO
methyleugenol results in increased expression of ARVCF mRNA
CTD
PMID:32234424
NCBI chr11:96,092,451...96,150,144
Ensembl chr11:82,587,881...82,645,805
G
Asb4
ankyrin repeat and SOCS box-containing 4
decreases expression
ISO
methyleugenol results in decreased expression of ASB4 mRNA
CTD
PMID:32234424
NCBI chr 4:34,473,527...34,511,163
Ensembl chr 4:33,506,992...33,544,630
G
Asgr1
asialoglycoprotein receptor 1
decreases expression
ISO
methyleugenol results in decreased expression of ASGR1 mRNA
CTD
PMID:32234424
NCBI chr10:55,274,299...55,278,323
Ensembl chr10:54,776,024...54,779,631
G
Aspdh
aspartate dehydrogenase domain containing
decreases expression
ISO
methyleugenol results in decreased expression of ASPDH mRNA
CTD
PMID:32234424
NCBI chr 1:104,094,983...104,097,244
Ensembl chr 1:94,958,316...94,960,722
G
Atl1
atlastin GTPase 1
decreases expression
ISO
methyleugenol results in decreased expression of ATL1 mRNA
CTD
PMID:32234424
NCBI chr 6:94,113,149...94,210,955
Ensembl chr 6:88,377,239...88,475,204
G
Atm
ATM serine/threonine kinase
increases phosphorylation decreases expression
ISO EXP
methyleugenol results in increased phosphorylation of ATM protein methyleugenol results in decreased expression of ATM mRNA
CTD
PMID:26011634 PMID:28818686
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Atp13a4
ATPase 13A4
decreases expression
ISO
methyleugenol results in decreased expression of ATP13A4 mRNA
CTD
PMID:32234424
NCBI chr11:71,222,196...71,359,933
Ensembl chr11:71,226,161...71,359,933
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
decreases expression
ISO
methyleugenol results in decreased expression of ATP2B2 mRNA
CTD
PMID:32234424
NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:146,896,332...147,140,665
G
Atp8b4
ATPase phospholipid transporting 8B4 (putative)
decreases expression
ISO
methyleugenol results in decreased expression of ATP8B4 mRNA
CTD
PMID:32234424
NCBI chr 3:113,554,979...113,757,635
Ensembl chr 3:113,556,192...113,757,225
G
Atr
ATR serine/threonine kinase
increases phosphorylation
ISO
methyleugenol results in increased phosphorylation of ATR protein
CTD
PMID:28818686
NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:96,426,724...96,524,136
G
Atrnl1
attractin like 1
decreases expression
ISO
methyleugenol results in decreased expression of ATRNL1 mRNA
CTD
PMID:32234424
NCBI chr 1:256,670,976...257,219,291
Ensembl chr 1:256,670,627...257,213,197
G
Atxn1
ataxin 1
decreases expression
ISO
methyleugenol results in decreased expression of ATXN1 mRNA
CTD
PMID:32234424
NCBI chr17:18,943,397...19,354,751
Ensembl chr17:18,737,533...19,142,360
G
Aurka
aurora kinase A
decreases expression
EXP ISO
methyleugenol results in decreased expression of AURKA mRNA
CTD
PMID:26011634 PMID:32234424
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
increases expression affects expression
EXP
methyleugenol results in increased expression of AURKB protein methyleugenol affects the expression of AURKB mRNA
CTD
PMID:23411599 PMID:26011634
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:53,745,142...53,750,837
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
decreases expression
ISO
methyleugenol results in decreased expression of AZGP1 mRNA
CTD
PMID:32234424
NCBI chr12:22,044,685...22,051,248
Ensembl chr12:16,931,024...16,939,091
G
B3galt1
Beta-1,3-galactosyltransferase 1
decreases expression
ISO
methyleugenol results in decreased expression of B3GALT1 mRNA
CTD
PMID:32234424
NCBI chr 3:52,253,413...52,826,508
Ensembl chr 3:52,253,618...52,825,313
G
B3gnt3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
increases expression
ISO
methyleugenol results in increased expression of B3GNT3 mRNA
CTD
PMID:32234424
NCBI chr16:18,434,114...18,444,851
Ensembl chr16:18,401,405...18,410,766
G
B4galnt1
beta-1,4-N-acetyl-galactosaminyl transferase 1
increases expression
ISO
methyleugenol results in increased expression of B4GALNT1 mRNA
CTD
PMID:32234424
NCBI chr 7:64,873,909...64,881,512
Ensembl chr 7:62,988,930...62,996,190
G
Baat
bile acid CoA:amino acid N-acyltransferase
decreases expression
ISO
methyleugenol results in decreased expression of BAAT mRNA
CTD
PMID:32234424
NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:63,850,705...63,860,685
G
Babam2
BRISC and BRCA1 A complex member 2
decreases expression
ISO
methyleugenol results in decreased expression of BABAM2 mRNA
CTD
PMID:32234424
NCBI chr 6:30,089,065...30,467,508
Ensembl chr 6:24,369,022...24,833,951
G
Baiap2l2
BAR/IMD domain containing adaptor protein 2 like 2
increases expression
ISO
methyleugenol results in increased expression of BAIAP2L2 mRNA
CTD
PMID:32234424
NCBI chr 7:110,824,370...110,850,702
Ensembl chr 7:110,824,375...110,850,702
G
Bank1
B-cell scaffold protein with ankyrin repeats 1
decreases expression
ISO
methyleugenol results in decreased expression of BANK1 mRNA
CTD
PMID:32234424
NCBI chr 2:227,203,998...227,474,008
Ensembl chr 2:224,530,475...224,800,405
G
Batf3
basic leucine zipper ATF-like transcription factor 3
increases expression
ISO
methyleugenol results in increased expression of BATF3 mRNA
CTD
PMID:32234424
NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
methyleugenol results in increased expression of BAX mRNA
CTD
PMID:32234424
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bbox1
gamma-butyrobetaine hydroxylase 1
decreases expression
ISO
methyleugenol results in decreased expression of BBOX1 mRNA
CTD
PMID:32234424
NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:96,822,655...96,871,458
G
Bbs9
Bardet-Biedl syndrome 9
decreases expression
ISO
methyleugenol results in decreased expression of BBS9 mRNA
CTD
PMID:32234424
NCBI chr 8:21,013,865...21,437,934
Ensembl chr 8:21,013,944...21,437,930
G
Bcas3
BCAS3, microtubule associated cell migration factor
decreases expression
ISO
methyleugenol results in decreased expression of BCAS3 mRNA
CTD
PMID:32234424
NCBI chr10:70,711,084...71,170,492
Ensembl chr10:70,214,098...70,673,080
G
Bckdhb
branched chain keto acid dehydrogenase E1 subunit beta
decreases expression
ISO
methyleugenol results in decreased expression of BCKDHB mRNA
CTD
PMID:32234424
NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:84,845,264...85,027,812
G
Bcl2l15
Bcl2-like 15
increases expression
ISO
methyleugenol results in increased expression of BCL2L15 mRNA
CTD
PMID:32234424
NCBI chr 2:194,019,158...194,032,516
Ensembl chr 2:191,338,959...191,344,078
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
decreases expression
ISO
methyleugenol results in decreased expression of BDH1 mRNA
CTD
PMID:32234424
NCBI chr11:82,806,125...82,848,133
Ensembl chr11:69,302,534...69,337,671
G
Bdkrb2
bradykinin receptor B2
increases expression
ISO
methyleugenol results in increased expression of BDKRB2 mRNA
CTD
PMID:32234424
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:124,472,566...124,502,497
G
Bhlhe41
basic helix-loop-helix family, member e41
increases expression
ISO
methyleugenol results in increased expression of BHLHE41 mRNA
CTD
PMID:32234424
NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:178,834,271...178,838,468
G
Bhmt
betaine-homocysteine S-methyltransferase
decreases expression
ISO
methyleugenol results in decreased expression of BHMT mRNA
CTD
PMID:32234424
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:24,859,873...24,879,742
G
Bmerb1
bMERB domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of BMERB1 mRNA
CTD
PMID:32234424
NCBI chr10:2,286,999...2,453,890
Ensembl chr10:1,779,835...1,946,575
G
Bmf
Bcl2 modifying factor
increases expression
ISO
methyleugenol results in increased expression of BMF mRNA
CTD
PMID:32234424
NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:105,499,538...105,520,145
G
Bmpr1b
bone morphogenetic protein receptor type 1B
decreases expression
ISO
methyleugenol results in decreased expression of BMPR1B mRNA
CTD
PMID:32234424
NCBI chr 2:233,211,525...233,544,344
Ensembl chr 2:230,541,558...230,871,368
G
Brca1
BRCA1, DNA repair associated
decreases expression
EXP
methyleugenol results in decreased expression of BRCA1 mRNA
CTD
PMID:21659616 PMID:26011634
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,418,000...86,477,304
G
Brca2
BRCA2, DNA repair associated
decreases expression
EXP
methyleugenol results in decreased expression of BRCA2 mRNA
CTD
PMID:26011634
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:59,819...100,567
G
Brcc3
BRCA1/BRCA2-containing complex subunit 3
affects expression
EXP
methyleugenol affects the expression of BRCC3 mRNA
CTD
PMID:26011634
NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:1,986,575...1,991,080
G
Brinp1
BMP/retinoic acid inducible neural specific 1
decreases expression
ISO
methyleugenol results in decreased expression of BRINP1 mRNA
CTD
PMID:32234424
NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:82,348,930...82,493,150
G
Bsn
bassoon (presynaptic cytomatrix protein)
decreases expression
ISO
methyleugenol results in decreased expression of BSN mRNA
CTD
PMID:32234424
NCBI chr 8:117,663,447...117,754,412
Ensembl chr 8:108,788,542...108,875,819
G
Btbd16
BTB domain containing 16
decreases expression
ISO
methyleugenol results in decreased expression of BTBD16 mRNA
CTD
PMID:32234424
NCBI chr 1:185,334,971...185,389,518
Ensembl chr 1:185,335,725...185,389,517
G
Btbd9
BTB domain containing 9
decreases expression
ISO
methyleugenol results in decreased expression of BTBD9 mRNA
CTD
PMID:32234424
NCBI chr20:8,287,813...8,645,437
Ensembl chr20:8,288,711...8,643,960
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
increases expression
EXP
methyleugenol results in increased expression of BUB1 mRNA
CTD
PMID:26011634
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:115,020,254...115,051,650
G
C13h1orf226
similar to human chromosome 1 open reading frame 226
decreases expression
ISO
methyleugenol results in decreased expression of C1ORF226 mRNA
CTD
PMID:32234424
NCBI chr13:82,530,589...82,538,676
Ensembl chr13:82,530,577...82,820,949
G
C1h11orf86
similar to human chromosome 11 open reading frame 86
decreases expression
ISO
methyleugenol results in decreased expression of C11ORF86 mRNA
CTD
PMID:32234424
NCBI chr 1:201,784,009...201,785,916
Ensembl chr 1:201,784,009...201,785,916
G
C2cd4a
C2 calcium-dependent domain containing 4A
increases expression
ISO
methyleugenol results in increased expression of C2CD4A mRNA
CTD
PMID:32234424
NCBI chr 8:77,348,161...77,359,996
Ensembl chr 8:68,466,664...68,470,031
G
C4bpa
complement component 4 binding protein, alpha
decreases expression
ISO
methyleugenol results in decreased expression of C4BPA mRNA
CTD
PMID:32234424
NCBI chr13:44,627,959...44,663,552
Ensembl chr13:42,075,717...42,111,205
G
C4bpb
complement component 4 binding protein, beta
decreases expression
ISO
methyleugenol results in decreased expression of C4BPB mRNA
CTD
PMID:32234424
NCBI chr13:44,673,064...44,683,781
Ensembl chr13:42,120,798...42,131,817
G
C5
complement C5
decreases expression
ISO
methyleugenol results in decreased expression of C5 mRNA
CTD
PMID:32234424
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:18,270,696...18,361,994
G
C6
complement C6
decreases expression
ISO
methyleugenol results in decreased expression of C6 mRNA
CTD
PMID:32234424
NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:53,851,985...53,921,275
G
C8a
complement C8 alpha chain
decreases expression
ISO
methyleugenol results in decreased expression of C8A mRNA
CTD
PMID:32234424
NCBI chr 5:124,812,131...124,866,631
Ensembl chr 5:119,583,174...119,637,754
G
C8b
complement C8 beta chain
decreases expression
ISO
methyleugenol results in decreased expression of C8B mRNA
CTD
PMID:32234424
NCBI chr 5:124,763,974...124,801,522
Ensembl chr 5:119,535,146...119,572,565
G
C8g
complement C8 gamma chain
decreases expression
ISO
methyleugenol results in decreased expression of C8G mRNA
CTD
PMID:32234424
NCBI chr 3:28,718,648...28,720,232
Ensembl chr 3:8,305,920...8,323,495
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
decreases expression
ISO
methyleugenol results in decreased expression of C11ORF54 mRNA
CTD
PMID:32234424
NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:12,123,823...12,146,473
G
C8h11orf65
similar to human chromosome 11 open reading frame 65
decreases expression
ISO
methyleugenol results in decreased expression of C11ORF65 mRNA
CTD
PMID:32234424
NCBI chr 8:62,692,123...62,720,951
Ensembl chr 8:53,796,366...53,824,748
G
C9
complement C9
decreases expression
ISO
methyleugenol results in decreased expression of C9 mRNA
CTD
PMID:32234424
NCBI chr 2:57,300,510...57,348,759
Ensembl chr 2:55,572,992...55,621,338
G
C9h6orf141
similar to human chromosome 6 open reading frame 141
increases expression
ISO
methyleugenol results in increased expression of C6ORF141 mRNA
CTD
PMID:32234424
NCBI chr 9:27,521,466...27,525,644
Ensembl chr 9:20,024,916...20,029,094
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
decreases expression
ISO
methyleugenol results in decreased expression of CACNA1D mRNA
CTD
PMID:32234424
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,228,306...5,668,215
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
decreases expression
ISO
methyleugenol results in decreased expression of CACNA2D1 mRNA
CTD
PMID:32234424
NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:18,951,002...19,374,969
G
Cacna2d3
calcium voltage-gated channel auxiliary subunit alpha2delta 3
decreases expression
ISO
methyleugenol results in decreased expression of CACNA2D3 mRNA
CTD
PMID:32234424
NCBI chr16:4,105,048...4,919,037
Ensembl chr16:4,098,445...4,912,351
G
Cacnb3
calcium voltage-gated channel auxiliary subunit beta 3
increases expression
ISO
methyleugenol results in increased expression of CACNB3 mRNA
CTD
PMID:32234424
NCBI chr 7:131,663,810...131,676,085
Ensembl chr 7:129,783,674...129,797,074
G
Cadm2
cell adhesion molecule 2
decreases expression
ISO
methyleugenol results in decreased expression of CADM2 mRNA
CTD
PMID:32234424
NCBI chr11:17,994,856...18,971,895
Ensembl chr11:4,555,159...5,525,400
G
Cadps2
calcium dependent secretion activator 2
decreases expression
ISO
methyleugenol results in decreased expression of CADPS2 mRNA
CTD
PMID:32234424
NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:51,781,053...52,309,829
G
Calb2
calbindin 2
increases expression
ISO
methyleugenol results in increased expression of CALB2 mRNA
CTD
PMID:32234424
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
G
Calml4
calmodulin-like 4
decreases expression
ISO
methyleugenol results in decreased expression of CALML4 mRNA
CTD
PMID:32234424
NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:63,323,351...63,335,234
G
Caln1
calneuron 1
decreases expression
ISO
methyleugenol results in decreased expression of CALN1 mRNA
CTD
PMID:32234424
NCBI chr12:31,447,964...31,939,847
Ensembl chr12:25,819,628...26,303,344
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
decreases expression
ISO
methyleugenol results in decreased expression of CAMK1D mRNA
CTD
PMID:32234424
NCBI chr17:77,491,191...77,892,018
Ensembl chr17:72,581,979...72,980,556
G
Camk4
calcium/calmodulin-dependent protein kinase IV
decreases expression
ISO
methyleugenol results in decreased expression of CAMK4 mRNA
CTD
PMID:32234424
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
G
Car12
carbonic anhydrase 12
increases expression
ISO
methyleugenol results in increased expression of CA12 mRNA
CTD
PMID:32234424
NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:67,274,359...67,330,440
G
Car3
carbonic anhydrase 3
decreases expression
ISO
methyleugenol results in decreased expression of CA3 mRNA
CTD
PMID:32234424
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280
G
Car9
carbonic anhydrase 9
decreases expression
ISO
methyleugenol results in decreased expression of CA9 mRNA
CTD
PMID:32234424
NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:57,763,206...57,769,838
G
Carmil3
capping protein regulator and myosin 1 linker 3
decreases expression
ISO
methyleugenol results in decreased expression of CARMIL3 mRNA
CTD
PMID:32234424
NCBI chr15:32,948,228...32,965,829
Ensembl chr15:28,979,007...28,996,225
G
Casp16
caspase 16
decreases expression
ISO
methyleugenol results in decreased expression of CASP16P mRNA
CTD
PMID:32234424
NCBI chr10:13,086,467...13,096,658
Ensembl chr10:12,586,729...12,589,053 Ensembl chr10:12,586,729...12,589,053
G
Casp3
caspase 3
increases cleavage increases activity
EXP ISO
methyleugenol results in increased cleavage of CASP3 protein methyleugenol results in increased activity of CASP3 protein
CTD
PMID:26011634 PMID:28818686
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
decreases expression
ISO
methyleugenol results in decreased expression of CAT mRNA
CTD
PMID:32234424
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Catsper3
cation channel, sperm associated 3
decreases expression
ISO
methyleugenol results in decreased expression of CATSPER3 mRNA
CTD
PMID:32234424
NCBI chr17:8,820,738...8,846,063
Ensembl chr17:8,815,561...8,840,864
G
Catspere
catsper channel auxiliary subunit epsilon
decreases expression
ISO
methyleugenol results in decreased expression of CATSPERE mRNA
CTD
PMID:32234424
NCBI chr13:92,331,826...92,487,215
Ensembl chr13:89,819,244...89,950,979
G
Cbarp
CACN subunit beta associated regulatory protein
decreases expression
ISO
methyleugenol results in decreased expression of CBARP mRNA
CTD
PMID:32234424
NCBI chr 7:10,217,314...10,225,855
Ensembl chr 7:9,566,364...9,575,204
G
Cbr3
carbonyl reductase 3
increases expression
ISO
methyleugenol results in increased expression of CBR3 mRNA
CTD
PMID:32234424
NCBI chr11:46,478,295...46,486,555
Ensembl chr11:33,008,615...33,016,875
G
Cbx5
chromobox 5
increases expression
EXP
methyleugenol results in increased expression of CBX5 protein
CTD
PMID:23411599
NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:134,331,335...134,375,022
G
Ccbe1
collagen and calcium binding EGF domains 1
decreases expression
ISO
methyleugenol results in decreased expression of CCBE1 mRNA
CTD
PMID:32234424
NCBI chr18:61,849,821...62,093,876
Ensembl chr18:59,580,768...59,824,400
G
Ccdc141
coiled-coil domain containing 141
decreases expression
ISO
methyleugenol results in decreased expression of CCDC141 mRNA
CTD
PMID:32234424
NCBI chr 3:82,357,046...82,517,199
Ensembl chr 3:61,948,646...62,110,079
G
Ccdc146
coiled-coil domain containing 146
decreases expression
ISO
methyleugenol results in decreased expression of CCDC146 mRNA
CTD
PMID:32234424
NCBI chr 4:14,554,966...14,703,801
Ensembl chr 4:13,662,766...13,811,608
G
Ccdc170
coiled-coil domain containing 170
decreases expression
ISO
methyleugenol results in decreased expression of CCDC170 mRNA
CTD
PMID:32234424
NCBI chr 1:40,945,607...41,050,010
Ensembl chr 1:40,945,961...41,085,040
G
Ccdc171
coiled-coil domain containing 171
decreases expression
ISO
methyleugenol results in decreased expression of CCDC171 mRNA
CTD
PMID:32234424
NCBI chr 5:97,919,965...98,403,853
Ensembl chr 5:97,920,002...98,282,833
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
methyleugenol results in decreased expression of CCN2 mRNA
CTD
PMID:32234424
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
G
Ccnb1
cyclin B1
decreases expression
ISO
methyleugenol results in decreased expression of CCNB1 mRNA
CTD
PMID:32234424
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccng1
cyclin G1
increases expression
ISO
methyleugenol results in increased expression of CCNG1 mRNA
CTD
PMID:15618236
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,176,234...25,181,641
G
Ccrl2
C-C motif chemokine receptor like 2
increases expression
ISO
methyleugenol results in increased expression of CCRL2 mRNA
CTD
PMID:32234424
NCBI chr 8:119,912,671...119,915,313
Ensembl chr 8:111,034,279...111,036,664
G
Ccser1
coiled-coil serine-rich protein 1
decreases expression
ISO
methyleugenol results in decreased expression of CCSER1 mRNA
CTD
PMID:32234424
NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786
G
Cd22
CD22 molecule
increases expression
ISO
methyleugenol results in increased expression of CD22 mRNA
CTD
PMID:32234424
NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:86,117,459...86,132,322
G
Cd44
CD44 molecule
increases expression
ISO
methyleugenol results in increased expression of CD44 mRNA
CTD
PMID:32234424
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
G
Cd9
CD9 molecule
increases expression
ISO
methyleugenol results in increased expression of CD9 mRNA
CTD
PMID:32234424
NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:158,256,328...158,289,222
G
Cdc14a
cell division cycle 14A
decreases expression
ISO
methyleugenol results in decreased expression of CDC14A mRNA
CTD
PMID:32234424
NCBI chr 2:206,910,475...207,070,537
Ensembl chr 2:204,225,540...204,380,927
G
Cdc20b
cell division cycle 20B
decreases expression
ISO
methyleugenol results in decreased expression of CDC20B mRNA
CTD
PMID:32234424
NCBI chr 2:44,688,349...44,738,056
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
methyleugenol results in decreased expression of CDCA3 mRNA
CTD
PMID:32234424
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:157,634,928...157,638,799
G
Cdh1
cadherin 1
decreases expression
ISO
methyleugenol results in decreased expression of CDH1 mRNA
CTD
PMID:32234424
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
G
Cdh12
cadherin 12
decreases expression
ISO
methyleugenol results in decreased expression of CDH12 mRNA
CTD
PMID:32234424
NCBI chr 2:72,201,859...73,436,039
Ensembl chr 2:70,475,043...71,700,572
G
Cdk1
cyclin-dependent kinase 1
increases expression
EXP
methyleugenol results in increased expression of CDK1 protein
CTD
PMID:23411599
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cdk14
cyclin-dependent kinase 14
decreases expression
ISO
methyleugenol results in decreased expression of CDK14 mRNA
CTD
PMID:32234424
NCBI chr 4:29,619,237...30,213,651
Ensembl chr 4:28,666,843...29,258,861
G
Cdk2ap2
cyclin-dependent kinase 2 associated protein 2
decreases expression
ISO
methyleugenol results in decreased expression of CDK2AP2 mRNA
CTD
PMID:32234424
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
G
Cdkal1
CDK5 regulatory subunit associated protein 1-like 1
decreases expression
ISO
methyleugenol results in decreased expression of CDKAL1 mRNA
CTD
PMID:32234424
NCBI chr17:34,927,221...35,479,827
Ensembl chr17:34,718,687...35,407,524
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression increases phosphorylation
ISO EXP
methyleugenol results in increased expression of CDKN1A mRNA methyleugenol results in increased phosphorylation of CDKN1A protein methyleugenol results in increased expression of CDKN1A mRNA; methyleugenol results in increased expression of CDKN1A protein
CTD
PMID:15618236 PMID:23411599 PMID:26011634
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases expression decreases expression
EXP
methyleugenol results in increased expression of CDKN2A protein methyleugenol results in decreased expression of CDKN2A mRNA
CTD
PMID:23411599 PMID:26011634
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Cdo1
cysteine dioxygenase type 1
decreases expression
ISO
methyleugenol results in decreased expression of CDO1 mRNA
CTD
PMID:32234424
NCBI chr18:41,619,076...41,633,719
Ensembl chr18:39,432,474...39,447,296
G
Cdr2l
cerebellar degeneration-related protein 2-like
increases expression
ISO
methyleugenol results in increased expression of CDR2L mRNA
CTD
PMID:32234424
NCBI chr10:100,625,150...100,638,669
Ensembl chr10:100,624,607...100,638,666
G
Ceacam1
CEA cell adhesion molecule 1
increases expression
ISO
methyleugenol results in increased expression of CEACAM1 mRNA
CTD
PMID:32234424
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:81,043,595...81,059,992
G
Ceacam20
CEA cell adhesion molecule 20
decreases expression
ISO
methyleugenol results in decreased expression of CEACAM20 mRNA
CTD
PMID:32234424
NCBI chr 1:88,750,010...88,771,679
Ensembl chr 1:79,622,077...79,643,782
G
Cemip
cell migration inducing hyaluronidase 1
decreases expression
ISO
methyleugenol results in decreased expression of CEMIP mRNA
CTD
PMID:32234424
NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:137,908,920...138,062,415
G
Cenpa
centromere protein A
decreases expression
ISO
methyleugenol results in decreased expression of CENPA mRNA
CTD
PMID:32234424
NCBI chr 6:31,420,062...31,431,703
Ensembl chr 6:25,700,142...25,711,675
G
Cenpe
centromere protein E
decreases expression
ISO
methyleugenol results in decreased expression of CENPE mRNA
CTD
PMID:32234424
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:223,636,998...223,695,669
G
Cep128
centrosomal protein 128
decreases expression
ISO
methyleugenol results in decreased expression of CEP128 mRNA
CTD
PMID:32234424
NCBI chr 6:115,681,753...116,059,758
Ensembl chr 6:109,951,061...110,328,713
G
Ces3a
carboxylesterase 3a
decreases expression
ISO
methyleugenol results in decreased expression of CES3 mRNA
CTD
PMID:32234424
NCBI chr19:49,902,312...49,910,484
G
Cfap20dc
CFAP20 domain containing
decreases expression
ISO
methyleugenol results in decreased expression of CFAP20DC mRNA
CTD
PMID:32234424
NCBI chr15:18,661,562...18,907,226
Ensembl chr15:16,231,299...16,476,977
G
Cfap52
cilia and flagella associated protein 52
decreases expression
ISO
methyleugenol results in decreased expression of CFAP52 mRNA
CTD
PMID:32234424
NCBI chr10:53,112,692...53,153,844
Ensembl chr10:52,613,762...52,654,934
G
Cfb
complement factor B
decreases expression
ISO
methyleugenol results in decreased expression of CFB mRNA
CTD
PMID:32234424
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505
G
Cfhr1
complement factor H-related 1
decreases expression
ISO
methyleugenol results in decreased expression of CFHR1 mRNA
CTD
PMID:32234424
NCBI chr13:53,946,298...53,961,282
Ensembl chr13:51,369,211...51,410,592
G
Cfhr4
complement factor H-related 4
decreases expression
ISO
methyleugenol results in decreased expression of CFHR4 mRNA
CTD
PMID:32234424
NCBI chr13:53,973,301...54,042,179
Ensembl chr13:51,422,592...51,491,502
G
Chek1
checkpoint kinase 1
affects expression
EXP
methyleugenol affects the expression of CHEK1 mRNA
CTD
PMID:26011634
NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:36,420,569...36,441,009
G
Chek2
checkpoint kinase 2
decreases expression
EXP
methyleugenol results in decreased expression of CHEK2 mRNA
CTD
PMID:26011634
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:45,788,827...45,821,286
G
Chn2
chimerin 2
decreases expression
ISO
methyleugenol results in decreased expression of CHN2 mRNA
CTD
PMID:32234424
NCBI chr 4:84,478,989...84,738,068
Ensembl chr 4:83,147,983...83,407,709
G
Cideb
cell death-inducing DFFA-like effector b
decreases expression
ISO
methyleugenol results in decreased expression of CIDEB mRNA
CTD
PMID:32234424
NCBI chr15:33,222,135...33,226,407
Ensembl chr15:29,252,213...29,256,605
G
Cish
cytokine inducible SH2-containing protein
decreases expression
ISO
methyleugenol results in decreased expression of CISH mRNA
CTD
PMID:15618236
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Clcnka
chloride voltage-gated channel Ka
decreases expression
ISO
methyleugenol results in decreased expression of CLCNKA mRNA
CTD
PMID:32234424
NCBI chr 5:158,974,190...158,989,275
Ensembl chr 5:153,691,209...153,706,148
G
Cldn14
claudin 14
decreases expression
ISO
methyleugenol results in decreased expression of CLDN14 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr11:46,701,940...46,799,049
Ensembl chr11:33,232,220...33,329,171
G
Cldn16
claudin 16
decreases expression
ISO
methyleugenol results in decreased expression of CLDN16 mRNA
CTD
PMID:32234424
NCBI chr11:74,290,298...74,309,588
Ensembl chr11:74,290,298...74,309,588
G
Clrn3
clarin 3
decreases expression
ISO
methyleugenol results in decreased expression of CLRN3 mRNA
CTD
PMID:32234424
NCBI chr 1:190,319,025...190,334,648
Ensembl chr 1:190,319,026...190,334,648
G
Clybl
citramalyl-CoA lyase
decreases expression
ISO
methyleugenol results in decreased expression of CLYBL mRNA
CTD
PMID:32234424
NCBI chr15:105,690,283...105,912,347
Ensembl chr15:99,283,650...99,505,695
G
Cmss1
cms1 ribosomal small subunit homolog
decreases expression
ISO
methyleugenol results in decreased expression of CMSS1 mRNA
CTD
PMID:32234424
NCBI chr11:56,403,620...56,701,751
Ensembl chr11:42,934,440...43,232,624
G
Cnga1
cyclic nucleotide gated channel subunit alpha 1
decreases expression
ISO
methyleugenol results in decreased expression of CNGA1 mRNA
CTD
PMID:32234424
NCBI chr14:35,920,948...35,959,065
Ensembl chr14:35,567,125...35,605,065
G
Cnksr2
connector enhancer of kinase suppressor of Ras 2
decreases expression
ISO
methyleugenol results in decreased expression of CNKSR2 mRNA
CTD
PMID:32234424
NCBI chr X:40,722,843...40,971,730
Ensembl chr X:36,907,850...37,150,555
G
Cntn1
contactin 1
decreases expression
ISO
methyleugenol results in decreased expression of CNTN1 mRNA
CTD
PMID:32234424
NCBI chr 7:125,142,638...125,440,397
Ensembl chr 7:123,372,792...123,558,541
G
Cntn5
contactin 5
decreases expression
ISO
methyleugenol results in decreased expression of CNTN5 mRNA
CTD
PMID:32234424
NCBI chr 8:15,017,424...16,249,418
Ensembl chr 8:6,738,239...7,967,957
G
Cobl
cordon-bleu WH2 repeat protein
decreases expression
ISO
methyleugenol results in decreased expression of COBL mRNA
CTD
PMID:32234424
NCBI chr14:86,828,137...87,060,682
Ensembl chr14:86,828,139...87,060,800
G
Col18a1
collagen type XVIII alpha 1 chain
decreases expression
ISO
methyleugenol results in decreased expression of COL18A1 mRNA
CTD
PMID:32234424
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,474,104...11,582,593
G
Col5a2
collagen type V alpha 2 chain
decreases expression
ISO
methyleugenol results in decreased expression of COL5A2 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:47,448,736...47,598,154
G
Col8a1
collagen type VIII alpha 1 chain
decreases expression
ISO
methyleugenol results in decreased expression of COL8A1 mRNA
CTD
PMID:32234424
NCBI chr11:56,245,998...56,378,586
Ensembl chr11:42,777,628...42,906,424
G
Commd1
copper metabolism domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of COMMD1 mRNA
CTD
PMID:32234424
NCBI chr14:101,081,667...101,185,738
Ensembl chr14:96,880,463...96,984,501
G
Commd10
COMM domain containing 10
decreases expression
ISO
methyleugenol results in decreased expression of COMMD10 mRNA
CTD
PMID:32234424
NCBI chr18:39,741,219...39,874,801
Ensembl chr18:39,741,298...39,874,903
G
Cox6a2
cytochrome c oxidase subunit 6A2
decreases expression
ISO
methyleugenol results in decreased expression of COX6A2 mRNA
CTD
PMID:32234424
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
G
Cpa4
carboxypeptidase A4
increases expression
ISO
methyleugenol results in increased expression of CPA4 mRNA
CTD
PMID:32234424
NCBI chr 4:60,155,675...60,179,644
Ensembl chr 4:59,188,284...59,212,255
G
Cpa5
carboxypeptidase A5
increases expression
ISO
methyleugenol results in increased expression of CPA5 mRNA
CTD
PMID:32234424
NCBI chr 4:60,197,123...60,216,883
Ensembl chr 4:59,230,964...59,249,490
G
Cpb2
carboxypeptidase B2
decreases expression
ISO
methyleugenol results in decreased expression of CPB2 mRNA
CTD
PMID:32234424
NCBI chr15:56,967,128...57,015,964
Ensembl chr15:50,557,717...50,606,556
G
Cped1
cadherin-like and PC-esterase domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of CPED1 mRNA
CTD
PMID:32234424
NCBI chr 4:50,516,712...50,789,651
Ensembl chr 4:50,516,819...50,788,674
G
Cplx1
complexin 1
decreases expression
ISO
methyleugenol results in decreased expression of CPLX1 mRNA
CTD
PMID:32234424
NCBI chr14:1,329,073...1,360,781
G
Cpn1
carboxypeptidase N subunit 1
decreases expression
ISO
methyleugenol results in decreased expression of CPN1 mRNA
CTD
PMID:32234424
NCBI chr 1:252,793,786...252,822,675
Ensembl chr 1:242,844,212...242,873,465
G
Cpne2
copine 2
increases expression
ISO
methyleugenol results in increased expression of CPNE2 mRNA
CTD
PMID:32234424
NCBI chr19:10,434,277...10,472,146
Ensembl chr19:10,434,277...10,471,820
G
Cpne4
copine 4
decreases expression
ISO
methyleugenol results in decreased expression of CPNE4 mRNA
CTD
PMID:32234424
NCBI chr 8:114,056,152...114,531,855
Ensembl chr 8:105,177,376...105,653,068
G
Cpne6
copine 6
decreases expression
ISO
methyleugenol results in decreased expression of CPNE6 mRNA
CTD
PMID:32234424
NCBI chr15:32,968,047...32,975,008
Ensembl chr15:28,998,293...29,005,044
G
Cpq
carboxypeptidase Q
decreases expression
ISO
methyleugenol results in decreased expression of CPQ mRNA
CTD
PMID:32234424
NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:64,264,081...64,724,546
G
Cps1
carbamoyl-phosphate synthase 1
decreases expression
ISO
methyleugenol results in decreased expression of CPS1 mRNA
CTD
PMID:32234424
NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:68,614,153...68,737,033
G
Cpvl
carboxypeptidase, vitellogenic-like
decreases expression
ISO
methyleugenol results in decreased expression of CPVL mRNA
CTD
PMID:32234424
NCBI chr 4:84,311,853...84,422,098
Ensembl chr 4:82,981,422...83,085,655
G
Crb1
crumbs cell polarity complex component 1
decreases expression
ISO
methyleugenol results in decreased expression of CRB1 mRNA
CTD
PMID:32234424
NCBI chr13:53,352,932...53,540,019
Ensembl chr13:50,800,959...50,989,261
G
Creld2
cysteine-rich with EGF-like domains 2
decreases expression
ISO
methyleugenol results in decreased expression of CRELD2 mRNA
CTD
PMID:32234424
NCBI chr 7:121,788,754...121,796,230
Ensembl chr 7:119,909,633...119,916,543
G
Crp
C-reactive protein
decreases expression
ISO
methyleugenol results in decreased expression of CRP mRNA
CTD
PMID:32234424
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Crppa
CDP-L-ribitol pyrophosphorylase A
decreases expression
ISO
methyleugenol results in decreased expression of CRPPA mRNA
CTD
PMID:32234424
NCBI chr 6:58,847,550...59,124,309
Ensembl chr 6:53,121,438...53,397,028
G
Crybg2
crystallin beta-gamma domain containing 2
increases expression
ISO
methyleugenol results in increased expression of CRYBG2 mRNA
CTD
PMID:32234424
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
G
Cth
cystathionine gamma-lyase
decreases expression
ISO
methyleugenol results in decreased expression of CTH mRNA
CTD
PMID:32234424
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:246,975,894...247,002,234
G
Ctnna3
catenin alpha 3
decreases expression
ISO
methyleugenol results in decreased expression of CTNNA3 mRNA
CTD
PMID:32234424
NCBI chr20:23,613,016...25,198,699
Ensembl chr20:23,623,560...25,199,978
G
Ctnnb1
catenin beta 1
increases mutagenesis
ISO
methyleugenol results in increased mutagenesis of CTNNB1 gene
CTD
PMID:10467420
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ctxn1
cortexin 1
increases expression
ISO
methyleugenol results in increased expression of CTXN1 mRNA
CTD
PMID:32234424
NCBI chr12:2,610,465...2,612,076
G
Cux2
cut-like homeobox 2
decreases expression
ISO
methyleugenol results in decreased expression of CUX2 mRNA
CTD
PMID:32234424
NCBI chr12:40,168,402...40,368,303
Ensembl chr12:34,520,959...34,705,806
G
Cx3cr1
C-X3-C motif chemokine receptor 1
decreases expression
ISO
methyleugenol results in decreased expression of CX3CR1 mRNA
CTD
PMID:32234424
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl13
C-X-C motif chemokine ligand 13
decreases expression
ISO
methyleugenol results in decreased expression of CXCL13 mRNA
CTD
PMID:32234424
NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,608,902...13,613,933
G
Cxxc4
CXXC finger protein 4
increases expression
ISO
methyleugenol results in increased expression of CXXC4 mRNA
CTD
PMID:32234424
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
G
Cyba
cytochrome b-245 alpha chain
decreases expression
ISO
methyleugenol results in decreased expression of CYBA mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
methyleugenol results in increased expression of CYP1A1 mRNA
CTD
PMID:32234424
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
ISO
methyleugenol results in increased expression of CYP1A2 mRNA
CTD
PMID:32234424
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
methyleugenol results in increased expression of CYP1B1 mRNA
CTD
PMID:32234424
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP2A13 mRNA
CTD
PMID:32234424
NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:82,231,611...82,244,887
G
Cyp2a3
cytochrome P450, family 2, subfamily a, polypeptide 3
decreases expression
ISO
methyleugenol results in decreased expression of CYP2A7 mRNA
CTD
PMID:32234424
NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:82,169,949...82,179,979
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases expression
ISO
methyleugenol results in decreased expression of CYP2B6 mRNA
CTD
PMID:32234424
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases expression
ISO
methyleugenol results in decreased expression of CYP2C19 mRNA
CTD
PMID:32234424
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases expression
ISO
methyleugenol results in decreased expression of CYP2C8 mRNA
CTD
PMID:32234424
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases expression
ISO
methyleugenol results in decreased expression of CYP2D6 mRNA
CTD
PMID:32234424
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP2E1 mRNA
CTD
PMID:32234424
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp46a1
cytochrome P450, family 46, subfamily a, polypeptide 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP46A1 mRNA
CTD
PMID:32234424
NCBI chr 6:133,011,948...133,039,167
Ensembl chr 6:127,243,315...127,274,760
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP4A22 mRNA
CTD
PMID:32234424
NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:129,123,336...129,137,464
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP4B1 mRNA
CTD
PMID:32234424
NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:129,139,038...129,156,348
G
Cyp4x1
cytochrome P450, family 4, subfamily x, polypeptide 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP4X1 mRNA
CTD
PMID:32234424
NCBI chr 5:133,888,439...133,923,254
Ensembl chr 5:128,651,776...128,682,779
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP7A1 mRNA
CTD
PMID:32234424
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:19,376,974...19,386,688
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP7B1 mRNA
CTD
PMID:32234424
NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:100,502,791...100,669,698
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
ISO
methyleugenol results in decreased expression of CYP8B1 mRNA
CTD
PMID:32234424
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166
G
Dab1
DAB adaptor protein 1
decreases expression
ISO
methyleugenol results in decreased expression of DAB1 mRNA
CTD
PMID:32234424
NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:119,140,533...119,510,552
G
Dach2
dachshund family transcription factor 2
decreases expression
ISO
methyleugenol results in decreased expression of DACH2 mRNA
CTD
PMID:32234424
NCBI chr X:78,718,963...79,018,023
Ensembl chr X:78,451,593...79,017,592
G
Dao
D-amino-acid oxidase
decreases expression
ISO
methyleugenol results in decreased expression of DAO mRNA
CTD
PMID:32234424
NCBI chr12:48,252,900...48,275,964
Ensembl chr12:42,592,343...42,612,741
G
Dbndd1
dysbindin domain containing 1
increases expression
ISO
methyleugenol results in increased expression of DBNDD1 mRNA
CTD
PMID:32234424
NCBI chr19:51,539,154...51,548,441
Ensembl chr19:51,539,148...51,548,444
G
Dcaf11
DDB1 and CUL4 associated factor 11
decreases expression
ISO
methyleugenol results in decreased expression of DCAF11 mRNA
CTD
PMID:32234424
NCBI chr15:33,015,370...33,027,407
Ensembl chr15:29,046,826...29,057,669
G
Dcdc1-ps1
doublecortin domain containing 1, pseudogene 1
decreases expression
ISO
methyleugenol results in decreased expression of DCDC1 mRNA
CTD
PMID:32234424
NCBI chr 3:92,486,054...92,896,696
Ensembl chr 3:92,718,047...92,896,542
G
Dchs2
dachsous cadherin-related 2
decreases expression
ISO
methyleugenol results in decreased expression of DCHS2 mRNA
CTD
PMID:32234424
NCBI chr 2:170,775,818...170,983,844
Ensembl chr 2:168,478,826...168,682,732
G
Dcxr
dicarbonyl and L-xylulose reductase
decreases expression
ISO
methyleugenol results in decreased expression of DCXR mRNA
CTD
PMID:32234424
NCBI chr10:106,504,730...106,506,619
G
Ddc
dopa decarboxylase
decreases expression
ISO
methyleugenol results in decreased expression of DDC mRNA
CTD
PMID:32234424
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:86,378,685...86,469,208
G
Ddr2
discoidin domain receptor tyrosine kinase 2
decreases expression
ISO
methyleugenol results in decreased expression of DDR2 mRNA
CTD
PMID:32234424
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:82,195,463...82,317,363
G
Ddt
D-dopachrome tautomerase
decreases expression
ISO
methyleugenol results in decreased expression of DDT mRNA
CTD
PMID:32234424
NCBI chr20:12,883,025...12,886,121
Ensembl chr20:12,884,243...12,888,482
G
Defb1
defensin beta 1
increases expression
ISO
methyleugenol results in increased expression of DEFB1 mRNA
CTD
PMID:32234424
NCBI chr16:77,001,326...77,016,068
Ensembl chr16:70,298,863...70,313,604
G
Dennd1a
DENN domain containing 1A
decreases expression
ISO
methyleugenol results in decreased expression of DENND1A mRNA
CTD
PMID:32234424
NCBI chr 3:41,974,502...42,461,816
Ensembl chr 3:21,564,749...22,052,062
G
Dgat1
diacylglycerol O-acyltransferase 1
decreases expression
ISO
methyleugenol results in decreased expression of DGAT1 mRNA
CTD
PMID:32234424
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:108,218,524...108,234,299
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
ISO
methyleugenol results in decreased expression of DGAT2 mRNA
CTD
PMID:32234424
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428
G
Dhrs2
dehydrogenase/reductase 2
decreases expression
ISO
methyleugenol results in decreased expression of DHRS2 mRNA
CTD
PMID:32234424
NCBI chr15:32,658,855...32,673,591
Ensembl chr15:28,688,940...28,703,644
G
Dhrs9
dehydrogenase/reductase 9
increases expression
ISO
methyleugenol results in increased expression of DHRS9 mRNA
CTD
PMID:32234424
NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:54,147,803...54,220,241
G
Dhrsx
dehydrogenase/reductase X-linked
decreases expression
ISO
methyleugenol results in decreased expression of DHRSX mRNA
CTD
PMID:32234424
NCBI chr12:16,299,768...16,304,553
Ensembl chr12:16,299,808...16,304,552
G
Dhtkd1
dehydrogenase E1 and transketolase domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of DHTKD1 mRNA
CTD
PMID:32234424
NCBI chr17:77,242,512...77,316,074
Ensembl chr17:72,355,201...72,406,723
G
Diaph2
diaphanous-related formin 2
decreases expression
ISO
methyleugenol results in decreased expression of DIAPH2 mRNA
CTD
PMID:32234424
NCBI chr X:96,700,535...97,528,080
Ensembl chr X:92,395,251...93,229,869
G
Dio1
iodothyronine deiodinase 1
decreases expression
ISO
methyleugenol results in decreased expression of DIO1 mRNA
CTD
PMID:32234424
NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:122,074,279...122,090,970
G
Dip2c
disco-interacting protein 2 homolog C
decreases expression
ISO
methyleugenol results in decreased expression of DIP2C mRNA
CTD
PMID:32234424
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
G
Diras3
DIRAS family GTPase 3
decreases expression
ISO
methyleugenol results in decreased expression of DIRAS3 mRNA
CTD
PMID:32234424
NCBI chr 6:136,346,157...136,347,371
Ensembl chr 6:130,524,742...130,530,825
G
Disc1
DISC1 scaffold protein
decreases expression
ISO
methyleugenol results in decreased expression of DISC1 mRNA
CTD
PMID:32234424
NCBI chr19:69,911,548...70,120,970
Ensembl chr19:53,014,616...53,219,778
G
Dlg2
discs large MAGUK scaffold protein 2
decreases expression
ISO
methyleugenol results in decreased expression of DLG2 mRNA
CTD
PMID:32234424
NCBI chr 1:153,864,545...155,916,238
Ensembl chr 1:144,451,472...146,499,475
G
Dmgdh
dimethylglycine dehydrogenase
decreases expression
ISO
methyleugenol results in decreased expression of DMGDH mRNA
CTD
PMID:32234424
NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:24,912,578...24,987,528
G
Dnah1
dynein, axonemal, heavy chain 1
decreases expression
ISO
methyleugenol results in decreased expression of DNAH1 mRNA
CTD
PMID:32234424
NCBI chr16:6,462,419...6,523,545
Ensembl chr16:6,456,002...6,518,350
G
Dnah11
dynein, axonemal, heavy chain 11
decreases expression
ISO
methyleugenol results in decreased expression of DNAH11 mRNA
CTD
PMID:32234424
NCBI chr 6:144,982,130...145,298,523
Ensembl chr 6:138,839,177...139,155,536
G
Dnah12
dynein, axonemal, heavy chain 12
decreases expression
ISO
methyleugenol results in decreased expression of DNAH12 mRNA
CTD
PMID:32234424
NCBI chr16:1,932,776...2,099,391
Ensembl chr16:1,937,817...2,092,664
G
Dnah5
dynein, axonemal, heavy chain 5
decreases expression
ISO
methyleugenol results in decreased expression of DNAH5 mRNA
CTD
PMID:32234424
NCBI chr 2:80,668,182...80,985,918
Ensembl chr 2:78,937,800...79,254,890
G
Dnah6
dynein, axonemal, heavy chain 6
decreases expression
ISO
methyleugenol results in decreased expression of DNAH6 mRNA
CTD
PMID:32234424
NCBI chr 4:106,622,235...106,842,461
Ensembl chr 4:105,064,125...105,284,376
G
Dnase2
deoxyribonuclease 2, lysosomal
increases expression
ISO
methyleugenol results in increased expression of DNASE2A mRNA
CTD
PMID:15618236
NCBI chr19:40,149,505...40,152,225
Ensembl chr19:23,244,664...23,247,376
G
Dock1
dedicator of cyto-kinesis 1
decreases expression
ISO
methyleugenol results in decreased expression of DOCK1 mRNA
CTD
PMID:32234424
NCBI chr 1:189,467,143...189,983,777
Ensembl chr 1:189,467,143...189,983,768
G
Dock8
dedicator of cytokinesis 8
decreases expression
ISO
methyleugenol results in decreased expression of DOCK8 mRNA
CTD
PMID:32234424
NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:222,649,309...222,842,474
G
Dpf3
double PHD fingers 3
decreases expression
ISO
methyleugenol results in decreased expression of DPF3 mRNA
CTD
PMID:32234424
NCBI chr 6:108,577,792...108,856,724
Ensembl chr 6:102,846,029...103,125,493
G
Dpyd
dihydropyrimidine dehydrogenase
decreases expression
ISO
methyleugenol results in decreased expression of DPYD mRNA
CTD
PMID:32234424
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:206,609,122...207,474,982
G
Dpys
dihydropyrimidinase
decreases expression
ISO
methyleugenol results in decreased expression of DPYS mRNA
CTD
PMID:32234424
NCBI chr 7:72,707,566...72,814,183
Ensembl chr 7:70,835,789...70,929,231
G
Draxin
dorsal inhibitory axon guidance protein
increases expression
ISO
methyleugenol results in increased expression of DRAXIN mRNA
CTD
PMID:32234424
NCBI chr 5:163,813,308...163,846,609
Ensembl chr 5:158,530,342...158,564,483
G
Drgx
dorsal root ganglia homeobox
decreases expression
ISO
methyleugenol results in decreased expression of DRGX mRNA
CTD
PMID:32234424
NCBI chr16:7,854,849...7,884,404
Ensembl chr16:7,854,849...7,900,600
G
Dsc2
desmocollin 2
increases expression
ISO
methyleugenol results in increased expression of DSC2 mRNA
CTD
PMID:32234424
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,450,390...11,482,392
G
Dusp15
dual specificity phosphatase 15
increases expression
ISO
methyleugenol results in increased expression of DUSP15 mRNA
CTD
PMID:32234424
NCBI chr 3:141,408,495...141,419,137
Ensembl chr 3:141,408,498...141,418,999
G
Dusp9
dual specificity phosphatase 9
decreases expression
ISO
methyleugenol results in decreased expression of DUSP9 mRNA
CTD
PMID:32234424
NCBI chr X:156,503,237...156,507,162
Ensembl chr X:151,351,897...151,355,821
G
Dync2h1
dynein cytoplasmic 2 heavy chain 1
decreases expression
ISO
methyleugenol results in decreased expression of DYNC2H1 mRNA
CTD
PMID:32234424
NCBI chr 8:12,473,955...12,697,075
Ensembl chr 8:4,189,257...4,412,183
G
Ebf1
EBF transcription factor 1
decreases expression
ISO
methyleugenol results in decreased expression of EBF1 mRNA
CTD
PMID:32234424
NCBI chr10:29,597,221...29,990,571
Ensembl chr10:29,099,933...29,487,665
G
Ecm2
extracellular matrix protein 2
decreases expression
ISO
methyleugenol results in decreased expression of ECM2 mRNA
CTD
PMID:32234424
NCBI chr17:15,326,359...15,358,938
Ensembl chr17:15,120,196...15,152,516
G
Edil3
EGF like repeats and discoidin domains 3
decreases expression
ISO
methyleugenol results in decreased expression of EDIL3 mRNA
CTD
PMID:32234424
NCBI chr 2:21,625,604...22,140,380
Ensembl chr 2:19,890,373...20,405,008
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
increases expression
ISO
methyleugenol results in increased expression of EEF1A2 mRNA
CTD
PMID:32234424
NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:168,195,357...168,275,071
G
Efcab11
EF-hand calcium binding domain 11
decreases expression
ISO
methyleugenol results in decreased expression of EFCAB11 mRNA
CTD
PMID:32234424
NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046
G
Efcab6
EF-hand calcium binding domain 6
decreases expression
ISO
methyleugenol results in decreased expression of EFCAB6 mRNA
CTD
PMID:32234424
NCBI chr 7:116,899,022...117,085,998
Ensembl chr 7:115,019,010...115,206,092
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
methyleugenol results in decreased expression of EGFR protein
CTD
PMID:15618236
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
increases expression
ISO
methyleugenol results in increased expression of EGR1 mRNA
CTD
PMID:15618236
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Ehbp1l1
EH domain binding protein 1-like 1
increases expression
ISO
methyleugenol results in increased expression of EHBP1L1 mRNA
CTD
PMID:32234424
NCBI chr 1:212,423,444...212,444,357
Ensembl chr 1:202,994,118...203,014,270
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
decreases expression
ISO
methyleugenol results in decreased expression of EHHADH mRNA
CTD
PMID:32234424
NCBI chr11:92,746,409...92,779,647
Ensembl chr11:79,241,938...79,275,188
G
Elapor1
endosome-lysosome associated apoptosis and autophagy regulator 1
increases expression
ISO
methyleugenol results in increased expression of ELAPOR1 mRNA
CTD
PMID:32234424
NCBI chr 2:198,777,323...198,856,497
Ensembl chr 2:196,091,646...196,168,716
G
Elmo1
engulfment and cell motility 1
decreases expression
ISO
methyleugenol results in decreased expression of ELMO1 mRNA
CTD
PMID:32234424
NCBI chr17:48,982,188...49,518,525
Ensembl chr17:44,286,485...44,822,788
G
Elp4
elongator acetyltransferase complex subunit 4
decreases expression
ISO
methyleugenol results in decreased expression of ELP4 mRNA
CTD
PMID:32234424
NCBI chr 3:92,162,271...92,385,251
Ensembl chr 3:92,162,280...92,385,243
G
Eml6
EMAP like 6
decreases expression
ISO
methyleugenol results in decreased expression of EML6 mRNA
CTD
PMID:32234424
NCBI chr14:103,471,537...103,806,120
Ensembl chr14:103,476,372...103,805,849
G
Enox1
ecto-NOX disulfide-thiol exchanger 1
decreases expression
ISO
methyleugenol results in decreased expression of ENOX1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr15:58,924,519...59,488,919
Ensembl chr15:52,515,178...53,079,749
G
Enpp3
ectonucleotide pyrophosphatase/phosphodiesterase 3
decreases expression
ISO
methyleugenol results in decreased expression of ENPP3 mRNA
CTD
PMID:32234424
NCBI chr 1:22,382,717...22,454,324
Ensembl chr 1:20,563,697...20,635,041
G
Enpp6
ectonucleotide pyrophosphatase/phosphodiesterase 6
decreases expression
ISO
methyleugenol results in decreased expression of ENPP6 mRNA
CTD
PMID:32234424
NCBI chr16:51,898,557...52,026,789
Ensembl chr16:45,169,178...45,294,077
G
Entpd8
ectonucleoside triphosphate diphosphohydrolase 8
decreases expression
ISO
methyleugenol results in decreased expression of ENTPD8 mRNA
CTD
PMID:32234424
NCBI chr 3:7,885,277...7,895,517
Ensembl chr 3:7,889,909...7,895,296
G
Ephx2
epoxide hydrolase 2
decreases expression
ISO
methyleugenol results in decreased expression of EPHX2 mRNA
CTD
PMID:32234424
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Epm2a
EPM2A glucan phosphatase, laforin
decreases expression
ISO
methyleugenol results in decreased expression of EPM2A mRNA
CTD
PMID:32234424
NCBI chr 1:7,547,369...7,673,449
Ensembl chr 1:5,727,066...5,920,555
G
Eps8l3
EPS8 signaling adaptor L3
increases expression
ISO
methyleugenol results in increased expression of EPS8L3 mRNA
CTD
PMID:32234424
NCBI chr 2:198,202,862...198,216,255
Ensembl chr 2:195,514,692...195,528,085
G
Erbb4
erb-b2 receptor tyrosine kinase 4
decreases expression
ISO
methyleugenol results in decreased expression of ERBB4 mRNA
CTD
PMID:32234424
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:69,531,481...70,596,595
G
Ereg
epiregulin
increases expression
ISO
methyleugenol results in increased expression of EREG mRNA
CTD
PMID:32234424
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,027,287...17,041,062
G
Erich4
glutamate-rich 4
decreases expression
ISO
methyleugenol results in decreased expression of ERICH4 mRNA
CTD
PMID:32234424
NCBI chr 1:81,123,556...81,125,296
Ensembl chr 1:81,123,556...81,125,296
G
Erln
endoregulin
increases expression
ISO
methyleugenol results in increased expression of ERLN mRNA
CTD
PMID:32234424
NCBI chr10:101,144,577...101,147,160
G
Erp27
endoplasmic reticulum protein 27
decreases expression
ISO
methyleugenol results in decreased expression of ERP27 mRNA
CTD
PMID:32234424
NCBI chr 4:169,804,656...169,821,660
Ensembl chr 4:169,804,658...169,821,660
G
Esam
endothelial cell adhesion molecule
increases expression
ISO
methyleugenol results in increased expression of ESAM mRNA
CTD
PMID:32234424
NCBI chr 8:45,426,985...45,437,976
Ensembl chr 8:37,238,287...37,249,215
G
Esco1
establishment of sister chromatid cohesion N-acetyltransferase 1
decreases expression
EXP
methyleugenol results in decreased expression of ESCO1 mRNA
CTD
PMID:26011634
NCBI chr18:1,904,748...1,959,609
Ensembl chr18:1,631,954...1,686,942
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
ISO
methyleugenol results in decreased expression of ESPL1 mRNA
CTD
PMID:32234424
NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:133,424,130...133,450,984
G
Espn
espin
decreases expression
ISO
methyleugenol results in decreased expression of ESPN mRNA
CTD
PMID:32234424
NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:162,626,560...162,660,256
G
Esrrg
estrogen-related receptor gamma
decreases expression
ISO
methyleugenol results in decreased expression of ESRRG mRNA
CTD
PMID:32234424
NCBI chr13:101,699,043...102,316,877
Ensembl chr13:99,564,669...99,783,397
G
Etnk2
ethanolamine kinase 2
decreases expression
ISO
methyleugenol results in decreased expression of ETNK2 mRNA
CTD
PMID:32234424
NCBI chr13:47,362,964...47,381,100
Ensembl chr13:44,811,015...44,829,037
G
Eva1b
eva-1 homolog B
increases expression
ISO
methyleugenol results in increased expression of EVA1B mRNA
CTD
PMID:32234424
NCBI chr 5:138,427,088...138,429,602
Ensembl chr 5:138,427,151...138,432,433
G
Exoc3l4
exocyst complex component 3-like 4
decreases expression
ISO
methyleugenol results in decreased expression of EXOC3L4 mRNA
CTD
PMID:32234424
NCBI chr 6:136,273,857...136,287,877
Ensembl chr 6:130,452,661...130,466,683
G
Exoc4
exocyst complex component 4
decreases expression
ISO
methyleugenol results in decreased expression of EXOC4 mRNA
CTD
PMID:32234424
NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:61,807,761...62,585,723
G
Eya2
EYA transcriptional coactivator and phosphatase 2
decreases expression
ISO
methyleugenol results in decreased expression of EYA2 mRNA
CTD
PMID:32234424
NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793
G
Eya4
EYA transcriptional coactivator and phosphatase 4
decreases expression
ISO
methyleugenol results in decreased expression of EYA4 mRNA
CTD
PMID:32234424
NCBI chr 1:23,991,431...24,235,132
Ensembl chr 1:22,172,275...22,415,976
G
F11
coagulation factor XI
decreases expression
ISO
methyleugenol results in decreased expression of F11 mRNA
CTD
PMID:32234424
NCBI chr16:53,720,502...53,741,547
Ensembl chr16:46,986,107...47,008,437
G
F12
coagulation factor XII
decreases expression
ISO
methyleugenol results in decreased expression of F12 mRNA
CTD
PMID:32234424
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530
G
F2rl2
coagulation factor II (thrombin) receptor-like 2
increases expression
ISO
methyleugenol results in increased expression of F2RL2 mRNA
CTD
PMID:32234424
NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:26,972,054...26,977,098
G
F7
coagulation factor VII
decreases expression
ISO
methyleugenol results in decreased expression of F7 mRNA
CTD
PMID:32234424
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
F9
coagulation factor IX
decreases expression
ISO
methyleugenol results in decreased expression of F9 mRNA
CTD
PMID:32234424
NCBI chr X:143,388,642...143,433,143
Ensembl chr X:138,352,298...138,396,835
G
Fabp1
fatty acid binding protein 1
decreases expression
ISO
methyleugenol results in decreased expression of FABP1 mRNA
CTD
PMID:32234424
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:103,191,006...103,194,788
G
Fam151a
family with sequence similarity 151, member A
decreases expression
ISO
methyleugenol results in decreased expression of FAM151A mRNA
CTD
PMID:32234424
NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:121,514,804...121,527,555
G
Fam167a
family with sequence similarity 167, member A
increases expression
ISO
methyleugenol results in increased expression of FAM167A mRNA
CTD
PMID:32234424
NCBI chr15:37,685,221...37,715,472
Ensembl chr15:37,700,919...37,715,469
G
Fam171a2
family with sequence similarity 171, member A2
increases expression
ISO
methyleugenol results in increased expression of FAM171A2 mRNA
CTD
PMID:32234424
NCBI chr10:87,393,888...87,404,051
Ensembl chr10:87,394,007...87,404,053
G
Fam78b
family with sequence similarity 78, member B
decreases expression
ISO
methyleugenol results in decreased expression of FAM78B mRNA
CTD
PMID:32234424
NCBI chr13:79,162,393...79,250,958
Ensembl chr13:79,162,228...79,250,500
G
Fam83d
family with sequence similarity 83, member D
decreases expression
ISO
methyleugenol results in decreased expression of FAM83D mRNA
CTD
PMID:32234424
NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:147,421,908...147,441,192
G
Fank1
fibronectin type III and ankyrin repeat domains 1
decreases expression
ISO
methyleugenol results in decreased expression of FANK1 mRNA
CTD
PMID:32234424
NCBI chr 1:198,007,496...198,114,790
Ensembl chr 1:188,577,575...188,685,504
G
Far1
fatty acyl CoA reductase 1
decreases expression
ISO
methyleugenol results in decreased expression of FAR1 mRNA
CTD
PMID:32234424
NCBI chr 1:177,078,973...177,140,363
Ensembl chr 1:167,644,677...167,705,730
G
Fars2
phenylalanyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
methyleugenol results in decreased expression of FARS2 mRNA
CTD
PMID:32234424
NCBI chr17:28,524,737...28,951,818
Ensembl chr17:28,319,280...28,746,337
G
Fasn
fatty acid synthase
decreases expression
ISO
methyleugenol results in decreased expression of FASN mRNA
CTD
PMID:32234424
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fat3
FAT atypical cadherin 3
decreases expression
ISO
methyleugenol results in decreased expression of FAT3 mRNA
CTD
PMID:32234424
NCBI chr 8:20,972,840...21,555,679
Ensembl chr 8:12,694,019...13,273,135
G
Fblim1
filamin binding LIM protein 1
increases expression
ISO
methyleugenol results in increased expression of FBLIM1 mRNA
CTD
PMID:32234424
NCBI chr 5:153,883,945...153,915,524
Ensembl chr 5:153,883,960...153,913,757
G
Fbp1
fructose-bisphosphatase 1
decreases expression
ISO
methyleugenol results in decreased expression of FBP1 mRNA
CTD
PMID:32234424
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,208,031...2,230,071
G
Fbxl17
F-box and leucine-rich repeat protein 17
decreases expression
ISO
methyleugenol results in decreased expression of FBXL17 mRNA
CTD
PMID:32234424
NCBI chr 9:110,227,609...110,666,184
Ensembl chr 9:102,782,440...103,208,950
G
Fbxo15
F-box protein 15
decreases expression
ISO
methyleugenol results in decreased expression of FBXO15 mRNA
CTD
PMID:32234424
NCBI chr18:80,594,444...80,909,549
Ensembl chr18:78,319,534...78,390,765
G
Fbxo43
F-box protein 43
decreases expression
ISO
methyleugenol results in decreased expression of FBXO43 mRNA
CTD
PMID:32234424
NCBI chr 7:67,333,161...67,346,751
Ensembl chr 7:67,333,162...67,346,751
G
Fer
FER tyrosine kinase
decreases expression
ISO
methyleugenol results in decreased expression of FER mRNA
CTD
PMID:32234424
NCBI chr 9:110,967,317...111,274,315
Ensembl chr 9:103,520,493...103,821,451
G
Fer1l6
fer-1-like family member 6
decreases expression
ISO
methyleugenol results in decreased expression of FER1L6 mRNA
CTD
PMID:32234424
NCBI chr 7:90,093,567...90,216,907
Ensembl chr 7:90,061,924...90,215,214
G
Fetub
fetuin B
decreases expression
ISO
methyleugenol results in decreased expression of FETUB mRNA
CTD
PMID:32234424
NCBI chr11:91,586,750...91,599,789
Ensembl chr11:78,082,156...78,095,135
G
Fga
fibrinogen alpha chain
decreases expression
ISO
methyleugenol results in decreased expression of FGA mRNA
CTD
PMID:32234424
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
decreases expression
ISO
methyleugenol results in decreased expression of FGB mRNA
CTD
PMID:32234424
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:168,394,916...168,405,979
G
Fgd5
FYVE, RhoGEF and PH domain containing 5
decreases expression
ISO
methyleugenol results in decreased expression of FGD5 mRNA
CTD
PMID:32234424
NCBI chr 4:124,497,061...124,594,564
Ensembl chr 4:124,497,068...124,594,563
G
Fgf12
fibroblast growth factor 12
decreases expression
ISO
methyleugenol results in decreased expression of FGF12 mRNA
CTD
PMID:32234424
NCBI chr11:85,501,947...86,069,543
Ensembl chr11:71,997,099...72,562,607
G
Fgf13
fibroblast growth factor 13
decreases expression
ISO
methyleugenol results in decreased expression of FGF13 mRNA
CTD
PMID:32234424
NCBI chr X:142,312,381...142,838,581
Ensembl chr X:137,276,511...137,800,391
G
Fgf14
fibroblast growth factor 14
decreases expression
ISO
methyleugenol results in decreased expression of FGF14 mRNA
CTD
PMID:32234424
NCBI chr15:107,442,800...108,086,486
Ensembl chr15:101,045,036...101,679,900
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
ISO
methyleugenol results in decreased expression of FGFR2 mRNA
CTD
PMID:32234424
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
G
Fggy
FGGY carbohydrate kinase domain containing
decreases expression
ISO
methyleugenol results in decreased expression of FGGY mRNA
CTD
PMID:32234424
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
G
Fgl2
fibrinogen-like 2
decreases expression
ISO
methyleugenol results in decreased expression of FGL2 mRNA
CTD
PMID:32234424
NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:13,710,575...13,716,207
G
Fhit
fragile histidine triad diadenosine triphosphatase
decreases expression
ISO
methyleugenol results in decreased expression of FHIT mRNA; methyleugenol results in decreased expression of FHIT protein
CTD
PMID:15618236 PMID:32234424 PMID:35690182
NCBI chr15:16,365,401...17,872,901
Ensembl chr15:13,934,995...15,442,340
G
Fhod3
formin homology 2 domain containing 3
decreases expression
ISO
methyleugenol results in decreased expression of FHOD3 mRNA
CTD
PMID:32234424
NCBI chr18:16,267,830...16,700,508
Ensembl chr18:15,993,324...16,425,796
G
Filip1
filamin A interacting protein 1
decreases expression
ISO
methyleugenol results in decreased expression of FILIP1 mRNA
CTD
PMID:32234424
NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549
G
Filip1l
filamin A interacting protein 1-like
increases expression
ISO
methyleugenol results in increased expression of FILIP1L mRNA
CTD
PMID:32234424
NCBI chr11:56,403,467...56,646,422
Ensembl chr11:42,940,467...43,177,415
G
Fitm1
fat storage-inducing transmembrane protein 1
decreases expression
ISO
methyleugenol results in decreased expression of FITM1 mRNA
CTD
PMID:32234424
NCBI chr15:33,034,705...33,035,974
Ensembl chr15:29,064,707...29,066,015
G
Flrt2
fibronectin leucine rich transmembrane protein 2
increases expression
ISO
methyleugenol results in increased expression of FLRT2 mRNA
CTD
PMID:32234424
NCBI chr 6:120,507,998...120,603,133
Ensembl chr 6:114,777,599...114,872,785
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
ISO
methyleugenol results in decreased expression of FMO1 mRNA
CTD
PMID:32234424
NCBI chr13:77,715,405...77,747,666
Ensembl chr13:75,182,176...75,214,647
G
Fmo5
flavin containing dimethylaniline monoxygenase 5
decreases expression
ISO
methyleugenol results in decreased expression of FMO5 mRNA
CTD
PMID:32234424
NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:185,222,204...185,249,693
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
methyleugenol results in increased expression of FOSL1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:202,754,529...202,764,930
G
Foxa3
forkhead box A3
increases expression
ISO
methyleugenol results in increased expression of FOXA3 mRNA
CTD
PMID:32234424
NCBI chr 1:87,790,111...87,800,259
Ensembl chr 1:78,662,431...78,672,155
G
Fras1
Fraser extracellular matrix complex subunit 1
decreases expression
ISO
methyleugenol results in decreased expression of FRAS1 mRNA
CTD
PMID:32234424
NCBI chr14:12,791,407...13,200,862
Ensembl chr14:12,793,599...13,200,726
G
Frmpd2
FERM and PDZ domain containing 2
decreases expression
ISO
methyleugenol results in decreased expression of FRMPD2 mRNA
CTD
PMID:32234424
NCBI chr16:8,763,889...8,883,558
Ensembl chr16:8,757,705...8,877,303
G
Fst
follistatin
increases expression
ISO
methyleugenol results in increased expression of FST mRNA
CTD
PMID:32234424
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:46,123,439...46,130,571
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
decreases expression
ISO
methyleugenol results in decreased expression of FTO mRNA
CTD
PMID:32234424
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:15,349,696...15,692,083
G
Fuom
fucose mutarotase
decreases expression
ISO
methyleugenol results in decreased expression of FUOM mRNA
CTD
PMID:32234424
NCBI chr 1:204,318,180...204,322,690
Ensembl chr 1:194,886,709...194,893,046
G
Fut4-ps1
fucosyltransferase 4, pseudogene 1
decreases expression
ISO
methyleugenol results in decreased expression of FUT6 mRNA
CTD
PMID:32234424
NCBI chr 9:1,569,605...1,572,022
G
Fxyd5
FXYD domain-containing ion transport regulator 5
increases expression
ISO
methyleugenol results in increased expression of FXYD5 mRNA
CTD
PMID:32234424
NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:86,267,406...86,277,519
G
Fyb2
FYN binding protein 2
decreases expression
ISO
methyleugenol results in decreased expression of FYB2 mRNA
CTD
PMID:32234424
NCBI chr 5:119,677,116...119,800,911
Ensembl chr 5:119,677,204...119,800,910
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
methyleugenol results in decreased expression of FYN mRNA
CTD
PMID:32234424
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:42,766,369...42,959,911
G
G0s2
G0/G1switch 2
decreases expression
ISO
methyleugenol results in decreased expression of G0S2 mRNA
CTD
PMID:32234424
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
methyleugenol results in decreased expression of G6PC1 mRNA
CTD
PMID:32234424
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804
G
Gad1
glutamate decarboxylase 1
increases expression
ISO
methyleugenol results in increased expression of GAD1 mRNA
CTD
PMID:32234424
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
methyleugenol results in increased expression of GADD45B mRNA
CTD
PMID:15618236
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:8,778,007...8,780,046
G
Galnt13
polypeptide N-acetylgalactosaminyltransferase 13
decreases expression
ISO
methyleugenol results in decreased expression of GALNT13 mRNA
CTD
PMID:32234424
NCBI chr 3:59,312,628...59,969,633
Ensembl chr 3:38,974,490...39,558,803
G
Galnt16
polypeptide N-acetylgalactosaminyltransferase 16
decreases expression
ISO
methyleugenol results in decreased expression of GALNT16 mRNA
CTD
PMID:32234424
NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:100,170,306...100,250,705
G
Galntl6
polypeptide N-acetylgalactosaminyltransferase-like 6
decreases expression
ISO
methyleugenol results in decreased expression of GALNTL6 mRNA
CTD
PMID:32234424
NCBI chr16:36,203,674...37,454,709
Ensembl chr16:31,186,462...32,441,960
G
Gas1
growth arrest-specific 1
decreases expression
ISO
methyleugenol results in decreased expression of GAS1 mRNA
CTD
PMID:32234424
NCBI chr17:4,487,716...4,490,701
G
Gatm
glycine amidinotransferase
decreases expression
ISO
methyleugenol results in decreased expression of GATM mRNA
CTD
PMID:32234424
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:109,658,951...109,684,129
G
Gba3
glucosylceramidase beta 3
decreases expression
ISO
methyleugenol results in decreased expression of GBA3 mRNA
CTD
PMID:32234424
NCBI chr14:64,787,601...64,934,043
Ensembl chr14:60,574,976...60,721,653
G
Gbp7
guanylate binding protein 7
decreases expression
ISO
methyleugenol results in decreased expression of GBP7 mRNA
CTD
PMID:32234424
NCBI chr 2:233,948,774...233,970,532
Ensembl chr 2:231,275,640...231,297,278
G
Gc
GC, vitamin D binding protein
decreases expression
ISO
methyleugenol results in decreased expression of GC mRNA
CTD
PMID:32234424
NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,632,135...18,667,567
G
Gcdh
glutaryl-CoA dehydrogenase
decreases expression
ISO
methyleugenol results in decreased expression of GCDH mRNA
CTD
PMID:32234424
NCBI chr19:40,168,038...40,174,536
Ensembl chr19:23,263,264...23,269,681
G
Gcgr
glucagon receptor
decreases expression
ISO
methyleugenol results in decreased expression of GCGR mRNA
CTD
PMID:32234424
NCBI chr10:106,306,803...106,314,970
Ensembl chr10:105,808,473...105,816,640
G
Gchfr
GTP cyclohydrolase I feedback regulator
decreases expression
ISO
methyleugenol results in decreased expression of GCHFR mRNA
CTD
PMID:32234424
NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:106,159,394...106,162,080
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
methyleugenol results in increased expression of GCNT3 mRNA
CTD
PMID:32234424
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gdf11
growth differentiation factor 11
increases expression
ISO
methyleugenol results in increased expression of GDF11 mRNA
CTD
PMID:32234424
NCBI chr 7:1,896,229...1,909,147
Ensembl chr 7:1,311,732...1,320,725
G
Gdf15
growth differentiation factor 15
increases expression
ISO
methyleugenol results in increased expression of GDF15 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Gdnf
glial cell derived neurotrophic factor
increases expression
ISO
methyleugenol results in increased expression of GDNF mRNA
CTD
PMID:32234424
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gem
GTP binding protein overexpressed in skeletal muscle
increases expression
ISO
methyleugenol results in increased expression of GEM mRNA
CTD
PMID:32234424
NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:25,214,309...25,225,222
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
increases expression
ISO
methyleugenol results in increased expression of GFPT2 mRNA
CTD
PMID:32234424
NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,115,052...34,161,329
G
Gfra1
GDNF family receptor alpha 1
decreases expression
ISO
methyleugenol results in decreased expression of GFRA1 mRNA
CTD
PMID:32234424
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:257,321,742...257,551,473
G
Ghr
growth hormone receptor
decreases expression
ISO
methyleugenol results in decreased expression of GHR mRNA
CTD
PMID:32234424
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:52,542,594...52,804,735
G
Gipc2
GIPC PDZ domain containing family, member 2
decreases expression
ISO
methyleugenol results in decreased expression of GIPC2 mRNA
CTD
PMID:32234424
NCBI chr 2:243,690,742...243,770,199
Ensembl chr 2:241,030,770...241,110,236
G
Gja3
gap junction protein, alpha 3
increases expression
ISO
methyleugenol results in increased expression of GJA3 mRNA
CTD
PMID:32234424
NCBI chr15:35,296,946...35,322,405
Ensembl chr15:31,181,369...31,206,810
G
Gla
galactosidase, alpha
increases expression
ISO
methyleugenol results in increased expression of GLA mRNA
CTD
PMID:32234424
NCBI chr X:102,062,497...102,073,915
Ensembl chr X:97,768,996...97,780,664
G
Gldc
glycine decarboxylase
decreases expression
ISO
methyleugenol results in decreased expression of GLDC mRNA
CTD
PMID:32234424
NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:227,883,249...227,962,097
G
Glipr1
GLI pathogenesis-related 1
increases expression
ISO
methyleugenol results in increased expression of GLIPR1 mRNA
CTD
PMID:32234424
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Glipr2
GLI pathogenesis-related 2
increases expression
ISO
methyleugenol results in increased expression of GLIPR2 mRNA
CTD
PMID:32234424
NCBI chr 5:62,966,163...62,998,016
Ensembl chr 5:58,170,425...58,202,272
G
Glra3
glycine receptor, alpha 3
decreases expression
ISO
methyleugenol results in decreased expression of GLRA3 mRNA
CTD
PMID:32234424
NCBI chr16:39,210,534...39,857,332
Ensembl chr16:34,204,811...34,848,753
G
Gls2
glutaminase 2
decreases expression
ISO
methyleugenol results in decreased expression of GLS2 mRNA
CTD
PMID:32234424
NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:617,288...633,426
G
Gltpd2
glycolipid transfer protein domain containing 2
decreases expression
ISO
methyleugenol results in decreased expression of GLTPD2 mRNA
CTD
PMID:32234424
NCBI chr10:55,732,199...55,734,974
Ensembl chr10:55,233,571...55,235,233
G
Glud1
glutamate dehydrogenase 1
decreases expression
ISO
methyleugenol results in decreased expression of GLUD1 mRNA
CTD
PMID:32234424
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,640,312...9,673,957
G
Glul
glutamate-ammonia ligase
decreases expression
ISO
methyleugenol results in decreased expression of GLUL mRNA
CTD
PMID:32234424
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
G
Glyat
glycine-N-acyltransferase
decreases expression
ISO
methyleugenol results in decreased expression of GLYAT mRNA
CTD
PMID:32234424
NCBI chr 1:219,128,798...219,149,615
Ensembl chr 1:209,704,268...209,724,942
G
Glyctk
glycerate kinase
decreases expression
ISO
methyleugenol results in decreased expression of GLYCTK mRNA
CTD
PMID:32234424
NCBI chr 8:115,676,071...115,681,403
Ensembl chr 8:106,797,343...106,802,397
G
Gmds
GDP-mannose 4, 6-dehydratase
decreases expression
ISO
methyleugenol results in decreased expression of GMDS mRNA
CTD
PMID:32234424
NCBI chr17:32,304,029...32,830,708
Ensembl chr17:32,095,386...32,621,961
G
Gng7
G protein subunit gamma 7
decreases expression
ISO
methyleugenol results in decreased expression of GNG7 mRNA
CTD
PMID:32234424
NCBI chr 7:9,348,148...9,411,924
Ensembl chr 7:8,697,521...8,761,240
G
Gnmt
glycine N-methyltransferase
decreases expression
ISO
methyleugenol results in decreased expression of GNMT mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:14,254,675...14,258,434
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
ISO
methyleugenol results in decreased expression of GPAM mRNA
CTD
PMID:32234424
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:254,106,331...254,142,639
G
Gpc2
glypican 2
increases expression
ISO
methyleugenol results in increased expression of GPC2 mRNA
CTD
PMID:32234424
NCBI chr12:17,277,875...17,284,297
Ensembl chr12:17,277,875...17,284,208
G
Gpc5
glypican 5
decreases expression
ISO
methyleugenol results in decreased expression of GPC5 mRNA
CTD
PMID:32234424
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
G
Gpc6
glypican 6
decreases expression
ISO
methyleugenol results in decreased expression of GPC6 mRNA
CTD
PMID:32234424
NCBI chr15:100,437,415...101,435,038
Ensembl chr15:94,029,884...95,024,006
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
decreases expression
ISO
methyleugenol results in decreased expression of GPD1 mRNA
CTD
PMID:32234424
NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:130,844,138...130,851,529
G
Gphn
gephyrin
decreases expression
ISO
methyleugenol results in decreased expression of GPHN mRNA
CTD
PMID:32234424
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:96,892,148...97,483,612
G
Gpm6a
glycoprotein m6a
decreases expression
ISO
methyleugenol results in decreased expression of GPM6A mRNA
CTD
PMID:32234424
NCBI chr16:43,374,385...43,706,461
Ensembl chr16:36,641,284...36,973,475
G
Gpr153
G protein-coupled receptor 153
decreases expression
ISO
methyleugenol results in decreased expression of GPR153 mRNA
CTD
PMID:32234424
NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971
G
Gpr160
G protein-coupled receptor 160
decreases expression
ISO
methyleugenol results in decreased expression of GPR160 mRNA
CTD
PMID:32234424
NCBI chr 2:112,483,364...112,563,072
Ensembl chr 2:112,484,935...112,563,148
G
Gpr87
G protein-coupled receptor 87
increases expression
ISO
methyleugenol results in increased expression of GPR87 mRNA
CTD
PMID:32234424
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
G
Gprc5a
G protein-coupled receptor, class C, group 5, member A
increases expression
ISO
methyleugenol results in increased expression of GPRC5A mRNA
CTD
PMID:32234424
NCBI chr 4:169,634,896...169,653,627
Ensembl chr 4:167,903,542...167,922,260
G
Gprc5b
G protein-coupled receptor, class C, group 5, member B
increases expression
ISO
methyleugenol results in increased expression of GPRC5B mRNA
CTD
PMID:32234424
NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:173,316,907...173,340,932
G
Gprin1
G protein-regulated inducer of neurite outgrowth 1
increases expression
ISO
methyleugenol results in increased expression of GPRIN1 mRNA
CTD
PMID:32234424
NCBI chr17:9,869,009...9,881,958
Ensembl chr17:9,863,571...9,876,915
G
Gpsm1
G-protein signaling modulator 1
increases expression
ISO
methyleugenol results in increased expression of GPSM1 mRNA
CTD
PMID:32234424
NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:9,128,636...9,167,827
G
Gpt
glutamic--pyruvic transaminase
decreases expression
ISO
methyleugenol results in decreased expression of GPT mRNA
CTD
PMID:32234424
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Grap
GRB2-related adaptor protein
decreases expression
ISO
methyleugenol results in decreased expression of GRAP mRNA
CTD
PMID:32234424
NCBI chr10:46,798,423...46,851,524
Ensembl chr10:46,332,909...46,352,056
G
Greb1
growth regulating estrogen receptor binding 1
decreases expression
ISO
methyleugenol results in decreased expression of GREB1 mRNA
CTD
PMID:32234424
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
G
Grid1
glutamate ionotropic receptor delta type subunit 1
decreases expression
ISO
methyleugenol results in decreased expression of GRID1 mRNA
CTD
PMID:32234424
NCBI chr16:10,145,018...10,894,184
Ensembl chr16:10,138,925...10,885,808
G
Grid2
glutamate ionotropic receptor delta type subunit 2
decreases expression
ISO
methyleugenol results in decreased expression of GRID2 mRNA
CTD
PMID:32234424
NCBI chr 4:93,745,165...95,222,354
Ensembl chr 4:92,415,230...93,889,355
G
Grik4
glutamate ionotropic receptor kainate type subunit 4
decreases expression
ISO
methyleugenol results in decreased expression of GRIK4 mRNA
CTD
PMID:32234424
NCBI chr 8:51,802,045...52,228,751
Ensembl chr 8:42,905,056...43,193,751
G
Grik5
glutamate ionotropic receptor kainate type subunit 5
decreases expression
ISO
methyleugenol results in decreased expression of GRIK5 mRNA
CTD
PMID:32234424
NCBI chr 1:89,733,736...89,795,769
Ensembl chr 1:80,605,892...80,667,125
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
ISO
methyleugenol results in increased expression of GRIN2C mRNA
CTD
PMID:32234424
NCBI chr10:100,987,410...101,006,064
Ensembl chr10:100,488,431...100,506,427
G
Grip1
glutamate receptor interacting protein 1
decreases expression
ISO
methyleugenol results in decreased expression of GRIP1 mRNA
CTD
PMID:32234424
NCBI chr 7:56,820,501...57,477,877
Ensembl chr 7:54,934,250...55,592,273
G
Grm3
glutamate metabotropic receptor 3
decreases expression
ISO
methyleugenol results in decreased expression of GRM3 mRNA
CTD
PMID:32234424
NCBI chr 4:25,319,218...25,600,721
Ensembl chr 4:24,365,115...24,609,804
G
Grm8
glutamate metabotropic receptor 8
decreases expression
ISO
methyleugenol results in decreased expression of GRM8 mRNA
CTD
PMID:32234424
NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:55,805,955...56,730,831
G
Gsta1
glutathione S-transferase alpha 1
decreases activity
ISO
methyleugenol results in decreased activity of GSTA1 protein
CTD
PMID:8620581
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:23,703,477...23,720,121
G
Gsta2
glutathione S-transferase alpha 2
decreases activity
EXP
methyleugenol results in decreased activity of GSTA2 protein
CTD
PMID:8620581
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3
glutathione S-transferase alpha 3
decreases activity
EXP
methyleugenol results in decreased activity of GSTA3 protein
CTD
PMID:8620581
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:23,658,574...23,684,240
G
Gstm1
glutathione S-transferase mu 1
decreases activity decreases expression
ISO EXP
methyleugenol results in decreased activity of GSTM1 protein methyleugenol results in decreased expression of GSTM1 mRNA
CTD
PMID:8620581 PMID:32234424
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
decreases activity
EXP
methyleugenol results in decreased activity of GSTM2 protein
CTD
PMID:8620581
NCBI chr 2:198,312,179...198,316,962
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
decreases activity
ISO EXP
methyleugenol results in decreased activity of GSTP1 protein
CTD
PMID:8620581
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gtdc1
glycosyltransferase-like domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of GTDC1 mRNA
CTD
PMID:32234424
NCBI chr 3:49,176,110...49,571,594
Ensembl chr 3:28,766,645...29,162,271
G
Gucy1a2
guanylate cyclase 1 soluble subunit alpha 2
decreases expression
ISO
methyleugenol results in decreased expression of GUCY1A2 mRNA
CTD
PMID:32234424
NCBI chr 8:8,785,212...9,174,322
Ensembl chr 8:500,212...889,203
G
Gucy2e
guanylate cyclase 2E
decreases expression
ISO
methyleugenol results in decreased expression of GUCY2D mRNA
CTD
PMID:32234424
NCBI chr10:54,453,753...54,478,639
Ensembl chr10:53,959,010...53,974,067
G
Gulp1
GULP PTB domain containing engulfment adaptor 1
decreases expression
ISO
methyleugenol results in decreased expression of GULP1 mRNA
CTD
PMID:32234424
NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:46,622,669...46,899,005
G
Gys2
glycogen synthase 2
decreases expression
ISO
methyleugenol results in decreased expression of GYS2 mRNA
CTD
PMID:32234424
NCBI chr 4:177,096,063...177,137,236
Ensembl chr 4:175,365,054...175,406,228
G
H2ax
H2A.X variant histone
increases expression
EXP
methyleugenol results in increased expression of H2AX protein
CTD
PMID:26011634
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
H2bc3
H2B clustered histone 3
decreases expression
ISO
methyleugenol results in decreased expression of H2BC3 mRNA
CTD
PMID:32234424
NCBI chr17:41,807,913...41,808,543
G
H2bc8
H2B clustered histone 8
decreases expression
ISO
methyleugenol results in decreased expression of H2BC8 mRNA
CTD
PMID:32234424
NCBI chr17:47,404,405...47,405,155
G
H3c1
H3 clustered histone 1
decreases expression
ISO
methyleugenol results in decreased expression of H3C1 mRNA
CTD
PMID:32234424
NCBI chr17:41,796,236...41,796,759
Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856
G
Hagh
hydroxyacyl glutathione hydrolase
decreases expression
ISO
methyleugenol results in decreased expression of HAGH mRNA
CTD
PMID:32234424
NCBI chr10:14,379,400...14,394,046
Ensembl chr10:13,875,241...13,889,504
G
Hao2
hydroxyacid oxidase 2
decreases expression
ISO
methyleugenol results in decreased expression of HAO2 mRNA
CTD
PMID:32234424
NCBI chr 2:188,888,848...188,921,567
Ensembl chr 2:186,200,504...186,224,425
G
Havcr2
hepatitis A virus cellular receptor 2
decreases expression
ISO
methyleugenol results in decreased expression of HAVCR2 mRNA
CTD
PMID:32234424
NCBI chr10:31,383,801...31,415,334
Ensembl chr10:30,882,606...30,909,137
G
Hdac4
histone deacetylase 4
decreases expression
ISO
methyleugenol results in decreased expression of HDAC4 mRNA
CTD
PMID:32234424
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:92,507,611...92,750,164
G
Hes2
hes family bHLH transcription factor 2
increases expression
ISO
methyleugenol results in increased expression of HES2 mRNA
CTD
PMID:32234424
NCBI chr 5:162,667,190...162,668,235
Ensembl chr 5:162,667,190...162,668,235
G
Hhat
hedgehog acyltransferase
decreases expression
ISO
methyleugenol results in decreased expression of HHAT mRNA
CTD
PMID:32234424
NCBI chr13:106,558,635...106,814,723
Ensembl chr13:104,010,916...104,282,893
G
Hjv
hemojuvelin BMP co-receptor
decreases expression
ISO
methyleugenol results in decreased expression of HJV mRNA
CTD
PMID:32234424
NCBI chr 2:186,754,801...186,758,708
Ensembl chr 2:184,065,970...184,069,850
G
Hmcn1
hemicentin 1
decreases expression
ISO
methyleugenol results in decreased expression of HMCN1 mRNA
CTD
PMID:32234424
NCBI chr13:65,165,532...65,634,681
Ensembl chr13:62,615,461...63,084,524
G
Hmcn2
hemicentin 2
decreases expression
ISO
methyleugenol results in decreased expression of HMCN2 mRNA
CTD
PMID:32234424
NCBI chr 3:34,986,246...35,136,047
Ensembl chr 3:14,588,662...14,738,025
G
Hmga1
high mobility group AT-hook 1
increases expression
ISO
methyleugenol results in increased expression of HMGA1 mRNA
CTD
PMID:32234424
NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,611,694...5,618,752
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
decreases expression
ISO
methyleugenol results in decreased expression of HMGCS1 mRNA
CTD
PMID:32234424
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:51,649,497...51,667,100
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
ISO
methyleugenol results in decreased expression of HMGCS2 mRNA
CTD
PMID:32234424
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:185,875,616...185,902,130
G
Hmmr
hyaluronan-mediated motility receptor
decreases expression
ISO
methyleugenol results in decreased expression of HMMR mRNA
CTD
PMID:32234424
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,132,977...25,163,060
G
Hnmt
histamine N-methyltransferase
decreases expression
ISO
methyleugenol results in decreased expression of HNMT mRNA
CTD
PMID:32234424
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:6,591,463...6,624,012
G
Hoga1
4-hydroxy-2-oxoglutarate aldolase 1
decreases expression
ISO
methyleugenol results in decreased expression of HOGA1 mRNA
CTD
PMID:32234424
NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:240,857,126...240,884,568
G
Homer3
homer scaffold protein 3
increases expression
ISO
methyleugenol results in increased expression of HOMER3 mRNA
CTD
PMID:32234424
NCBI chr16:19,166,141...19,176,701
Ensembl chr16:19,132,162...19,142,680
G
Hoxb9
homeo box B9
increases expression
ISO
methyleugenol results in increased expression of HOXB9 mRNA
CTD
PMID:32234424
NCBI chr10:81,733,857...81,737,363
Ensembl chr10:81,237,312...81,240,818
G
Hp
haptoglobin
decreases expression
ISO
methyleugenol results in decreased expression of HP mRNA
CTD
PMID:32234424
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hpd
4-hydroxyphenylpyruvate dioxygenase
decreases expression
ISO
methyleugenol results in decreased expression of HPD mRNA
CTD
PMID:32234424
NCBI chr12:39,042,246...39,053,596
Ensembl chr12:33,381,231...33,392,766
G
Hpn
hepsin
decreases expression
ISO
methyleugenol results in decreased expression of HPN mRNA
CTD
PMID:32234424
NCBI chr 1:95,464,468...95,480,169
Ensembl chr 1:86,337,087...86,352,811
G
Hpx
hemopexin
decreases expression
ISO
methyleugenol results in decreased expression of HPX mRNA
CTD
PMID:32234424
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:159,932,755...159,940,328
G
Hrg
histidine-rich glycoprotein
decreases expression
ISO
methyleugenol results in decreased expression of HRG mRNA
CTD
PMID:32234424
NCBI chr11:91,559,087...91,573,982
Ensembl chr11:78,054,498...78,069,389
G
Hs6st3
heparan sulfate 6-O-sulfotransferase 3
decreases expression
ISO
methyleugenol results in decreased expression of HS6ST3 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr15:102,688,420...103,407,725
Ensembl chr15:96,281,646...97,000,462
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
ISO
methyleugenol results in decreased expression of HSD17B2 mRNA
CTD
PMID:32234424
NCBI chr19:62,662,320...62,733,944
Ensembl chr19:45,753,574...45,825,202
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
decreases expression
ISO
methyleugenol results in decreased expression of HSD17B6 mRNA
CTD
PMID:32234424
NCBI chr 7:831,407...850,950
Ensembl chr 7:422,480...442,425
G
Htr3a
5-hydroxytryptamine receptor 3A
increases expression
ISO
methyleugenol results in increased expression of HTR3A mRNA
CTD
PMID:32234424
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
methyleugenol results in decreased expression of ID2 mRNA
CTD
PMID:32234424
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:41,728,946...41,744,400
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
methyleugenol results in decreased expression of IDI1 mRNA
CTD
PMID:32234424
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:61,629,594...61,637,357
G
Idnk
Idnk, gluconokinase
decreases expression
ISO
methyleugenol results in decreased expression of IDNK mRNA
CTD
PMID:32234424
NCBI chr17:6,483,575...6,490,780
Ensembl chr17:6,483,576...6,490,905
G
Ier3
immediate early response 3
increases expression
ISO
methyleugenol results in increased expression of IER3 mRNA
CTD
PMID:32234424
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,928,378...2,929,583
G
Igf1
insulin-like growth factor 1
decreases expression
ISO
methyleugenol results in decreased expression of IGF1 mRNA
CTD
PMID:32234424
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igsf23
immunoglobulin superfamily, member 23
decreases expression
ISO
methyleugenol results in decreased expression of IGSF23 mRNA
CTD
PMID:32234424
NCBI chr 1:79,591,059...79,606,323
Ensembl chr 1:79,592,088...79,610,438
G
Igsf9
immunoglobulin superfamily, member 9
decreases expression
ISO
methyleugenol results in decreased expression of IGSF9 mRNA
CTD
PMID:32234424
NCBI chr13:87,480,979...87,497,974
Ensembl chr13:84,948,619...84,965,607
G
Il16
interleukin 16
decreases expression
ISO
methyleugenol results in decreased expression of IL16 mRNA
CTD
PMID:32234424
NCBI chr 1:147,026,852...147,127,177
Ensembl chr 1:137,617,944...137,718,130
G
Il1b
interleukin 1 beta
increases expression
ISO
methyleugenol results in increased expression of IL1B mRNA
CTD
PMID:32234424
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
increases expression
ISO
methyleugenol results in increased expression of IL1RL1 mRNA
CTD
PMID:32234424
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:42,697,192...42,727,256
G
Immp2l
inner mitochondrial membrane peptidase subunit 2
decreases expression
ISO
methyleugenol results in decreased expression of IMMP2L mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 6:63,797,189...64,696,906
Ensembl chr 6:58,070,283...58,969,840
G
Impdh1
inosine monophosphate dehydrogenase 1
increases expression
ISO
methyleugenol results in increased expression of IMPDH1 mRNA
CTD
PMID:32234424
NCBI chr 4:58,767,230...58,782,825
Ensembl chr 4:57,801,831...57,819,076
G
Impg2
interphotoreceptor matrix proteoglycan 2
decreases expression
ISO
methyleugenol results in decreased expression of IMPG2 mRNA
CTD
PMID:32234424
NCBI chr11:57,787,914...57,887,450
Ensembl chr11:44,318,836...44,418,382
G
Incenp
inner centromere protein
increases expression
EXP
methyleugenol results in increased expression of INCENP protein
CTD
PMID:23411599
NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265
G
Inhba
inhibin subunit beta A
decreases expression
ISO
methyleugenol results in decreased expression of INHBA mRNA
CTD
PMID:15618236 PMID:32234424
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Inhbc
inhibin subunit beta C
decreases expression
ISO
methyleugenol results in decreased expression of INHBC mRNA
CTD
PMID:32234424
NCBI chr 7:65,069,450...65,082,919
Ensembl chr 7:63,184,142...63,197,630
G
Inhbe
inhibin subunit beta E
decreases expression
ISO
methyleugenol results in decreased expression of INHBE mRNA
CTD
PMID:32234424
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:63,176,219...63,179,172
G
Inka2
inka box actin regulator 2
increases expression
ISO
methyleugenol results in increased expression of INKA2 mRNA
CTD
PMID:32234424
NCBI chr 2:195,873,617...195,888,983
Ensembl chr 2:193,185,275...193,200,642
G
Inpp4b
inositol polyphosphate-4-phosphatase type II B
decreases expression
ISO
methyleugenol results in decreased expression of INPP4B mRNA
CTD
PMID:32234424
NCBI chr19:42,824,710...43,575,039
Ensembl chr19:25,925,358...26,280,634
G
Insig1
insulin induced gene 1
decreases expression
ISO
methyleugenol results in decreased expression of INSIG1 mRNA
CTD
PMID:32234424
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:7,315,495...7,323,952
G
Iqgap2
IQ motif containing GTPase activating protein 2
decreases expression
ISO
methyleugenol results in decreased expression of IQGAP2 mRNA
CTD
PMID:32234424
NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:26,894,825...27,170,279
G
Iqub
IQ motif and ubiquitin domain containing
decreases expression
ISO
methyleugenol results in decreased expression of IQUB mRNA
CTD
PMID:32234424
NCBI chr 4:53,897,336...53,962,279
Ensembl chr 4:52,931,767...52,993,834
G
Irag1
inositol 1,4,5-triphosphate receptor associated 1
decreases expression
ISO
methyleugenol results in decreased expression of IRAG1 mRNA
CTD
PMID:32234424
NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176
G
Itga11
integrin subunit alpha 11
increases expression
ISO
methyleugenol results in increased expression of ITGA11 mRNA
CTD
PMID:32234424
NCBI chr 8:72,041,432...72,150,137
Ensembl chr 8:63,146,001...63,254,407
G
Itga2
integrin subunit alpha 2
increases expression
ISO
methyleugenol results in increased expression of ITGA2 mRNA
CTD
PMID:32234424
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:46,523,948...46,621,481
G
Itga8
integrin subunit alpha 8
decreases expression
ISO
methyleugenol results in decreased expression of ITGA8 mRNA
CTD
PMID:32234424
NCBI chr17:80,213,139...80,410,633
Ensembl chr17:75,304,008...75,501,510
G
Itgax
integrin subunit alpha X
increases expression
ISO
methyleugenol results in increased expression of ITGAX mRNA
CTD
PMID:32234424
NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:182,719,609...182,740,698
G
Itih1
inter-alpha trypsin inhibitor, heavy chain 1
decreases expression
ISO
methyleugenol results in decreased expression of ITIH1 mRNA
CTD
PMID:32234424
NCBI chr16:6,128,696...6,142,813
Ensembl chr16:6,122,248...6,136,363
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
decreases expression
ISO
methyleugenol results in decreased expression of ITPR1 mRNA
CTD
PMID:32234424
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:141,187,418...141,510,491
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
increases expression
ISO
methyleugenol results in increased expression of ITPR3 mRNA
CTD
PMID:32234424
NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,136,441...5,202,337
G
Iyd
iodotyrosine deiodinase
decreases expression
ISO
methyleugenol results in decreased expression of IYD mRNA
CTD
PMID:32234424
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:40,004,041...40,019,319
G
Jakmip2
janus kinase and microtubule interacting protein 2
decreases expression
ISO
methyleugenol results in decreased expression of JAKMIP2 mRNA
CTD
PMID:32234424
NCBI chr18:35,783,472...35,998,849
Ensembl chr18:35,532,552...35,747,775
G
Jph2
junctophilin 2
decreases expression
ISO
methyleugenol results in decreased expression of JPH2 mRNA
CTD
PMID:32234424
NCBI chr 3:172,414,246...172,478,678
Ensembl chr 3:151,994,778...152,058,904
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
methyleugenol results in increased expression of JUNB mRNA
CTD
PMID:15618236
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
G
Kcnd3
potassium voltage-gated channel subfamily D member 3
decreases expression
ISO
methyleugenol results in decreased expression of KCND3 mRNA
CTD
PMID:32234424
NCBI chr 2:195,626,316...195,843,690
Ensembl chr 2:192,937,950...193,155,345
G
Kcnh5
potassium voltage-gated channel subfamily H member 5
decreases expression
ISO
methyleugenol results in decreased expression of KCNH5 mRNA
CTD
PMID:32234424
NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107
G
Kcnh7
potassium voltage-gated channel subfamily H member 7
decreases expression
ISO
methyleugenol results in decreased expression of KCNH7 mRNA
CTD
PMID:32234424
NCBI chr 3:67,737,900...68,230,950
Ensembl chr 3:47,338,501...47,822,195
G
Kcnh8
potassium voltage-gated channel subfamily H member 8
decreases expression
ISO
methyleugenol results in decreased expression of KCNH8 mRNA
CTD
PMID:32234424
NCBI chr 9:5,742,683...6,182,445
Ensembl chr 9:5,506,044...5,945,828
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
decreases expression
ISO
methyleugenol results in decreased expression of KCNJ3 mRNA
CTD
PMID:32234424
NCBI chr 3:60,353,990...60,518,110
Ensembl chr 3:39,945,351...40,109,124
G
Kcnk13
potassium two pore domain channel subfamily K member 13
decreases expression
ISO
methyleugenol results in decreased expression of KCNK13 mRNA
CTD
PMID:32234424
NCBI chr 6:124,970,363...125,074,919
Ensembl chr 6:119,242,188...119,345,240
G
Kcnk5
potassium two pore domain channel subfamily K member 5
decreases expression
ISO
methyleugenol results in decreased expression of KCNK5 mRNA
CTD
PMID:32234424
NCBI chr15:4,171,625...4,213,896
Ensembl chr15:4,122,442...4,164,718
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
decreases expression
ISO
methyleugenol results in decreased expression of KCNMA1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr15:351,065...1,057,117
Ensembl chr15:302,214...1,001,198
G
Kcnq5
potassium voltage-gated channel subfamily Q member 5
decreases expression
ISO
methyleugenol results in decreased expression of KCNQ5 mRNA
CTD
PMID:32234424
NCBI chr 9:23,830,185...24,395,984
Ensembl chr 9:23,833,087...24,394,704
G
Kcnt2
potassium sodium-activated channel subfamily T member 2
decreases expression
ISO
methyleugenol results in decreased expression of KCNT2 mRNA
CTD
PMID:32234424
NCBI chr13:54,214,831...54,609,889
Ensembl chr13:51,664,686...52,056,987
G
Kcnv1
potassium voltage-gated channel modifier subfamily V member 1
increases expression
ISO
methyleugenol results in increased expression of KCNV1 mRNA
CTD
PMID:32234424
NCBI chr 7:78,145,319...78,153,794
Ensembl chr 7:76,260,695...76,269,170
G
Kctd15
potassium channel tetramerization domain containing 15
increases expression
ISO
methyleugenol results in increased expression of KCTD15 mRNA
CTD
PMID:32234424
NCBI chr 1:96,395,794...96,411,502
Ensembl chr 1:87,258,658...87,273,497
G
Kctd16
potassium channel tetramerization domain containing 16
decreases expression
ISO
methyleugenol results in decreased expression of KCTD16 mRNA
CTD
PMID:32234424
NCBI chr18:32,417,306...32,711,928
Ensembl chr18:32,166,861...32,491,749
G
Kdm8
lysine demethylase 8
decreases expression
ISO
methyleugenol results in decreased expression of KDM8 mRNA
CTD
PMID:32234424
NCBI chr 1:189,444,527...189,459,507
Ensembl chr 1:180,020,656...180,028,841
G
Kdr
kinase insert domain receptor
decreases expression
ISO
methyleugenol results in decreased expression of KDR mRNA
CTD
PMID:32234424
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Khk
ketohexokinase
decreases expression
ISO
methyleugenol results in decreased expression of KHK mRNA
CTD
PMID:32234424
NCBI chr 6:31,165,246...31,175,779
Ensembl chr 6:25,445,300...25,455,717
G
Kiaa0825
KIAA0825 homolog
decreases expression
ISO
methyleugenol results in decreased expression of KIAA0825 mRNA
CTD
PMID:32234424
NCBI chr 2:6,874,474...7,437,032
Ensembl chr 2:6,874,539...7,434,521
G
Kiaa1328
KIAA1328 homolog
decreases expression
ISO
methyleugenol results in decreased expression of KIAA1328 mRNA
CTD
PMID:32234424
NCBI chr18:16,762,421...17,061,439
Ensembl chr18:16,489,408...16,775,548
G
Kif17
kinesin family member 17
decreases expression
ISO
methyleugenol results in decreased expression of KIF17 mRNA
CTD
PMID:32234424
NCBI chr 5:150,482,288...150,521,471
Ensembl chr 5:150,481,578...150,519,638
G
Kif20a
kinesin family member 20A
decreases expression
ISO
methyleugenol results in decreased expression of KIF20A mRNA
CTD
PMID:32234424
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,230,230...26,238,780
G
Kif26b
kinesin family member 26B
decreases expression
ISO
methyleugenol results in decreased expression of KIF26B mRNA
CTD
PMID:32234424
NCBI chr13:92,815,427...93,221,071
Ensembl chr13:90,283,404...90,682,811
G
Klb
klotho beta
decreases expression
ISO
methyleugenol results in decreased expression of KLB mRNA
CTD
PMID:32234424
NCBI chr14:43,253,963...43,304,532
Ensembl chr14:42,899,510...42,950,799
G
Klc4
kinesin light chain 4
decreases expression
ISO
methyleugenol results in decreased expression of KLC4 mRNA
CTD
PMID:32234424
NCBI chr 9:14,337,164...14,351,075
Ensembl chr 9:14,337,534...14,351,066
G
Klf12
KLF transcription factor 12
decreases expression
ISO
methyleugenol results in decreased expression of KLF12 mRNA
CTD
PMID:32234424
NCBI chr15:83,037,548...83,469,998
Ensembl chr15:76,637,654...77,062,056
G
Klf15
KLF transcription factor 15
decreases expression
ISO
methyleugenol results in decreased expression of KLF15 mRNA
CTD
PMID:32234424
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:122,965,807...122,978,374
G
Klf6
KLF transcription factor 6
increases expression
EXP
methyleugenol results in increased expression of KLF6 mRNA
CTD
PMID:23411599
NCBI chr17:69,449,483...69,458,478
Ensembl chr17:64,531,463...64,588,570
G
Klhl32
kelch-like family member 32
decreases expression
ISO
methyleugenol results in decreased expression of KLHL32 mRNA
CTD
PMID:32234424
NCBI chr 5:38,321,237...38,568,453
Ensembl chr 5:38,325,543...38,568,650
G
Klkb1
kallikrein B1
decreases expression
ISO
methyleugenol results in decreased expression of KLKB1 mRNA
CTD
PMID:32234424
NCBI chr16:53,690,180...53,714,570
Ensembl chr16:46,958,707...46,982,053
G
Kmo
kynurenine 3-monooxygenase
decreases expression
ISO
methyleugenol results in decreased expression of KMO mRNA
CTD
PMID:32234424
NCBI chr13:90,089,340...90,121,108
Ensembl chr13:87,557,286...87,588,881
G
Kng1
kininogen 1
decreases expression
ISO
methyleugenol results in decreased expression of KNG1 mRNA
CTD
PMID:32234424
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:77,812,752...77,835,555
G
Krt20
keratin 20
increases expression
ISO
methyleugenol results in increased expression of KRT20 mRNA
CTD
PMID:32234424
NCBI chr10:84,880,952...84,890,285
Ensembl chr10:84,384,802...84,394,107
G
Krt4
keratin 4
decreases expression
ISO
methyleugenol results in decreased expression of KRT4 mRNA
CTD
PMID:32234424
NCBI chr 7:133,046,067...133,052,027
Ensembl chr 7:133,046,515...133,052,019
G
Krt5
keratin 5
decreases expression
ISO
methyleugenol results in decreased expression of KRT5 mRNA
CTD
PMID:32234424
NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:132,846,136...132,851,850
G
Lair1
leukocyte-associated immunoglobulin-like receptor 1
decreases expression
ISO
methyleugenol results in decreased expression of LAIR1 mRNA
CTD
PMID:32234424
NCBI chr 1:70,068,571...70,187,851
Ensembl chr 1:70,157,681...70,185,807
G
Large1
LARGE xylosyl- and glucuronyltransferase 1
decreases expression
ISO
methyleugenol results in decreased expression of LARGE1 mRNA
CTD
PMID:32234424
NCBI chr19:11,609,004...12,057,174
Ensembl chr19:11,603,129...12,048,930
G
Lasp1
LIM and SH3 protein 1
increases expression
ISO
methyleugenol results in increased expression of LASP1 mRNA
CTD
PMID:32234424
NCBI chr10:82,795,177...82,835,659
Ensembl chr10:82,795,137...82,943,292
G
Lat2
linker for activation of T cells family, member 2
decreases expression
ISO
methyleugenol results in decreased expression of LAT2 mRNA
CTD
PMID:32234424
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
G
Lbp
lipopolysaccharide binding protein
decreases expression
ISO
methyleugenol results in decreased expression of LBP mRNA
CTD
PMID:32234424
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:146,954,015...146,981,586
G
Lcn12
lipocalin 12
decreases expression
ISO
methyleugenol results in decreased expression of LCN12 mRNA
CTD
PMID:32234424
NCBI chr 3:28,710,557...28,713,537
Ensembl chr 3:8,305,920...8,323,495
G
Ldb2
LIM domain binding 2
decreases expression
ISO
methyleugenol results in decreased expression of LDB2 mRNA
CTD
PMID:32234424
NCBI chr14:70,489,243...70,810,573
Ensembl chr14:66,277,085...66,597,778
G
Ldlrad4
low density lipoprotein receptor class A domain containing 4
decreases expression
ISO
methyleugenol results in decreased expression of LDLRAD4 mRNA
CTD
PMID:32234424
NCBI chr18:63,789,089...64,118,166
Ensembl chr18:61,521,428...61,843,238
G
Leap2
liver enriched antimicrobial peptide 2
decreases expression
ISO
methyleugenol results in decreased expression of LEAP2 mRNA
CTD
PMID:32234424
NCBI chr10:38,081,001...38,082,073
Ensembl chr10:37,577,855...37,581,244
G
Lfng
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
increases expression
ISO
methyleugenol results in increased expression of LFNG mRNA
CTD
PMID:32234424
NCBI chr12:19,144,474...19,152,951
Ensembl chr12:14,018,333...14,039,008
G
Lgals4
galectin 4
decreases expression
ISO
methyleugenol results in decreased expression of LGALS4 mRNA
CTD
PMID:32234424
NCBI chr 1:93,248,463...93,260,002
Ensembl chr 1:84,124,764...84,132,481
G
Lhpp
phospholysine phosphohistidine inorganic pyrophosphate phosphatase
decreases expression
ISO
methyleugenol results in decreased expression of LHPP mRNA
CTD
PMID:32234424
NCBI chr 1:196,833,516...196,924,687
Ensembl chr 1:187,403,433...187,494,578
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
methyleugenol results in increased expression of LIF mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:79,134,574...79,140,482
G
Lingo2
leucine rich repeat and Ig domain containing 2
decreases expression
ISO
methyleugenol results in decreased expression of LINGO2 mRNA
CTD
PMID:32234424
NCBI chr 5:55,166,250...56,488,672
Ensembl chr 5:50,367,101...50,516,956
G
Lingo4
leucine rich repeat and Ig domain containing 4
decreases expression
ISO
methyleugenol results in decreased expression of LINGO4 mRNA
CTD
PMID:32234424
NCBI chr 2:182,035,522...182,040,787
Ensembl chr 2:182,014,326...182,040,787
G
Lipc
lipase C, hepatic type
decreases expression
ISO
methyleugenol results in decreased expression of LIPC mRNA
CTD
PMID:32234424
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464
G
Lipg
lipase G, endothelial type
decreases expression
ISO
methyleugenol results in decreased expression of LIPG mRNA
CTD
PMID:32234424
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:68,514,923...68,536,260
G
Lmo2
LIM domain only 2
increases expression
ISO
methyleugenol results in increased expression of LMO2 mRNA
CTD
PMID:32234424
NCBI chr 3:110,810,162...110,832,895
Ensembl chr 3:90,365,883...90,377,953
G
LOC120094884
U1 spliceosomal RNA
decreases expression
ISO
methyleugenol results in decreased expression of RNU1-70P mRNA
CTD
PMID:32234424
NCBI chr 9:1,931,716...1,931,879
Ensembl chr 9:1,931,716...1,931,879
G
LOC120098360
small nucleolar RNA SNORA13
increases expression
ISO
methyleugenol results in increased expression of SNORA13 mRNA
CTD
PMID:32234424
NCBI chr18:25,404,452...25,404,585
Ensembl chr18:25,404,452...25,404,585
G
Lpcat3
lysophosphatidylcholine acyltransferase 3
decreases expression
ISO
methyleugenol results in decreased expression of LPCAT3 mRNA
CTD
PMID:32234424
NCBI chr 4:159,154,690...159,196,176
Ensembl chr 4:157,468,290...157,509,880
G
Lrba
LPS responsive beige-like anchor protein
decreases expression
ISO
methyleugenol results in decreased expression of LRBA mRNA
CTD
PMID:32234424
NCBI chr 2:173,919,330...174,500,536
Ensembl chr 2:171,621,507...172,202,724
G
Lrfn1
leucine rich repeat and fibronectin type III domain containing 1
increases expression
ISO
methyleugenol results in increased expression of LRFN1 mRNA
CTD
PMID:32234424
NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449
G
Lrmda
leucine rich melanocyte differentiation associated
decreases expression
ISO
methyleugenol results in decreased expression of LRMDA mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr15:1,223,098...2,284,764
Ensembl chr15:1,225,710...2,284,749
G
Lrp1b
LDL receptor related protein 1B
decreases expression
ISO
methyleugenol results in decreased expression of LRP1B mRNA
CTD
PMID:32234424
NCBI chr 3:45,004,001...47,125,147
Ensembl chr 3:24,594,991...26,715,505
G
Lrp2
LDL receptor related protein 2
decreases expression
ISO
methyleugenol results in decreased expression of LRP2 mRNA
CTD
PMID:32234424
NCBI chr 3:74,597,148...74,754,535
Ensembl chr 3:54,189,308...54,346,708
G
Lrp8
LDL receptor related protein 8
increases expression
ISO
methyleugenol results in increased expression of LRP8 mRNA
CTD
PMID:32234424
NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:122,563,453...122,631,352
G
Ltbp1
latent transforming growth factor beta binding protein 1
decreases expression
ISO
methyleugenol results in decreased expression of LTBP1 mRNA
CTD
PMID:32234424
NCBI chr 6:25,781,625...26,177,346
Ensembl chr 6:20,029,629...20,425,349
G
Ly96
lymphocyte antigen 96
increases expression
ISO
methyleugenol results in increased expression of LY96 mRNA
CTD
PMID:32234424
NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:2,582,254...2,612,386
G
Lypd1
Ly6/Plaur domain containing 1
increases expression
ISO
methyleugenol results in increased expression of LYPD1 mRNA
CTD
PMID:32234424
NCBI chr13:39,874,937...39,922,385
Ensembl chr13:37,326,464...37,368,493
G
Mab21l4
mab-21 like 4
decreases expression
ISO
methyleugenol results in decreased expression of MAB21L4 mRNA
CTD
PMID:32234424
NCBI chr 9:101,138,408...101,148,516
Ensembl chr 9:93,690,999...93,700,506
G
Macrod2
mono-ADP ribosylhydrolase 2
decreases expression
ISO
methyleugenol results in decreased expression of MACROD2 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 3:148,173,821...150,191,077
Ensembl chr 3:127,720,181...129,734,492
G
Mad1l1
mitotic arrest deficient 1 like 1
decreases expression
EXP ISO
methyleugenol results in decreased expression of MAD1L1 mRNA
CTD
PMID:26011634 PMID:32234424
NCBI chr12:19,434,782...19,744,574
Ensembl chr12:14,320,892...14,630,703
G
Mad2l1
mitotic arrest deficient 2 like 1
affects expression
EXP
methyleugenol affects the expression of MAD2L1 mRNA
CTD
PMID:26011634
NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:95,906,817...95,913,470
G
Magi1
membrane associated guanylate kinase, WW and PDZ domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of MAGI1 mRNA
CTD
PMID:32234424
NCBI chr 4:127,762,590...128,368,228
Ensembl chr 4:126,206,816...126,811,691
G
Malrd1
MAM and LDL receptor class A domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of MALRD1 mRNA
CTD
PMID:32234424
NCBI chr17:83,327,372...84,039,558
Ensembl chr17:78,418,819...79,131,016
G
Man1c1
mannosidase, alpha, class 1C, member 1
decreases expression
ISO
methyleugenol results in decreased expression of MAN1C1 mRNA
CTD
PMID:32234424
NCBI chr 5:152,057,839...152,197,737
Ensembl chr 5:146,775,842...146,913,421
G
Map3k7cl
MAP3K7 C-terminal like
decreases expression
ISO
methyleugenol results in decreased expression of MAP3K7CL mRNA
CTD
PMID:32234424
NCBI chr11:26,791,044...26,835,605
Ensembl chr11:26,791,316...26,835,602
G
Marchf1
membrane associated ring-CH-type finger 1
decreases expression
ISO
methyleugenol results in decreased expression of MARCHF1 mRNA
CTD
PMID:32234424
NCBI chr16:28,022,159...28,880,872
Ensembl chr16:23,258,799...24,114,277
G
Marcks
myristoylated alanine rich protein kinase C substrate
increases expression
ISO
methyleugenol results in increased expression of MARCKS mRNA
CTD
PMID:32234424
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:40,685,315...40,691,012
G
Marcksl1
MARCKS-like 1
increases expression
ISO
methyleugenol results in increased expression of MARCKSL1 mRNA
CTD
PMID:32234424
NCBI chr 5:147,135,827...147,138,150
Ensembl chr 5:141,850,110...141,853,817
G
Mat1a
methionine adenosyltransferase 1A
decreases expression
ISO
methyleugenol results in decreased expression of MAT1A mRNA
CTD
PMID:32234424
NCBI chr16:17,017,168...17,035,368
Ensembl chr16:16,983,022...17,001,274
G
Matn2
matrilin 2
decreases expression
ISO
methyleugenol results in decreased expression of MATN2 mRNA
CTD
PMID:32234424
NCBI chr 7:67,380,140...67,529,767
Ensembl chr 7:65,494,834...65,645,113
G
Mb
myoglobin
decreases expression
ISO
methyleugenol results in decreased expression of MB mRNA
CTD
PMID:32234424
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mb21d2
Mab-21 domain containing 2
increases expression
ISO
methyleugenol results in increased expression of MB21D2 mRNA
CTD
PMID:32234424
NCBI chr11:71,825,748...71,924,770
Ensembl chr11:71,825,748...71,924,769
G
Mbl2
mannose binding lectin 2
decreases expression
ISO
methyleugenol results in decreased expression of MBL2 mRNA
CTD
PMID:32234424
NCBI chr 1:237,429,873...237,465,567
G
Mcf2
MCF.2 cell line derived transforming sequence
decreases expression
ISO
methyleugenol results in decreased expression of MCF2 mRNA
CTD
PMID:32234424
NCBI chr X:138,414,077...138,514,828
Ensembl chr X:138,409,256...138,514,446
G
Mchr1
melanin-concentrating hormone receptor 1
decreases expression
ISO
methyleugenol results in decreased expression of MCHR1 mRNA
CTD
PMID:32234424
NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032
G
Mctp1
multiple C2 and transmembrane domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of MCTP1 mRNA
CTD
PMID:32234424
NCBI chr 2:7,798,968...8,493,596
Ensembl chr 2:6,065,808...6,761,833
G
Mdga2
MAM domain containing glycosylphosphatidylinositol anchor 2
decreases expression
ISO
methyleugenol results in decreased expression of MDGA2 mRNA
CTD
PMID:32234424
NCBI chr 6:90,482,687...91,346,784
Ensembl chr 6:84,761,941...85,608,126
G
Mdk
midkine
increases expression
ISO
methyleugenol results in increased expression of MDK mRNA
CTD
PMID:32234424
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130
G
Mdm2
MDM2 proto-oncogene
increases expression
EXP
methyleugenol results in increased expression of MDM2 mRNA
CTD
PMID:26011634
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Meltf
melanotransferrin
increases expression
ISO
methyleugenol results in increased expression of MELTF mRNA
CTD
PMID:32234424
NCBI chr11:82,389,420...82,411,270
Ensembl chr11:68,884,446...68,906,300
G
Mep1b
meprin A subunit beta
decreases expression
ISO
methyleugenol results in decreased expression of MEP1B mRNA
CTD
PMID:32234424
NCBI chr18:12,641,041...12,667,759
Ensembl chr18:12,365,289...12,392,840
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
decreases expression
ISO
methyleugenol results in decreased expression of MFSD2A mRNA
CTD
PMID:32234424
NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:135,225,816...135,240,690
G
Mgmt
O-6-methylguanine-DNA methyltransferase
decreases expression
ISO
methyleugenol results in decreased expression of MGMT mRNA
CTD
PMID:32234424
NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:191,710,930...191,937,756
G
Milr1
mast cell immunoglobulin-like receptor 1
increases expression
ISO
methyleugenol results in increased expression of MILR1 mRNA
CTD
PMID:32234424
NCBI chr10:92,184,002...92,205,001
Ensembl chr10:91,687,831...91,705,282
G
Mki67
marker of proliferation Ki-67
increases expression
EXP
methyleugenol results in increased expression of MKI67 protein
CTD
PMID:23411599 PMID:26011634
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mlip
muscular LMNA-interacting protein
decreases expression
ISO
methyleugenol results in decreased expression of MLIP mRNA
CTD
PMID:32234424
NCBI chr 8:86,815,491...87,085,117
Ensembl chr 8:77,935,079...78,204,254
G
Mlkl
mixed lineage kinase domain like pseudokinase
increases expression
ISO
methyleugenol results in increased expression of MLKL mRNA
CTD
PMID:32234424
NCBI chr19:56,186,860...56,213,886
Ensembl chr19:39,276,785...39,304,502
G
Mlph
melanophilin
increases expression
ISO
methyleugenol results in increased expression of MLPH mRNA
CTD
PMID:32234424
NCBI chr 9:98,955,036...98,990,566
Ensembl chr 9:91,507,591...91,542,983
G
Mmp10
matrix metallopeptidase 10
increases expression
ISO
methyleugenol results in increased expression of MMP10 mRNA
CTD
PMID:32234424
NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:4,689,840...4,697,748
G
Mmp12
matrix metallopeptidase 12
increases expression
ISO
methyleugenol results in increased expression of MMP12 mRNA
CTD
PMID:32234424
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:4,581,785...4,599,611
G
Mmut
methylmalonyl-CoA mutase
decreases expression
ISO
methyleugenol results in decreased expression of MMUT mRNA
CTD
PMID:32234424
NCBI chr 9:27,425,935...27,454,202
Ensembl chr 9:19,928,727...19,957,046
G
Mogat2
monoacylglycerol O-acyltransferase 2
decreases expression
ISO
methyleugenol results in decreased expression of MOGAT2 mRNA
CTD
PMID:32234424
NCBI chr 1:162,933,964...162,957,896
Ensembl chr 1:153,521,815...153,545,756
G
Mpdz
multiple PDZ domain crumbs cell polarity complex component
decreases expression
ISO
methyleugenol results in decreased expression of MPDZ mRNA
CTD
PMID:32234424
NCBI chr 5:100,812,121...100,966,566
Ensembl chr 5:95,766,118...95,920,499
G
Mpg
N-methylpurine-DNA glycosylase
decreases expression
EXP
methyleugenol results in decreased expression of MPG mRNA
CTD
PMID:21659616
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
G
Mpp3
MAGUK p55 scaffold protein 3
increases expression
ISO
methyleugenol results in increased expression of MPP3 mRNA
CTD
PMID:32234424
NCBI chr10:86,945,705...86,975,261
Ensembl chr10:86,945,714...86,974,737
G
Mroh8
maestro heat-like repeat family member 8
decreases expression
ISO
methyleugenol results in decreased expression of MROH8 mRNA
CTD
PMID:32234424
NCBI chr 3:145,873,995...145,942,439
Ensembl chr 3:145,873,996...145,942,319
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
methyleugenol results in decreased expression of MSMO1 mRNA
CTD
PMID:32234424
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:24,980,697...24,998,016
G
Msra
methionine sulfoxide reductase A
decreases expression
ISO
methyleugenol results in decreased expression of MSRA mRNA
CTD
PMID:32234424
NCBI chr15:42,514,818...42,853,278
Ensembl chr15:38,351,445...38,676,585
G
Mst1
macrophage stimulating 1
decreases expression
ISO
methyleugenol results in decreased expression of MST1 mRNA
CTD
PMID:32234424
NCBI chr 8:117,646,485...117,652,016
Ensembl chr 8:108,768,839...108,773,416
G
Mst1r
macrophage stimulating 1 receptor
increases expression
ISO
methyleugenol results in increased expression of MST1R mRNA
CTD
PMID:32234424
NCBI chr 8:117,471,928...117,491,059
Ensembl chr 8:108,597,299...108,612,455
G
Mstn
myostatin
decreases expression
ISO
methyleugenol results in decreased expression of MSTN mRNA
CTD
PMID:32234424
NCBI chr 9:55,944,513...55,950,913
Ensembl chr 9:48,452,533...48,458,933
G
Mtmr11
myotubularin related protein 11
increases expression
ISO
methyleugenol results in increased expression of MTMR11 mRNA
CTD
PMID:32234424
NCBI chr 2:183,721,983...183,732,148
Ensembl chr 2:183,723,530...183,732,148
G
Mtmr4
myotubularin related protein 4
decreases expression
ISO
methyleugenol results in decreased expression of MTMR4 mRNA
CTD
PMID:32234424
NCBI chr10:72,890,665...72,913,598
Ensembl chr10:72,392,551...72,416,342
G
Mtss1
MTSS I-BAR domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of MTSS1 mRNA
CTD
PMID:32234424
NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:90,488,754...90,627,968
G
Mttp
microsomal triglyceride transfer protein
decreases expression
ISO
methyleugenol results in decreased expression of MTTP mRNA
CTD
PMID:32234424
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:226,613,090...226,654,239
G
Muc13
mucin 13, cell surface associated
increases expression
ISO
methyleugenol results in increased expression of MUC13 mRNA
CTD
PMID:32234424
NCBI chr11:80,462,350...80,489,773
Ensembl chr11:66,960,595...66,984,727
G
Mvd
mevalonate diphosphate decarboxylase
decreases expression
ISO
methyleugenol results in decreased expression of MVD mRNA
CTD
PMID:32234424
NCBI chr19:67,404,911...67,414,974
Ensembl chr19:50,496,367...50,507,971
G
Mvk
mevalonate kinase
decreases expression
ISO
methyleugenol results in decreased expression of MVK mRNA
CTD
PMID:32234424
NCBI chr12:47,802,002...47,819,503
Ensembl chr12:42,141,384...42,158,882
G
Mylk4
myosin light chain kinase family, member 4
decreases expression
ISO
methyleugenol results in decreased expression of MYLK4 mRNA
CTD
PMID:32234424
NCBI chr17:31,669,028...31,747,250
Ensembl chr17:31,661,513...31,744,544
G
Myo15a
myosin XVA
decreases expression
ISO
methyleugenol results in decreased expression of MYO15A mRNA
CTD
PMID:32234424
NCBI chr10:45,776,907...45,835,473
Ensembl chr10:45,278,737...45,335,340
G
Myo16
myosin XVI
decreases expression
ISO
methyleugenol results in decreased expression of MYO16 mRNA
CTD
PMID:32234424
NCBI chr16:85,586,428...86,066,537
Ensembl chr16:78,884,406...79,248,388
G
Myom2
myomesin 2
decreases expression
ISO
methyleugenol results in decreased expression of MYOM2 mRNA
CTD
PMID:32234424
NCBI chr16:81,222,467...81,295,025
Ensembl chr16:74,520,157...74,592,772
G
Myoz2
myozenin 2
decreases expression
ISO
methyleugenol results in decreased expression of MYOZ2 mRNA
CTD
PMID:32234424
NCBI chr 2:213,826,052...213,852,778
Ensembl chr 2:211,141,463...211,168,221
G
Myrf
myelin regulatory factor
increases expression
ISO
methyleugenol results in increased expression of MYRF mRNA
CTD
PMID:32234424
NCBI chr 1:216,279,057...216,311,155
Ensembl chr 1:206,854,175...206,886,157
G
Myrip
myosin VIIA and Rab interacting protein
decreases expression
ISO
methyleugenol results in decreased expression of MYRIP mRNA
CTD
PMID:32234424
NCBI chr 8:128,895,371...129,062,420
Ensembl chr 8:120,017,524...120,183,833
G
Naaladl2
N-acetylated alpha-linked acidic dipeptidase-like 2
decreases expression
ISO
methyleugenol results in decreased expression of NAALADL2 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 2:106,639,146...107,992,218
Ensembl chr 2:106,645,608...107,991,689
G
Nbas
NBAS subunit of NRZ tethering complex
decreases expression
ISO
methyleugenol results in decreased expression of NBAS mRNA
CTD
PMID:32234424
NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984
G
Nbeal2
neurobeachin-like 2
increases expression
ISO
methyleugenol results in increased expression of NBEAL2 mRNA
CTD
PMID:32234424
NCBI chr 8:119,481,608...119,511,997
Ensembl chr 8:110,599,389...110,633,707
G
Nbl1
NBL1, DAN family BMP antagonist
increases expression
ISO
methyleugenol results in increased expression of NBL1 mRNA
CTD
PMID:32234424
NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:151,318,754...151,338,719
G
Ncan
neurocan
decreases expression
ISO
methyleugenol results in decreased expression of NCAN mRNA
CTD
PMID:32234424
NCBI chr16:19,301,969...19,328,436
Ensembl chr16:19,301,969...19,328,436
G
Ncf2
neutrophil cytosolic factor 2
increases expression
ISO
methyleugenol results in increased expression of NCF2 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr13:67,505,492...67,536,015
Ensembl chr13:64,955,503...64,986,277
G
Nckap5
NCK-associated protein 5
decreases expression
ISO
methyleugenol results in decreased expression of NCKAP5 mRNA
CTD
PMID:32234424
NCBI chr13:39,922,576...40,835,849
Ensembl chr13:37,370,792...38,283,268
G
Neb
nebulin
decreases expression
ISO
methyleugenol results in decreased expression of NEB mRNA
CTD
PMID:32234424
NCBI chr 3:57,022,822...57,220,752
Ensembl chr 3:36,613,716...36,811,574
G
Necab1
N-terminal EF-hand calcium binding protein 1
decreases expression
ISO
methyleugenol results in decreased expression of NECAB1 mRNA
CTD
PMID:32234424
NCBI chr 5:33,155,078...33,375,707
Ensembl chr 5:28,357,859...28,578,642 Ensembl chr 5:28,357,859...28,578,642
G
Nectin4
nectin cell adhesion molecule 4
increases expression
ISO
methyleugenol results in increased expression of NECTIN4 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr13:86,335,027...86,354,152
Ensembl chr13:83,803,184...83,821,709
G
Nefl
neurofilament light chain
increases expression
ISO
methyleugenol results in increased expression of NEFL mRNA
CTD
PMID:32234424
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:42,301,916...42,305,793
G
Nes
nestin
increases expression
ISO
methyleugenol results in increased expression of NES mRNA
CTD
PMID:32234424
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
G
Neu4
neuraminidase 4
decreases expression
ISO
methyleugenol results in decreased expression of NEU4 mRNA
CTD
PMID:32234424
NCBI chr 9:101,844,261...101,849,917
Ensembl chr 9:94,396,920...94,402,576
G
Neurog3
neurogenin 3
decreases expression
ISO
methyleugenol results in decreased expression of NEUROG3 mRNA
CTD
PMID:32234424
NCBI chr20:30,622,533...30,624,015
Ensembl chr20:30,079,780...30,081,262
G
Nfasc
neurofascin
decreases expression
ISO
methyleugenol results in decreased expression of NFASC mRNA
CTD
PMID:32234424
NCBI chr13:46,549,369...46,735,989
Ensembl chr13:43,997,224...44,183,880
G
Nfe2l3
NFE2 like bZIP transcription factor 3
increases expression
ISO
methyleugenol results in increased expression of NFE2L3 mRNA
CTD
PMID:32234424
NCBI chr 4:81,837,404...81,865,258
Ensembl chr 4:80,506,756...80,534,629
G
Ngfr
nerve growth factor receptor
increases expression
ISO
methyleugenol results in increased expression of NGFR mRNA
CTD
PMID:32234424
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Nhej1
nonhomologous end-joining factor 1
decreases expression
ISO
methyleugenol results in decreased expression of NHEJ1 mRNA
CTD
PMID:32234424
NCBI chr 9:83,974,995...84,071,161
Ensembl chr 9:76,526,324...76,622,444
G
Ninl
ninein-like
decreases expression
ISO
methyleugenol results in decreased expression of NINL mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 3:139,748,353...139,814,683
Ensembl chr 3:139,748,355...139,814,622
G
Nkain2
sodium/potassium transporting ATPase interacting 2
decreases expression
ISO
methyleugenol results in decreased expression of NKAIN2 mRNA
CTD
PMID:32234424
NCBI chr 1:26,488,381...27,696,134
Ensembl chr 1:24,669,462...25,877,064
G
Nkd2
NKD inhibitor of WNT signaling pathway 2
increases expression
ISO
methyleugenol results in increased expression of NKD2 mRNA
CTD
PMID:32234424
NCBI chr 1:31,268,856...31,299,390
Ensembl chr 1:29,441,328...29,470,821
G
Nkpd1
NTPase, KAP family P-loop domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of NKPD1 mRNA
CTD
PMID:32234424
NCBI chr 1:79,165,642...79,175,126
Ensembl chr 1:79,167,130...79,174,234
G
Nlgn1
neuroligin 1
decreases expression
ISO
methyleugenol results in decreased expression of NLGN1 mRNA
CTD
PMID:32234424
NCBI chr 2:110,184,987...111,110,316
Ensembl chr 2:108,257,824...109,002,464
G
Nlrp6
NLR family, pyrin domain containing 6
decreases expression
ISO
methyleugenol results in decreased expression of NLRP6 mRNA
CTD
PMID:32234424
NCBI chr 1:205,434,484...205,441,245
Ensembl chr 1:196,004,953...196,011,113
G
Nol4
nucleolar protein 4
decreases expression
ISO
methyleugenol results in decreased expression of NOL4 mRNA
CTD
PMID:32234424
NCBI chr18:13,932,499...14,294,873
Ensembl chr18:13,932,510...14,296,286
G
Nos2
nitric oxide synthase 2
decreases expression
ISO
methyleugenol results in decreased expression of NOS2 mRNA
CTD
PMID:32234424
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nostrin
nitric oxide synthase trafficking
increases expression
ISO
methyleugenol results in increased expression of NOSTRIN mRNA
CTD
PMID:32234424
NCBI chr 3:53,904,746...53,970,995
Ensembl chr 3:53,904,827...53,970,988
G
Noxo1
NADPH oxidase organizer 1
decreases expression
ISO
methyleugenol results in decreased expression of NOXO1 mRNA
CTD
PMID:32234424
NCBI chr10:14,226,473...14,230,541
Ensembl chr10:13,721,473...13,726,061
G
Npas1
neuronal PAS domain protein 1
increases expression
ISO
methyleugenol results in increased expression of NPAS1 mRNA
CTD
PMID:32234424
NCBI chr 1:86,295,509...86,316,018
Ensembl chr 1:77,167,381...77,186,762
G
Npas3
neuronal PAS domain protein 3
decreases expression
ISO
methyleugenol results in decreased expression of NPAS3 mRNA
CTD
PMID:32234424
NCBI chr 6:76,438,064...77,263,185
Ensembl chr 6:70,703,170...71,524,884
G
Npy1r
neuropeptide Y receptor Y1
increases expression
ISO
methyleugenol results in increased expression of NPY1R mRNA
CTD
PMID:32234424
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Npy5r
neuropeptide Y receptor Y5
increases expression
ISO
methyleugenol results in increased expression of NPY5R mRNA
CTD
PMID:32234424
NCBI chr16:27,822,055...27,830,012
Ensembl chr16:23,055,427...23,063,382
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
decreases expression
ISO
methyleugenol results in decreased expression of NR0B2 mRNA
CTD
PMID:32234424
NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:145,779,294...145,782,609
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases expression
ISO
methyleugenol results in decreased expression of NR1I3 mRNA
CTD
PMID:32234424
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:83,632,899...83,637,906
G
Nrxn2
neurexin 2
decreases expression
ISO
methyleugenol results in decreased expression of NRXN2 mRNA
CTD
PMID:32234424
NCBI chr 1:213,155,673...213,271,526
Ensembl chr 1:203,735,753...203,842,297
G
Nrxn3
neurexin 3
decreases expression
ISO
methyleugenol results in decreased expression of NRXN3 mRNA
CTD
PMID:32234424
NCBI chr 6:113,372,667...115,004,073
Ensembl chr 6:107,641,780...109,272,044
G
Nsdhl
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL
decreases expression
ISO
methyleugenol results in decreased expression of NSDHL mRNA
CTD
PMID:32234424
NCBI chr X:155,817,301...155,848,224
Ensembl chr X:150,775,080...150,807,142
G
Nts
neurotensin
decreases expression
ISO
methyleugenol results in decreased expression of NTS mRNA
CTD
PMID:32234424
NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:37,564,533...37,574,423
G
Nubpl
NUBP iron-sulfur cluster assembly factor like
decreases expression
ISO
methyleugenol results in decreased expression of NUBPL mRNA
CTD
PMID:32234424
NCBI chr 6:75,294,609...75,516,603
Ensembl chr 6:69,559,291...69,781,253
G
Nuggc
nuclear GTPase, germinal center associated
decreases expression
ISO
methyleugenol results in decreased expression of NUGGC mRNA
CTD
PMID:32234424
NCBI chr15:39,821,851...39,866,122
Ensembl chr15:39,821,855...39,866,122
G
Ogdhl
oxoglutarate dehydrogenase L
decreases expression
ISO
methyleugenol results in decreased expression of OGDHL mRNA
CTD
PMID:32234424
NCBI chr16:7,578,343...7,604,385
Ensembl chr16:7,578,367...7,604,386
G
Ogg1
8-oxoguanine DNA glycosylase
decreases expression
EXP
methyleugenol results in decreased expression of OGG1 mRNA
CTD
PMID:21659616
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766
G
Olfm3
olfactomedin 3
decreases expression
ISO
methyleugenol results in decreased expression of OLFM3 mRNA
CTD
PMID:32234424
NCBI chr 2:205,417,962...205,640,479
Ensembl chr 2:202,729,936...202,952,112
G
Olfml2a
olfactomedin-like 2A
decreases expression
ISO
methyleugenol results in decreased expression of OLFML2A mRNA
CTD
PMID:32234424
NCBI chr 3:43,098,299...43,127,621
Ensembl chr 3:22,688,598...22,717,909
G
Ophn1
oligophrenin 1
decreases expression
ISO
methyleugenol results in decreased expression of OPHN1 mRNA
CTD
PMID:32234424
NCBI chr X:67,639,956...68,018,217
Ensembl chr X:63,603,042...63,976,633
G
Orm1
orosomucoid 1
decreases expression
ISO
methyleugenol results in decreased expression of ORM1 mRNA
CTD
PMID:32234424
NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:76,772,941...76,776,154
G
Osbp2
oxysterol binding protein 2
decreases expression
ISO
methyleugenol results in decreased expression of OSBP2 mRNA
CTD
PMID:32234424
NCBI chr14:82,808,693...82,970,386
Ensembl chr14:78,585,089...78,746,786
G
Otc
ornithine transcarbamylase
decreases expression
ISO
methyleugenol results in decreased expression of OTC mRNA
CTD
PMID:32234424
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:12,453,834...12,566,918
G
Otud7a
OTU deubiquitinase 7A
decreases expression
ISO
methyleugenol results in decreased expression of OTUD7A mRNA
CTD
PMID:32234424
NCBI chr 1:126,476,275...126,800,037
Ensembl chr 1:117,064,496...117,386,480
G
Padi2
peptidyl arginine deiminase 2
decreases expression
ISO
methyleugenol results in decreased expression of PADI2 mRNA
CTD
PMID:32234424
NCBI chr 5:158,492,087...158,534,662
Ensembl chr 5:153,209,053...153,251,632
G
Pah
phenylalanine hydroxylase
decreases expression
ISO
methyleugenol results in decreased expression of PAH mRNA
CTD
PMID:32234424
NCBI chr 7:23,793,096...23,885,631
Ensembl chr 7:21,933,179...21,998,130
G
Pak5
p21 (RAC1) activated kinase 5
decreases expression
ISO
methyleugenol results in decreased expression of PAK5 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 3:143,848,404...144,156,674
Ensembl chr 3:123,396,497...123,703,930
G
Palm3
paralemmin 3
decreases expression
ISO
methyleugenol results in decreased expression of PALM3 mRNA
CTD
PMID:32234424
NCBI chr19:24,121,984...24,126,079
Ensembl chr19:24,122,239...24,130,448
G
Pank1
pantothenate kinase 1
decreases expression
ISO
methyleugenol results in decreased expression of PANK1 mRNA
CTD
PMID:32234424
NCBI chr 1:241,737,371...241,808,126
Ensembl chr 1:232,328,430...232,396,829
G
Panx2
pannexin 2
increases expression
ISO
methyleugenol results in increased expression of PANX2 mRNA
CTD
PMID:32234424
NCBI chr 7:122,018,937...122,032,009
Ensembl chr 7:120,139,294...120,152,361
G
Pard3b
par-3 family cell polarity regulator beta
decreases expression
ISO
methyleugenol results in decreased expression of PARD3B mRNA
CTD
PMID:32234424
NCBI chr 9:70,532,358...71,561,044
Ensembl chr 9:63,038,436...64,068,053
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
methyleugenol results in increased cleavage of PARP1 protein
CTD
PMID:28818686
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of PBLD mRNA
CTD
PMID:32234424
NCBI chr20:25,549,974...25,565,390
Ensembl chr20:25,551,275...25,565,614
G
Pcca
propionyl-CoA carboxylase subunit alpha
decreases expression
ISO
methyleugenol results in decreased expression of PCCA mRNA
CTD
PMID:32234424
NCBI chr15:106,034,586...106,374,908
Ensembl chr15:99,627,982...99,968,266
G
Pcdhac2
protocadherin alpha subfamily C, 2
increases expression
ISO
methyleugenol results in increased expression of PCDHAC2 mRNA
CTD
PMID:32234424
Ensembl chr18:28,581,225...28,846,211
G
Pck1
phosphoenolpyruvate carboxykinase 1
decreases expression
ISO
methyleugenol results in decreased expression of PCK1 mRNA
CTD
PMID:32234424
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression
ISO
methyleugenol results in decreased expression of PCK2 mRNA
CTD
PMID:32234424
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:29,027,894...29,037,283
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
decreases expression
ISO
methyleugenol results in decreased expression of PCSK9 mRNA
CTD
PMID:32234424
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:121,211,278...121,233,688
G
Pde11a
phosphodiesterase 11A
decreases expression
ISO
methyleugenol results in decreased expression of PDE11A mRNA
CTD
PMID:32234424
NCBI chr 3:81,320,822...81,704,397
Ensembl chr 3:60,913,562...61,297,158
G
Pde1a
phosphodiesterase 1A
decreases expression
ISO
methyleugenol results in decreased expression of PDE1A mRNA
CTD
PMID:32234424
NCBI chr 3:85,152,053...85,432,289
Ensembl chr 3:64,747,269...65,024,874
G
Pde4d
phosphodiesterase 4D
decreases expression
ISO
methyleugenol results in decreased expression of PDE4D mRNA
CTD
PMID:32234424
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:40,019,933...41,525,884
G
Pde7b
phosphodiesterase 7B
decreases expression
ISO
methyleugenol results in decreased expression of PDE7B mRNA
CTD
PMID:32234424
NCBI chr 1:16,994,072...17,312,828
Ensembl chr 1:15,182,704...15,492,900
G
Pde8b
phosphodiesterase 8B
decreases expression
ISO
methyleugenol results in decreased expression of PDE8B mRNA
CTD
PMID:32234424
NCBI chr 2:28,009,841...28,244,050
Ensembl chr 2:26,276,635...26,509,209
G
Pdlim2
PDZ and LIM domain 2
decreases expression
ISO
methyleugenol results in decreased expression of PDLIM2 mRNA
CTD
PMID:32234424
NCBI chr15:51,647,195...51,659,904
Ensembl chr15:45,237,477...45,249,242
G
Pdlim3
PDZ and LIM domain 3
increases expression
ISO
methyleugenol results in increased expression of PDLIM3 mRNA
CTD
PMID:32234424
NCBI chr16:53,085,020...53,116,495
Ensembl chr16:46,352,467...46,383,657
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
methyleugenol results in increased expression of PDLIM7 mRNA
CTD
PMID:32234424
NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,124,649...9,139,811
G
Pdzk1
PDZ domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of PDZK1 mRNA
CTD
PMID:32234424
NCBI chr 2:187,064,995...187,096,348
Ensembl chr 2:184,376,161...184,407,514
G
Pdzk1ip1
PDZK1 interacting protein 1
decreases expression
ISO
methyleugenol results in decreased expression of PDZK1IP1 mRNA
CTD
PMID:32234424
NCBI chr 5:128,618,050...128,623,131
Ensembl chr 5:128,618,237...128,623,131
G
Pecr
peroxisomal trans-2-enoyl-CoA reductase
decreases expression
ISO
methyleugenol results in decreased expression of PECR mRNA
CTD
PMID:32234424
NCBI chr 9:81,347,170...81,375,809
Ensembl chr 9:73,897,880...73,926,511
G
Peg10
paternally expressed 10
decreases expression
ISO
methyleugenol results in decreased expression of PEG10 mRNA
CTD
PMID:32234424
NCBI chr 4:33,809,026...33,822,224
Ensembl chr 4:32,848,493...32,852,621
G
Pepd
peptidase D
decreases expression
ISO
methyleugenol results in decreased expression of PEPD mRNA
CTD
PMID:32234424
NCBI chr 1:96,673,624...96,818,197
Ensembl chr 1:87,536,609...87,681,231
G
Perm1
PPARGC1 and ESRR induced regulator, muscle 1
decreases expression
ISO
methyleugenol results in decreased expression of PERM1 mRNA
CTD
PMID:32234424
NCBI chr 5:166,800,030...166,805,323
Ensembl chr 5:166,800,030...166,805,323
G
Pfkfb1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
decreases expression
ISO
methyleugenol results in decreased expression of PFKFB1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr X:22,936,038...22,989,691
Ensembl chr X:19,508,546...19,562,182
G
Pfkp
phosphofructokinase, platelet
increases expression
ISO
methyleugenol results in increased expression of PFKP mRNA
CTD
PMID:32234424
NCBI chr17:68,639,749...68,704,055
Ensembl chr17:63,729,780...63,794,018
G
Pglyrp2
peptidoglycan recognition protein 2
decreases expression
ISO
methyleugenol results in decreased expression of PGLYRP2 mRNA
CTD
PMID:32234424
NCBI chr 7:12,069,414...12,082,437
Ensembl chr 7:11,418,880...11,427,773
G
Pgm2l1
phosphoglucomutase 2-like 1
increases expression
ISO
methyleugenol results in increased expression of PGM2L1 mRNA
CTD
PMID:32234424
NCBI chr 1:154,571,410...154,620,901
Ensembl chr 1:154,571,766...154,620,902
G
Pgm5
phosphoglucomutase 5
decreases expression
ISO
methyleugenol results in decreased expression of PGM5 mRNA
CTD
PMID:32234424
NCBI chr 1:231,752,052...231,939,812
Ensembl chr 1:222,325,643...222,513,437
G
Phyhd1
phytanoyl-CoA dioxygenase domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of PHYHD1 mRNA
CTD
PMID:32234424
NCBI chr 3:13,535,670...13,553,797
Ensembl chr 3:13,540,056...13,553,797
G
Pid1
phosphotyrosine interaction domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of PID1 mRNA
CTD
PMID:32234424
NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:85,284,335...85,503,044
G
Pif1
PIF1 5'-to-3' DNA helicase
decreases expression
ISO
methyleugenol results in decreased expression of PIF1 mRNA
CTD
PMID:32234424
NCBI chr 8:75,005,820...75,015,331
Ensembl chr 8:66,111,072...66,120,200
G
Pik3ap1
phosphoinositide-3-kinase adaptor protein 1
decreases expression
ISO
methyleugenol results in decreased expression of PIK3AP1 mRNA
CTD
PMID:32234424
NCBI chr 1:250,040,250...250,194,364
Ensembl chr 1:240,093,065...240,204,828
G
Pik3c2g
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
decreases expression
ISO
methyleugenol results in decreased expression of PIK3C2G mRNA
CTD
PMID:32234424
NCBI chr 4:174,215,527...174,583,378
Ensembl chr 4:172,484,345...172,850,544
G
Pipox
pipecolic acid and sarcosine oxidase
decreases expression
ISO
methyleugenol results in decreased expression of PIPOX mRNA
CTD
PMID:32234424
NCBI chr10:62,769,874...62,783,484
Ensembl chr10:62,769,900...62,782,370
G
Pkd1l1
polycystin 1 like 1, transient receptor potential channel interacting
decreases expression
ISO
methyleugenol results in decreased expression of PKD1L1 mRNA
CTD
PMID:32234424
NCBI chr14:83,552,964...83,670,062
Ensembl chr14:83,545,469...83,638,498
G
Pkd1l2
polycystin 1 like 2
decreases expression
ISO
methyleugenol results in decreased expression of PKD1L2 mRNA
CTD
PMID:32234424
NCBI chr19:45,049,713...45,136,503
Ensembl chr19:45,049,719...45,135,532
G
Pkhd1
PKHD1 ciliary IPT domain containing fibrocystin/polyductin
decreases expression
ISO
methyleugenol results in decreased expression of PKHD1 mRNA
CTD
PMID:32234424
NCBI chr 9:22,547,396...23,037,443
Ensembl chr 9:22,549,513...23,037,381
G
Pkig
cAMP-dependent protein kinase inhibitor gamma
decreases expression
ISO
methyleugenol results in decreased expression of PKIG mRNA
CTD
PMID:32234424
NCBI chr 3:172,749,871...172,817,514
Ensembl chr 3:152,366,041...152,398,082
G
Pklr
pyruvate kinase L/R
decreases expression
ISO
methyleugenol results in decreased expression of PKLR mRNA
CTD
PMID:32234424
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:174,543,039...174,551,870
G
Pkn1
protein kinase N1
increases expression
ISO
methyleugenol results in increased expression of PKN1 mRNA
CTD
PMID:32234424
NCBI chr19:41,346,855...41,374,832
Ensembl chr19:24,442,122...24,470,107
G
Pla2g12b
phospholipase A2, group XIIB
decreases expression
ISO
methyleugenol results in decreased expression of PLA2G12B mRNA
CTD
PMID:32234424
NCBI chr20:27,369,196...27,389,517
Ensembl chr20:27,370,266...27,388,743
G
Pla2g1b
phospholipase A2 group IB
decreases expression
ISO
methyleugenol results in decreased expression of PLA2G1B mRNA
CTD
PMID:32234424
NCBI chr12:46,802,932...46,814,511
Ensembl chr12:41,142,200...41,153,226
G
Pla2g4c
phospholipase A2 group IVC
increases expression
ISO
methyleugenol results in increased expression of PLA2G4C mRNA
CTD
PMID:32234424
NCBI chr 1:74,237,714...74,275,757
Ensembl chr 1:74,236,211...74,274,656
G
Plcb1
phospholipase C beta 1
decreases expression
ISO
methyleugenol results in decreased expression of PLCB1 mRNA
CTD
PMID:32234424
NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:122,060,031...122,772,869
G
Plcg2
phospholipase C, gamma 2
decreases expression
ISO
methyleugenol results in decreased expression of PLCG2 mRNA
CTD
PMID:32234424
NCBI chr19:62,456,196...62,592,684
Ensembl chr19:45,547,416...45,683,930
G
Plcxd1
phosphatidylinositol-specific phospholipase C, X domain containing 1
decreases expression
ISO
methyleugenol results in decreased expression of PLCXD1 mRNA
CTD
PMID:32234424
NCBI chr12:46,578,917...46,582,181
Ensembl chr12:46,579,225...46,582,392
G
Plekhg4
pleckstrin homology and RhoGEF domain containing G4
increases expression
ISO
methyleugenol results in increased expression of PLEKHG4 mRNA
CTD
PMID:32234424
NCBI chr19:50,161,722...50,176,491
Ensembl chr19:33,249,706...33,266,357
G
Plekhn1
pleckstrin homology domain containing N1
increases expression
ISO
methyleugenol results in increased expression of PLEKHN1 mRNA
CTD
PMID:32234424
NCBI chr 5:166,805,309...166,813,339
Ensembl chr 5:166,804,837...166,813,155
G
Plg
plasminogen
decreases expression
ISO
methyleugenol results in decreased expression of PLG mRNA
CTD
PMID:32234424
NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:48,325,185...48,367,786
G
Plk1
polo-like kinase 1
affects expression decreases expression
EXP ISO
methyleugenol affects the expression of PLK1 mRNA methyleugenol results in decreased expression of PLK1 mRNA
CTD
PMID:26011634 PMID:32234424
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:176,716,420...176,726,400
G
Plppr1
phospholipid phosphatase related 1
decreases expression
ISO
methyleugenol results in decreased expression of PLPPR1 mRNA
CTD
PMID:32234424
NCBI chr 5:68,232,963...68,520,784
Ensembl chr 5:63,437,816...63,763,835
G
Plxna3
plexin A3
increases expression
ISO
methyleugenol results in increased expression of PLXNA3 mRNA
CTD
PMID:32234424
NCBI chr X:157,266,986...157,282,896
Ensembl chr X:152,115,819...152,131,603
G
Pmepa1
prostate transmembrane protein, androgen induced 1
increases expression
ISO
methyleugenol results in increased expression of PMEPA1 mRNA
CTD
PMID:32234424
NCBI chr 3:182,430,193...182,478,649
Ensembl chr 3:162,012,751...162,060,454
G
Pms1
PMS1 homolog 1, mismatch repair system component
decreases expression
EXP
methyleugenol results in decreased expression of PMS1 mRNA
CTD
PMID:21659616
NCBI chr 9:55,721,393...55,832,225
Ensembl chr 9:48,253,410...48,340,237
G
Pms2
PMS1 homolog 2, mismatch repair system component
decreases expression
EXP
methyleugenol results in decreased expression of PMS2 mRNA
CTD
PMID:21659616
NCBI chr12:15,790,478...15,814,790
Ensembl chr12:10,676,764...10,701,066
G
Pnma2
PNMA family member 2
increases expression
ISO
methyleugenol results in increased expression of PNMA2 mRNA
CTD
PMID:32234424
NCBI chr15:45,287,445...45,296,340
Ensembl chr15:41,112,009...41,121,427
G
Pnpla3
patatin-like phospholipase domain containing 3
decreases expression
ISO
methyleugenol results in decreased expression of PNPLA3 mRNA
CTD
PMID:32234424
NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:115,293,538...115,314,077
G
Pold3
DNA polymerase delta 3, accessory subunit
decreases expression
EXP
methyleugenol results in decreased expression of POLD3 mRNA
CTD
PMID:21659616
NCBI chr 1:163,830,217...163,870,015
Ensembl chr 1:154,418,084...154,456,665
G
Pon1
paraoxonase 1
decreases expression
ISO
methyleugenol results in decreased expression of PON1 mRNA
CTD
PMID:32234424
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Pon3
paraoxonase 3
decreases expression
ISO
methyleugenol results in decreased expression of PON3 mRNA
CTD
PMID:32234424
NCBI chr 4:34,323,546...34,350,244
Ensembl chr 4:33,349,168...33,383,855
G
Ppfia2
PTPRF interacting protein alpha 2
decreases expression
ISO
methyleugenol results in decreased expression of PPFIA2 mRNA
CTD
PMID:32234424
NCBI chr 7:43,652,258...44,126,555
Ensembl chr 7:41,765,575...42,239,599
G
Ppm1j
protein phosphatase, Mg2+/Mn2+ dependent, 1J
increases expression
ISO
methyleugenol results in increased expression of PPM1J mRNA
CTD
PMID:32234424
NCBI chr 2:194,966,854...194,972,228
Ensembl chr 2:192,278,517...192,283,882
G
Ppp1r1a
protein phosphatase 1, regulatory (inhibitor) subunit 1A
decreases expression
ISO
methyleugenol results in decreased expression of PPP1R1A mRNA
CTD
PMID:32234424
NCBI chr 7:136,533,031...136,540,687
Ensembl chr 7:134,654,579...134,662,230
G
Ppp1r27
protein phosphatase 1, regulatory subunit 27
decreases expression
ISO
methyleugenol results in decreased expression of PPP1R27 mRNA
CTD
PMID:32234424
NCBI chr10:106,326,691...106,327,860
Ensembl chr10:105,828,364...105,829,533
G
Ppp1r3b
protein phosphatase 1, regulatory subunit 3B
decreases expression
ISO
methyleugenol results in decreased expression of PPP1R3B mRNA
CTD
PMID:32234424
NCBI chr16:63,533,318...63,545,683
Ensembl chr16:56,829,660...56,842,406
G
Ppp2r2b
protein phosphatase 2, regulatory subunit B, beta
decreases expression
ISO
methyleugenol results in decreased expression of PPP2R2B mRNA
CTD
PMID:32234424
NCBI chr18:34,904,686...35,357,299
Ensembl chr18:34,653,721...35,081,025
G
Prdm16
PR/SET domain 16
decreases expression
ISO
methyleugenol results in decreased expression of PRDM16 mRNA
CTD
PMID:32234424
NCBI chr 5:170,162,275...170,486,371
Ensembl chr 5:164,880,587...165,203,601
G
Prdm6
PR/SET domain 6
decreases expression
ISO
methyleugenol results in decreased expression of PRDM6 mRNA
CTD
PMID:32234424
NCBI chr18:49,102,290...49,206,763
Ensembl chr18:46,904,127...47,007,823
G
Prex1
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
decreases expression
ISO
methyleugenol results in decreased expression of PREX1 mRNA
CTD
PMID:32234424
NCBI chr 3:175,724,939...175,875,764
Ensembl chr 3:155,306,950...155,456,688
G
Prkag2
protein kinase AMP-activated non-catalytic subunit gamma 2
decreases expression
ISO
methyleugenol results in decreased expression of PRKAG2 mRNA
CTD
PMID:32234424
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,010,890...10,252,142
G
Prkar1b
protein kinase cAMP-dependent type I regulatory subunit beta
decreases expression
ISO
methyleugenol results in decreased expression of PRKAR1B mRNA
CTD
PMID:32234424
NCBI chr12:20,606,066...20,738,766
Ensembl chr12:15,511,801...15,624,942
G
Prkce
protein kinase C, epsilon
decreases expression
ISO
methyleugenol results in decreased expression of PRKCE mRNA
CTD
PMID:32234424
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Prkg1
protein kinase cGMP-dependent 1
decreases expression
ISO
methyleugenol results in decreased expression of PRKG1 mRNA
CTD
PMID:32234424
NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:228,408,947...229,639,080
G
Prkn
parkin RBR E3 ubiquitin protein ligase
decreases expression
ISO
methyleugenol results in decreased expression of PARK2 mRNA; methyleugenol results in decreased expression of PRKN mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555
G
Prlr
prolactin receptor
decreases expression
ISO
methyleugenol results in decreased expression of PRLR mRNA
CTD
PMID:32234424
NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:59,134,588...59,324,718
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
decreases expression
ISO
methyleugenol results in decreased expression of PROC mRNA
CTD
PMID:32234424
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:23,764,368...23,775,133
G
Procr
protein C receptor
increases expression
ISO
methyleugenol results in increased expression of PROCR mRNA
CTD
PMID:32234424
NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:144,254,380...144,258,903
G
Prodh
proline dehydrogenase
decreases expression
ISO
methyleugenol results in decreased expression of PRODH mRNA
CTD
PMID:32234424
NCBI chr11:96,414,275...96,431,604
Ensembl chr11:82,910,137...82,927,305
G
Prox1
prospero homeobox 1
decreases expression
ISO
methyleugenol results in decreased expression of PROX1 mRNA
CTD
PMID:32234424
NCBI chr13:104,196,615...104,251,007
Ensembl chr13:101,669,184...101,711,183
G
Proz
protein Z, vitamin K-dependent plasma glycoprotein
decreases expression
ISO
methyleugenol results in decreased expression of PROZ mRNA
CTD
PMID:32234424
NCBI chr16:83,150,104...83,165,688
Ensembl chr16:76,450,013...76,463,480
G
Prr11
proline rich 11
decreases expression
ISO
methyleugenol results in decreased expression of PRR11 mRNA
CTD
PMID:32234424
NCBI chr10:71,898,858...71,943,325
Ensembl chr10:71,901,202...71,921,012
G
Prr5l
proline rich 5 like
increases expression
ISO
methyleugenol results in increased expression of PRR5L mRNA
CTD
PMID:32234424
NCBI chr 3:108,458,107...108,628,552
Ensembl chr 3:88,003,617...88,082,763
G
Prr7
proline rich 7 (synaptic)
increases expression
ISO
methyleugenol results in increased expression of PRR7 mRNA
CTD
PMID:32234424
NCBI chr17:9,170,405...9,178,814
Ensembl chr17:9,165,269...9,172,536
G
Prrt1
proline-rich transmembrane protein 1
decreases expression
ISO
methyleugenol results in decreased expression of PRRT1 mRNA
CTD
PMID:32234424
NCBI chr20:4,122,565...4,126,386
Ensembl chr20:4,117,957...4,121,600
G
Pth1r
parathyroid hormone 1 receptor
decreases expression
ISO
methyleugenol results in decreased expression of PTH1R mRNA
CTD
PMID:32234424
NCBI chr 8:119,572,295...119,597,405
Ensembl chr 8:110,697,485...110,719,729
G
Pthlh
parathyroid hormone-like hormone
increases expression
ISO
methyleugenol results in increased expression of PTHLH mRNA
CTD
PMID:32234424
NCBI chr 4:181,919,400...181,930,454
Ensembl chr 4:180,188,792...180,199,847
G
Ptprd
protein tyrosine phosphatase, receptor type, D
decreases expression
ISO
methyleugenol results in decreased expression of PTPRD mRNA
CTD
PMID:32234424
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:90,048,966...92,369,396
G
Ptprq
protein tyrosine phosphatase, receptor type, Q
decreases expression
ISO
methyleugenol results in decreased expression of PTPRQ mRNA
CTD
PMID:32234424
NCBI chr 7:44,720,916...44,903,291
Ensembl chr 7:42,837,109...43,016,917
G
Pwwp2b
PWWP domain containing 2B
increases expression
ISO
methyleugenol results in increased expression of PWWP2B mRNA
CTD
PMID:32234424
NCBI chr 1:194,040,395...194,059,979
Ensembl chr 1:194,041,341...194,059,958
G
Rab3c
RAB3C, member RAS oncogene family
decreases expression
ISO
methyleugenol results in decreased expression of RAB3C mRNA
CTD
PMID:32234424
NCBI chr 2:43,353,822...43,577,226
Ensembl chr 2:41,627,720...41,843,749
G
Rab3il1
RAB3A interacting protein-like 1
increases expression
ISO
methyleugenol results in increased expression of RAB3IL1 mRNA
CTD
PMID:32234424
NCBI chr 1:216,071,043...216,107,609
Ensembl chr 1:206,646,155...206,679,972
G
Rabepk
Rab9 effector protein with kelch motifs
decreases expression
ISO
methyleugenol results in decreased expression of RABEPK mRNA
CTD
PMID:32234424
NCBI chr 3:18,061,299...18,083,191
Ensembl chr 3:18,061,574...18,083,191
G
Rabgap1l
RAB GTPase activating protein 1-like
decreases expression
ISO
methyleugenol results in decreased expression of RABGAP1L mRNA
CTD
PMID:32234424
NCBI chr13:74,997,542...75,593,240
Ensembl chr13:72,468,110...73,059,984
G
Rac2
Rac family small GTPase 2
increases expression
ISO
methyleugenol results in increased expression of RAC2 mRNA
CTD
PMID:32234424
NCBI chr 7:111,981,825...112,009,201
Ensembl chr 7:110,116,260...110,128,720
G
Rad1
RAD1 checkpoint DNA exonuclease
decreases expression
EXP
methyleugenol results in decreased expression of RAD1 mRNA
CTD
PMID:21659616
NCBI chr 2:61,188,755...61,196,868
Ensembl chr 2:59,461,607...59,469,689
G
Rad17
RAD17 checkpoint clamp loader component
decreases expression
EXP
methyleugenol results in decreased expression of RAD17 mRNA
CTD
PMID:26011634
NCBI chr 2:33,498,335...33,528,614
Ensembl chr 2:31,764,261...31,794,072
G
Rad50
RAD50 double strand break repair protein
decreases expression
EXP
methyleugenol results in decreased expression of RAD50 mRNA
CTD
PMID:26011634
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:37,808,726...37,861,396
G
Rad51b
RAD51 paralog B
decreases expression
ISO
methyleugenol results in decreased expression of RAD51B mRNA
CTD
PMID:32234424
NCBI chr 6:103,829,390...104,373,923
Ensembl chr 6:98,098,868...98,640,979
G
Rad52
RAD52 homolog, DNA repair protein
decreases expression
EXP
methyleugenol results in decreased expression of RAD52 mRNA
CTD
PMID:21659616
NCBI chr 4:154,778,320...154,802,002
Ensembl chr 4:153,106,062...153,128,207
G
Rad9a
RAD9 checkpoint clamp component A
decreases expression
EXP
methyleugenol results in decreased expression of RAD9A mRNA
CTD
PMID:21659616
NCBI chr 1:210,917,970...210,983,038
Ensembl chr 1:201,487,136...201,553,608
G
Ralgps1
Ral GEF with PH domain and SH3 binding motif 1
decreases expression
ISO
methyleugenol results in decreased expression of RALGPS1 mRNA
CTD
PMID:32234424
NCBI chr 3:16,433,323...16,670,276
Ensembl chr 3:16,433,742...16,669,972
G
Rap1gap
Rap1 GTPase-activating protein
increases expression
ISO
methyleugenol results in increased expression of RAP1GAP mRNA
CTD
PMID:32234424
NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:149,892,019...149,939,253
G
Rasd1
ras related dexamethasone induced 1
increases expression
ISO
methyleugenol results in increased expression of RASD1 mRNA
CTD
PMID:32234424
NCBI chr10:45,265,975...45,275,279
Ensembl chr10:44,766,455...44,768,186
G
Rasgrf2
RAS protein-specific guanine nucleotide-releasing factor 2
decreases expression
ISO
methyleugenol results in decreased expression of RASGRF2 mRNA
CTD
PMID:32234424
NCBI chr 2:24,848,699...25,096,773
Ensembl chr 2:23,117,004...23,361,240
G
Rasgrp1
RAS guanyl releasing protein 1
increases expression
ISO
methyleugenol results in increased expression of RASGRP1 mRNA
CTD
PMID:32234424
NCBI chr 3:124,624,039...124,684,079
Ensembl chr 3:104,170,013...104,230,056
G
Rasl10b
RAS-like, family 10, member B
decreases expression
ISO
methyleugenol results in decreased expression of RASL10B mRNA
CTD
PMID:32234424
NCBI chr10:68,209,761...68,222,118
Ensembl chr10:68,210,275...68,220,376
G
Rasl11a
RAS-like family 11 member A
decreases expression
ISO
methyleugenol results in decreased expression of RASL11A mRNA
CTD
PMID:32234424
NCBI chr12:8,258,148...8,260,909
Ensembl chr12:8,258,159...8,262,576
G
Rassf3
Ras association domain family member 3
increases expression
ISO
methyleugenol results in increased expression of RASSF3 mRNA
CTD
PMID:32234424
NCBI chr 7:58,821,360...58,886,020
Ensembl chr 7:56,935,973...57,000,553
G
Rassf6
Ras association domain family member 6
increases expression
ISO
methyleugenol results in increased expression of RASSF6 mRNA
CTD
PMID:32234424
NCBI chr14:17,433,328...17,473,565
Ensembl chr14:17,442,789...17,473,330
G
Rb1
RB transcriptional corepressor 1
decreases expression
EXP
methyleugenol results in decreased expression of RB1 mRNA
CTD
PMID:26011634
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
EXP
methyleugenol results in decreased expression of RBL2 mRNA
CTD
PMID:26011634
NCBI chr19:32,049,690...32,096,467
Ensembl chr19:15,876,853...15,923,572
G
Rbp4
retinol binding protein 4
decreases expression
ISO
methyleugenol results in decreased expression of RBP4 mRNA
CTD
PMID:32234424
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
Rdh16
retinol dehydrogenase 16
decreases expression
ISO
methyleugenol results in decreased expression of RDH16 mRNA
CTD
PMID:32234424
NCBI chr 7:65,499,763...65,510,304
Ensembl chr 7:63,597,536...63,624,124
G
Reep1
receptor accessory protein 1
decreases expression
ISO
methyleugenol results in decreased expression of REEP1 mRNA
CTD
PMID:32234424
NCBI chr 4:105,303,974...105,420,611
Ensembl chr 4:103,745,633...103,862,338
G
Reep6
receptor accessory protein 6
decreases expression
ISO
methyleugenol results in decreased expression of REEP6 mRNA
CTD
PMID:32234424
NCBI chr 7:10,024,601...10,031,507
Ensembl chr 7:9,373,927...9,380,597
G
Ren
renin
decreases expression
ISO
methyleugenol results in decreased expression of REN mRNA
CTD
PMID:32234424
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
Retreg1
reticulophagy regulator 1
decreases expression
ISO
methyleugenol results in decreased expression of RETREG1 mRNA
CTD
PMID:32234424
NCBI chr 2:78,045,435...78,205,316
Ensembl chr 2:76,335,609...76,493,898
G
Rfpl4a
ret finger protein-like 4A
increases expression
ISO
methyleugenol results in increased expression of RFPL4A mRNA
CTD
PMID:32234424
NCBI chr 1:68,728,964...68,735,423
Ensembl chr 1:68,728,964...68,735,423
G
Rftn1
raftlin lipid raft linker 1
decreases expression
ISO
methyleugenol results in decreased expression of RFTN1 mRNA
CTD
PMID:32234424
NCBI chr 9:18,302,143...18,499,819
Ensembl chr 9:10,804,611...11,002,084
G
Rgn
regucalcin
decreases expression
ISO
methyleugenol results in decreased expression of RGN mRNA
CTD
PMID:32234424
NCBI chr X:4,172,537...4,190,112
Ensembl chr X:1,619,032...1,634,450
G
Rgs5
regulator of G-protein signaling 5
decreases expression
ISO
methyleugenol results in decreased expression of RGS5 mRNA
CTD
PMID:32234424
NCBI chr13:84,381,077...84,417,875
Ensembl chr13:81,836,304...81,885,518
G
Rhbdf2
rhomboid 5 homolog 2
increases expression
ISO
methyleugenol results in increased expression of RHBDF2 mRNA
CTD
PMID:32234424
NCBI chr10:102,331,991...102,359,117
Ensembl chr10:101,833,157...101,860,283
G
Rhbg
Rh family B glycoprotein
decreases expression
ISO
methyleugenol results in decreased expression of RHBG mRNA
CTD
PMID:32234424
NCBI chr 2:176,002,886...176,015,201
Ensembl chr 2:173,704,562...173,717,321
G
Rhebl1
RHEB like 1
increases expression
ISO
methyleugenol results in increased expression of RHEBL1 mRNA
CTD
PMID:32234424
NCBI chr 7:130,026,255...130,031,127
Ensembl chr 7:130,026,341...130,030,248
G
Rhpn1
rhophilin, Rho GTPase binding protein 1
increases expression
ISO
methyleugenol results in increased expression of RHPN1 mRNA
CTD
PMID:32234424
NCBI chr 7:107,391,948...107,402,713
Ensembl chr 7:107,391,984...107,402,713
G
Rida
reactive intermediate imine deaminase A homolog
decreases expression
ISO
methyleugenol results in decreased expression of RIDA mRNA
CTD
PMID:32234424
NCBI chr 7:67,576,586...67,590,493
Ensembl chr 7:65,691,435...65,705,716
G
Rims2
regulating synaptic membrane exocytosis 2
decreases expression
ISO
methyleugenol results in decreased expression of RIMS2 mRNA
CTD
PMID:32234424
NCBI chr 7:72,133,004...72,644,059
Ensembl chr 7:70,243,872...70,757,491
G
Rin1
Ras and Rab interactor 1
increases expression
ISO
methyleugenol results in increased expression of RIN1 mRNA
CTD
PMID:32234424
NCBI chr 1:211,785,107...211,789,755
Ensembl chr 1:202,355,890...202,362,729
G
Rnf125
ring finger protein 125
decreases expression
ISO
methyleugenol results in decreased expression of RNF125 mRNA
CTD
PMID:32234424
NCBI chr18:12,528,995...12,550,646
Ensembl chr18:12,253,852...12,275,983
G
Rnf133
ring finger protein 133
decreases expression
ISO
methyleugenol results in decreased expression of RNF133 mRNA
CTD
PMID:32234424
NCBI chr 4:53,106,097...53,109,032
Ensembl chr 4:52,140,247...52,143,379
G
Rnf152
ring finger protein 152
decreases expression
ISO
methyleugenol results in decreased expression of RNF152 mRNA
CTD
PMID:32234424
NCBI chr13:21,838,634...21,918,000
Ensembl chr13:21,323,824...21,403,113
G
Rnf157
ring finger protein 157
decreases expression
ISO
methyleugenol results in decreased expression of RNF157 mRNA
CTD
PMID:32234424
NCBI chr10:102,070,842...102,138,738
Ensembl chr10:101,566,295...101,639,942
G
Rnft2
ring finger protein, transmembrane 2
decreases expression
ISO
methyleugenol results in decreased expression of RNFT2 mRNA
CTD
PMID:32234424
NCBI chr12:43,990,113...44,048,215
Ensembl chr12:38,329,269...38,387,290
G
Rnls
renalase, FAD-dependent amine oxidase
decreases expression
ISO
methyleugenol results in decreased expression of RNLS mRNA
CTD
PMID:32234424
NCBI chr 1:240,450,702...240,723,472
Ensembl chr 1:231,037,486...231,309,823
G
Robo2
roundabout guidance receptor 2
decreases expression
ISO
methyleugenol results in decreased expression of ROBO2 mRNA
CTD
PMID:32234424
NCBI chr11:26,015,919...27,583,750
Ensembl chr11:12,528,951...13,041,536
G
Rorc
RAR-related orphan receptor C
decreases expression
ISO
methyleugenol results in decreased expression of RORC mRNA
CTD
PMID:32234424
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:182,009,286...182,034,907
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
methyleugenol results in increased expression of RRAD mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr19:360,581...363,874
Ensembl chr19:354,198...357,417
G
Rsrc1
arginine and serine rich coiled-coil 1
decreases expression
ISO
methyleugenol results in decreased expression of RSRC1 mRNA
CTD
PMID:32234424
NCBI chr 2:153,536,839...153,942,825
Ensembl chr 2:151,231,156...151,632,765
G
Rtl9
retrotransposon Gag like 9
decreases expression
ISO
methyleugenol results in decreased expression of RTL9 mRNA
CTD
PMID:32234424
NCBI chr X:111,470,972...111,517,356
Ensembl chr X:106,714,868...106,719,794
G
Rundc3b
RUN domain containing 3B
decreases expression
ISO
methyleugenol results in decreased expression of RUNDC3B mRNA
CTD
PMID:32234424
NCBI chr 4:25,462,543...25,599,477
Ensembl chr 4:25,462,752...25,599,471
G
Ryr2
ryanodine receptor 2
decreases expression
ISO
methyleugenol results in decreased expression of RYR2 mRNA
CTD
PMID:32234424
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:58,389,925...58,975,142
G
S100a11
S100 calcium binding protein A11
increases expression
ISO
methyleugenol results in increased expression of S100A11 mRNA
CTD
PMID:32234424
NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:179,191,715...179,197,044
G
S100a14
S100 calcium binding protein A14
increases expression
ISO
methyleugenol results in increased expression of S100A14 mRNA
CTD
PMID:32234424
NCBI chr 2:178,305,976...178,308,004
Ensembl chr 2:176,008,395...176,010,423
G
S100a2
S100 calcium binding protein A2
increases expression
ISO
methyleugenol results in increased expression of S100A2 mRNA
CTD
PMID:32234424
NCBI chr 2:176,077,081...176,078,325
G
S1pr2
sphingosine-1-phosphate receptor 2
increases expression
ISO
methyleugenol results in increased expression of S1PR2 mRNA
CTD
PMID:32234424
NCBI chr 8:27,779,452...27,790,344
Ensembl chr 8:19,502,627...19,523,574
G
Sardh
sarcosine dehydrogenase
decreases expression
ISO
methyleugenol results in decreased expression of SARDH mRNA
CTD
PMID:32234424
NCBI chr 3:30,908,621...30,973,409
Ensembl chr 3:10,510,553...10,573,874
G
Saxo1
stabilizer of axonemal microtubules 1
decreases expression
ISO
methyleugenol results in decreased expression of SAXO1 mRNA
CTD
PMID:32234424
NCBI chr 5:105,982,949...106,139,298
Ensembl chr 5:100,937,130...101,093,281
G
Sc5d
sterol-C5-desaturase
decreases expression
ISO
methyleugenol results in decreased expression of SC5D mRNA
CTD
PMID:32234424
NCBI chr 8:51,526,669...51,538,277
Ensembl chr 8:42,632,672...42,641,273
G
Scaper
S-phase cyclin A-associated protein in the ER
decreases expression
ISO
methyleugenol results in decreased expression of SCAPER mRNA
CTD
PMID:32234424
NCBI chr 8:55,932,717...56,332,222
Ensembl chr 8:55,933,306...56,332,122
G
Scart1
scavenger receptor family member expressed on T-cells 1
decreases expression
ISO
methyleugenol results in decreased expression of SCART1 mRNA
CTD
PMID:32234424
NCBI chr 1:204,450,386...204,462,094
Ensembl chr 1:195,020,750...195,031,807
G
Scfd2
sec1 family domain containing 2
decreases expression
ISO
methyleugenol results in decreased expression of SCFD2 mRNA
CTD
PMID:32234424
NCBI chr14:34,037,392...34,369,423
Ensembl chr14:33,683,273...34,008,213
G
Scgn
secretagogin, EF-hand calcium binding protein
decreases expression
ISO
methyleugenol results in decreased expression of SCGN mRNA
CTD
PMID:32234424
NCBI chr17:41,106,681...41,148,656
Ensembl chr17:41,106,467...41,148,667
G
Scp2
sterol carrier protein 2
decreases expression
ISO
methyleugenol results in decreased expression of SCP2 mRNA
CTD
PMID:32234424
NCBI chr 5:128,035,714...128,110,015
Ensembl chr 5:122,776,549...122,881,287
G
Scrn1
secernin 1
increases expression
ISO
methyleugenol results in increased expression of SCRN1 mRNA
CTD
PMID:32234424
NCBI chr 4:84,962,450...85,024,577
Ensembl chr 4:83,632,131...83,693,852
G
Sdk1
sidekick cell adhesion molecule 1
decreases expression
ISO
methyleugenol results in decreased expression of SDK1 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr12:17,491,430...18,477,914
Ensembl chr12:12,380,524...13,363,976
G
Sdk2
sidekick cell adhesion molecule 2
decreases expression
ISO
methyleugenol results in decreased expression of SDK2 mRNA
CTD
PMID:32234424
NCBI chr10:99,324,047...99,601,683
Ensembl chr10:98,828,348...99,101,759
G
Sdr16c5
short chain dehydrogenase/reductase family 16C, member 5
increases expression
ISO
methyleugenol results in increased expression of SDR16C5 mRNA
CTD
PMID:32234424
NCBI chr 5:21,816,394...21,841,596
Ensembl chr 5:17,018,813...17,040,970
G
Sec14l5
SEC14-like lipid binding 5
decreases expression
ISO
methyleugenol results in decreased expression of SEC14L5 mRNA
CTD
PMID:32234424
NCBI chr10:10,394,963...10,436,076
Ensembl chr10:10,396,878...10,435,917
G
Selenbp1
selenium binding protein 1
decreases expression
ISO
methyleugenol results in decreased expression of SELENBP1 mRNA
CTD
PMID:32234424
NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:182,493,978...182,504,594
G
Sema5b
semaphorin 5B
decreases expression
ISO
methyleugenol results in decreased expression of SEMA5B mRNA
CTD
PMID:32234424
NCBI chr11:78,607,805...78,730,724
Ensembl chr11:65,102,031...65,225,311
G
Septin4
septin 4
decreases expression
ISO
methyleugenol results in decreased expression of SEPTIN4 mRNA
CTD
PMID:32234424
NCBI chr10:72,863,969...72,888,018
Ensembl chr10:72,366,873...72,390,768
G
Serinc2
serine incorporator 2
increases expression
ISO
methyleugenol results in increased expression of SERINC2 mRNA
CTD
PMID:32234424
NCBI chr 5:147,876,477...147,898,797
Ensembl chr 5:142,592,309...142,618,364
G
Serpina10
serpin family A member 10
decreases expression
ISO
methyleugenol results in decreased expression of SERPINA10 mRNA
CTD
PMID:32234424
NCBI chr 6:128,520,894...128,529,332
Ensembl chr 6:122,756,108...122,764,544
G
Serpina11
serpin family A member 11
decreases expression
ISO
methyleugenol results in decreased expression of SERPINA11 mRNA
CTD
PMID:32234424
NCBI chr 6:128,668,030...128,677,476
Ensembl chr 6:122,903,250...122,912,670
G
Serpina4
serpin family A member 4
decreases expression
ISO
methyleugenol results in decreased expression of SERPINA4 mRNA
CTD
PMID:32234424
NCBI chr 6:128,764,738...128,773,858
Ensembl chr 6:122,999,900...123,009,082
G
Serpinb2
serpin family B member 2
increases expression
ISO
methyleugenol results in increased expression of SERPINB2 mRNA
CTD
PMID:32234424
NCBI chr13:24,051,933...24,065,032
Ensembl chr13:23,541,400...23,550,408
G
Serpinc1
serpin family C member 1
decreases expression
ISO
methyleugenol results in decreased expression of SERPINC1 mRNA
CTD
PMID:32234424
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293
G
Serpind1
serpin family D member 1
decreases expression
ISO
methyleugenol results in decreased expression of SERPIND1 mRNA
CTD
PMID:32234424
NCBI chr11:97,168,753...97,179,830
Ensembl chr11:83,664,518...83,675,519
G
Serpine2
serpin family E member 2
increases expression
ISO
methyleugenol results in increased expression of SERPINE2 mRNA
CTD
PMID:32234424
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:81,124,804...81,188,826
G
Serpinf1
serpin family F member 1
decreases expression
ISO
methyleugenol results in decreased expression of SERPINF1 mRNA
CTD
PMID:32234424
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Serpinf2
serpin family F member 2
decreases expression
ISO
methyleugenol results in decreased expression of SERPINF2 mRNA
CTD
PMID:32234424
NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,272,400...60,281,243
G
Sftpd
surfactant protein D
decreases expression
ISO
methyleugenol results in decreased expression of SFTPD mRNA
CTD
PMID:32234424
NCBI chr16:17,080,575...17,093,047
Ensembl chr16:17,046,483...17,059,927
G
Sgcz
sarcoglycan zeta
decreases expression
ISO
methyleugenol results in decreased expression of SGCZ mRNA
CTD
PMID:32234424
NCBI chr16:53,660,283...54,740,811
Ensembl chr16:53,660,502...54,735,193
G
Sh3gl2
SH3 domain containing GRB2 like 2, endophilin A1
decreases expression
ISO
methyleugenol results in decreased expression of SH3GL2 mRNA
CTD
PMID:32234424
NCBI chr 5:104,699,270...104,874,724
Ensembl chr 5:99,653,152...100,113,843
G
Sh3pxd2a
SH3 and PX domains 2A
decreases expression
ISO
methyleugenol results in decreased expression of SH3PXD2A mRNA
CTD
PMID:32234424
NCBI chr 1:256,094,991...256,301,120
Ensembl chr 1:246,160,502...246,360,166
G
Sh3rf3
SH3 domain containing ring finger 3
decreases expression
ISO
methyleugenol results in decreased expression of SH3RF3 mRNA
CTD
PMID:32234424
NCBI chr20:27,306,937...27,642,315
Ensembl chr20:26,765,015...27,099,257
G
Sh3tc2
SH3 domain and tetratricopeptide repeats 2
decreases expression
ISO
methyleugenol results in decreased expression of SH3TC2 mRNA
CTD
PMID:32234424
NCBI chr18:57,686,701...57,747,735
Ensembl chr18:55,416,413...55,483,083
G
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
methyleugenol results in decreased expression of SHANK2 mRNA
CTD
PMID:32234424
NCBI chr 1:208,575,144...209,020,300
Ensembl chr 1:199,169,429...199,589,394
G
Shd
src homology 2 domain-containing transforming protein D
decreases expression
ISO
methyleugenol results in decreased expression of SHD mRNA
CTD
PMID:32234424
NCBI chr 9:799,652...809,769
Ensembl chr 9:795,674...808,371
G
Shld1
shieldin complex subunit 1
decreases expression
ISO
methyleugenol results in decreased expression of SHLD1 mRNA
CTD
PMID:32234424
NCBI chr 3:140,391,611...140,462,273
Ensembl chr 3:119,938,833...120,009,550
G
Shmt1
serine hydroxymethyltransferase 1
decreases expression
ISO
methyleugenol results in decreased expression of SHMT1 mRNA
CTD
PMID:32234424
NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,468,700...45,497,820
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
ISO
methyleugenol results in decreased expression of SHMT2 mRNA
CTD
PMID:32234424
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:63,358,961...63,364,236
G
Siglec1
sialic acid binding Ig like lectin 1
decreases expression
ISO
methyleugenol results in decreased expression of SIGLEC1 mRNA
CTD
PMID:32234424
NCBI chr 3:138,740,171...138,759,966
Ensembl chr 3:118,287,988...118,306,850
G
Sim1
SIM bHLH transcription factor 1
decreases expression
ISO
methyleugenol results in decreased expression of SIM1 mRNA
CTD
PMID:32234424
NCBI chr20:53,827,601...53,907,219
Ensembl chr20:53,828,364...53,907,212
G
Slamf7
SLAM family member 7
increases expression
ISO
methyleugenol results in increased expression of SLAMF7 mRNA
CTD
PMID:32234424
NCBI chr13:84,135,656...84,154,528
Ensembl chr13:84,136,899...84,154,105
G
Slc10a1
solute carrier family 10 member 1
decreases expression
ISO
methyleugenol results in decreased expression of SLC10A1 mRNA
CTD
PMID:32234424
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:100,613,045...100,626,670
G
Slc10a5
solute carrier family 10, member 5
decreases expression
ISO
methyleugenol results in decreased expression of SLC10A5 mRNA
CTD
PMID:32234424
NCBI chr 2:91,457,540...91,458,844
Ensembl chr 2:91,444,454...91,489,651
G
Slc10a7
solute carrier family 10, member 7
decreases expression
ISO
methyleugenol results in decreased expression of SLC10A7 mRNA
CTD
PMID:32234424
NCBI chr19:29,183,143...29,407,470
Ensembl chr19:29,183,155...29,407,464
G
Slc15a1
solute carrier family 15 member 1
decreases expression
ISO
methyleugenol results in decreased expression of SLC15A1 mRNA
CTD
PMID:32234424
NCBI chr15:104,944,461...104,991,316
Ensembl chr15:98,537,641...98,582,545
G
Slc16a12
solute carrier family 16, member 12
decreases expression
ISO
methyleugenol results in decreased expression of SLC16A12 mRNA
CTD
PMID:32234424
NCBI chr 1:241,597,165...241,674,821
Ensembl chr 1:232,185,907...232,262,141
G
Slc16a2
solute carrier family 16 member 2
decreases expression
ISO
methyleugenol results in decreased expression of SLC16A2 mRNA
CTD
PMID:32234424
NCBI chr X:72,791,096...72,914,299
Ensembl chr X:68,723,261...68,848,771
G
Slc22a1
solute carrier family 22 member 1
decreases expression
ISO
methyleugenol results in decreased expression of SLC22A1 mRNA
CTD
PMID:32234424
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a22
solute carrier family 22 member 22
decreases expression
ISO
methyleugenol results in decreased expression of SLC22A10 mRNA
CTD
PMID:32234424
NCBI chr 7:90,610,007...90,639,718
Ensembl chr 7:88,720,427...88,750,111
G
Slc22a25
solute carrier family 22, member 25
decreases expression
ISO
methyleugenol results in decreased expression of SLC22A9 mRNA
CTD
PMID:32234424
NCBI chr 1:214,767,837...214,956,535
Ensembl chr 1:205,338,699...205,433,085
G
Slc22a7
solute carrier family 22 member 7
decreases expression
ISO
methyleugenol results in decreased expression of SLC22A7 mRNA
CTD
PMID:32234424
NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:14,547,849...14,553,921
G
Slc23a1
solute carrier family 23 member 1
decreases expression
ISO
methyleugenol results in decreased expression of SLC23A1 mRNA
CTD
PMID:32234424
NCBI chr18:27,214,940...27,230,564
Ensembl chr18:27,216,281...27,230,697
G
Slc25a21
solute carrier family 25 member 21
decreases expression
ISO
methyleugenol results in decreased expression of SLC25A21 mRNA
CTD
PMID:32234424
NCBI chr 6:74,203,439...74,702,902
Ensembl chr 6:74,203,440...74,702,680
G
Slc25a33
solute carrier family 25 member 33
decreases expression
ISO
methyleugenol results in decreased expression of SLC25A33 mRNA
CTD
PMID:32234424
NCBI chr 5:165,478,070...165,518,186
Ensembl chr 5:160,195,042...160,219,961
G
Slc25a34
solute carrier family 25, member 34
decreases expression
ISO
methyleugenol results in decreased expression of SLC25A34 mRNA
CTD
PMID:32234424
NCBI chr 5:159,215,120...159,219,892
G
Slc26a3
solute carrier family 26 member 3
decreases expression
ISO
methyleugenol results in decreased expression of SLC26A3 mRNA
CTD
PMID:32234424
NCBI chr 6:53,751,415...53,792,300
Ensembl chr 6:48,023,892...48,064,772
G
Slc27a5
solute carrier family 27 member 5
decreases expression
ISO
methyleugenol results in decreased expression of SLC27A5 mRNA
CTD
PMID:32234424
NCBI chr 1:82,688,742...82,699,335
Ensembl chr 1:73,616,564...73,627,172
G
Slc29a1
solute carrier family 29 member 1
increases expression
ISO
methyleugenol results in increased expression of SLC29A1 mRNA
CTD
PMID:32234424
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:15,399,612...15,414,203
G
Slc2a2
solute carrier family 2 member 2
decreases expression
ISO
methyleugenol results in decreased expression of SLC2A2 mRNA
CTD
PMID:32234424
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933
G
Slc2a9
solute carrier family 2 member 9
decreases expression
ISO
methyleugenol results in decreased expression of SLC2A9 mRNA
CTD
PMID:32234424
NCBI chr14:76,540,649...76,674,277
Ensembl chr14:72,328,320...72,461,981
G
Slc37a2
solute carrier family 37 member 2
increases expression
ISO
methyleugenol results in increased expression of SLC37A2 mRNA
CTD
PMID:32234424
NCBI chr 8:36,945,787...36,971,748
Ensembl chr 8:36,946,930...36,971,482
G
Slc37a4
solute carrier family 37 member 4
decreases expression
ISO
methyleugenol results in decreased expression of SLC37A4 mRNA
CTD
PMID:32234424
NCBI chr 8:53,619,952...53,626,110
Ensembl chr 8:44,723,339...44,729,301
G
Slc38a11
solute carrier family 38, member 11
decreases expression
ISO
methyleugenol results in decreased expression of SLC38A11 mRNA
CTD
PMID:32234424
NCBI chr 3:49,987,119...50,033,615
Ensembl chr 3:49,987,124...50,033,615
G
Slc38a3
solute carrier family 38, member 3
decreases expression
ISO
methyleugenol results in decreased expression of SLC38A3 mRNA
CTD
PMID:32234424
NCBI chr 8:117,202,534...117,220,310
Ensembl chr 8:108,323,894...108,339,988
G
Slc38a4
solute carrier family 38, member 4
decreases expression
ISO
methyleugenol results in decreased expression of SLC38A4 mRNA
CTD
PMID:32234424
NCBI chr 7:128,142,866...128,203,000
Ensembl chr 7:128,144,807...128,202,995
G
Slc39a11
solute carrier family 39, member 11
decreases expression
ISO
methyleugenol results in decreased expression of SLC39A11 mRNA
CTD
PMID:32234424
NCBI chr10:98,775,155...99,196,302
Ensembl chr10:98,275,960...98,611,295
G
Slc39a5
solute carrier family 39 member 5
decreases expression
ISO
methyleugenol results in decreased expression of SLC39A5 mRNA
CTD
PMID:32234424
NCBI chr 7:1,409,360...1,415,407
Ensembl chr 7:824,818...830,242
G
Slc3a1
solute carrier family 3 member 1
increases expression
ISO
methyleugenol results in increased expression of SLC3A1 mRNA
CTD
PMID:32234424
NCBI chr 6:15,361,037...15,396,695
Ensembl chr 6:9,608,178...9,641,907
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
methyleugenol results in increased expression of SLC3A2 mRNA
CTD
PMID:32234424
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:205,604,468...205,618,931
G
Slc44a2
solute carrier family 44 member 2
increases expression
ISO
methyleugenol results in increased expression of SLC44A2 mRNA
CTD
PMID:32234424
NCBI chr 8:28,147,023...28,181,496
Ensembl chr 8:19,870,888...19,905,342
G
Slc47a1
solute carrier family 47 member 1
decreases expression
ISO
methyleugenol results in decreased expression of SLC47A1 mRNA
CTD
PMID:32234424
NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,034,122...46,087,637
G
Slc4a11
solute carrier family 4 member 11
increases expression
ISO
methyleugenol results in increased expression of SLC4A11 mRNA
CTD
PMID:32234424
NCBI chr 3:117,900,223...117,912,787
Ensembl chr 3:117,900,223...117,912,674
G
Slc4a4
solute carrier family 4 member 4
decreases expression
ISO
methyleugenol results in decreased expression of SLC4A4 mRNA
CTD
PMID:32234424
NCBI chr14:19,125,394...19,577,379
Ensembl chr14:18,845,159...19,272,883
G
Slc4a5
solute carrier family 4 member 5
decreases expression
ISO
methyleugenol results in decreased expression of SLC4A5 mRNA
CTD
PMID:32234424
NCBI chr 4:115,710,101...115,810,330
Ensembl chr 4:115,725,592...115,810,323
G
Slc51a
solute carrier family 51 member A
decreases expression
ISO
methyleugenol results in decreased expression of SLC51A mRNA
CTD
PMID:32234424
NCBI chr11:81,804,141...81,818,539
Ensembl chr11:68,299,086...68,313,485
G
Slc5a1
solute carrier family 5 member 1
decreases expression
ISO
methyleugenol results in decreased expression of SLC5A1 mRNA
CTD
PMID:32234424
NCBI chr14:81,778,495...81,843,084
Ensembl chr14:77,553,843...77,618,547
G
Slc5a11
solute carrier family 5 member 11
increases expression
ISO
methyleugenol results in increased expression of SLC5A11 mRNA
CTD
PMID:32234424
NCBI chr 1:187,166,609...187,226,291
Ensembl chr 1:177,756,561...177,795,193
G
Slc5a12
solute carrier family 5 member 12
decreases expression
ISO
methyleugenol results in decreased expression of SLC5A12 mRNA
CTD
PMID:32234424
NCBI chr 3:117,633,885...117,683,966
Ensembl chr 3:97,179,326...97,228,405
G
Slc5a2
solute carrier family 5 member 2
decreases expression
ISO
methyleugenol results in decreased expression of SLC5A2 mRNA
CTD
PMID:32234424
NCBI chr 1:192,277,621...192,283,742
Ensembl chr 1:182,847,106...182,853,306
G
Slc5a9
solute carrier family 5 member 9
decreases expression
ISO
methyleugenol results in decreased expression of SLC5A9 mRNA
CTD
PMID:32234424
NCBI chr 5:131,937,368...131,966,405
Ensembl chr 5:126,709,769...126,733,468
G
Slc6a13
solute carrier family 6 member 13
decreases expression
ISO
methyleugenol results in decreased expression of SLC6A13 mRNA
CTD
PMID:32234424
NCBI chr 4:156,211,381...156,248,491
Ensembl chr 4:154,540,468...154,576,152
G
Slc6a20a
solute carrier family 6 member 20a
decreases expression
ISO
methyleugenol results in decreased expression of SLC6A20 mRNA
CTD
PMID:32234424
NCBI chr 8:132,159,768...132,200,016
Ensembl chr 8:123,281,472...123,322,573
G
Slc6a4
solute carrier family 6 member 4
decreases expression
ISO
methyleugenol results in decreased expression of SLC6A4 mRNA
CTD
PMID:32234424
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Slc6a6
solute carrier family 6 member 6
increases expression
ISO
methyleugenol results in increased expression of SLC6A6 mRNA
CTD
PMID:32234424
NCBI chr 4:125,752,340...125,826,033
Ensembl chr 4:124,195,218...124,268,875
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
methyleugenol results in increased expression of SLC7A11 mRNA
CTD
PMID:32234424
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Slc7a9
solute carrier family 7 member 9
decreases expression
ISO
methyleugenol results in decreased expression of SLC7A9 mRNA
CTD
PMID:32234424
NCBI chr 1:97,246,253...97,269,546
Ensembl chr 1:88,110,644...88,132,641
G
Slc8a1
solute carrier family 8 member A1
decreases expression
ISO
methyleugenol results in decreased expression of SLC8A1 mRNA
CTD
PMID:32234424
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628
G
Slc8a3
solute carrier family 8 member A3
decreases expression
ISO
methyleugenol results in decreased expression of SLC8A3 mRNA
CTD
PMID:32234424
NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:100,874,369...101,007,508
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
decreases expression
ISO
methyleugenol results in decreased expression of SLCO2B1 mRNA
CTD
PMID:32234424
NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:153,959,293...154,007,353
G
Slit2
slit guidance ligand 2
decreases expression
ISO
methyleugenol results in decreased expression of SLIT2 mRNA
CTD
PMID:32234424
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:62,617,067...62,955,948
G
Smim24
small integral membrane protein 24
decreases expression
ISO
methyleugenol results in decreased expression of SMIM24 mRNA
CTD
PMID:32234424
NCBI chr 7:8,313,369...8,316,498
G
Smoc1
SPARC related modular calcium binding 1
decreases expression
ISO
methyleugenol results in decreased expression of SMOC1 mRNA
CTD
PMID:32234424
NCBI chr 6:106,432,592...106,593,956
Ensembl chr 6:100,701,346...100,862,699
G
Smpd3
sphingomyelin phosphodiesterase 3
decreases expression
ISO
methyleugenol results in decreased expression of SMPD3 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr19:51,072,209...51,155,639
Ensembl chr19:34,162,341...34,245,749
G
Smpx
small muscle protein, X-linked
decreases expression
ISO
methyleugenol results in decreased expression of SMPX mRNA
CTD
PMID:32234424
NCBI chr X:41,049,354...41,107,323
Ensembl chr X:37,234,294...37,276,708
G
Smyd3
SET and MYND domain containing 3
decreases expression
ISO
methyleugenol results in decreased expression of SMYD3 mRNA
CTD
PMID:32234424
NCBI chr13:93,241,274...93,798,221
Ensembl chr13:90,709,270...91,266,253
G
Sntb1
syntrophin, beta 1
decreases expression
ISO
methyleugenol results in decreased expression of SNTB1 mRNA
CTD
PMID:32234424
NCBI chr 7:88,950,642...89,219,017
Ensembl chr 7:87,060,926...87,329,315
G
Sntg2
syntrophin, gamma 2
decreases expression
ISO
methyleugenol results in decreased expression of SNTG2 mRNA
CTD
PMID:32234424
NCBI chr 6:52,529,481...52,730,972
Ensembl chr 6:46,801,377...47,003,372
G
Snx29
sorting nexin 29
decreases expression
ISO
methyleugenol results in decreased expression of SNX29 mRNA
CTD
PMID:32234424
NCBI chr10:4,391,866...4,805,682
Ensembl chr10:3,888,301...4,298,655
G
Sord
sorbitol dehydrogenase
decreases expression
ISO
methyleugenol results in decreased expression of SORD mRNA
CTD
PMID:32234424
NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:109,184,676...109,216,133
G
Sorl1
sortilin related receptor 1
decreases expression
ISO
methyleugenol results in decreased expression of SORL1 mRNA
CTD
PMID:32234424
NCBI chr 8:51,238,713...51,401,458
Ensembl chr 8:42,341,704...42,504,513
G
Sox4
SRY-box transcription factor 4
increases expression
ISO
methyleugenol results in increased expression of SOX4 mRNA
CTD
PMID:32234424
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,667,537...35,673,665
G
Sox5
SRY-box transcription factor 5
decreases expression
ISO
methyleugenol results in decreased expression of SOX5 mRNA
CTD
PMID:32234424
NCBI chr 4:178,512,272...179,467,686
Ensembl chr 4:176,785,892...177,736,852
G
Sparcl1
SPARC like 1
decreases expression
ISO
methyleugenol results in decreased expression of SPARCL1 mRNA
CTD
PMID:32234424
NCBI chr14:5,937,484...5,968,532
Ensembl chr14:5,632,569...5,663,865
G
Spata17
spermatogenesis associated 17
decreases expression
ISO
methyleugenol results in decreased expression of SPATA17 mRNA
CTD
PMID:32234424
NCBI chr13:101,137,415...101,316,221
Ensembl chr13:98,605,986...98,784,929
G
Spns2
SPNS lysolipid transporter 2, sphingosine-1-phosphate
decreases expression
ISO
methyleugenol results in decreased expression of SPNS2 mRNA
CTD
PMID:32234424
NCBI chr10:57,565,909...57,604,546
Ensembl chr10:57,066,897...57,105,957
G
Spock3
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3
decreases expression
ISO
methyleugenol results in decreased expression of SPOCK3 mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr16:31,149,698...31,582,280
Ensembl chr16:26,383,383...26,815,205
G
Spon1
spondin 1
decreases expression
ISO
methyleugenol results in decreased expression of SPON1 mRNA
CTD
PMID:32234424
NCBI chr 1:177,363,526...177,662,689
Ensembl chr 1:167,928,972...168,228,226
G
Spp1
secreted phosphoprotein 1
increases expression
ISO
methyleugenol results in increased expression of SPP1 mRNA
CTD
PMID:32234424
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Spp2
secreted phosphoprotein 2
decreases expression
ISO
methyleugenol results in decreased expression of SPP2 mRNA
CTD
PMID:32234424
NCBI chr 9:96,454,636...96,474,453
Ensembl chr 9:89,007,175...89,026,688
G
Sprn
shadow of prion protein
decreases expression
ISO
methyleugenol results in decreased expression of SPRN mRNA
CTD
PMID:32234424
NCBI chr 1:194,944,602...194,948,448
Ensembl chr 1:194,943,826...194,948,460
G
Sptb
spectrin, beta, erythrocytic
decreases expression
ISO
methyleugenol results in decreased expression of SPTB mRNA
CTD
PMID:32234424
NCBI chr 6:101,043,512...101,170,389
Ensembl chr 6:95,310,326...95,437,118
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
increases expression
ISO
methyleugenol results in increased expression of SRC mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Srd5a2
steroid 5 alpha-reductase 2
decreases expression
ISO
methyleugenol results in decreased expression of SRD5A2 mRNA
CTD
PMID:32234424
NCBI chr 6:27,178,089...27,217,588
Ensembl chr 6:21,426,215...21,462,112
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
methyleugenol results in decreased expression of SREBF1 mRNA
CTD
PMID:32234424
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Srpx2
sushi-repeat-containing protein, X-linked 2
increases expression
ISO
methyleugenol results in increased expression of SRPX2 mRNA
CTD
PMID:32234424
NCBI chr X:97,106,455...97,132,197
Ensembl chr X:97,106,561...97,132,195
G
St18
ST18 C2H2C-type zinc finger transcription factor
decreases expression
ISO
methyleugenol results in decreased expression of ST18 mRNA
CTD
PMID:32234424
NCBI chr 5:12,582,493...12,914,221
Ensembl chr 5:12,584,110...12,671,790
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
decreases expression
ISO
methyleugenol results in decreased expression of ST6GAL1 mRNA
CTD
PMID:32234424
NCBI chr11:91,031,481...91,158,111
Ensembl chr11:77,526,837...77,653,310
G
Stc1
stanniocalcin 1
decreases expression
ISO
methyleugenol results in decreased expression of STC1 mRNA
CTD
PMID:32234424
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:44,299,621...44,310,264
G
Stk31
serine threonine kinase 31
decreases expression
ISO
methyleugenol results in decreased expression of STK31 mRNA
CTD
PMID:32234424
NCBI chr 4:79,701,470...79,797,085
Ensembl chr 4:78,370,649...78,466,240
G
Stpg2
sperm-tail PG-rich repeat containing 2
decreases expression
ISO
methyleugenol results in decreased expression of STPG2 mRNA
CTD
PMID:32234424
NCBI chr 2:227,764,266...228,285,664
Ensembl chr 2:227,764,353...228,285,663
G
Stx8
syntaxin 8
decreases expression
ISO
methyleugenol results in decreased expression of STX8 mRNA
CTD
PMID:32234424
NCBI chr10:53,154,572...53,393,912
Ensembl chr10:52,654,990...52,894,993
G
Sucnr1
succinate receptor 1
decreases expression
ISO
methyleugenol results in decreased expression of SUCNR1 mRNA
CTD
PMID:32234424
NCBI chr 2:146,368,858...146,380,360
Ensembl chr 2:144,219,122...144,230,034
G
Sugct
succinylCoA:glutarate-CoA transferase
decreases expression
ISO
methyleugenol results in decreased expression of SUGCT mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr17:52,072,012...52,929,852
Ensembl chr17:47,376,521...48,234,376
G
Sult1b1
sulfotransferase family 1B member 1
decreases expression
ISO
methyleugenol results in decreased expression of SULT1B1 mRNA
CTD
PMID:32234424
NCBI chr14:20,771,917...20,784,665
Ensembl chr14:20,492,708...20,505,483
G
Sult1e1
sulfotransferase family 1E member 1
decreases expression
ISO
methyleugenol results in decreased expression of SULT1E1 mRNA
CTD
PMID:32234424
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,422,324...20,439,275
G
Sult2a1
sulfotransferase family 2A member 1
decreases expression
ISO
methyleugenol results in decreased expression of SULT2A1 mRNA
CTD
PMID:32234424
NCBI chr 1:84,582,011...84,639,001
Ensembl chr 1:74,911,100...75,508,134
G
Supt3h
SPT3 homolog, SAGA and STAGA complex component
decreases expression
ISO
methyleugenol results in decreased expression of SUPT3H mRNA
CTD
PMID:32234424
NCBI chr 9:23,375,889...23,704,229
Ensembl chr 9:15,868,287...16,206,706
G
Susd3
sushi domain containing 3
decreases expression
ISO
methyleugenol results in decreased expression of SUSD3 mRNA
CTD
PMID:32234424
NCBI chr17:15,400,845...15,417,851
Ensembl chr17:15,400,845...15,417,044
G
Susd4
sushi domain containing 4
decreases expression
ISO
methyleugenol results in decreased expression of SUSD4 mRNA
CTD
PMID:32234424
NCBI chr13:96,982,867...97,109,419
Ensembl chr13:94,455,165...94,577,750
G
Syndig1l
synapse differentiation inducing 1-like
decreases expression
ISO
methyleugenol results in decreased expression of SYNDIG1L mRNA
CTD
PMID:32234424
NCBI chr 6:104,318,096...104,344,989
Ensembl chr 6:104,323,424...104,344,891
G
Synpo2
synaptopodin 2
decreases expression
ISO
methyleugenol results in decreased expression of SYNPO2 mRNA
CTD
PMID:32234424
NCBI chr 2:213,901,685...214,055,844
Ensembl chr 2:211,216,783...211,371,267
G
Syt13
synaptotagmin 13
increases expression
ISO
methyleugenol results in increased expression of SYT13 mRNA
CTD
PMID:32234424
NCBI chr 3:99,332,554...99,372,960
Ensembl chr 3:78,877,114...78,917,392
G
Syt7
synaptotagmin 7
decreases expression
ISO
methyleugenol results in decreased expression of SYT7 mRNA
CTD
PMID:32234424
NCBI chr 1:216,456,148...216,518,718
Ensembl chr 1:207,031,592...207,089,026
G
Syt9
synaptotagmin 9
decreases expression
ISO
methyleugenol results in decreased expression of SYT9 mRNA
CTD
PMID:32234424
NCBI chr 1:170,687,666...170,868,146
Ensembl chr 1:161,275,734...161,455,007
G
Sytl1
synaptotagmin-like 1
increases expression
ISO
methyleugenol results in increased expression of SYTL1 mRNA
CTD
PMID:32234424
NCBI chr 5:150,736,425...150,746,840
Ensembl chr 5:145,422,669...145,462,940
G
Sytl5
synaptotagmin-like 5
decreases expression
ISO
methyleugenol results in decreased expression of SYTL5 mRNA
CTD
PMID:32234424
NCBI chr X:15,461,215...15,702,660
Ensembl chr X:12,788,698...13,030,175
G
Tac1
tachykinin, precursor 1
increases expression
ISO
methyleugenol results in increased expression of TAC1 mRNA
CTD
PMID:32234424
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:35,679,704...35,687,178
G
Tafa2
TAFA chemokine like family member 2
decreases expression
ISO
methyleugenol results in decreased expression of TAFA2 mRNA
CTD
PMID:32234424
NCBI chr 7:60,827,985...61,303,873
Ensembl chr 7:58,942,610...59,417,299
G
Tat
tyrosine aminotransferase
decreases expression
ISO
methyleugenol results in decreased expression of TAT mRNA
CTD
PMID:32234424
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:37,947,112...37,958,031
G
Tdo2
tryptophan 2,3-dioxygenase
decreases expression
ISO
methyleugenol results in decreased expression of TDO2 mRNA
CTD
PMID:32234424
NCBI chr 2:169,567,656...169,585,586
Ensembl chr 2:167,269,579...167,287,511
G
Tead2
TEA domain transcription factor 2
increases expression
ISO
methyleugenol results in increased expression of TEAD2 mRNA
CTD
PMID:32234424
NCBI chr 1:95,702,366...95,719,186
Ensembl chr 1:95,703,005...95,719,186
G
Tecta
tectorin alpha
decreases expression
ISO
methyleugenol results in decreased expression of TECTA mRNA
CTD
PMID:32234424
NCBI chr 8:51,604,974...51,676,745
Ensembl chr 8:42,707,962...42,779,707
G
Tenm1
teneurin transmembrane protein 1
decreases expression
ISO
methyleugenol results in decreased expression of TENM1 mRNA
CTD
PMID:32234424
NCBI chr X:126,265,968...127,155,737
Ensembl chr X:121,403,649...122,290,207
G
Tenm2
teneurin transmembrane protein 2
decreases expression
ISO
methyleugenol results in decreased expression of TENM2 mRNA
CTD
PMID:32234424
NCBI chr10:20,984,710...22,121,001
Ensembl chr10:20,481,854...21,705,597
G
Tf
transferrin
decreases expression
ISO
methyleugenol results in decreased expression of TF mRNA
CTD
PMID:32234424
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
methyleugenol results in increased expression of TFPI2 mRNA
CTD
PMID:32234424
NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:31,982,178...31,986,600
G
Tg
thyroglobulin
decreases expression
ISO
methyleugenol results in decreased expression of TG mRNA
CTD
PMID:32234424
NCBI chr 7:100,307,349...100,492,246
Ensembl chr 7:98,418,293...98,603,210
G
Thrsp
thyroid hormone responsive
decreases expression
ISO
methyleugenol results in decreased expression of THRSP mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:151,723,086...151,728,075
G
Thsd1
thrombospondin type 1 domain containing 1
increases expression
ISO
methyleugenol results in increased expression of THSD1 mRNA
CTD
PMID:32234424
NCBI chr16:76,473,026...76,507,404
Ensembl chr16:69,771,408...69,801,504
G
Thsd7a
thrombospondin type 1 domain containing 7A
decreases expression
ISO
methyleugenol results in decreased expression of THSD7A mRNA
CTD
PMID:32234424
NCBI chr 4:41,427,276...41,865,524
Ensembl chr 4:40,460,814...40,899,583
G
Tinagl1
tubulointerstitial nephritis antigen-like 1
decreases expression
ISO
methyleugenol results in decreased expression of TINAGL1 mRNA
CTD
PMID:32234424
NCBI chr 5:147,797,884...147,807,925
Ensembl chr 5:142,513,714...142,523,720
G
Tjp3
tight junction protein 3
decreases expression
ISO
methyleugenol results in decreased expression of TJP3 mRNA
CTD
PMID:32234424
NCBI chr 7:8,427,650...8,446,279
Ensembl chr 7:8,432,811...8,446,279
G
Tln2
talin 2
decreases expression
ISO
methyleugenol results in decreased expression of TLN2 mRNA
CTD
PMID:32234424
NCBI chr 8:76,712,112...77,133,361
Ensembl chr 8:67,834,326...68,252,219
G
Tlr6
toll-like receptor 6
increases expression
ISO
methyleugenol results in increased expression of TLR6 mRNA
CTD
PMID:32234424
NCBI chr14:43,715,809...43,727,019
Ensembl chr14:43,362,164...43,375,685
G
Tlx1
T-cell leukemia, homeobox 1
decreases expression
ISO
methyleugenol results in decreased expression of TLX1 mRNA
CTD
PMID:32234424
NCBI chr 1:253,954,197...253,960,458
Ensembl chr 1:244,005,057...244,011,318
G
Tm6sf2
transmembrane 6 superfamily member 2
decreases expression
ISO
methyleugenol results in decreased expression of TM6SF2 mRNA
CTD
PMID:32234424
NCBI chr16:19,378,148...19,385,360
Ensembl chr16:19,344,222...19,351,431
G
Tmc6
transmembrane channel like 6
increases expression
ISO
methyleugenol results in increased expression of TMC6 mRNA
CTD
PMID:32234424
NCBI chr10:102,982,059...102,999,509
Ensembl chr10:102,971,229...102,998,960
G
Tmem100
transmembrane protein 100
decreases expression
ISO
methyleugenol results in decreased expression of TMEM100 mRNA
CTD
PMID:32234424
NCBI chr10:75,351,891...75,357,748
Ensembl chr10:74,854,468...74,862,941
G
Tmem117
transmembrane protein 117
decreases expression
ISO
methyleugenol results in decreased expression of TMEM117 mRNA
CTD
PMID:32234424
NCBI chr 7:127,636,862...128,098,944
Ensembl chr 7:125,757,591...126,219,690
G
Tmem132a
transmembrane protein 132A
increases expression
ISO
methyleugenol results in increased expression of TMEM132A mRNA
CTD
PMID:32234424
NCBI chr 1:216,931,962...216,943,644
Ensembl chr 1:207,507,077...207,518,758
G
Tmem135
transmembrane protein 135
decreases expression
ISO
methyleugenol results in decreased expression of TMEM135 mRNA
CTD
PMID:32234424
NCBI chr 1:152,418,929...152,692,405
Ensembl chr 1:143,006,344...143,221,171
G
Tmem139
transmembrane protein 139
decreases expression
ISO
methyleugenol results in decreased expression of TMEM139 mRNA
CTD
PMID:32234424
NCBI chr 4:71,147,072...71,149,151
Ensembl chr 4:71,146,724...71,167,399
G
Tmem156
transmembrane protein 156
increases expression
ISO
methyleugenol results in increased expression of TMEM156 mRNA
CTD
PMID:32234424
NCBI chr14:43,221,464...43,252,453
Ensembl chr14:43,223,381...43,252,449
G
Tmem176a
transmembrane protein 176A
decreases expression
ISO
methyleugenol results in decreased expression of TMEM176A mRNA
CTD
PMID:32234424
NCBI chr 4:79,101,946...79,109,499
Ensembl chr 4:77,774,843...77,778,620
G
Tmem178a
transmembrane protein 178A
decreases expression
ISO
methyleugenol results in decreased expression of TMEM178A mRNA
CTD
PMID:32234424
NCBI chr 6:19,756,919...19,815,961
Ensembl chr 6:14,004,630...14,063,549
G
Tmem178b
transmembrane protein 178B
decreases expression
ISO
methyleugenol results in decreased expression of TMEM178B mRNA
CTD
PMID:32234424
NCBI chr 4:68,659,425...69,035,690
Ensembl chr 4:68,657,343...69,035,690
G
Tmem200a
transmembrane protein 200A
decreases expression
ISO
methyleugenol results in decreased expression of TMEM200A mRNA
CTD
PMID:32234424
NCBI chr 1:19,323,646...19,408,324
Ensembl chr 1:19,323,829...19,406,453
G
Tmem232
transmembrane protein 232
decreases expression
ISO
methyleugenol results in decreased expression of TMEM232 mRNA
CTD
PMID:32234424
NCBI chr 9:112,334,569...112,562,627
Ensembl chr 9:104,887,669...105,143,027
G
Tmem266
transmembrane protein 266
decreases expression
ISO
methyleugenol results in decreased expression of TMEM266 mRNA
CTD
PMID:32234424
NCBI chr 8:55,707,122...55,820,692
Ensembl chr 8:55,707,122...55,820,692
G
Tmem44
transmembrane protein 44
increases expression
ISO
methyleugenol results in increased expression of TMEM44 mRNA
CTD
PMID:32234424
NCBI chr11:83,685,191...83,725,254
Ensembl chr11:70,181,345...70,216,958
G
Tmem82
transmembrane protein 82
decreases expression
ISO
methyleugenol results in decreased expression of TMEM82 mRNA
CTD
PMID:32234424
NCBI chr 5:159,210,531...159,214,462
Ensembl chr 5:153,927,471...153,936,979
G
Tmprss6
transmembrane serine protease 6
decreases expression
ISO
methyleugenol results in decreased expression of TMPRSS6 mRNA
CTD
PMID:32234424
NCBI chr 7:111,871,504...111,902,127
Ensembl chr 7:109,985,931...110,021,624
G
Tmsb10
thymosin, beta 10
increases expression
ISO
methyleugenol results in increased expression of TMSB10 mRNA
CTD
PMID:32234424
NCBI chr 4:106,568,080...106,569,210
Ensembl chr 4:105,009,212...105,011,028
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
methyleugenol results in increased expression of TNFRSF10A mRNA
CTD
PMID:32234424
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf11a
TNF receptor superfamily member 11A
increases expression
ISO
methyleugenol results in increased expression of TNFRSF11A mRNA
CTD
PMID:32234424
NCBI chr13:22,442,930...22,501,257
Ensembl chr13:21,928,408...21,986,695
G
Tnfrsf11b
TNF receptor superfamily member 11B
decreases expression
ISO
methyleugenol results in decreased expression of TNFRSF11B mRNA
CTD
PMID:32234424
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
methyleugenol results in increased expression of TNFRSF9 mRNA
CTD
PMID:32234424
NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf4
TNF superfamily member 4
decreases expression
ISO
methyleugenol results in decreased expression of TNFSF4 mRNA
CTD
PMID:32234424
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:73,723,329...73,746,788
G
Tnip3
TNFAIP3 interacting protein 3
decreases expression
ISO
methyleugenol results in decreased expression of TNIP3 mRNA
CTD
PMID:32234424
NCBI chr 4:96,197,019...96,237,357
Ensembl chr 4:94,811,097...94,907,605
G
Tns1
tensin 1
decreases expression
ISO
methyleugenol results in decreased expression of TNS1 mRNA
CTD
PMID:32234424
NCBI chr 9:82,941,068...83,152,007
Ensembl chr 9:75,495,814...75,703,225
G
Top2a
DNA topoisomerase II alpha
affects expression
EXP
methyleugenol affects the expression of TOP2A protein
CTD
PMID:26011634
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874
G
Tox3
TOX high mobility group box family member 3
increases expression
ISO
methyleugenol results in increased expression of TOX3 mRNA
CTD
PMID:32234424
NCBI chr19:32,820,957...32,929,776
Ensembl chr19:16,648,342...16,757,148
G
Tp53
tumor protein p53
increases expression decreases expression
EXP
methyleugenol results in increased expression of TP53 protein methyleugenol results in decreased expression of TP53 mRNA
CTD
PMID:23411599 PMID:26011634
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tph2
tryptophan hydroxylase 2
decreases expression
ISO
methyleugenol results in decreased expression of TPH2 mRNA
CTD
PMID:32234424
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Tpk1
thiamin pyrophosphokinase 1
decreases expression
ISO
methyleugenol results in decreased expression of TPK1 mRNA
CTD
PMID:32234424
NCBI chr 4:73,170,125...73,557,683
Ensembl chr 4:72,170,134...72,557,694
G
Tprg1
tumor protein p63 regulated 1
decreases expression
ISO
methyleugenol results in decreased expression of TPRG1 mRNA
CTD
PMID:32234424
NCBI chr11:75,322,470...75,449,907
Ensembl chr11:75,322,470...75,449,907
G
Trappc9
trafficking protein particle complex subunit 9
decreases expression
ISO
methyleugenol results in decreased expression of TRAPPC9 mRNA
CTD
PMID:32234424
NCBI chr 7:104,521,593...104,998,352
Ensembl chr 7:104,521,593...104,998,352
G
Trhde
thyrotropin-releasing hormone degrading enzyme
decreases expression
ISO
methyleugenol results in decreased expression of TRHDE mRNA
CTD
PMID:32234424
NCBI chr 7:51,829,473...52,236,843
Ensembl chr 7:49,945,766...50,367,371
G
Trim31
tripartite motif-containing 31
increases expression
ISO
methyleugenol results in increased expression of TRIM31 mRNA
CTD
PMID:32234424
NCBI chr20:1,658,386...1,671,711
Ensembl chr20:1,653,165...1,666,494
G
Trim63
tripartite motif containing 63
decreases expression
ISO
methyleugenol results in decreased expression of TRIM63 mRNA
CTD
PMID:32234424
NCBI chr 5:151,817,209...151,831,026
Ensembl chr 5:146,533,507...146,547,322
G
Tspan15
tetraspanin 15
increases expression
ISO
methyleugenol results in increased expression of TSPAN15 mRNA
CTD
PMID:32234424
NCBI chr20:30,673,271...30,717,651
Ensembl chr20:30,130,530...30,174,930
G
Tst
thiosulfate sulfurtransferase
decreases expression
ISO
methyleugenol results in decreased expression of TST mRNA
CTD
PMID:32234424
NCBI chr 7:111,828,557...111,836,980
Ensembl chr 7:109,948,062...109,957,216
G
Ttc28
tetratricopeptide repeat domain 28
decreases expression
ISO
methyleugenol results in decreased expression of TTC28 mRNA
CTD
PMID:32234424
NCBI chr12:51,002,816...51,443,461
Ensembl chr12:45,345,399...45,783,547
G
Ttc7b
tetratricopeptide repeat domain 7B
decreases expression
ISO
methyleugenol results in decreased expression of TTC7B mRNA
CTD
PMID:32234424
NCBI chr 6:125,317,011...125,528,843
Ensembl chr 6:119,587,390...119,799,330
G
Ttn
titin
decreases expression
ISO
methyleugenol results in decreased expression of TTN mRNA
CTD
PMID:32234424
NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:61,652,439...61,924,741
G
Ttpa
alpha tocopherol transfer protein
decreases expression
ISO
methyleugenol results in decreased expression of TTPA mRNA
CTD
PMID:32234424
NCBI chr 5:38,294,415...38,315,471
Ensembl chr 5:33,497,137...33,518,073
G
Tuba1a
tubulin, alpha 1A
increases expression
ISO
methyleugenol results in increased expression of TUBA1A mRNA
CTD
PMID:32234424
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:130,081,032...130,196,186
G
Tuba3a
tubulin, alpha 3A
decreases expression
ISO
methyleugenol results in decreased expression of TUBA3E mRNA
CTD
PMID:32234424
NCBI chr 4:158,075,083...158,083,972
Ensembl chr 4:158,075,083...158,083,972
G
Tuba3b
tubulin, alpha 3B
decreases expression
ISO
methyleugenol results in decreased expression of TUBA3D mRNA
CTD
PMID:32234424
NCBI chr 4:180,319,600...180,325,149
Ensembl chr 4:178,588,779...178,594,326
G
Tyro3
TYRO3 protein tyrosine kinase
increases expression
ISO
methyleugenol results in increased expression of TYRO3 mRNA
CTD
PMID:32234424
NCBI chr 3:127,231,468...127,254,806
Ensembl chr 3:106,777,635...106,797,142
G
Tyrp1
tyrosinase-related protein 1
decreases expression
ISO
methyleugenol results in decreased expression of TYRP1 mRNA
CTD
PMID:32234424
NCBI chr 5:100,327,111...100,345,657
Ensembl chr 5:95,280,982...95,299,516
G
Ubd
ubiquitin D
affects expression
EXP
methyleugenol affects the expression of UBD protein
CTD
PMID:26011634
NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases expression
ISO
methyleugenol results in decreased expression of UGT2B17 mRNA
CTD
PMID:32234424
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,024,006...21,035,986
G
Ulk4
unc-51 like kinase 4
decreases expression
ISO
methyleugenol results in decreased expression of ULK4 mRNA
CTD
PMID:32234424
NCBI chr 8:129,548,431...129,843,555
Ensembl chr 8:120,670,866...120,966,924
G
Upb1
beta-ureidopropionase 1
decreases expression
ISO
methyleugenol results in decreased expression of UPB1 mRNA
CTD
PMID:32234424
NCBI chr20:13,216,693...13,243,016
Ensembl chr20:13,217,258...13,243,590
G
Upp2
uridine phosphorylase 2
decreases expression
ISO
methyleugenol results in decreased expression of UPP2 mRNA
CTD
PMID:32234424
NCBI chr 3:63,681,671...63,726,194
Ensembl chr 3:43,273,048...43,317,417
G
Uroc1
urocanate hydratase 1
decreases expression
ISO
methyleugenol results in decreased expression of UROC1 mRNA
CTD
PMID:32234424
NCBI chr 4:124,402,119...124,433,787
Ensembl chr 4:122,844,926...122,876,591
G
Ush2a
usherin
decreases expression
ISO
methyleugenol results in decreased expression of USH2A mRNA
CTD
PMID:32234424
NCBI chr13:102,368,783...103,035,230
Ensembl chr13:99,837,445...100,503,922
G
Ust5r
integral membrane transport protein UST5r
decreases expression
ISO
methyleugenol results in decreased expression of SLC22A25 mRNA
CTD
PMID:32234424
NCBI chr 1:214,640,172...214,716,024
Ensembl chr 1:205,211,034...205,286,718
G
Vdr
vitamin D receptor
increases expression
ISO
methyleugenol results in increased expression of VDR mRNA
CTD
PMID:32234424
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
G
Veph1
ventricular zone expressed PH domain-containing 1
decreases expression
ISO
methyleugenol results in decreased expression of VEPH1 mRNA
CTD
PMID:32234424
NCBI chr 2:152,592,648...152,847,566
Ensembl chr 2:150,296,573...150,537,266
G
Vps13b
vacuolar protein sorting 13 homolog B
decreases expression
ISO
methyleugenol results in decreased expression of VPS13B mRNA
CTD
PMID:32234424
NCBI chr 7:68,436,996...69,013,574
Ensembl chr 7:66,558,471...67,128,429
G
Vsig1
V-set and immunoglobulin domain containing 1
increases expression
ISO
methyleugenol results in increased expression of VSIG1 mRNA
CTD
PMID:32234424
NCBI chr X:104,607,031...104,640,128
Ensembl chr X:104,607,031...104,639,249
G
Vsnl1
visinin-like 1
decreases expression
ISO
methyleugenol results in decreased expression of VSNL1 mRNA
CTD
PMID:32234424
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Vtn
vitronectin
decreases expression
ISO
methyleugenol results in decreased expression of VTN mRNA
CTD
PMID:32234424
NCBI chr10:63,892,782...63,895,862
Ensembl chr10:63,394,719...63,397,810
G
Vwa5b2
von Willebrand factor A domain containing 5B2
increases expression
ISO
methyleugenol results in increased expression of VWA5B2 mRNA
CTD
PMID:32234424
NCBI chr11:80,306,067...80,323,220
Ensembl chr11:80,306,350...80,323,220
G
Wdpcp
WD repeat containing planar cell polarity effector
decreases expression
ISO
methyleugenol results in decreased expression of WDPCP mRNA
CTD
PMID:32234424
NCBI chr14:99,847,463...100,178,392
Ensembl chr14:95,646,038...95,977,113
G
Wdr72
WD repeat domain 72
decreases expression
ISO
methyleugenol results in decreased expression of WDR72 mRNA
CTD
PMID:32234424
NCBI chr 8:83,718,897...83,902,128
Ensembl chr 8:74,838,318...75,018,229
G
Wnk3
WNK lysine deficient protein kinase 3
decreases expression
ISO
methyleugenol results in decreased expression of WNK3 mRNA
CTD
PMID:32234424
NCBI chr X:23,599,278...23,742,290
Ensembl chr X:20,157,041...20,296,821
G
Wnt10b
Wnt family member 10B
increases expression
ISO
methyleugenol results in increased expression of WNT10B mRNA
CTD
PMID:32234424
NCBI chr 7:131,801,046...131,806,850
Ensembl chr 7:129,922,088...129,927,892
G
Wnt4
Wnt family member 4
increases expression
ISO
methyleugenol results in increased expression of WNT4 mRNA
CTD
PMID:32234424
NCBI chr 5:154,797,245...154,818,565
Ensembl chr 5:149,514,018...149,532,859
G
Wnt5b
Wnt family member 5B
decreases expression
ISO
methyleugenol results in decreased expression of WNT5B mRNA
CTD
PMID:32234424
NCBI chr 4:154,281,852...154,406,081
Ensembl chr 4:152,609,569...152,733,407
G
Wnt6
Wnt family member 6
decreases expression
ISO
methyleugenol results in decreased expression of WNT6 mRNA
CTD
PMID:32234424
NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:76,329,882...76,343,523
G
Wnt7b
Wnt family member 7B
increases expression
ISO
methyleugenol results in increased expression of WNT7B mRNA
CTD
PMID:32234424 PMID:35690182
NCBI chr 7:118,514,684...118,559,316
Ensembl chr 7:116,634,814...116,679,581
G
Wwox
WW domain-containing oxidoreductase
decreases expression
ISO
methyleugenol results in decreased expression of WWOX protein methyleugenol results in decreased expression of WWOX mRNA
CTD
PMID:15618236 PMID:32234424 PMID:35690182
NCBI chr19:59,338,402...60,269,323
Ensembl chr19:42,432,152...43,359,391
G
Xdh
xanthine dehydrogenase
decreases expression
ISO
methyleugenol results in decreased expression of XDH mRNA
CTD
PMID:32234424
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Xrcc4
X-ray repair cross complementing 4
decreases expression
ISO
methyleugenol results in decreased expression of XRCC4 mRNA
CTD
PMID:32234424
NCBI chr 2:22,686,506...22,932,929
Ensembl chr 2:20,951,200...21,197,808
G
Zbtb7c
zinc finger and BTB domain containing 7C
decreases expression
ISO
methyleugenol results in decreased expression of ZBTB7C mRNA
CTD
PMID:32234424
NCBI chr18:69,441,616...69,765,744
Ensembl chr18:69,441,616...69,765,297
G
Zfp423
zinc finger protein 423
decreases expression
ISO
methyleugenol results in decreased expression of ZNF423 mRNA
CTD
PMID:32234424
NCBI chr19:35,282,149...35,580,775
Ensembl chr19:19,110,238...19,407,373
G
Zfp470
zinc finger protein 470
decreases expression
ISO
methyleugenol results in decreased expression of ZNF470 mRNA
CTD
PMID:32234424
NCBI chr 1:91,063,905...91,111,883
Ensembl chr 1:91,087,361...91,112,065
G
Zfp521
zinc finger protein 521
decreases expression
ISO
methyleugenol results in decreased expression of ZNF521 mRNA
CTD
PMID:32234424
NCBI chr18:4,775,952...5,068,592
Ensembl chr18:4,787,295...5,068,458
G
Zfp648
zinc finger protein 648
decreases expression
ISO
methyleugenol results in decreased expression of ZNF648 mRNA
CTD
PMID:32234424
NCBI chr13:66,337,098...66,344,963
Ensembl chr13:66,342,427...66,344,031
G
Zfp878
zinc finger protein 878
increases expression
ISO
methyleugenol results in increased expression of ZNF878 mRNA
CTD
PMID:32234424
NCBI chr16:17,856,860...17,887,122
Ensembl chr16:17,856,878...17,868,403
G
Zg16
zymogen granule protein 16
decreases expression
ISO
methyleugenol results in decreased expression of ZG16 mRNA
CTD
PMID:32234424
NCBI chr 1:191,088,248...191,090,605
Ensembl chr 1:181,657,722...181,660,079
G
Zg16b
zymogen granule protein 16B
increases expression
ISO
methyleugenol results in increased expression of ZG16B mRNA
CTD
PMID:32234424
NCBI chr10:12,970,888...12,984,170
Ensembl chr10:12,979,020...12,983,572
G
Zmynd12
zinc finger, MYND-type containing 12
decreases expression
ISO
methyleugenol results in decreased expression of ZMYND12 mRNA
CTD
PMID:32234424
NCBI chr 5:138,312,257...138,345,269
Ensembl chr 5:133,027,009...133,059,995
G
Znf709l
zinc finger protein 709 like
increases expression
ISO
methyleugenol results in increased expression of ZNF709 mRNA
CTD
PMID:32234424
NCBI chr 8:20,710,114...20,721,236
Ensembl chr 8:20,710,461...20,720,246
G
Zp1
zona pellucida glycoprotein 1
increases expression
ISO
methyleugenol results in increased expression of ZP1 mRNA
CTD
PMID:32234424
NCBI chr 1:216,984,343...216,993,882
Ensembl chr 1:207,560,881...207,567,261
G
Zranb3
zinc finger RANBP2-type containing 3
decreases expression
ISO
methyleugenol results in decreased expression of ZRANB3 mRNA
CTD
PMID:32234424
NCBI chr13:41,993,110...42,148,298
Ensembl chr13:39,440,889...39,595,670
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of 2-vanillin
CTD
PMID:15117964
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation
ISO
osimertinib affects the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; osimertinib inhibits the reaction [Derp2 allergen, Dermatophagoides pteronyssinus results in increased phosphorylation of AKT1 protein]; osimertinib results in decreased expression of and results in decreased phosphorylation of AKT1 protein osimertinib results in decreased phosphorylation of AKT1 protein osimertinib decreases phosphorylation of AKT1 protein in lung
CTD RGD
PMID:30145802 PMID:30623574 PMID:30993382 PMID:36807944 PMID:32276600
RGD:151357000
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
osimertinib results in decreased expression of BIRC5 protein
CTD
PMID:36807944
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Casp3
caspase 3
multiple interactions increases expression
ISO
[ginsenoside Rg3 co-treated with osimertinib] results in increased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; CAT protein inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]
CTD
PMID:28237877 PMID:31916386
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions decreases response to substance
ISO
CAT protein inhibits the reaction [osimertinib results in increased abundance of Hydrogen Peroxide]; CAT protein inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; CAT protein inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form] CAT protein results in decreased susceptibility to osimertinib
CTD
PMID:28237877
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cftr
CF transmembrane conductance regulator
multiple interactions
ISO
osimertinib inhibits the reaction [Dronabinol results in decreased expression of and results in decreased activity of CFTR protein]
CTD
PMID:29928919
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:46,560,885...46,728,756
G
Egf
epidermal growth factor
multiple interactions
ISO
osimertinib affects the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; osimertinib affects the reaction [EGF protein results in increased phosphorylation of EGFR protein]; osimertinib affects the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; osimertinib affects the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; osimertinib affects the reaction [EGF protein results in increased phosphorylation of STAT3 protein]
CTD
PMID:30623574
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
multiple interactions decreases phosphorylation decreases activity
ISO
osimertinib affects the reaction [EGF protein results in increased phosphorylation of EGFR protein]; osimertinib inhibits the reaction [EGFR protein mutant form results in decreased susceptibility to Gefitinib]; osimertinib promotes the reaction [Derp2 allergen, Dermatophagoides pteronyssinus results in increased phosphorylation of EGFR protein]; osimertinib results in decreased expression of and results in decreased phosphorylation of EGFR protein osimertinib results in decreased phosphorylation of EGFR protein osimertinib decreases phosphorylation of EGFR protein in lung osimertinib results in decreased activity of EGFR protein
CTD RGD
PMID:28237877 PMID:30145802 PMID:30623574 PMID:30993382 PMID:35970427 PMID:36807944 PMID:32276600 More...
RGD:151357000
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Gpt
glutamic--pyruvic transaminase
increases secretion
ISO
osimertinib results in increased secretion of GPT protein
CTD
PMID:29655783
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Il6
interleukin 6
multiple interactions
ISO
osimertinib inhibits the reaction [Derp2 allergen, Dermatophagoides pteronyssinus results in increased expression of IL6 mRNA]; osimertinib inhibits the reaction [Derp2 allergen, Dermatophagoides pteronyssinus results in increased secretion of IL6 protein]
CTD
PMID:30623574
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ldha
lactate dehydrogenase A
increases secretion
ISO
osimertinib results in increased secretion of LDHA protein
CTD
PMID:37660997
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases phosphorylation
ISO
osimertinib affects the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; osimertinib inhibits the reaction [Dronabinol results in increased phosphorylation of MAPK1 protein]; osimertinib results in decreased expression of and results in increased phosphorylation of MAPK1 protein osimertinib results in decreased phosphorylation of MAPK1 protein
CTD
PMID:29928919 PMID:30623574 PMID:30993382 PMID:34861243 PMID:36807944
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation
ISO
osimertinib affects the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; osimertinib inhibits the reaction [Dronabinol results in increased phosphorylation of MAPK3 protein]; osimertinib results in decreased expression of and results in increased phosphorylation of MAPK3 protein osimertinib results in decreased phosphorylation of MAPK3 protein
CTD
PMID:29928919 PMID:30623574 PMID:30993382 PMID:34861243 PMID:36807944
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
osimertinib decreases expression of MCL1 protein in lung
RGD
PMID:31301315 PMID:32276600
RGD:151356917 , RGD:151357000
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:183,219,220...183,222,303
G
Met
MET proto-oncogene, receptor tyrosine kinase
multiple interactions
ISO
osimertinib results in decreased expression of and results in decreased phosphorylation of MET protein
CTD
PMID:34861243
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
[ginsenoside Rg3 co-treated with osimertinib] results in decreased expression of MKI67 protein
CTD
PMID:31916386
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Parp1
poly (ADP-ribose) polymerase 1
increases expression increases cleavage multiple interactions
ISO
osimertinib results in increased expression of PARP1 protein modified form osimertinib results in increased cleavage of PARP1 protein [ginsenoside Rg3 co-treated with osimertinib] results in increased cleavage of PARP1 protein; [TWIST1 protein results in decreased susceptibility to osimertinib] which results in decreased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form]; CAT protein inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form]; TWIST1 protein inhibits the reaction [osimertinib results in increased cleavage of PARP1 protein]; Vitamin E inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form]
CTD
PMID:28237877 PMID:30171258 PMID:31916386
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Sqstm1
sequestosome 1
decreases expression
ISO
osimertinib results in decreased expression of SQSTM1 protein
CTD
PMID:30145802
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Stat3
signal transducer and activator of transcription 3
multiple interactions decreases phosphorylation
ISO
osimertinib affects the reaction [EGF protein results in increased phosphorylation of STAT3 protein]; osimertinib inhibits the reaction [Derp2 allergen, Dermatophagoides pteronyssinus results in increased phosphorylation of STAT3 protein] osimertinib results in decreased phosphorylation of STAT3 protein
CTD
PMID:30623574 PMID:35970427
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Twist1
twist family bHLH transcription factor 1
decreases response to substance multiple interactions affects response to substance
ISO
TWIST1 protein results in decreased susceptibility to osimertinib [TWIST1 protein results in decreased susceptibility to osimertinib] which results in decreased cleavage of PARP1 protein; TWIST1 protein inhibits the reaction [osimertinib results in increased cleavage of PARP1 protein] TWIST1 protein affects the susceptibility to osimertinib
CTD
PMID:30171258 PMID:30993382
NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:50,674,678...50,677,653
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions decreases activity
ISO
osimertinib inhibits the reaction [UGT1A1 protein results in increased glucuronidation of Hymecromone] osimertinib results in decreased activity of UGT1A1 protein
CTD
PMID:34044055
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
decreases activity
ISO
osimertinib results in decreased activity of UGT1A3 protein
CTD
PMID:34044055
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
decreases activity
ISO
osimertinib results in decreased activity of UGT1A6 protein
CTD
PMID:34044055
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
decreases activity
ISO
osimertinib results in decreased activity of UGT2B7 protein
CTD
PMID:34044055
NCBI chr14:21,251,535...21,274,451
Ensembl chr14:20,896,682...20,919,604
G
Acad10
acyl-CoA dehydrogenase family, member 10
increases expression
EXP
oxybenzone results in increased expression of ACAD10 mRNA
CTD
PMID:30316929
NCBI chr12:40,561,900...40,604,378
Ensembl chr12:34,901,219...34,982,521
G
Acad9
acyl-CoA dehydrogenase family, member 9
increases expression
EXP
oxybenzone results in increased expression of ACAD9 mRNA
CTD
PMID:30316929
NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:118,943,174...118,966,547
G
Acbd3
acyl-CoA binding domain containing 3
decreases expression
EXP
oxybenzone results in decreased expression of ACBD3 mRNA
CTD
PMID:30316929
NCBI chr13:94,987,643...95,016,356
Ensembl chr13:92,455,655...92,483,380
G
Ache
acetylcholinesterase
decreases expression
ISO
oxybenzone results in decreased expression of ACHE mRNA
CTD
PMID:39343157
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Aco2
aconitase 2
affects expression
EXP
oxybenzone affects the expression of ACO2 mRNA
CTD
PMID:30316929
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:113,385,646...113,428,261
G
Acot2
acyl-CoA thioesterase 2
increases expression
EXP
oxybenzone results in increased expression of ACOT2 mRNA
CTD
PMID:30316929
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:103,611,544...103,619,245
G
Acox1
acyl-CoA oxidase 1
increases expression
EXP
oxybenzone results in increased expression of ACOX1 mRNA
CTD
PMID:30316929
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232
G
Acsl5
acyl-CoA synthetase long-chain family member 5
decreases expression
EXP
oxybenzone results in decreased expression of ACSL5 mRNA
CTD
PMID:30316929
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:254,292,521...254,336,607
G
Acss2
acyl-CoA synthetase short-chain family member 2
increases expression
EXP
oxybenzone results in increased expression of ACSS2 mRNA
CTD
PMID:30316929
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:144,004,336...144,059,675
G
Acvrl1
activin A receptor like type 1
decreases expression
ISO
oxybenzone results in decreased expression of ACVRL1 mRNA
CTD
PMID:39343157
NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:132,239,729...132,256,591
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
decreases expression
ISO
oxybenzone results in decreased expression of ADAMTS1 mRNA
CTD
PMID:39343157
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:24,931,761...24,941,103
G
Adcy4
adenylate cyclase 4
decreases expression
ISO
oxybenzone results in decreased expression of ADCY4 mRNA
CTD
PMID:39343157
NCBI chr15:33,236,201...33,252,070
Ensembl chr15:29,266,287...29,282,108
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
CTD
PMID:32407875 PMID:34864131
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adora2b
adenosine A2B receptor
decreases expression
ISO
oxybenzone results in decreased expression of ADORA2B mRNA
CTD
PMID:39343157
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:46,940,384...46,956,772
G
Adprhl1
ADP-ribosylhydrolase like 1
affects expression
EXP
oxybenzone affects the expression of ADPRHL1 mRNA
CTD
PMID:30316929
NCBI chr16:82,985,355...83,017,240
Ensembl chr16:76,283,103...76,354,440
G
Ahr
aryl hydrocarbon receptor
decreases expression increases expression
EXP
oxybenzone results in decreased expression of AHR mRNA oxybenzone results in increased expression of AHR protein
CTD
PMID:15458797 PMID:30099065
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Aif1
allograft inflammatory factor 1
increases expression
EXP
oxybenzone results in increased expression of AIF1 mRNA; oxybenzone results in increased expression of AIF1 protein
CTD
PMID:31368502
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668
G
Akt3
AKT serine/threonine kinase 3
increases expression
ISO
oxybenzone results in increased expression of AKT3 mRNA
CTD
PMID:36581016
NCBI chr13:91,475,839...91,758,060
Ensembl chr13:88,946,091...89,225,708
G
Angpt1
angiopoietin 1
multiple interactions
ISO
[oxybenzone co-treated with Dietary Fats analog] results in decreased expression of ANGPT1 mRNA
CTD
PMID:38387520
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067
G
Angpt2
angiopoietin 2
multiple interactions
ISO
[oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of ANGPT2 mRNA
CTD
PMID:38387520
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:71,088,364...71,138,804
G
Angpt4
angiopoietin 4
multiple interactions
ISO
[oxybenzone co-treated with Dietary Fats analog] results in decreased expression of ANGPT4 mRNA
CTD
PMID:38387520
NCBI chr 3:160,880,539...160,913,923
Ensembl chr 3:140,420,389...140,453,583
G
Angptl4
angiopoietin-like 4
multiple interactions
ISO
[oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of ANGPTL4 mRNA
CTD
PMID:38387520
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:14,550,311...14,556,519
G
Apc
APC regulator of WNT signaling pathway
increases expression decreases expression
ISO
oxybenzone results in increased expression of APC mRNA oxybenzone results in decreased expression of APC mRNA
CTD
PMID:36581016 PMID:39343157
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Apln
apelin
decreases expression
ISO
oxybenzone results in decreased expression of APLN mRNA
CTD
PMID:39343157
NCBI chr X:132,058,739...132,091,518
Ensembl chr X:127,203,823...127,213,391
G
Apoc3
apolipoprotein C3
increases expression
EXP
oxybenzone results in increased expression of APOC3 mRNA
CTD
PMID:30316929
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583
G
Apoe
apolipoprotein E
decreases expression
ISO
oxybenzone results in decreased expression of APOE mRNA
CTD
PMID:39343157
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Apol2
apolipoprotein L2
increases expression
EXP
oxybenzone results in increased expression of APOL2 mRNA
CTD
PMID:30316929
NCBI chr 7:109,331,367...109,338,632
Ensembl chr 7:109,331,392...109,338,558
G
Apold1
apolipoprotein L domain containing 1
decreases expression
ISO
oxybenzone results in decreased expression of APOLD1 mRNA
CTD
PMID:39343157
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
G
Aqp1
aquaporin 1
decreases expression
EXP ISO
oxybenzone results in decreased expression of AQP1 mRNA
CTD
PMID:30316929 PMID:39343157
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:84,482,512...84,494,690
G
Ar
androgen receptor
multiple interactions affects localization
ISO EXP
oxybenzone binds to and results in decreased activity of AR protein; oxybenzone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; oxybenzone inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] oxybenzone affects the localization of AR protein
CTD
PMID:12730620 PMID:15537743 PMID:15950433 PMID:30099065 PMID:33049310
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Areg
amphiregulin
increases expression decreases expression
ISO
oxybenzone results in increased expression of AREG mRNA oxybenzone results in decreased expression of AREG mRNA
CTD
PMID:31939680 PMID:38382712
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
G
Atf2
activating transcription factor 2
increases expression
ISO
oxybenzone results in increased expression of ATF2 mRNA
CTD
PMID:36581016
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:58,718,332...58,795,236
G
Atg2b
autophagy related 2B
increases expression
ISO
oxybenzone results in increased expression of ATG2B mRNA
CTD
PMID:36581016
NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:124,525,523...124,592,015
G
Atm
ATM serine/threonine kinase
increases expression
ISO
oxybenzone results in increased expression of ATM mRNA
CTD
PMID:36581016
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Atp5f1a
ATP synthase F1 subunit alpha
increases expression
EXP
oxybenzone results in increased expression of ATP5F1A mRNA
CTD
PMID:30316929
NCBI chr18:73,567,537...73,575,473
Ensembl chr18:71,292,374...71,300,794
G
Atp5f1b
ATP synthase F1 subunit beta
increases expression
EXP
oxybenzone results in increased expression of ATP5F1B mRNA
CTD
PMID:30316929
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:515,460...567,273
G
Atp5f1c
ATP synthase F1 subunit gamma
increases expression
EXP
oxybenzone results in increased expression of ATP5F1C mRNA
CTD
PMID:30316929
NCBI chr17:73,333,584...73,355,872
Ensembl chr17:68,423,909...68,608,367
G
Atp5mc2
ATP synthase membrane subunit c locus 2
decreases expression
EXP
oxybenzone results in decreased expression of ATP5MC2 mRNA
CTD
PMID:30316929
NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:133,791,342...133,799,733
G
Atr
ATR serine/threonine kinase
increases expression
ISO
oxybenzone results in increased expression of ATR mRNA
CTD
PMID:36581016
NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:96,426,724...96,524,136
G
Bad
BCL2-associated agonist of cell death
increases expression
EXP
oxybenzone results in increased expression of BAD mRNA
CTD
PMID:30316929
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
increases expression
EXP
oxybenzone results in increased expression of BAK1 mRNA; oxybenzone results in increased expression of BAK1 protein
CTD
PMID:30099065 PMID:30316929
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
oxybenzone results in increased expression of BAX mRNA; oxybenzone results in increased expression of BAX protein
CTD
PMID:30099065 PMID:30316929
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2l1
Bcl2-like 1
decreases expression
EXP
oxybenzone results in decreased expression of BCL2L1 mRNA
CTD
PMID:30316929
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcs1l
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone
increases expression
EXP
oxybenzone results in increased expression of BCS1L mRNA
CTD
PMID:30316929
NCBI chr 9:76,164,925...76,168,940
Ensembl chr 9:76,164,932...76,168,938
G
Blm
BLM RecQ like helicase
increases expression
ISO
oxybenzone results in increased expression of BLM mRNA
CTD
PMID:36581016
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:134,409,857...134,484,312
G
Brca1
BRCA1, DNA repair associated
increases expression
ISO
oxybenzone results in increased expression of BRCA1 mRNA
CTD
PMID:36581016
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,418,000...86,477,304
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
increases expression
ISO
oxybenzone results in increased expression of CACNA2D1 mRNA
CTD
PMID:36581016
NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:18,951,002...19,374,969
G
Calr
calreticulin
decreases expression
ISO
oxybenzone results in decreased expression of CALR mRNA
CTD
PMID:39343157
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
G
Casp1
caspase 1
decreases expression
EXP
oxybenzone results in decreased expression of CASP1 mRNA
CTD
PMID:30316929
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
G
Casp2
caspase 2
increases expression
EXP
oxybenzone results in increased expression of CASP2 mRNA
CTD
PMID:30316929
NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:71,149,669...71,167,379
G
Casp3
caspase 3
increases activity multiple interactions
EXP
oxybenzone results in increased activity of CASP3 protein oxybenzone results in increased expression of and results in increased activity of CASP3 protein
CTD
PMID:30099065 PMID:31368502
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
decreases expression
EXP
oxybenzone results in decreased expression of CASP4 mRNA
CTD
PMID:30316929
NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:2,598,876...2,635,092
G
Casp9
caspase 9
increases activity increases expression
EXP
oxybenzone results in increased activity of CASP9 protein oxybenzone results in increased expression of CASP9 mRNA
CTD
PMID:30099065 PMID:30316929
Ensembl chr 5:154,109,046...154,126,626
G
Ccl21
C-C motif chemokine ligand 21
decreases expression
EXP
oxybenzone results in decreased expression of CCL21 mRNA
CTD
PMID:30316929
NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:56,980,558...56,981,686
G
Ccne2
cyclin E2
increases expression
ISO
oxybenzone results in increased expression of CCNE2 mRNA
CTD
PMID:36581016
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:24,284,922...24,297,632
G
Cdh5
cadherin 5
decreases expression
ISO
oxybenzone results in decreased expression of CDH5 mRNA
CTD
PMID:39343157
NCBI chr19:821,875...860,931
Ensembl chr19:815,411...854,368
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
increases expression
ISO
oxybenzone results in increased expression of CHUK mRNA
CTD
PMID:36581016
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
G
Cited4
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
increases expression
EXP
oxybenzone results in increased expression of CITED4 mRNA
CTD
PMID:30316929
NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:134,246,682...134,248,135
G
Cldn1
claudin 1
decreases expression
ISO
oxybenzone results in decreased expression of CLDN1 mRNA
CTD
PMID:39343157
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:74,421,569...74,436,724
G
Cldn11
claudin 11
decreases expression
ISO
oxybenzone results in decreased expression of CLDN11 mRNA
CTD
PMID:39343157
NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:112,207,745...112,221,050
G
Cldn5
claudin 5
decreases expression
ISO
oxybenzone results in decreased expression of CLDN5 mRNA oxybenzone results in decreased expression of CLDN5 protein
CTD
PMID:39343157
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:82,211,475...82,214,992
G
Clec14a
C-type lectin domain containing 14A
decreases expression
ISO
oxybenzone results in decreased expression of CLEC14A mRNA
CTD
PMID:39343157
NCBI chr 6:81,616,414...81,619,556
Ensembl chr 6:75,881,473...75,884,612
G
Cox15
cytochrome c oxidase assembly homolog COX15
increases expression
EXP
oxybenzone results in increased expression of COX15 mRNA
CTD
PMID:30316929
NCBI chr 1:252,554,811...252,571,471
Ensembl chr 1:242,605,588...242,622,261
G
Cox16
cytochrome c oxidase assembly factor COX16
decreases expression
EXP
oxybenzone results in decreased expression of COX16 mRNA
CTD
PMID:30316929
NCBI chr 6:101,162,231...101,181,277
Ensembl chr 6:101,019,680...101,181,246
G
Cox17
cytochrome c oxidase copper chaperone COX17
increases expression
EXP
oxybenzone results in increased expression of COX17 mRNA
CTD
PMID:30316929
NCBI chr11:75,906,245...75,912,036
G
Cox18
cytochrome c oxidase assembly factor COX18
increases expression
EXP
oxybenzone results in increased expression of COX18 mRNA
CTD
PMID:30316929
NCBI chr14:18,147,558...18,161,622
Ensembl chr14:17,865,857...17,877,480
G
Cox5a
cytochrome c oxidase subunit 5A
increases expression
EXP
oxybenzone results in increased expression of COX5A mRNA
CTD
PMID:30316929
NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:57,922,290...57,933,781
G
Cox6b2
cytochrome c oxidase subunit 6B2
decreases expression
EXP
oxybenzone results in decreased expression of COX6B2 mRNA
CTD
PMID:30316929
NCBI chr 1:69,094,009...69,095,312
G
Cox7a2
cytochrome c oxidase subunit 7A2
decreases expression
EXP
oxybenzone results in decreased expression of COX7A2 mRNA
CTD
PMID:30316929
NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:51,301,168...51,301,633 Ensembl chr 8:51,301,168...51,301,633
G
Cpt1b
carnitine palmitoyltransferase 1B
increases expression
EXP
oxybenzone results in increased expression of CPT1B mRNA
CTD
PMID:30316929
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:120,491,354...120,500,404
G
Cpt2
carnitine palmitoyltransferase 2
increases expression
EXP
oxybenzone results in increased expression of CPT2 mRNA
CTD
PMID:30316929
NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:122,664,677...122,682,095
G
Cpxm2
carboxypeptidase X (M14 family), member 2
decreases expression
EXP
oxybenzone results in decreased expression of CPXM2 mRNA
CTD
PMID:30316929
NCBI chr 1:196,266,930...196,377,350
Ensembl chr 1:186,836,797...186,947,220
G
Creb1
cAMP responsive element binding protein 1
increases expression
ISO
oxybenzone results in increased expression of CREB1 mRNA
CTD
PMID:36581016
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Creb3l1
cAMP responsive element binding protein 3-like 1
decreases expression
ISO
oxybenzone results in decreased expression of CREB3L1 mRNA
CTD
PMID:39343157
NCBI chr 3:98,408,240...98,449,104
Ensembl chr 3:77,952,540...77,993,456
G
Csn2
casein beta
increases expression decreases methylation
ISO
oxybenzone results in increased expression of CSN2 mRNA; oxybenzone results in increased expression of CSN2 protein oxybenzone results in decreased methylation of CSN2 promoter
CTD
PMID:32946892
NCBI chr14:20,322,581...20,329,818
Ensembl chr14:20,322,581...20,329,817
G
Cstl1
cystatin-like 1
decreases expression
EXP
oxybenzone results in decreased expression of CSTL1 mRNA
CTD
PMID:30316929
NCBI chr 3:156,652,967...156,658,049
Ensembl chr 3:136,199,914...136,204,912
G
Ctnnb1
catenin beta 1
decreases expression
ISO
oxybenzone results in decreased expression of CTNNB1 mRNA
CTD
PMID:39343157
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cybrd1
cytochrome b reductase 1
increases expression
EXP
oxybenzone results in increased expression of CYBRD1 mRNA
CTD
PMID:30316929
NCBI chr 3:55,934,874...55,962,132
Ensembl chr 3:55,934,874...55,962,108
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
increases expression
EXP
oxybenzone results in increased expression of CYP19A1 mRNA
CTD
PMID:30599193
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
decreases expression
EXP
oxybenzone results in decreased expression of CYP24A1 mRNA
CTD
PMID:30316929
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:159,275,947...159,290,383
G
Cyp26c1
cytochrome P450, family 26, subfamily C, polypeptide 1
increases expression
EXP
oxybenzone results in increased expression of CYP26C1 mRNA
CTD
PMID:30316929
NCBI chr 1:244,870,412...244,881,610
Ensembl chr 1:235,459,356...235,466,842
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
increases expression
EXP
oxybenzone results in increased expression of CYP27B1 mRNA
CTD
PMID:30316929
NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:62,871,297...62,876,241
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases expression
EXP
oxybenzone results in decreased expression of CYP2B3 mRNA
CTD
PMID:30316929
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2d3
cytochrome P450, family 2, subfamily d, polypeptide 3
increases expression
EXP
oxybenzone results in increased expression of CYP2D3 mRNA
CTD
PMID:30316929
NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
decreases expression
EXP
oxybenzone results in decreased expression of CYP4A3 mRNA
CTD
PMID:30316929
NCBI chr 5:134,334,396...134,352,268
Ensembl chr 5:129,097,926...129,115,463
G
Cyp4f18
cytochrome P450, family 4, subfamily f, polypeptide 18
increases expression
EXP
oxybenzone results in increased expression of CYP4F18 mRNA
CTD
PMID:30316929
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
increases expression
EXP
oxybenzone results in increased expression of CYP7A1 mRNA
CTD
PMID:30316929
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:19,376,974...19,386,688
G
Dap
death-associated protein
decreases expression
EXP
oxybenzone results in decreased expression of DAP mRNA
CTD
PMID:30316929
NCBI chr 2:83,910,113...83,962,673
Ensembl chr 2:82,199,280...82,251,752
G
Dapk3
death-associated protein kinase 3
increases expression
EXP
oxybenzone results in increased expression of DAPK3 mRNA
CTD
PMID:30316929
NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:8,524,183...8,532,558
G
Daxx
death-domain associated protein
increases expression increases methylation
EXP ISO
oxybenzone results in increased expression of DAXX mRNA oxybenzone results in increased methylation of DAXX gene
CTD
PMID:30316929 PMID:34523531
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,970,092...4,975,843
G
Dedd
death effector domain-containing
increases expression
EXP
oxybenzone results in increased expression of DEDD mRNA
CTD
PMID:30316929
NCBI chr13:83,755,874...83,769,982
Ensembl chr13:83,756,108...83,769,332
G
Dffa
DNA fragmentation factor subunit alpha
increases expression
EXP
oxybenzone results in increased expression of DFFA mRNA
CTD
PMID:30316929
NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:159,540,715...159,553,633
G
Dhodh
dihydroorotate dehydrogenase
increases expression
EXP
oxybenzone results in increased expression of DHODH mRNA
CTD
PMID:30316929
NCBI chr19:54,460,636...54,483,049
Ensembl chr19:37,558,177...37,591,654
G
Dld
dihydrolipoamide dehydrogenase
increases expression
ISO
oxybenzone results in increased expression of DLD mRNA
CTD
PMID:36581016
NCBI chr 6:53,631,686...53,655,059
Ensembl chr 6:47,903,914...47,924,795
G
Dll4
delta like canonical Notch ligand 4
decreases expression
ISO
oxybenzone results in decreased expression of DLL4 mRNA
CTD
PMID:39343157
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:106,316,986...106,326,931
G
Dlst
dihydrolipoamide S-succinyltransferase
increases expression
EXP
oxybenzone results in increased expression of DLST mRNA
CTD
PMID:30316929
NCBI chr 6:110,489,576...110,512,841
Ensembl chr 6:104,758,631...104,783,296
G
Dlx3
distal-less homeobox 3
affects expression
EXP
oxybenzone affects the expression of DLX3 mRNA
CTD
PMID:30316929
NCBI chr10:80,561,335...80,566,730
Ensembl chr10:80,064,489...80,069,872
G
Dmtf1
cyclin D binding myb-like transcription factor 1
increases expression
ISO
oxybenzone results in increased expression of DMTF1 mRNA
CTD
PMID:36581016
NCBI chr 4:25,864,891...25,905,916
Ensembl chr 4:24,910,534...24,950,967
G
Dnajc15
DnaJ heat shock protein family (Hsp40) member C15
decreases expression
EXP
oxybenzone results in decreased expression of DNAJC15 mRNA
CTD
PMID:30316929
NCBI chr15:59,594,314...59,658,862
Ensembl chr15:53,184,855...53,249,675
G
Dpp4
dipeptidylpeptidase 4
decreases expression
ISO
oxybenzone results in decreased expression of DPP4 mRNA
CTD
PMID:39343157
NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:46,962,243...47,043,901
G
Dusp9
dual specificity phosphatase 9
decreases expression
ISO
oxybenzone results in decreased expression of DUSP9 mRNA
CTD
PMID:39343157
NCBI chr X:156,503,237...156,507,162
Ensembl chr X:151,351,897...151,355,821
G
Echs1
enoyl-CoA hydratase, short chain 1
increases expression
EXP
oxybenzone results in increased expression of ECHS1 mRNA
CTD
PMID:30316929
NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:194,895,036...194,903,884
G
Ednra
endothelin receptor type A
decreases expression
ISO
oxybenzone results in decreased expression of EDNRA mRNA
CTD
PMID:39343157
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049
G
Egfl7
EGF-like-domain, multiple 7
decreases expression
ISO
oxybenzone results in decreased expression of EGFL7 mRNA
CTD
PMID:39343157
NCBI chr 3:29,802,481...29,814,966
Ensembl chr 3:9,407,520...9,416,879
G
Egr1
early growth response 1
decreases expression
ISO
oxybenzone results in decreased expression of EGR1 mRNA
CTD
PMID:39343157
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eif4e
eukaryotic translation initiation factor 4E
increases expression
ISO
oxybenzone results in increased expression of EIF4E mRNA
CTD
PMID:36581016
NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:227,066,673...227,098,683
G
Enah
ENAH, actin regulator
decreases expression
ISO
oxybenzone results in decreased expression of ENAH mRNA
CTD
PMID:39343157
NCBI chr13:96,149,437...96,269,841
Ensembl chr13:93,626,944...93,740,955
G
Epha1
Eph receptor A1
decreases expression
ISO
oxybenzone results in decreased expression of EPHA1 mRNA
CTD
PMID:39343157
NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:71,246,409...71,260,846
G
Esr1
estrogen receptor 1
decreases expression increases expression multiple interactions
EXP ISO
oxybenzone results in decreased expression of ESR1 mRNA; oxybenzone results in decreased expression of ESR1 protein oxybenzone results in increased expression of ESR1 mRNA oxybenzone binds to and results in increased activity of ESR1 protein; oxybenzone promotes the reaction [ESR1 protein binds to ESR1 protein]
CTD
PMID:15458797 PMID:16079615 PMID:30099065 PMID:32946892 PMID:33049310 PMID:37696476 More...
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions affects expression decreases expression
ISO EXP
oxybenzone binds to and results in increased activity of ESR2 protein oxybenzone affects the expression of ESR2 protein oxybenzone results in decreased expression of ESR2 mRNA
CTD
PMID:16079615 PMID:30099065 PMID:33049310
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Esrra
estrogen related receptor, alpha
decreases expression
EXP
oxybenzone results in decreased expression of ESRRA mRNA
CTD
PMID:15458797
NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:204,104,101...204,114,268
G
F11r
F11 receptor
decreases expression
ISO
oxybenzone results in decreased expression of F11R mRNA
CTD
PMID:39343157
NCBI chr13:86,406,229...86,429,819
Ensembl chr13:83,873,797...83,897,402
G
Fabp4
fatty acid binding protein 4
multiple interactions
ISO
oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]
CTD
PMID:32407875 PMID:34864131
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578
G
Fam180a
family with sequence similarity 180, member A
decreases expression
EXP
oxybenzone results in decreased expression of FAM180A mRNA
CTD
PMID:30316929
NCBI chr 4:64,959,999...64,975,176
Ensembl chr 4:63,992,867...64,008,047
G
Fgf2
fibroblast growth factor 2
increases expression
ISO
oxybenzone results in increased expression of FGF2 mRNA
CTD
PMID:36581016
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fgfrl1
fibroblast growth factor receptor-like 1
decreases expression
ISO
oxybenzone results in decreased expression of FGFRL1 mRNA
CTD
PMID:39343157
NCBI chr14:1,154,275...1,166,334
Ensembl chr14:1,009,786...1,021,928
G
Flg
filaggrin
affects response to substance multiple interactions
ISO
FLG gene mutant form affects the susceptibility to oxybenzone [FLG gene mutant form affects the susceptibility to oxybenzone] which results in decreased secretion of FSHB protein; [FLG gene mutant form affects the susceptibility to oxybenzone] which results in increased secretion of Estradiol; [FLG gene mutant form affects the susceptibility to oxybenzone] which results in increased secretion of Testosterone
CTD
PMID:30245359
NCBI chr 2:178,884,793...178,912,986
G
Fli1
Fli-1 proto-oncogene, ETS transcription factor
decreases expression
ISO
oxybenzone results in decreased expression of FLI1 mRNA
CTD
PMID:39343157
NCBI chr 8:39,089,526...39,209,511
Ensembl chr 8:30,832,753...30,950,433
G
Fn1
fibronectin 1
multiple interactions
ISO
[oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of FN1 mRNA
CTD
PMID:38387520
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Foxc1
forkhead box C1
decreases expression
ISO
oxybenzone results in decreased expression of FOXC1 mRNA
CTD
PMID:39343157
NCBI chr17:32,840,119...32,844,100
Ensembl chr17:32,633,142...32,634,803
G
Foxl2
forkhead box L2
increases expression multiple interactions
EXP
oxybenzone results in increased expression of FOXL2 mRNA 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol inhibits the reaction [oxybenzone results in increased expression of FOXL2 mRNA]
CTD
PMID:30599193
NCBI chr 8:108,392,466...108,395,553
Ensembl chr 8:99,513,303...99,514,427
G
Frzb
frizzled-related protein
decreases expression
EXP
oxybenzone results in decreased expression of FRZB mRNA
CTD
PMID:30316929
NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:65,332,277...65,365,208
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
ISO
[FLG gene mutant form affects the susceptibility to oxybenzone] which results in decreased secretion of FSHB protein
CTD
PMID:30245359
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
G
Fst
follistatin
increases expression
EXP
oxybenzone results in increased expression of FST mRNA
CTD
PMID:30599193
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:46,123,439...46,130,571
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
increases expression
ISO
oxybenzone results in increased expression of GABRA1 mRNA
CTD
PMID:39343157
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:26,595,160...26,650,864
G
Gad2
glutamate decarboxylase 2
increases expression
ISO
oxybenzone results in increased expression of GAD2 mRNA
CTD
PMID:39343157
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Garin1a
golgi associated RAB2 interactor 1A
decreases expression
EXP
oxybenzone results in decreased expression of GARIN1A mRNA
CTD
PMID:30316929
NCBI chr 4:57,880,019...57,890,824
Ensembl chr 4:57,880,019...57,890,820
G
Garin3
golgi associated RAB2 interactor family member 3
decreases expression
EXP
oxybenzone results in decreased expression of GARIN3 mRNA
CTD
PMID:30316929
NCBI chr10:31,331,196...31,334,434
Ensembl chr10:30,829,877...30,833,111
G
Gfap
glial fibrillary acidic protein
increases expression
ISO
oxybenzone results in increased expression of GFAP mRNA
CTD
PMID:39343157
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
G
Gja4
gap junction protein, alpha 4
decreases expression
ISO
oxybenzone results in decreased expression of GJA4 mRNA
CTD
PMID:39343157
NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:139,633,287...139,635,925
G
Gper1
G protein-coupled estrogen receptor 1
affects expression
EXP
oxybenzone affects the expression of GPER1 protein
CTD
PMID:30099065
NCBI chr12:20,331,073...20,336,527
Ensembl chr12:15,217,442...15,221,889
G
Greb1
growth regulating estrogen receptor binding 1
multiple interactions increases expression
ISO
Fulvestrant inhibits the reaction [oxybenzone results in increased expression of GREB1 mRNA]
CTD
PMID:33405908
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
G
Grem1
gremlin 1, DAN family BMP antagonist
decreases expression
ISO
oxybenzone results in decreased expression of GREM1 mRNA
CTD
PMID:39343157
NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:100,512,313...100,524,082
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
affects expression
EXP
oxybenzone affects the expression of GRIN1 protein
CTD
PMID:31368502
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
affects expression
EXP
oxybenzone affects the expression of GRIN2A protein
CTD
PMID:31368502
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grn
granulin precursor
decreases expression
ISO
oxybenzone results in decreased expression of GRN mRNA
CTD
PMID:39343157
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,387,638...87,393,775
G
Gsk3b
glycogen synthase kinase 3 beta
decreases expression
ISO
oxybenzone results in decreased expression of GSK3B mRNA
CTD
PMID:39343157
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gsta2
glutathione S-transferase alpha 2
decreases expression
EXP
oxybenzone results in decreased expression of GSTA2 mRNA
CTD
PMID:30316929
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798
G
Gsta5
glutathione S-transferase alpha 5
decreases expression
EXP
oxybenzone results in decreased expression of GSTA5 mRNA
CTD
PMID:30316929
NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:79,105,661...79,117,472
G
Gstm1
glutathione S-transferase mu 1
increases expression
EXP
oxybenzone results in increased expression of GSTM1 mRNA
CTD
PMID:30316929
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
oxybenzone results in increased expression of GSTP1 mRNA
CTD
PMID:30316929
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gstt2
glutathione S-transferase theta 2
increases expression
EXP
oxybenzone results in increased expression of GSTT2 mRNA
CTD
PMID:30316929
NCBI chr20:12,819,053...12,822,724
Ensembl chr20:12,819,170...12,823,288
G
Gstt4
glutathione S-transferase, theta 4
decreases expression
EXP
oxybenzone results in decreased expression of GSTT4 mRNA
CTD
PMID:30316929
NCBI chr20:12,835,178...12,842,306
Ensembl chr20:12,835,178...12,842,292
G
Gzmb
granzyme B
decreases expression
ISO
oxybenzone results in decreased expression of GZMB mRNA
CTD
PMID:38431166
NCBI chr15:34,459,007...34,462,469
Ensembl chr15:30,173,603...30,346,814
G
H2ax
H2A.X variant histone
increases expression multiple interactions
ISO
oxybenzone results in increased expression of H2AX protein modified form Fulvestrant inhibits the reaction [oxybenzone results in increased expression of H2AX protein modified form]
CTD
PMID:31939680
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
EXP
oxybenzone results in decreased expression of HADHA mRNA
CTD
PMID:30316929
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:26,187,956...26,227,869
G
Hdac1
histone deacetylase 1
increases expression
EXP
oxybenzone results in increased expression of HDAC1 protein
CTD
PMID:31368502
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
G
Hdac2
histone deacetylase 2
increases expression
EXP
oxybenzone results in increased expression of HDAC2 protein
CTD
PMID:31368502
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
Hdac9
histone deacetylase 9
increases expression
ISO
oxybenzone results in increased expression of HDAC9 mRNA
CTD
PMID:36581016
NCBI chr 6:56,489,472...57,351,654
Ensembl chr 6:50,763,590...51,625,333
G
Hes1
hes family bHLH transcription factor 1
decreases expression
ISO
oxybenzone results in decreased expression of HES1 mRNA
CTD
PMID:39343157
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:70,705,764...70,708,192
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
decreases expression
ISO
oxybenzone results in decreased expression of HEY1 mRNA
CTD
PMID:39343157
NCBI chr 2:95,003,935...95,006,457
Ensembl chr 2:93,095,498...93,100,312
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression multiple interactions
ISO
oxybenzone results in increased expression of HIF1A mRNA [oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of HIF1A mRNA
CTD
PMID:36581016 PMID:38387520
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hltf
helicase-like transcription factor
increases expression
ISO
oxybenzone results in increased expression of HLTF mRNA
CTD
PMID:36581016
NCBI chr 2:104,478,725...104,538,531
Ensembl chr 2:102,549,724...102,609,327
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
oxybenzone results in increased expression of HMGCR mRNA
CTD
PMID:32407875
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
oxybenzone results in increased expression of HMGCS1 mRNA
CTD
PMID:32407875
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:51,649,497...51,667,100
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
oxybenzone results in decreased expression of HMGCS2 mRNA
CTD
PMID:30316929
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:185,875,616...185,902,130
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
decreases expression
EXP
oxybenzone results in decreased expression of HSD17B10 mRNA
CTD
PMID:30316929
NCBI chr X:24,568,551...24,571,012
Ensembl chr X:21,089,122...21,109,488
G
Hsd3b2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
decreases activity
EXP
oxybenzone results in decreased activity of HSD3B2 protein
CTD
PMID:37217011
NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:186,095,897...186,101,852
G
Hsdl2
hydroxysteroid dehydrogenase like 2
decreases expression
EXP
oxybenzone results in decreased expression of HSDL2 mRNA
CTD
PMID:30316929
NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:74,443,872...74,479,839
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
oxybenzone results in increased expression of HSP90AA1 mRNA
CTD
PMID:36581016
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268
G
Hykk
hydroxylysine kinase
increases expression
EXP
oxybenzone results in increased expression of HYKK mRNA
CTD
PMID:30316929
NCBI chr 8:55,315,919...55,339,720
Ensembl chr 8:55,315,969...55,337,339
G
Icam1
intercellular adhesion molecule 1
multiple interactions decreases expression
ISO
bisphenol A inhibits the reaction [oxybenzone results in decreased expression of ICAM1 mRNA]
CTD
PMID:38431166
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Id3
inhibitor of DNA binding 3
decreases expression
ISO
oxybenzone results in decreased expression of ID3 mRNA
CTD
PMID:39343157
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:148,372,762...148,374,349
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
decreases expression
EXP
oxybenzone results in decreased expression of IDH2 mRNA
CTD
PMID:30316929
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Idh3g
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
increases expression
EXP
oxybenzone results in increased expression of IDH3G mRNA
CTD
PMID:30316929
NCBI chr X:156,666,573...156,675,482
Ensembl chr X:151,515,247...151,524,171
G
Il19
interleukin 19
increases expression
EXP
oxybenzone results in increased expression of IL19 mRNA
CTD
PMID:30316929
NCBI chr13:44,949,989...44,958,714
Ensembl chr13:42,399,138...42,405,473
G
Ins1
insulin 1
multiple interactions
ISO
oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]
CTD
PMID:32407875
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Ins2
insulin 2
multiple interactions
ISO
oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]
CTD
PMID:34864131
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:197,843,281...197,864,775
G
Iqcf6
IQ motif containing F6
decreases expression
EXP
oxybenzone results in decreased expression of IQCF6 mRNA
CTD
PMID:30316929
NCBI chr 8:107,263,673...107,264,726
Ensembl chr 8:107,263,654...107,264,724
G
Itga4
integrin subunit alpha 4
increases expression
ISO
oxybenzone results in increased expression of ITGA4 mRNA
CTD
PMID:36581016
NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:64,163,085...64,233,715
G
Itga5
integrin subunit alpha 5
decreases expression
ISO
oxybenzone results in decreased expression of ITGA5 mRNA
CTD
PMID:39343157
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:134,478,968...134,502,837
G
Kdr
kinase insert domain receptor
decreases expression
ISO
oxybenzone results in decreased expression of KDR mRNA
CTD
PMID:39343157
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Klf2
KLF transcription factor 2
decreases expression
ISO
oxybenzone results in decreased expression of KLF2 mRNA
CTD
PMID:39343157
NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,514,552...17,523,944
G
Klf4
KLF transcription factor 4
decreases expression
ISO
oxybenzone results in decreased expression of KLF4 mRNA
CTD
PMID:39343157
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:70,278,972...70,283,602
G
Kras
KRAS proto-oncogene, GTPase
increases expression
ISO
oxybenzone results in increased expression of KRAS mRNA
CTD
PMID:36581016
NCBI chr 4:179,916,255...179,949,613
G
Krt18
keratin 18
decreases expression
EXP
oxybenzone results in decreased expression of KRT18 mRNA
CTD
PMID:30316929
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
G
Lck
LCK proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
oxybenzone results in decreased expression of LCK mRNA
CTD
PMID:36581016
NCBI chr 5:147,172,642...147,201,267
Ensembl chr 5:141,888,326...141,903,794
G
Lcn2
lipocalin 2
decreases expression
ISO
oxybenzone results in decreased expression of LCN2 mRNA
CTD
PMID:39343157
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Ldhd
lactate dehydrogenase D
increases methylation
ISO
oxybenzone results in increased methylation of LDHD gene
CTD
PMID:34523531
NCBI chr19:56,492,827...56,497,695
Ensembl chr19:39,573,621...39,595,575
G
Lef1
lymphoid enhancer binding factor 1
multiple interactions
ISO
[oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of LEF1 mRNA
CTD
PMID:38387520
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:219,666,592...219,779,794
G
Lifr
LIF receptor subunit alpha
increases expression
ISO
oxybenzone results in increased expression of LIFR mRNA
CTD
PMID:36581016
NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:56,250,120...56,286,699
G
Loxl1
lysyl oxidase-like 1
decreases expression
ISO
oxybenzone results in decreased expression of LOXL1 mRNA
CTD
PMID:39343157
NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:58,692,593...58,716,356
G
Lsmem1
leucine-rich single-pass membrane protein 1
increases expression
EXP
oxybenzone results in increased expression of LSMEM1 mRNA
CTD
PMID:30316929
NCBI chr 6:62,978,880...62,988,750
Ensembl chr 6:57,252,056...57,261,653
G
Magel2
MAGE family member L2
increases expression
EXP
oxybenzone results in increased expression of MAGEL2 mRNA
CTD
PMID:30316929
NCBI chr 1:115,880,142...115,884,684
Ensembl chr 1:115,880,474...115,884,250
G
Maob
monoamine oxidase B
decreases expression
ISO
oxybenzone results in decreased expression of MAOB mRNA
CTD
PMID:39343157
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:5,907,266...6,011,003
G
Map2k1
mitogen activated protein kinase kinase 1
decreases expression
ISO
oxybenzone results in decreased expression of MAP2K1 mRNA
CTD
PMID:39343157
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Map2k3
mitogen activated protein kinase kinase 3
decreases expression
ISO
oxybenzone results in decreased expression of MAP2K3 mRNA
CTD
PMID:39343157
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:45,607,163...45,629,492
G
Mapk6
mitogen-activated protein kinase 6
increases expression
ISO
oxybenzone results in increased expression of MAPK6 mRNA
CTD
PMID:36581016
NCBI chr 8:85,027,141...85,050,236
Ensembl chr 8:76,146,690...76,169,720
G
Mcc
MCC regulator of WNT signaling pathway
decreases expression
EXP
oxybenzone results in decreased expression of MCC mRNA
CTD
PMID:30316929
NCBI chr18:36,794,206...37,266,237
Ensembl chr18:36,798,372...37,266,819
G
Med13
mediator complex subunit 13
increases expression
ISO
oxybenzone results in increased expression of MED13 mRNA
CTD
PMID:36581016
NCBI chr10:71,584,354...71,674,614
Ensembl chr10:71,090,516...71,177,242
G
Medag
mesenteric estrogen-dependent adipogenesis
decreases expression
EXP
oxybenzone results in decreased expression of MEDAG mRNA
CTD
PMID:30316929
NCBI chr12:10,649,526...10,670,913
Ensembl chr12:5,613,208...5,634,767
G
Mgp
matrix Gla protein
decreases expression
ISO
oxybenzone results in decreased expression of MGP mRNA
CTD
PMID:39343157
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:169,766,279...169,769,667
G
Mov10
Mov10 RNA helicase
decreases expression
ISO
oxybenzone results in decreased expression of MOV10 mRNA
CTD
PMID:39343157
NCBI chr 2:194,982,014...195,003,513
Ensembl chr 2:192,293,470...192,315,083
G
Mpped2
metallophosphoesterase domain containing 2
increases expression
ISO
oxybenzone results in increased expression of MPPED2 mRNA
CTD
PMID:39343157
NCBI chr 3:93,180,895...93,355,605
Ensembl chr 3:93,181,167...93,355,618
G
Mre11
MRE11 homolog, double strand break repair nuclease
increases expression
ISO
oxybenzone results in increased expression of MRE11 mRNA
CTD
PMID:36581016
NCBI chr 8:19,900,211...19,961,906
Ensembl chr 8:11,632,354...11,678,279
G
Msh2
mutS homolog 2
increases expression
ISO
oxybenzone results in increased expression of MSH2 mRNA
CTD
PMID:36581016
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:6,813,795...6,872,938
G
Mybl1
MYB proto-oncogene like 1
increases expression multiple interactions
ISO
oxybenzone results in increased expression of MYBL1 mRNA Fulvestrant inhibits the reaction [oxybenzone results in increased expression of MYBL1 mRNA]
CTD
PMID:33405908
NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:9,582,934...9,618,183
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
increases expression
ISO
oxybenzone results in increased expression of MYCN mRNA
CTD
PMID:39343157
NCBI chr 6:41,446,683...41,452,584
Ensembl chr 6:35,717,764...35,723,590
G
Nbl1
NBL1, DAN family BMP antagonist
decreases expression increases expression
ISO
oxybenzone results in decreased expression of NBL1 mRNA oxybenzone results in increased expression of NBL1 mRNA
CTD
PMID:39343157
NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:151,318,754...151,338,719
G
Nbn
nibrin
increases expression
ISO
oxybenzone results in increased expression of NBN mRNA
CTD
PMID:36581016
NCBI chr 5:34,256,678...34,291,163
Ensembl chr 5:29,459,457...29,494,150
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions increases expression
ISO
oxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein] oxybenzone results in increased expression of NCOA2 mRNA
CTD
PMID:32407875 PMID:36581016
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:5,835,706...6,067,451
G
Ndufa11
NADH:ubiquinone oxidoreductase subunit A11
decreases expression
EXP
oxybenzone results in decreased expression of NDUFA11 mRNA
CTD
PMID:30316929
NCBI chr 9:1,637,614...1,641,673
Ensembl chr 9:1,550,468...1,555,601
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
decreases expression
EXP
oxybenzone results in decreased expression of NDUFA3 mRNA
CTD
PMID:30316929
NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235
G
Ndufa9
NADH:ubiquinone oxidoreductase subunit A9
increases expression
EXP
oxybenzone results in increased expression of NDUFA9 mRNA
CTD
PMID:30316929
NCBI chr 4:161,345,398...161,374,188
Ensembl chr 4:159,659,242...159,688,018
G
Ndufab1
NADH:ubiquinone oxidoreductase subunit AB1
increases expression
EXP
oxybenzone results in increased expression of NDUFAB1 mRNA
CTD
PMID:30316929
NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:176,644,703...176,658,099
G
Ndufb10
NADH:ubiquinone oxidoreductase subunit B10
increases expression
EXP
oxybenzone results in increased expression of NDUFB10 mRNA
CTD
PMID:30316929
NCBI chr10:14,253,805...14,255,966
Ensembl chr10:13,749,275...13,751,442
G
Ndufb7
NADH:ubiquinone oxidoreductase subunit B7
increases expression
EXP
oxybenzone results in increased expression of NDUFB7 mRNA
CTD
PMID:30316929
NCBI chr19:41,472,953...41,477,291
Ensembl chr19:24,568,241...24,572,579
G
Ndufs2
NADH:ubiquinone oxidoreductase core subunit S2
decreases expression
EXP
oxybenzone results in decreased expression of NDUFS2 mRNA
CTD
PMID:30316929
NCBI chr13:86,186,867...86,203,914
Ensembl chr13:83,654,406...83,671,420
G
Ndufv3
NADH:ubiquinone oxidoreductase subunit V3
affects expression
EXP
oxybenzone affects the expression of NDUFV3 mRNA
CTD
PMID:30316929
NCBI chr20:9,612,462...9,621,622
Ensembl chr20:9,612,431...9,623,074 Ensembl chr13:9,612,431...9,623,074
G
Nes
nestin
decreases expression
ISO
oxybenzone results in decreased expression of NES protein
CTD
PMID:39343157
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
G
Nf1
neurofibromin 1
increases expression
ISO
oxybenzone results in increased expression of NF1 mRNA
CTD
PMID:36581016
NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,306,301...64,536,658
G
Nfat5
nuclear factor of activated T-cells 5
increases expression
ISO
oxybenzone results in increased expression of NFAT5 mRNA
CTD
PMID:36581016
NCBI chr19:52,108,982...52,196,418
Ensembl chr19:35,199,016...35,286,675
G
Nfia
nuclear factor I/A
increases expression
ISO
oxybenzone results in increased expression of NFIA mRNA
CTD
PMID:39343157
NCBI chr 5:117,359,006...117,897,391
Ensembl chr 5:112,436,644...112,775,885
G
Nfib
nuclear factor I/B
increases expression
ISO
oxybenzone results in increased expression of NFIB mRNA
CTD
PMID:39343157
NCBI chr 5:101,805,168...102,020,618
Ensembl chr 5:96,764,653...96,975,479
G
Nkx2-2
NK2 homeobox 2
increases expression
ISO
oxybenzone results in increased expression of NKX2-2 mRNA
CTD
PMID:39343157
NCBI chr 3:155,072,621...155,083,699
Ensembl chr 3:134,620,039...134,622,411
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
oxybenzone binds to and results in increased activity of NR1I2 protein
CTD
PMID:33049310
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
ISO
oxybenzone results in increased activity of NR1I3 protein
CTD
PMID:28927721
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:83,632,899...83,637,906
G
Nr2f6
nuclear receptor subfamily 2, group F, member 6
decreases expression increases expression
ISO
oxybenzone results in decreased expression of NR2F6 mRNA oxybenzone results in increased expression of NR2F6 mRNA
CTD
PMID:39343157
NCBI chr16:18,080,003...18,087,449
Ensembl chr16:18,046,013...18,053,459
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases expression
ISO
oxybenzone results in increased expression of NR3C1 mRNA
CTD
PMID:36581016
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
decreases expression
ISO
oxybenzone results in decreased expression of NR4A1 mRNA
CTD
PMID:39343157
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297
G
Nrarp
Notch-regulated ankyrin repeat protein
decreases expression
ISO
oxybenzone results in decreased expression of NRARP mRNA
CTD
PMID:39343157
NCBI chr 3:28,390,745...28,393,299
Ensembl chr 3:7,992,552...7,995,133
G
Nrf1
nuclear respiratory factor 1
increases expression
EXP
oxybenzone results in increased expression of NRF1 mRNA
CTD
PMID:30316929
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:58,664,957...58,825,328
G
Nrg1
neuregulin 1
increases expression
ISO
oxybenzone results in increased expression of NRG1 mRNA
CTD
PMID:39343157
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Nrip1
nuclear receptor interacting protein 1
increases expression
ISO
oxybenzone results in increased expression of NRIP1 mRNA
CTD
PMID:36581016
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:14,895,553...14,981,761
G
Nrp1
neuropilin 1
decreases expression
ISO
oxybenzone results in decreased expression of NRP1 mRNA
CTD
PMID:39343157
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:56,359,455...56,513,633
G
Ntn5
netrin 5
increases expression
EXP
oxybenzone results in increased expression of NTN5 mRNA
CTD
PMID:30316929
NCBI chr 1:96,156,948...96,165,997
Ensembl chr 1:96,156,985...96,165,630
G
Ocln
occludin
decreases expression
ISO
oxybenzone results in decreased expression of OCLN mRNA
CTD
PMID:39343157
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150
G
Ogdh
oxoglutarate dehydrogenase
increases expression decreases expression
EXP
oxybenzone results in increased expression of OGDH mRNA oxybenzone results in decreased expression of OGDH mRNA
CTD
PMID:30316929
NCBI chr14:85,363,949...85,431,405
Ensembl chr14:81,150,091...81,217,479
G
Pdcd11
programmed cell death 11
increases expression
EXP
oxybenzone results in increased expression of PDCD11 mRNA
CTD
PMID:30316929
NCBI chr 1:255,922,198...255,963,336
Ensembl chr 1:245,980,880...246,021,999
G
Pdcd6ip
programmed cell death 6 interacting protein
decreases expression
EXP
oxybenzone results in decreased expression of PDCD6IP mRNA
CTD
PMID:30316929
NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:113,590,998...113,646,773
G
Pdcd7
programmed cell death 7
increases expression
EXP
oxybenzone results in increased expression of PDCD7 mRNA
CTD
PMID:30316929
NCBI chr 8:65,862,606...65,877,333
Ensembl chr 8:65,862,387...65,877,333
G
Pdgfb
platelet derived growth factor subunit B
decreases expression
ISO
oxybenzone results in decreased expression of PDGFB mRNA
CTD
PMID:39343157
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
decreases expression
ISO
oxybenzone results in decreased expression of PDGFRA mRNA
CTD
PMID:39343157
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
G
Pecam1
platelet and endothelial cell adhesion molecule 1
decreases expression
ISO
oxybenzone results in decreased expression of PECAM1 protein
CTD
PMID:39343157
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Pgr
progesterone receptor
multiple interactions decreases expression increases expression
ISO
oxybenzone binds to and results in decreased activity of PGR protein oxybenzone results in decreased expression of PGR mRNA oxybenzone results in increased expression of PGR mRNA
CTD
PMID:15537743 PMID:31939680 PMID:32946892 PMID:38382712 PMID:38431166
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
G
Phf24
PHD finger protein 24
increases expression
EXP
oxybenzone results in increased expression of PHF24 mRNA
CTD
PMID:30316929
NCBI chr 5:61,939,261...61,966,879
Ensembl chr 5:57,142,632...57,168,497
G
Phox2b
paired-like homeobox 2b
decreases expression
ISO
oxybenzone results in decreased expression of PHOX2B mRNA
CTD
PMID:39343157
NCBI chr14:41,420,011...41,424,527
Ensembl chr14:41,066,264...41,068,978
G
Pias1
protein inhibitor of activated STAT, 1
increases expression
ISO
oxybenzone results in increased expression of PIAS1 mRNA
CTD
PMID:36581016
NCBI chr 8:72,233,566...72,347,085
Ensembl chr 8:63,338,150...63,438,905
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
oxybenzone results in increased expression of PIK3R1 mRNA
CTD
PMID:36581016
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r5
phosphoinositide-3-kinase, regulatory subunit 5
decreases expression
ISO
oxybenzone results in decreased expression of PIK3R5 mRNA
CTD
PMID:39343157
NCBI chr10:53,631,469...53,699,550
Ensembl chr10:53,132,603...53,199,374
G
Pld2
phospholipase D2
decreases expression
ISO
oxybenzone results in decreased expression of PLD2 mRNA
CTD
PMID:39343157
NCBI chr10:55,754,957...55,772,819
Ensembl chr10:55,256,359...55,272,808
G
Plxnb3
plexin B3
decreases expression
ISO
oxybenzone results in decreased expression of PLXNB3 mRNA
CTD
PMID:39343157
NCBI chr X:156,645,505...156,660,011
Ensembl chr X:151,494,207...151,508,674
G
Polm
DNA polymerase mu
decreases expression
EXP
oxybenzone results in decreased expression of POLM mRNA
CTD
PMID:30316929
NCBI chr14:80,707,075...80,716,677
Ensembl chr14:80,706,345...80,717,086
G
Ppara
peroxisome proliferator activated receptor alpha
increases expression
ISO
oxybenzone results in increased expression of PPARA mRNA
CTD
PMID:32407875
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
affects binding multiple interactions increases expression
ISO
oxybenzone binds to PPARG protein oxybenzone binds to and results in increased activity of PPARG protein oxybenzone binds to and results in increased activity of PPARG protein; oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; oxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein] oxybenzone results in increased expression of PPARG mRNA
CTD
PMID:32407875 PMID:33049310 PMID:34864131
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
increases expression
ISO
oxybenzone results in increased expression of PPP1CB mRNA
CTD
PMID:36581016
NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:23,960,998...23,992,824
G
Prickle1
prickle planar cell polarity protein 1
decreases expression
ISO
oxybenzone results in decreased expression of PRICKLE1 mRNA
CTD
PMID:39343157
NCBI chr 7:126,518,587...126,614,581
Ensembl chr 7:124,639,142...124,658,113
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
increases expression
ISO
oxybenzone results in increased expression of PRKACB mRNA
CTD
PMID:36581016
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:235,636,885...235,726,198
G
Prkci
protein kinase C, iota
increases expression
ISO
oxybenzone results in increased expression of PRKCI mRNA
CTD
PMID:36581016
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:112,321,929...112,382,352
G
Prss37
serine protease 37
decreases expression
EXP
oxybenzone results in decreased expression of PRSS37 mRNA
CTD
PMID:30316929
NCBI chr 4:70,289,678...70,301,259
Ensembl chr 4:69,322,977...69,334,555
G
Pten
phosphatase and tensin homolog
increases expression
ISO
oxybenzone results in increased expression of PTEN mRNA
CTD
PMID:36581016
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
oxybenzone results in increased expression of PTGS2 mRNA
CTD
PMID:36581016
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptpn4
protein tyrosine phosphatase, non-receptor type 4
increases expression
ISO
oxybenzone results in increased expression of PTPN4 mRNA
CTD
PMID:36581016
NCBI chr13:33,324,808...33,504,957
Ensembl chr13:30,776,682...30,952,170
G
Rad17
RAD17 checkpoint clamp loader component
increases expression
ISO
oxybenzone results in increased expression of RAD17 mRNA
CTD
PMID:36581016
NCBI chr 2:33,498,335...33,528,614
Ensembl chr 2:31,764,261...31,794,072
G
Rad50
RAD50 double strand break repair protein
increases expression
ISO
oxybenzone results in increased expression of RAD50 mRNA
CTD
PMID:36581016
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:37,808,726...37,861,396
G
Rap2a
RAP2A, member of RAS oncogene family
increases expression
ISO
oxybenzone results in increased expression of RAP2A mRNA
CTD
PMID:36581016
NCBI chr15:104,003,744...104,004,234
Ensembl chr15:97,596,020...97,624,138
G
Rara
retinoic acid receptor, alpha
decreases expression
ISO
oxybenzone results in decreased expression of RARA mRNA
CTD
PMID:39343157
NCBI chr10:84,379,780...84,424,371
Ensembl chr10:83,893,384...83,928,142
G
Rb1
RB transcriptional corepressor 1
increases expression
ISO
oxybenzone results in increased expression of RB1 mRNA
CTD
PMID:36581016
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rb1cc1
RB1-inducible coiled-coil 1
increases expression
ISO
oxybenzone results in increased expression of RB1CC1 mRNA
CTD
PMID:36581016
NCBI chr 5:17,948,522...18,012,434
Ensembl chr 5:13,161,648...13,225,560
G
Rbbp8
RB binding protein 8, endonuclease
increases expression
ISO
oxybenzone results in increased expression of RBBP8 mRNA
CTD
PMID:36581016
NCBI chr18:3,198,188...3,263,643
Ensembl chr18:2,921,286...2,988,846
G
Rbl1
RB transcriptional corepressor like 1
increases expression
ISO
oxybenzone results in increased expression of RBL1 mRNA
CTD
PMID:36581016
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rel
REL proto-oncogene, NF-kB subunit
increases expression
ISO
oxybenzone results in increased expression of REL mRNA
CTD
PMID:36581016
NCBI chr14:101,891,238...101,922,324
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
increases expression
EXP
oxybenzone results in increased expression of RELA protein
CTD
PMID:31368502
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Retn
resistin
decreases expression
EXP
oxybenzone results in decreased expression of RETN mRNA
CTD
PMID:30316929
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620
G
Rfc1
replication factor C subunit 1
increases expression
ISO
oxybenzone results in increased expression of RFC1 mRNA
CTD
PMID:36581016
NCBI chr14:43,319,768...43,395,028
Ensembl chr14:42,966,324...43,041,370
G
Rictor
RPTOR independent companion of MTOR, complex 2
increases expression
ISO
oxybenzone results in increased expression of RICTOR mRNA
CTD
PMID:36581016
NCBI chr 2:57,539,279...57,631,291
Ensembl chr 2:55,811,322...55,901,426
G
Rims2
regulating synaptic membrane exocytosis 2
increases expression
ISO
oxybenzone results in increased expression of RIMS2 mRNA
CTD
PMID:39343157
NCBI chr 7:72,133,004...72,644,059
Ensembl chr 7:70,243,872...70,757,491
G
Robo4
roundabout guidance receptor 4
decreases expression
ISO
oxybenzone results in decreased expression of ROBO4 mRNA
CTD
PMID:39343157
NCBI chr 8:45,308,739...45,322,522
Ensembl chr 8:37,119,988...37,132,519
G
Rock1
Rho-associated coiled-coil containing protein kinase 1
increases expression
ISO
oxybenzone results in increased expression of ROCK1 mRNA
CTD
PMID:36581016
NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,115,905...1,235,571
G
Rock2
Rho-associated coiled-coil containing protein kinase 2
increases expression
ISO
oxybenzone results in increased expression of ROCK2 mRNA
CTD
PMID:36581016
NCBI chr 6:45,407,823...45,502,773
Ensembl chr 6:39,679,082...39,774,031
G
Rps6kb1
ribosomal protein S6 kinase B1
increases expression
ISO
oxybenzone results in increased expression of RPS6KB1 mRNA
CTD
PMID:36581016
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
ISO
oxybenzone results in increased expression of RRM2B mRNA
CTD
PMID:36581016
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:69,078,291...69,108,633
G
Sdha
succinate dehydrogenase complex flavoprotein subunit A
increases expression
EXP
oxybenzone results in increased expression of SDHA mRNA
CTD
PMID:30316929
NCBI chr 1:30,764,553...30,789,523
Ensembl chr 1:28,940,164...28,961,535
G
Serpinc1
serpin family C member 1
increases expression
EXP
oxybenzone results in increased expression of SERPINC1 mRNA
CTD
PMID:30316929
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293
G
Serpine2
serpin family E member 2
increases expression
ISO
oxybenzone results in increased expression of SERPINE2 mRNA
CTD
PMID:39343157
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:81,124,804...81,188,826
G
Sgk1
serum/glucocorticoid regulated kinase 1
multiple interactions increases expression
ISO
Fulvestrant inhibits the reaction [oxybenzone results in increased expression of SGK1 mRNA]
CTD
PMID:33405908
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:22,980,261...23,098,283
G
Sh3bp1
SH3-domain binding protein 1
decreases expression
ISO
oxybenzone results in decreased expression of SH3BP1 mRNA
CTD
PMID:39343157
NCBI chr 7:112,338,087...112,350,659
Ensembl chr 7:110,457,710...110,470,201
G
Sh3glb1
SH3 domain -containing GRB2-like endophilin B1
increases expression
EXP
oxybenzone results in increased expression of SH3GLB1 mRNA
CTD
PMID:30316929
NCBI chr 2:236,411,194...236,445,225
Ensembl chr 2:233,750,838...233,784,784
G
Shank1
SH3 and multiple ankyrin repeat domains 1
increases expression
EXP
oxybenzone results in increased expression of SHANK1 mRNA
CTD
PMID:30316929
NCBI chr 1:103,944,416...103,993,887
Ensembl chr 1:94,808,276...94,855,824
G
Slc18a2
solute carrier family 18 member A2
increases expression
ISO
oxybenzone results in increased expression of SLC18A2 mRNA
CTD
PMID:39343157
NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:258,413,959...258,448,325
G
Slc1a2
solute carrier family 1 member 2
affects expression
EXP
oxybenzone affects the expression of SLC1A2 protein
CTD
PMID:31368502
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:89,005,129...89,126,498
G
Slc6a1
solute carrier family 6 member 1
increases expression
ISO
oxybenzone results in increased expression of SLC6A1 mRNA
CTD
PMID:39343157
NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:147,466,965...147,482,293
G
Slc7a11
solute carrier family 7 member 11
affects expression
EXP
oxybenzone affects the expression of SLC7A11 protein
CTD
PMID:31368502
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Smad9
SMAD family member 9
decreases expression
ISO
oxybenzone results in decreased expression of SMAD9 mRNA
CTD
PMID:39343157
NCBI chr 2:141,106,668...141,156,477
Ensembl chr 2:138,986,471...139,006,307
G
Smc3
structural maintenance of chromosomes 3
increases expression
ISO
oxybenzone results in increased expression of SMC3 mRNA
CTD
PMID:36581016
NCBI chr 1:262,606,731...262,649,832
Ensembl chr 1:252,601,753...252,644,522
G
Sox18
SRY-box transcription factor 18
decreases expression
ISO
oxybenzone results in decreased expression of SOX18 mRNA
CTD
PMID:39343157
NCBI chr 3:189,163,000...189,164,802
Ensembl chr 3:168,785,490...168,787,290
G
Sox9
SRY-box transcription factor 9
multiple interactions increases expression
EXP
4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol inhibits the reaction [oxybenzone results in increased expression of SOX9 mRNA]
CTD
PMID:30599193
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:97,806,485...97,811,994
G
Sstr3
somatostatin receptor 3
increases expression
EXP
oxybenzone results in increased expression of SSTR3 mRNA
CTD
PMID:30316929
NCBI chr 7:111,973,049...111,980,250
Ensembl chr 7:110,092,575...110,099,769
G
Stag1
STAG1 cohesin complex component
increases expression
ISO
oxybenzone results in increased expression of STAG1 mRNA
CTD
PMID:36581016
NCBI chr 8:110,057,981...110,443,666
Ensembl chr 8:101,179,039...101,564,677
G
Stat5a
signal transducer and activator of transcription 5A
increases expression affects localization
ISO
oxybenzone results in increased expression of STAT5A mRNA oxybenzone affects the localization of STAT5A protein
CTD
PMID:32946892
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866
G
Sult1a1
sulfotransferase family 1A member 1
decreases expression
EXP
oxybenzone results in decreased expression of SULT1A1 mRNA
CTD
PMID:30316929
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:181,272,023...181,275,562
G
Taf9b
TATA-box binding protein associated factor 9b
increases expression
ISO
oxybenzone results in increased expression of TAF9B mRNA
CTD
PMID:36581016
NCBI chr X:71,289,290...71,300,142
Ensembl chr X:71,289,290...71,300,604
G
Tbk1
TANK-binding kinase 1
increases expression
ISO
oxybenzone results in increased expression of TBK1 mRNA
CTD
PMID:36581016
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:57,077,830...57,110,892
G
Tcf7l2
transcription factor 7 like 2
increases expression
ISO
oxybenzone results in increased expression of TCF7L2 mRNA
CTD
PMID:39343157
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:254,786,091...254,978,967
G
Tek
TEK receptor tyrosine kinase
decreases expression
ISO
oxybenzone results in decreased expression of TEK mRNA
CTD
PMID:39343157
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:109,607,077...109,733,804
G
Tex46
testis expressed 46
decreases expression
EXP
oxybenzone results in decreased expression of TEX46 mRNA
CTD
PMID:30316929
NCBI chr 5:148,849,307...148,853,742
Ensembl chr 5:148,849,307...148,853,742
G
Tfam
transcription factor A, mitochondrial
increases expression
EXP ISO
oxybenzone results in increased expression of TFAM mRNA
CTD
PMID:30316929 PMID:36581016
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
G
Tff1
trefoil factor 1
multiple interactions increases expression
ISO
[oxybenzone co-treated with 2,4-dihydroxybenzophenone co-treated with octylmethoxycinnamate co-treated with enzacamene] results in increased expression of TFF1 mRNA; [oxybenzone co-treated with 2,4-dihydroxybenzophenone] results in increased expression of TFF1 mRNA oxybenzone results in increased expression of TFF1 mRNA
CTD
PMID:16183391
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,235,736...9,239,597
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[oxybenzone co-treated with Dietary Fats analog] results in decreased expression of TGFB1 mRNA; [oxybenzone co-treated with Dietary Fats] results in decreased expression of TGFB1 mRNA
CTD
PMID:38387520
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
increases expression
ISO
oxybenzone results in increased expression of TGFBR1 mRNA
CTD
PMID:36581016
NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:61,653,233...61,710,777
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions decreases expression
ISO
[oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of TIMP1 mRNA; [oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of TIMP1 protein oxybenzone results in decreased expression of TIMP1 mRNA
CTD
PMID:38387520
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Tjp1
tight junction protein 1
decreases expression
ISO
oxybenzone results in decreased expression of TJP1 mRNA; oxybenzone results in decreased expression of TJP1 protein
CTD
PMID:39343157
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Tlx3
T-cell leukemia, homeobox 3
decreases expression
ISO
oxybenzone results in decreased expression of TLX3 mRNA
CTD
PMID:39343157
NCBI chr10:18,293,932...18,296,551
Ensembl chr10:17,790,053...17,792,207
G
Tmem100
transmembrane protein 100
decreases expression
ISO
oxybenzone results in decreased expression of TMEM100 mRNA
CTD
PMID:39343157
NCBI chr10:75,351,891...75,357,748
Ensembl chr10:74,854,468...74,862,941
G
Tmprss4
transmembrane serine protease 4
increases expression
EXP
oxybenzone results in increased expression of TMPRSS4 mRNA
CTD
PMID:30316929
NCBI chr 8:54,372,805...54,405,157
Ensembl chr 8:45,476,053...45,508,409
G
Tnfsf11
TNF superfamily member 11
decreases expression
ISO
oxybenzone results in decreased expression of TNFSF11 mRNA
CTD
PMID:38382712
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
G
Topbp1
DNA topoisomerase II binding protein 1
increases expression
ISO
oxybenzone results in increased expression of TOPBP1 mRNA
CTD
PMID:36581016
NCBI chr 8:112,766,791...112,815,203
Ensembl chr 8:103,887,865...103,931,674
G
Tp53
tumor protein p53
decreases expression
EXP
oxybenzone results in decreased expression of TP53 mRNA
CTD
PMID:30316929
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tp53bp1
tumor protein p53 binding protein 1
increases expression
ISO
oxybenzone results in increased expression of TP53BP1 protein
CTD
PMID:31939680
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:108,169,980...108,269,822
G
Tpr
translocated promoter region, nuclear basket protein
increases expression
ISO
oxybenzone results in increased expression of TPR mRNA
CTD
PMID:36581016
NCBI chr13:64,974,419...65,037,604
Ensembl chr13:62,424,312...62,487,496
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
decreases expression
ISO
oxybenzone results in decreased expression of TRPV4 mRNA
CTD
PMID:39343157
NCBI chr12:47,599,161...47,638,143
Ensembl chr12:41,938,560...41,977,517
G
Tspo
translocator protein
decreases expression
EXP
oxybenzone results in decreased expression of TSPO mRNA
CTD
PMID:30316929
NCBI chr 7:116,600,214...116,610,461
Ensembl chr 7:114,720,188...114,730,450
G
Twist1
twist family bHLH transcription factor 1
multiple interactions
ISO
[oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of TWIST1 mRNA; [oxybenzone co-treated with Dietary Fats analog] results in decreased expression of TWIST1 mRNA
CTD
PMID:38387520
NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:50,674,678...50,677,653
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
decreases expression
EXP
oxybenzone results in decreased expression of UGT1A6 mRNA
CTD
PMID:30316929
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2a3
UDP glucuronosyltransferase family 2 member A3
decreases expression
EXP
oxybenzone results in decreased expression of UGT2A3 mRNA
CTD
PMID:30316929
NCBI chr14:20,572,793...20,590,795
Ensembl chr14:20,572,808...20,590,729
G
Upk1b
uroplakin 1B
decreases expression
EXP
oxybenzone results in decreased expression of UPK1B mRNA
CTD
PMID:30316929
NCBI chr11:61,953,687...61,991,029
Ensembl chr11:61,953,648...61,991,029
G
Uqcr11
ubiquinol-cytochrome c reductase, complex III subunit XI
affects expression
EXP
oxybenzone affects the expression of UQCR11 mRNA
CTD
PMID:30316929
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
increases expression
EXP
oxybenzone results in increased expression of UQCRC1 mRNA
CTD
PMID:30316929
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:109,589,706...109,601,480
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
decreases expression
EXP
oxybenzone results in decreased expression of UQCRFS1 mRNA
CTD
PMID:30316929
NCBI chr17:34,173,787...34,190,952
Ensembl chr17:33,977,921...33,982,479
G
Uqcrq
ubiquinol-cytochrome c reductase, complex III subunit VII
increases expression
EXP
oxybenzone results in increased expression of UQCRQ mRNA
CTD
PMID:30316929
NCBI chr10:37,585,864...37,589,328
Ensembl chr10:37,586,888...37,589,169
G
Vdac1
voltage-dependent anion channel 1
decreases expression
EXP
oxybenzone results in decreased expression of VDAC1 mRNA
CTD
PMID:30316929
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:36,532,244...36,559,640
G
Vegfa
vascular endothelial growth factor A
multiple interactions decreases expression
ISO
[oxybenzone co-treated with Dietary Fats analog co-treated with Dietary Fats] results in decreased expression of VEGFA mRNA oxybenzone results in decreased expression of VEGFA mRNA
CTD
PMID:38387520 PMID:39343157
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Wnt4
Wnt family member 4
decreases expression
ISO
oxybenzone results in decreased expression of WNT4 mRNA
CTD
PMID:38382712
NCBI chr 5:154,797,245...154,818,565
Ensembl chr 5:149,514,018...149,532,859
G
Wnt5a
Wnt family member 5A
decreases expression
ISO
oxybenzone results in decreased expression of WNT5A mRNA
CTD
PMID:39343157
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,697,032...3,718,234
G
Wrn
WRN RecQ like helicase
increases expression
ISO
oxybenzone results in increased expression of WRN mRNA
CTD
PMID:36581016
NCBI chr16:65,466,552...65,602,951
Ensembl chr16:58,763,504...58,895,450
G
Xbp1
X-box binding protein 1
decreases expression
ISO
oxybenzone results in decreased expression of XBP1 mRNA
CTD
PMID:39343157
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693
G
Zeb1
zinc finger E-box binding homeobox 1
increases expression
ISO
oxybenzone results in increased expression of ZEB1 mRNA
CTD
PMID:36581016
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:51,948,948...52,115,214
G
Zfp420
zinc finger protein 420
increases expression
ISO
oxybenzone results in increased expression of ZNF420 mRNA
CTD
PMID:36581016
NCBI chr 1:94,259,715...94,271,102
Ensembl chr 1:85,132,520...85,143,679
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
Ranolazine inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Ranolazine results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity multiple interactions
ISO
Ranolazine results in decreased activity of KCNH2 protein Ranolazine inhibits the reaction [arsenic trioxide results in increased degradation of KCNH2 protein]
CTD
PMID:24052561 PMID:28521025
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
G
Scn5a
sodium voltage-gated channel alpha subunit 5
multiple interactions
ISO
Ranolazine inhibits the reaction [2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate results in increased activity of SCN5A protein]
CTD
PMID:29306026
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:119,220,905...119,318,769
G
Calca
calcitonin-related polypeptide alpha
multiple interactions decreases expression
ISO
4-methylcatechol inhibits the reaction [resiniferatoxin results in decreased expression of CALCA protein]; resiniferatoxin inhibits the reaction [Lipopolysaccharides results in increased expression of CALCA protein]
CTD
PMID:17291600 PMID:18219259
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP ISO
resiniferatoxin inhibits the reaction [anandamide results in increased expression of FOS protein]; resiniferatoxin inhibits the reaction [Cyclophosphamide results in increased expression of FOS protein] resiniferatoxin promotes the reaction [Bee Venoms results in increased expression of FOS protein]
CTD
PMID:15217452 PMID:15601931 PMID:16621078
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Ifng
interferon gamma
multiple interactions
ISO
resiniferatoxin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; resiniferatoxin inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]; resiniferatoxin inhibits the reaction [IFNG results in increased activity of STAT1 protein]; resiniferatoxin inhibits the reaction [IFNG results in increased expression of NOS2 protein]
CTD
PMID:14530214
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
increases expression
EXP
resiniferatoxin results in increased expression of IL10 mRNA; resiniferatoxin results in increased expression of IL10 protein
CTD
PMID:18460982
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions
ISO
resiniferatoxin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
CTD
PMID:17291600
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
resiniferatoxin inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK1 protein]
CTD
PMID:14530214
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
resiniferatoxin inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK3 protein]
CTD
PMID:14530214
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases activity
ISO
resiniferatoxin results in increased activity of MAPK8 protein
CTD
PMID:9580328
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases activity
ISO
resiniferatoxin results in increased activity of MAPK9 protein
CTD
PMID:9580328
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
resiniferatoxin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; resiniferatoxin inhibits the reaction [[Lipopolysaccharides results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; resiniferatoxin inhibits the reaction [IFNG results in increased expression of NOS2 protein]; resiniferatoxin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; resiniferatoxin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:14530214
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Sst
somatostatin
multiple interactions
ISO
resiniferatoxin inhibits the reaction [Lipopolysaccharides results in increased expression of SST protein]
CTD
PMID:17291600
NCBI chr11:90,461,546...90,462,823
Ensembl chr11:76,956,896...76,958,173
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
resiniferatoxin inhibits the reaction [IFNG results in increased activity of STAT1 protein]
CTD
PMID:14530214
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Tac1
tachykinin, precursor 1
multiple interactions decreases expression
ISO
resiniferatoxin inhibits the reaction [Lipopolysaccharides results in increased expression of TAC1 protein] resiniferatoxin results in decreased expression of TAC1 protein
CTD
PMID:17291600 PMID:18219259
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:35,679,704...35,687,178
G
Tnf
tumor necrosis factor
decreases expression
EXP
resiniferatoxin results in decreased expression of TNF mRNA
CTD
PMID:18460982
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
multiple interactions increases expression
ISO
capsazepine inhibits the reaction [resiniferatoxin results in increased expression of TNFRSF1A protein]; phenyl-N-tert-butylnitrone inhibits the reaction [resiniferatoxin results in increased expression of TNFRSF1A protein]; TRPV1 gene mutant form inhibits the reaction [resiniferatoxin results in increased expression of TNFRSF1A protein]
CTD
PMID:19531269
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
decreases expression
EXP
resiniferatoxin results in decreased expression of TRPA1 mRNA
CTD
PMID:25077949
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:4,379,999...4,433,570
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
multiple interactions decreases expression increases activity affects binding
ISO EXP
[resiniferatoxin binds to and results in increased activity of TRPV1 protein] which results in increased abundance of Calcium; [resiniferatoxin binds to TRPV1 protein] which results in increased uptake of Calcium; Cannabidiol inhibits the reaction [[resiniferatoxin binds to TRPV1 protein] which results in increased uptake of Calcium]; Cannabidiol inhibits the reaction [resiniferatoxin binds to TRPV1 protein]; resiniferatoxin binds to and results in increased activity of TRPV1 protein resiniferatoxin results in decreased expression of TRPV1 mRNA resiniferatoxin results in increased activity of TRPV1 protein capsazepine inhibits the reaction [resiniferatoxin promotes the reaction [TRPV1 protein binds to TRPV1 protein]]; Cyclosporine affects the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]; Docosahexaenoic Acids inhibits the reaction [resiniferatoxin binds to and results in increased activity of TRPV1 protein]; Eicosapentaenoic Acid inhibits the reaction [resiniferatoxin binds to and results in increased activity of TRPV1 protein]; Ionomycin inhibits the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]; JYL 1421 inhibits the reaction [resiniferatoxin binds to TRPV1 protein]; KJM 429 inhibits the reaction [resiniferatoxin binds to TRPV1 protein]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]; resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]; resiniferatoxin binds to and results in increased activity of TRPV1 protein; resiniferatoxin promotes the reaction [Calcium Chloride results in increased activity of TRPV1 protein]; resiniferatoxin promotes the reaction [TRPV1 protein binds to TRPV1 protein]; Tacrolimus affects the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]; Tetradecanoylphorbol Acetate affects the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [resiniferatoxin binds to TRPV1 protein] 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [resiniferatoxin inhibits the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester promotes the reaction [resiniferatoxin promotes the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]; Calcium Chloride inhibits the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]; Ionomycin promotes the reaction [Calcium Chloride inhibits the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]]; resiniferatoxin inhibits the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]; resiniferatoxin promotes the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]; TRPV1 gene mutant form inhibits the reaction [resiniferatoxin results in increased abundance of Reactive Oxygen Species]; TRPV1 gene mutant form inhibits the reaction [resiniferatoxin results in increased expression of TNFRSF1A protein]
CTD
PMID:11358970 PMID:11606325 PMID:12237342 PMID:15363968 PMID:16597917 PMID:17038422 PMID:19531269 PMID:19553475 PMID:21908651 PMID:25077949 More...
NCBI chr10:58,349,936...58,375,021
Ensembl chr10:57,851,428...57,876,513
G
Uchl1
ubiquitin C-terminal hydrolase L1
multiple interactions decreases expression
ISO
4-methylcatechol inhibits the reaction [resiniferatoxin results in decreased expression of UCHL1 protein]
CTD
PMID:18219259
NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,485,031...41,495,590
G
Esr1
estrogen receptor 1
increases activity
ISO
rhapontigenin analog results in increased activity of ESR1 protein
CTD
PMID:17935960
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
increases activity multiple interactions
ISO
rhapontigenin analog results in increased activity of ESR2 protein Fulvestrant inhibits the reaction [rhapontigenin analog results in increased activity of ESR2 protein]
CTD
PMID:17692514 PMID:17935960
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Tf
transferrin
multiple interactions
ISO
rhapontigenin analog inhibits the reaction [Lipopolysaccharides results in increased activity of TF protein]
CTD
PMID:16507316
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
rocaglamide results in increased expression of BAX protein
CTD
PMID:31433962
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
rocaglamide results in decreased expression of BCL2 protein
CTD
PMID:31433962
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
decreases expression
ISO
rocaglamide results in decreased expression of CHUK protein
CTD
PMID:31433962
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
G
Cycs
cytochrome c, somatic
increases expression
ISO
rocaglamide results in increased expression of CYCS protein
CTD
PMID:31433962
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
decreases expression
ISO
rocaglamide results in decreased expression of IKBKB protein
CTD
PMID:31433962
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
rocaglamide results in decreased expression of NFKB1 protein
CTD
PMID:31433962
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Parp1
poly (ADP-ribose) polymerase 1
decreases expression
ISO
rocaglamide results in decreased expression of PARP1 protein
CTD
PMID:31433962
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Rela
RELA proto-oncogene, NF-kB subunit
decreases expression
ISO
rocaglamide results in decreased expression of RELA protein
CTD
PMID:31433962
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
affects localization
ISO
sappanchalcone affects the localization of AIFM1 protein
CTD
PMID:32590072
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
sappanchalcone results in increased expression of BAX protein
CTD
PMID:21963806 PMID:32590072
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
sappanchalcone results in decreased expression of BCL2 protein
CTD
PMID:21963806 PMID:32590072
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity increases cleavage
ISO
sappanchalcone results in increased activity of CASP3 protein sappanchalcone results in increased cleavage of CASP3 protein
CTD
PMID:21963806 PMID:32590072
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases cleavage
ISO
sappanchalcone results in increased cleavage of CASP7 protein
CTD
PMID:32590072
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
increases cleavage
ISO
sappanchalcone results in increased cleavage of CASP8 protein
CTD
PMID:32590072
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity increases cleavage
ISO
sappanchalcone results in increased activity of CASP9 protein sappanchalcone results in increased cleavage of CASP9 protein
CTD
PMID:21963806 PMID:32590072
Ensembl chr 5:154,109,046...154,126,626
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
ISO
sappanchalcone results in increased phosphorylation of MAPK8 protein
CTD
PMID:21963806
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
sappanchalcone results in increased degradation of and results in increased phosphorylation of NFKBIA protein
CTD
PMID:21963806
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
sappanchalcone results in increased cleavage of PARP1 protein
CTD
PMID:32590072
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization
ISO
sappanchalcone affects the localization of RELA protein
CTD
PMID:21963806
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Tp53
tumor protein p53
increases expression multiple interactions
ISO
sappanchalcone results in increased expression of TP53 protein sappanchalcone results in increased expression of and results in increased phosphorylation of TP53 protein
CTD
PMID:21963806 PMID:32590072
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Map3k7
mitogen activated protein kinase kinase kinase 7
decreases phosphorylation
EXP
Satavaptan decreases phosphorylation of Map3k7 protein in inner medullary collecting duct
RGD
PMID:24259510
RGD:401827158
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
anethole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
CTD
PMID:29191726
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation
ISO
anethole results in decreased phosphorylation of AKT1 protein
CTD
PMID:21212515
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of BAX mRNA]
CTD
PMID:35430261 PMID:39029857
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of BCL2 mRNA]
CTD
PMID:35430261 PMID:39029857
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP3 protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein]; anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP9 protein]
CTD
PMID:35430261 PMID:39029857
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; anethole inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cst3
cystatin C
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of CST3 protein]
CTD
PMID:39029857
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
anethole inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD
PMID:29191726
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Esr1
estrogen receptor 1
affects binding multiple interactions
ISO EXP
anethole metabolite binds to ESR1 protein anethole analog binds to ESR1 protein anethole metabolite inhibits the reaction [Estradiol binds to ESR1 protein]
CTD
PMID:12818366 PMID:27420082
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Ggt1
gamma-glutamyltransferase 1
decreases activity
EXP
anethole analog results in decreased activity of GGT1 protein
CTD
PMID:20171274
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442
G
Gsta2
glutathione S-transferase alpha 2
increases expression
EXP
anethole results in increased expression of GSTA2 protein
CTD
PMID:8406240
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798
G
Havcr1
hepatitis A virus cellular receptor 1
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of HAVCR1 protein]
CTD
PMID:39029857
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
anethole promotes the reaction [Isoproterenol results in increased expression of HMOX1 mRNA]; anethole promotes the reaction [Isoproterenol results in increased expression of HMOX1 protein]
CTD
PMID:35430261
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
decreases activity
ISO
anethole results in decreased activity of IKBKB protein
CTD
PMID:10871845
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il1b
interleukin 1 beta
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of IL1B protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
multiple interactions
ISO
anethole inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; anethole inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein]
CTD
PMID:16531003
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of IL6 protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
EXP
anethole inhibits the reaction [Isoproterenol results in increased expression of KEAP1 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of KEAP1 protein]
CTD
PMID:35430261
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Lcn2
lipocalin 2
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of LCN2 protein]
CTD
PMID:39029857
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
anethole inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein]
CTD
PMID:10871845
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
anethole results in decreased phosphorylation of MAPK1 protein
CTD
PMID:21212515
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
ISO
anethole results in decreased phosphorylation of MAPK3 protein
CTD
PMID:21212515
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
anethole inhibits the reaction [TNF protein results in increased activity of MAPK8 protein]
CTD
PMID:10871845
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mmp2
matrix metallopeptidase 2
decreases activity decreases expression
ISO
anethole results in decreased activity of MMP2 protein anethole results in decreased expression of MMP2 mRNA
CTD
PMID:21212515
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
decreases activity decreases expression
ISO
anethole results in decreased activity of MMP9 protein anethole results in decreased expression of MMP9 mRNA
CTD
PMID:21212515
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of MYD88 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of MYD88 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of MYD88 protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 mRNA]; anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 protein]
CTD
PMID:35430261
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO EXP
anethole inhibits the reaction [Ceramides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Hydrogen Peroxide results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] anethole inhibits the reaction [Doxorubicin results in increased expression of NFKB1 mRNA]
CTD
PMID:10871845 PMID:39029857
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions decreases degradation
ISO
anethole inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; anethole inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] anethole results in decreased degradation of NFKBIA protein
CTD
PMID:10871845 PMID:21212515
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
anethole inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein]
CTD
PMID:10871845
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Plau
plasminogen activator, urokinase
decreases expression
ISO
anethole results in decreased expression of PLAU mRNA
CTD
PMID:21212515
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO EXP
anethole inhibits the reaction [Ceramides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Hydrogen Peroxide results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] anethole inhibits the reaction [Isoproterenol results in increased expression of RELA protein]
CTD
PMID:10871845 PMID:35430261
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
anethole results in increased expression of TIMP1 mRNA
CTD
PMID:21212515
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Tlr4
toll-like receptor 4
multiple interactions
EXP
anethole inhibits the reaction [Doxorubicin results in increased expression of TLR4 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of TLR4 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of TLR4 protein]
CTD
PMID:35430261 PMID:39029857
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein]; anethole inhibits the reaction [TNF protein results in increased activity of MAPK8 protein]; anethole inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein]; anethole inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; anethole inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] anethole inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of TNF protein]
CTD
PMID:10871845 PMID:35430261 PMID:39029857
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnni3
troponin I3, cardiac type
multiple interactions
EXP
anethole inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein]
CTD
PMID:35430261
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
G
Ahr
aryl hydrocarbon receptor
affects localization increases activity multiple interactions
ISO
isoeugenol affects the localization of AHR protein isoeugenol results in increased activity of AHR protein 3'-methoxy-4'-nitroflavone inhibits the reaction [isoeugenol results in increased activity of AHR protein]
CTD
PMID:16972787 PMID:22686307
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Ahrr
aryl-hydrocarbon receptor repressor
increases expression
ISO
isoeugenol results in increased expression of AHRR mRNA
CTD
PMID:22686307
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:28,993,634...29,088,673
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
ISO
isoeugenol results in increased expression of AKR1B1 mRNA
CTD
PMID:20566472
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
isoeugenol results in increased expression of AKR1B10 mRNA
CTD
PMID:20566472
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
isoeugenol results in increased expression of AKR1C1 mRNA
CTD
PMID:20566472
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression increases activity
ISO
isoeugenol results in increased expression of AKR1C2 mRNA isoeugenol results in increased activity of AKR1C2 promoter
CTD
PMID:20491607 PMID:21195160
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
isoeugenol results in increased expression of AKR1C3 mRNA
CTD
PMID:20566472
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
G
Ar
androgen receptor
affects binding
EXP
isoeugenol binds to AR protein
CTD
PMID:14565775
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Atf3
activating transcription factor 3
increases expression
ISO
isoeugenol results in increased expression of ATF3 mRNA
CTD
PMID:23999411
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Cat
catalase
increases expression
ISO
isoeugenol results in increased expression of CAT mRNA
CTD
PMID:20566472
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
decreases secretion
ISO
isoeugenol results in decreased secretion of CCL2 protein
CTD
PMID:20488241
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl27
C-C motif chemokine ligand 27
increases expression
ISO
isoeugenol results in increased expression of CCL27 mRNA
CTD
PMID:17936526
NCBI chr 5:61,737,261...61,744,375
Ensembl chr 5:56,941,402...56,948,506
G
Cd274
CD274 molecule
increases expression
ISO
isoeugenol results in increased expression of CD274 protein
CTD
PMID:20488241
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:227,116,649...227,134,450
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
isoeugenol results in decreased expression of CDK6 protein
CTD
PMID:22686307
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
isoeugenol results in increased expression of CDKN1B protein
CTD
PMID:22686307
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
isoeugenol results in increased expression of CXCL2 protein
CTD
PMID:23178550
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
isoeugenol results in increased expression of CYP1A1 mRNA
CTD
PMID:20491607 PMID:22686307
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
isoeugenol results in increased expression of DNAJB4 mRNA
CTD
PMID:23999411 PMID:27965148
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:241,130,340...241,159,089
G
Fech
ferrochelatase
increases expression
ISO
isoeugenol results in increased expression of FECH mRNA
CTD
PMID:20566472
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:57,945,122...57,979,348
G
Ftl1
ferritin light chain 1
increases expression
ISO
isoeugenol results in increased expression of FTL mRNA
CTD
PMID:20566472
NCBI chr 1:105,072,858...105,074,705
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
isoeugenol results in increased expression of G6PD mRNA
CTD
PMID:20566472
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
isoeugenol results in increased expression of GCLC mRNA
CTD
PMID:20566472
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
isoeugenol results in increased expression of GCLM mRNA
CTD
PMID:20566472 PMID:23999411 PMID:27965148
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
isoeugenol results in increased expression of GPX3 mRNA
CTD
PMID:20566472
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
isoeugenol results in increased expression of GSR mRNA
CTD
PMID:20566472
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
increases expression
ISO
isoeugenol results in increased expression of HMOX1 mRNA
CTD
PMID:20491607 PMID:20566472 PMID:23445166
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
isoeugenol results in increased expression of HSPA6 mRNA
CTD
PMID:23999411
NCBI chr13:85,805,911...85,807,052
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
isoeugenol results in increased expression of HSPH1 mRNA
CTD
PMID:23999411
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:5,390,922...5,410,224
G
Ifng
interferon gamma
increases secretion
ISO
isoeugenol results in increased secretion of IFNG protein
CTD
PMID:22245253
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Il18
interleukin 18
increases expression
ISO
isoeugenol results in increased expression of IL18 protein
CTD
PMID:23063874
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
increases expression
ISO
isoeugenol results in increased expression of IL1A protein
CTD
PMID:23178550
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il2
interleukin 2
multiple interactions increases secretion
ISO
isoeugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; isoeugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein] isoeugenol results in increased secretion of IL2 protein
CTD
PMID:17630204 PMID:22245253
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
increases secretion
ISO
isoeugenol results in increased secretion of IL6 protein
CTD
PMID:22245253
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
isoeugenol results in increased expression of MAFF mRNA
CTD
PMID:20491607 PMID:20566472
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression
ISO
isoeugenol results in increased expression of MAFG mRNA
CTD
PMID:20566472
NCBI chr10:106,401,633...106,410,159
Ensembl chr10:105,903,237...105,912,026
G
Mafk
MAF bZIP transcription factor K
increases expression
ISO
isoeugenol results in increased expression of MAFK mRNA
CTD
PMID:20566472
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; MAPK1 protein affects the reaction [isoeugenol affects the expression of NOS2]
CTD
PMID:17698059
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]; MAPK3 protein affects the reaction [isoeugenol affects the expression of NOS2]
CTD
PMID:17698059
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Me1
malic enzyme 1
increases expression
ISO
isoeugenol results in increased expression of ME1 mRNA
CTD
PMID:20566472
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
G
Mgst1
microsomal glutathione S-transferase 1
increases expression
ISO
isoeugenol results in increased expression of MGST1 mRNA
CTD
PMID:20566472
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:171,029,630...171,044,892
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:10871845
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; NFKBIA protein affects the reaction [isoeugenol affects the expression of NOS2]
CTD
PMID:17698059
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; isoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; MAPK1 protein affects the reaction [isoeugenol affects the expression of NOS2]; MAPK3 protein affects the reaction [isoeugenol affects the expression of NOS2]; NFKBIA protein affects the reaction [isoeugenol affects the expression of NOS2]
CTD
PMID:17698059
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
isoeugenol results in increased expression of NQO1 mRNA
CTD
PMID:20491607 PMID:20566472
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Or5d18
olfactory receptor family 5 subfamily D member 18
multiple interactions
ISO
isoeugenol binds to and results in decreased activity of OR5D18 protein; isoeugenol binds to and results in increased activity of OR5D18 protein
CTD
PMID:15574817 PMID:21142015
NCBI chr 3:93,972,754...93,973,695
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
G
Pgd
phosphogluconate dehydrogenase
increases expression
ISO
isoeugenol results in increased expression of PGD mRNA
CTD
PMID:20566472
NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:159,561,271...159,742,778
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
isoeugenol results in increased expression of PTGR1 mRNA
CTD
PMID:20566472
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:73,784,009...73,802,666
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
isoeugenol results in decreased expression of RB1 protein
CTD
PMID:22686307
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
isoeugenol inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:10871845 PMID:17698059
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Socs3
suppressor of cytokine signaling 3
increases expression multiple interactions
ISO
isoeugenol results in increased expression of SOCS3 mRNA; isoeugenol results in increased expression of SOCS3 protein KT 5720 inhibits the reaction [isoeugenol results in increased expression of SOCS3 mRNA]
CTD
PMID:21969073
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Sod1
superoxide dismutase 1
increases expression
ISO
isoeugenol results in increased expression of SOD1 mRNA
CTD
PMID:20566472
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases expression
ISO
isoeugenol results in increased expression of SOD2 mRNA
CTD
PMID:20566472
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
increases expression
ISO
isoeugenol results in increased expression of SOD3 mRNA
CTD
PMID:20566472
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Srxn1
sulfiredoxin 1
increases expression
ISO
isoeugenol results in increased expression of SRXN1 mRNA
CTD
PMID:20566472
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:140,599,608...140,628,448
G
Tlr2
toll-like receptor 2
increases expression
ISO
isoeugenol results in increased expression of TLR2 mRNA
CTD
PMID:17936526
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tnf
tumor necrosis factor
multiple interactions increases secretion
ISO
isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] isoeugenol results in increased secretion of TNF protein
CTD
PMID:10871845 PMID:22245253
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Trim16
tripartite motif-containing 16
multiple interactions increases expression
ISO
[Indomethacin co-treated with isoeugenol] results in increased expression of TRIM16 mRNA isoeugenol results in increased expression of TRIM16 mRNA
CTD
PMID:21284934
NCBI chr10:47,985,235...48,008,242
Ensembl chr10:47,486,297...47,551,907
G
Txn2
thioredoxin 2
increases expression
ISO
isoeugenol results in increased expression of TXN2 mRNA
CTD
PMID:20566472
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:109,496,761...109,510,359
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
isoeugenol results in increased expression of TXNRD1 mRNA
CTD
PMID:20566472 PMID:23445166
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
isoeugenol results in increased expression of TXNRD2 mRNA
CTD
PMID:20566472
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:82,519,999...82,568,156
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
ISO
isoeugenol results in increased expression of UGT1A6 mRNA
CTD
PMID:20566472
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Zfp36
zinc finger protein 36
increases expression multiple interactions
ISO
isoeugenol results in increased expression of ZFP36 protein KT 5720 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein]; SB 203580 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein]
CTD
PMID:21969073
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564
G
Cat
catalase
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in decreased activity of CAT protein]
CTD
PMID:32662907
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in decreased expression of HMOX1 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of HMOX1 protein]
CTD
PMID:32662907
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Il10
interleukin 10
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in decreased expression of IL10 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of IL10 protein]
CTD
PMID:32662907
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Ins1
insulin 1
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein]
CTD
PMID:32662907
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in increased expression of KEAP1 mRNA]; rhapontin inhibits the reaction [Streptozocin results in increased expression of KEAP1 protein]
CTD
PMID:32662907
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Mmp2
matrix metallopeptidase 2
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in increased expression of MMP2 mRNA]
CTD
PMID:32662907
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein]
CTD
PMID:32662907
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in decreased expression of NQO1 mRNA]
CTD
PMID:32662907
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in decreased expression of TIMP1 mRNA]
CTD
PMID:32662907
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Tnf
tumor necrosis factor
multiple interactions
EXP
rhapontin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA]
CTD
PMID:32662907
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Ache
acetylcholinesterase
multiple interactions
EXP
vanillin inhibits the reaction [[Fructose co-treated with Streptozocin] results in increased expression of ACHE protein]
CTD
PMID:33823243
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
vanillin results in increased expression of AKR1C2 mRNA
CTD
PMID:20491607
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
G
Car1
carbonic anhydrase 1
decreases activity
ISO
vanillin results in decreased activity of CA1 protein
CTD
PMID:19231207
NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:86,861,897...86,872,208
G
Car2
carbonic anhydrase 2
decreases activity
ISO
vanillin results in decreased activity of CA2 protein
CTD
PMID:19231207
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818
G
Casp3
caspase 3
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; vanillin inhibits the reaction [Methotrexate results in increased activity of CASP3 protein]
CTD
PMID:29216766
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
ISO EXP
vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein] vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein] vanillin inhibits the reaction [[Fructose co-treated with Streptozocin] results in decreased activity of CAT protein]
CTD
PMID:26296324 PMID:33823243 PMID:37336463
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]
CTD
PMID:36416909
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
vanillin results in decreased expression of CCN2 mRNA
CTD
PMID:17178418
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
G
Clk2
CDC-like kinase 2
increases expression
ISO
vanillin results in increased expression of CLK2 mRNA
CTD
PMID:17178418
NCBI chr 2:176,868,423...176,880,412
Ensembl chr 2:174,570,653...174,588,985
G
Cst3
cystatin C
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of CST3 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of CST3 protein]
CTD
PMID:29216766
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
vanillin results in increased expression of CYP1A1 mRNA
CTD
PMID:20491607
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
vanillin results in increased expression of DDIT4 mRNA
CTD
PMID:17178418
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
G
Dnmt3b
DNA methyltransferase 3 beta
decreases expression
ISO
vanillin results in decreased expression of DNMT3B mRNA
CTD
PMID:17178418
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
Dusp6
dual specificity phosphatase 6
decreases expression
ISO
vanillin results in decreased expression of DUSP6 mRNA
CTD
PMID:17178418
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:34,092,943...34,097,185
G
Faslg
Fas ligand
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of FASLG protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of FASLG protein]
CTD
PMID:29216766
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fbp1
fructose-bisphosphatase 1
affects binding
ISO
vanillin binds to FBP1 protein
CTD
PMID:33823243
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,208,031...2,230,071
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
ISO
vanillin results in decreased expression of FGFR2 mRNA
CTD
PMID:17178418
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
G
Fzd2
frizzled class receptor 2
decreases expression
ISO
vanillin results in decreased expression of FZD2 mRNA
CTD
PMID:17178418
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:87,561,326...87,565,334
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
affects binding
ISO
vanillin binds to G6PC1 protein
CTD
PMID:33823243
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein]
CTD
PMID:37336463
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GAPDH protein]
CTD
PMID:37336463
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
vanillin results in increased expression of GCLC mRNA
CTD
PMID:17178418
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
vanillin results in increased expression of GCLM mRNA
CTD
PMID:17178418
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Glo1
glyoxalase 1
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GLO1 protein]
CTD
PMID:37336463
NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,662,801...8,681,649
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]
CTD
PMID:37336463
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
increases expression
ISO
vanillin results in increased expression of HMOX1 mRNA
CTD
PMID:17178418
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
decreases mutagenesis
ISO
vanillin results in decreased mutagenesis of HPRT1 gene
CTD
PMID:17178418
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:132,736,096...132,768,154
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
vanillin results in increased expression of HSPA1B mRNA
CTD
PMID:17178418
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Il12b
interleukin 12B
multiple interactions
ISO
vanillin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]
CTD
PMID:36416909
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
G
Il18
interleukin 18
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of IL18 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of IL18 protein]
CTD
PMID:29216766
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
multiple interactions
ISO
vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mRNA]
CTD
PMID:26296324
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mRNA]
CTD
PMID:26296324
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Insig1
insulin induced gene 1
decreases expression
ISO
vanillin results in decreased expression of INSIG1 mRNA
CTD
PMID:17178418
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:7,315,495...7,323,952
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
vanillin results in decreased expression of JUND mRNA
CTD
PMID:17178418
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799
G
Lcn2
lipocalin 2
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of LCN2 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of LCN2 protein]
CTD
PMID:29216766
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
affects lipidation
ISO
vanillin affects the lipidation of MAP1LC3B protein
CTD
PMID:38608998
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map2k2
mitogen activated protein kinase kinase 2
decreases expression
ISO
vanillin results in decreased expression of MAP2K2 mRNA
CTD
PMID:17178418
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:8,580,905...8,610,243
G
Mark4
microtubule affinity regulating kinase 4
decreases expression
ISO
vanillin results in decreased expression of MARK4 mRNA
CTD
PMID:17178418
NCBI chr 1:88,203,352...88,239,858
Ensembl chr 1:79,068,904...79,108,556
G
Mt1
metallothionein 1
multiple interactions
ISO
vanillin inhibits the reaction [potassium bromate results in increased expression of MT1 mRNA]
CTD
PMID:27074584
NCBI chr19:10,831,959...10,832,975
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2
metallothionein 2
increases expression multiple interactions
ISO
vanillin results in increased expression of MT2A mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA]
CTD
PMID:20491607 PMID:27074584
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of NOS2 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of NOS2 protein]
CTD
PMID:29216766
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
decreases expression
ISO
vanillin results in decreased expression of PPP1R10 mRNA
CTD
PMID:17178418
NCBI chr20:2,827,802...2,842,418
Ensembl chr20:2,822,995...2,837,611
G
Prkn
parkin RBR E3 ubiquitin protein ligase
affects expression
ISO
vanillin affects the expression of PRKN protein
CTD
PMID:38608998
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
vanillin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mRNA]
CTD
PMID:17465205 PMID:26296324
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Pygl
glycogen phosphorylase L
affects binding
ISO
vanillin binds to PYGL protein
CTD
PMID:33823243
NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:88,697,593...88,740,310
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of RELA protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of RELA protein]
CTD
PMID:29216766
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Slc35d2
solute carrier family 35 member D2
decreases expression
ISO
vanillin results in decreased expression of SLC35D2 mRNA
CTD
PMID:17178418
NCBI chr17:987,899...1,019,747
Ensembl chr17:988,157...1,019,743
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
vanillin results in increased expression of SLC7A11 mRNA
CTD
PMID:17178418
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
decreases expression
ISO
vanillin results in decreased expression of TGFB1I1 mRNA
CTD
PMID:17178418
NCBI chr 1:192,258,992...192,265,903
Ensembl chr 1:182,828,544...182,837,080
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mRNA] vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein] vanillin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of TNF protein]
CTD
PMID:26296324 PMID:29216766 PMID:36416909
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
decreases expression
ISO
vanillin results in decreased expression of TP53 mRNA
CTD
PMID:17178418
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Trim16
tripartite motif-containing 16
increases expression
ISO
vanillin results in increased expression of TRIM16 mRNA
CTD
PMID:17178418
NCBI chr10:47,985,235...48,008,242
Ensembl chr10:47,486,297...47,551,907
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
ISO
vanillin results in increased activity of TRPV3 protein
CTD
PMID:16617338
NCBI chr10:58,382,054...58,413,657
Ensembl chr10:57,883,546...57,913,296
G
Ugp2
UDP-glucose pyrophosphorylase 2
increases expression
ISO
vanillin results in increased expression of UGP2 mRNA
CTD
PMID:17178418
NCBI chr14:99,657,637...99,698,573
Ensembl chr14:95,456,330...95,496,830
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of vanillin
CTD
PMID:15117964
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Or5d18
olfactory receptor family 5 subfamily D member 18
multiple interactions
ISO
vanillyl alcohol binds to and results in increased activity of OR5D18 protein
CTD
PMID:21142015
NCBI chr 3:93,972,754...93,973,695
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression increases export
ISO
Venlafaxine Hydrochloride results in increased expression of ABCB1 mRNA ABCB1 protein results in increased export of Venlafaxine Hydrochloride
CTD
PMID:14550684 PMID:17191263
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of ABCC1 mRNA
CTD
PMID:17191263
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
G
Ace
angiotensin I converting enzyme
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ACE mRNA
CTD
PMID:25423262
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Acp5
acid phosphatase 5, tartrate resistant
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of ACP5 mRNA
CTD
PMID:16341940
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:20,663,985...20,667,929
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
EXP
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of ACTA2 protein]]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of ACTA2 protein]
CTD
PMID:35104487
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
G
Acvr1c
activin A receptor type 1C
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ACVR1C mRNA
CTD
PMID:25423262
NCBI chr 3:63,224,322...63,301,252
Ensembl chr 3:42,822,610...42,892,327
G
Adam10
ADAM metallopeptidase domain 10
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ADAM10 mRNA
CTD
PMID:25423262
NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:71,345,837...71,477,889
G
Adgrl1
adhesion G protein-coupled receptor L1
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of ADGRL1 mRNA
CTD
PMID:25423262
NCBI chr19:41,107,162...41,148,752
Ensembl chr19:24,204,360...24,244,139
G
Ago2
argonaute RISC catalytic component 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of AGO2 mRNA
CTD
PMID:25423262
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:105,029,120...105,104,974
G
Ahr
aryl hydrocarbon receptor
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of AHR mRNA
CTD
PMID:25423262
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Akap5
A-kinase anchoring protein 5
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of AKAP5 mRNA
CTD
PMID:25423262
NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:95,051,537...95,061,578
G
Akt1
AKT serine/threonine kinase 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of AKT1 protein
CTD
PMID:18511088
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
multiple interactions
EXP
Venlafaxine Hydrochloride inhibits the reaction [Cisplatin results in decreased expression of ALB protein]
CTD
PMID:29852128
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Alcam
activated leukocyte cell adhesion molecule
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ALCAM mRNA
CTD
PMID:25423262
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:48,336,169...48,537,954
G
Ankrd55
ankyrin repeat domain 55
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of ANKRD55 mRNA
CTD
PMID:16341940
NCBI chr 2:43,883,877...43,983,820
Ensembl chr 2:43,883,857...43,983,680
G
Ap2b1
adaptor related protein complex 2 subunit beta 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of AP2B1 mRNA
CTD
PMID:25423262
NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,099,547...68,205,013
G
Ar
androgen receptor
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of AR protein
CTD
PMID:36063371
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Arc
activity-regulated cytoskeleton-associated protein
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ARC mRNA; Venlafaxine Hydrochloride results in increased expression of ARC protein
CTD
PMID:14580947 PMID:15087240 PMID:15838995
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Arf3
ARF GTPase 3
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of ARF3 mRNA
CTD
PMID:25423262
NCBI chr 7:129,886,082...129,912,022
Ensembl chr 7:129,886,082...129,912,002
G
Arhgap10
Rho GTPase activating protein 10
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of ARHGAP10 mRNA
CTD
PMID:16341940
NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313
G
Arhgef9
Cdc42 guanine nucleotide exchange factor 9
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ARHGEF9 mRNA
CTD
PMID:25423262
NCBI chr X:59,919,560...60,077,538
Ensembl chr X:59,920,870...60,077,513
G
Ascl1
achaete-scute family bHLH transcription factor 1
decreases expression increases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of ASCL1 mRNA Venlafaxine Hydrochloride results in increased expression of ASCL1 mRNA
CTD
PMID:25423262
NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:21,903,126...21,905,993
G
Atp2b3
ATPase plasma membrane Ca2+ transporting 3
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ATP2B3 mRNA
CTD
PMID:25423262
NCBI chr X:156,367,582...156,464,085
Ensembl chr X:151,216,507...151,286,775
G
Atrx
ATRX, chromatin remodeler
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ATRX mRNA
CTD
PMID:25423262
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:70,850,981...70,997,330
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of BAX protein]]; Venlafaxine Hydrochloride inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of BAX protein]
CTD
PMID:29852128 PMID:35104487
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
EXP
Venlafaxine Hydrochloride results in decreased expression of BCL2 mRNA Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]]; Venlafaxine Hydrochloride inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]
CTD
PMID:25423262 PMID:29852128 PMID:35104487
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of BDNF mRNA
CTD
PMID:17950272
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
multiple interactions
EXP
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of BECN1 protein]]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of BECN1 protein]
CTD
PMID:35104487
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Brinp3
BMP/retinoic acid inducible neural specific 3
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of BRINP3 mRNA
CTD
PMID:16341940
NCBI chr13:60,964,127...61,397,044
Ensembl chr13:58,413,883...58,846,770
G
Cacnb4
calcium voltage-gated channel auxiliary subunit beta 4
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CACNB4 mRNA
CTD
PMID:25423262
NCBI chr 3:57,315,900...57,578,271
Ensembl chr 3:36,910,427...37,168,944
G
Calm3
calmodulin 3
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of CALM3 mRNA
CTD
PMID:25423262
NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:77,589,230...77,592,207
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CAMK2A mRNA
CTD
PMID:25423262
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:54,378,784...54,438,994
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of CAMK2B mRNA
CTD
PMID:25423262
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:80,845,238...80,933,994
G
Camk2g
calcium/calmodulin-dependent protein kinase II gamma
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of CAMK2G mRNA
CTD
PMID:25423262
NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,504,085...3,563,050
G
Casp3
caspase 3
multiple interactions
EXP
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of CASP3 protein]]; Venlafaxine Hydrochloride inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of CASP3 protein]
CTD
PMID:29852128 PMID:35104487
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
EXP
Nitric Oxide promotes the reaction [Venlafaxine Hydrochloride inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]]; Venlafaxine Hydrochloride inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; Venlafaxine Hydrochloride inhibits the reaction [Cisplatin results in decreased activity of CAT protein]
CTD
PMID:20305041 PMID:29852128
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cd47
Cd47 molecule
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of CD47 mRNA
CTD
PMID:25423262
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:50,906,177...50,969,425
G
Cdh22
cadherin 22
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of CDH22 mRNA
CTD
PMID:25423262
NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:153,845,787...153,970,588
G
Celf2
CUGBP, Elav-like family member 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CELF2 mRNA
CTD
PMID:25423262
NCBI chr17:75,813,928...76,639,300
Ensembl chr17:71,210,853...71,728,333
G
Clns1a
chloride nucleotide-sensitive channel 1A
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of CLNS1A mRNA
CTD
PMID:25423262
NCBI chr 1:161,429,437...161,450,904
Ensembl chr 1:152,019,378...152,039,661
G
Clstn2
calsyntenin 2
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of CLSTN2 mRNA
CTD
PMID:25423262
NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:98,021,666...98,637,731
G
Cnbp
CCHC-type zinc finger, nucleic acid binding protein
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CNBP mRNA
CTD
PMID:25423262
NCBI chr 4:121,860,102...121,868,976
Ensembl chr 4:120,302,771...120,311,637
G
Cnr1
cannabinoid receptor 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CNR1 mRNA
CTD
PMID:25423262
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Cntn2
contactin 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CNTN2 mRNA
CTD
PMID:25423262
NCBI chr13:46,497,269...46,528,112
Ensembl chr13:43,947,265...43,975,887
G
Cox17
cytochrome c oxidase copper chaperone COX17
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of COX17 mRNA
CTD
PMID:25423262
NCBI chr11:75,906,245...75,912,036
G
Cpd
carboxypeptidase D
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CPD mRNA
CTD
PMID:25423262
NCBI chr10:62,121,681...62,185,638
Ensembl chr10:61,623,526...61,687,491
G
Ctnnb1
catenin beta 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CTNNB1 protein
CTD
PMID:18511088
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cxxc4
CXXC finger protein 4
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of CXXC4 mRNA
CTD
PMID:25423262
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
multiple interactions decreases activity
ISO
Venlafaxine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased hydroxylation of Pregnenolone] which results in increased chemical synthesis of 17-alpha-Hydroxypregnenolone]; Venlafaxine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 17-alpha-Hydroxyprogesterone]; Venlafaxine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxypregnenolone] which results in increased chemical synthesis of Dehydroepiandrosterone]; Venlafaxine Hydrochloride inhibits the reaction [[CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone] which results in increased chemical synthesis of Androstenedione]; Venlafaxine Hydrochloride inhibits the reaction [CYP17A1 protein results in increased hydroxylation of Pregnenolone]; Venlafaxine Hydrochloride inhibits the reaction [CYP17A1 protein results in increased hydroxylation of Progesterone]; Venlafaxine Hydrochloride inhibits the reaction [CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxypregnenolone]; Venlafaxine Hydrochloride inhibits the reaction [CYP17A1 protein results in increased metabolism of 17-alpha-Hydroxyprogesterone] Venlafaxine Hydrochloride results in decreased activity of CYP17A1 protein
CTD
PMID:29100959
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
affects methylation decreases methylation
ISO
CYP2C19 gene polymorphism affects the methylation of Venlafaxine Hydrochloride CYP2C19 protein results in decreased methylation of Venlafaxine Hydrochloride
CTD
PMID:10877013
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects metabolic processing affects methylation affects response to substance decreases methylation increases metabolic processing decreases activity
ISO
CYP2D6 gene mutant form affects the metabolism of Venlafaxine Hydrochloride; CYP2D6 gene polymorphism affects the metabolism of Venlafaxine Hydrochloride CYP2D6 gene polymorphism affects the methylation of Venlafaxine Hydrochloride CYP2D6 protein affects the susceptibility to Venlafaxine Hydrochloride CYP2D6 protein results in decreased methylation of Venlafaxine Hydrochloride CYP2D6 protein results in increased metabolism of Venlafaxine Hydrochloride Venlafaxine Hydrochloride results in decreased activity of CYP2D6 protein
CTD
PMID:10774634 PMID:10877013 PMID:10933885 PMID:15632378 PMID:16044105 PMID:16958828 PMID:17803873 PMID:18214456 More...
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Dab2
DAB adaptor protein 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of DAB2 mRNA
CTD
PMID:25423262
NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:55,514,700...55,567,476
G
Ddah1
dimethylarginine dimethylaminohydrolase 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of DDAH1 mRNA
CTD
PMID:25423262
NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:234,667,491...234,799,339
G
Dmac1
distal membrane arm assembly component 1
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of DMAC1 mRNA
CTD
PMID:16341940
NCBI chr 5:89,241,173...89,243,793
Ensembl chr 5:89,242,661...89,243,757
G
Dnmt3a
DNA methyltransferase 3 alpha
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of DNMT3A mRNA
CTD
PMID:25423262
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687
G
Dpp4
dipeptidylpeptidase 4
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of DPP4 mRNA
CTD
PMID:25423262
NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:46,962,243...47,043,901
G
Ednrb
endothelin receptor type B
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of EDNRB mRNA
CTD
PMID:25423262
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of ENPP1 mRNA
CTD
PMID:25423262
NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:20,698,764...20,763,715
G
Epha5
EPH receptor A5
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of EPHA5 mRNA
CTD
PMID:25423262
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
G
Fmnl1
formin-like 1
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of FMNL1 mRNA
CTD
PMID:16341940
NCBI chr10:88,615,290...88,643,411
Ensembl chr10:88,116,009...88,143,357
G
Gabrb1
gamma-aminobutyric acid type A receptor subunit beta1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of GABRB1 mRNA
CTD
PMID:25423262
NCBI chr14:36,434,339...36,917,920
Ensembl chr14:36,080,393...36,548,948
G
Gabrb2
gamma-aminobutyric acid type A receptor subunit beta 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of GABRB2 mRNA
CTD
PMID:25423262
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:26,936,551...27,151,251
G
Gad2
glutamate decarboxylase 2
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of GAD2 mRNA
CTD
PMID:25423262
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Gas2
growth arrest-specific 2
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of GAS2 mRNA
CTD
PMID:25423262
NCBI chr 1:110,587,952...110,721,572
Ensembl chr 1:101,482,591...101,582,619
G
Gas6
growth arrest specific 6
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of GAS6 mRNA
CTD
PMID:25423262
NCBI chr16:82,747,676...82,778,090
Ensembl chr16:76,045,426...76,075,904
G
Gda
guanine deaminase
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of GDA mRNA
CTD
PMID:25423262
NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:218,906,815...218,982,416
G
Gfap
glial fibrillary acidic protein
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of GFAP mRNA
CTD
PMID:25423262
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
G
Glp1r
glucagon-like peptide 1 receptor
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of GLP1R mRNA
CTD
PMID:25423262
NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,972,004...9,010,241
G
Gnao1
G protein subunit alpha o1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of GNAO1 mRNA
CTD
PMID:25423262
NCBI chr19:11,040,788...11,198,437
Ensembl chr19:11,035,956...11,192,493
G
Gnaq
G protein subunit alpha q
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of GNAQ mRNA
CTD
PMID:25423262
NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:213,424,465...213,667,672
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of GRIA1 mRNA
CTD
PMID:25423262
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of GRIA3 mRNA
CTD
PMID:25423262
NCBI chr X:125,103,975...125,369,690
Ensembl chr X:120,238,534...120,504,096
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of GRIN2A mRNA
CTD
PMID:25423262
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of GRIN2B mRNA
CTD
PMID:25423262
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of HCN1 mRNA
CTD
PMID:25423262
NCBI chr 2:51,228,710...51,632,806
Ensembl chr 2:49,495,771...49,899,774
G
Hdac6
histone deacetylase 6
multiple interactions
EXP
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of HDAC6 protein]]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of HDAC6 protein]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of HDAC6 protein]
CTD
PMID:35104487
NCBI chr X:17,222,538...17,244,373
Ensembl chr X:14,551,044...14,572,441
G
Hook2
hook microtubule-tethering protein 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of HOOK2 mRNA
CTD
PMID:25423262
NCBI chr19:23,151,869...23,170,139
Ensembl chr19:23,151,870...23,164,181
G
Il1rapl1
interleukin 1 receptor accessory protein-like 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of IL1RAPL1 mRNA
CTD
PMID:25423262
NCBI chr X:55,322,779...56,827,486
Ensembl chr X:51,378,215...52,876,772
G
Kcnc2
potassium voltage-gated channel subfamily C member 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of KCNC2 mRNA
CTD
PMID:25423262
NCBI chr 7:49,586,274...49,770,212
Ensembl chr 7:47,700,288...47,883,968
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Venlafaxine Hydrochloride results in decreased activity of KCNH2 protein
CTD
PMID:21158687
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
multiple interactions
ISO
Venlafaxine Hydrochloride affects the activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]; Venlafaxine Hydrochloride affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]
CTD
PMID:22164246
NCBI chr 3:60,353,990...60,518,110
Ensembl chr 3:39,945,351...40,109,124
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
multiple interactions
ISO
Venlafaxine Hydrochloride affects the activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]
CTD
PMID:22164246
NCBI chr 8:38,981,598...39,011,197
Ensembl chr 8:30,724,925...30,753,518
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
multiple interactions
ISO
Venlafaxine Hydrochloride affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]
CTD
PMID:22164246
NCBI chr11:47,531,312...47,778,348
Ensembl chr11:34,061,708...34,308,758
G
Kcnk1
potassium two pore domain channel subfamily K member 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of KCNK1 mRNA
CTD
PMID:25423262
NCBI chr19:70,856,985...70,895,053
Ensembl chr19:53,959,657...53,997,724
G
Kif1b
kinesin family member 1B
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of KIF1B mRNA
CTD
PMID:25423262
NCBI chr 5:164,890,778...165,025,848
Ensembl chr 5:159,561,271...159,742,778
G
Kif2b
kinesin family member 2B
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of KIF2B mRNA
CTD
PMID:25423262
NCBI chr10:76,891,199...76,893,418
G
Kif5a
kinesin family member 5A
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of KIF5A mRNA
CTD
PMID:25423262
NCBI chr 7:64,937,210...64,974,339
Ensembl chr 7:63,049,424...63,092,858
G
Klf6
KLF transcription factor 6
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of KLF6 mRNA
CTD
PMID:25423262
NCBI chr17:69,449,483...69,458,478
Ensembl chr17:64,531,463...64,588,570
G
Klhl24
kelch-like family member 24
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of KLHL24 mRNA
CTD
PMID:25423262
NCBI chr11:94,348,024...94,382,085
Ensembl chr11:80,846,755...80,877,636
G
Klk10
kallikrein related-peptidase 10
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of KLK10 mRNA
CTD
PMID:16341940
NCBI chr 1:103,371,638...103,375,918
Ensembl chr 1:94,235,096...94,239,376
G
Large1
LARGE xylosyl- and glucuronyltransferase 1
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of LARGE1 mRNA
CTD
PMID:16341940
NCBI chr19:11,609,004...12,057,174
Ensembl chr19:11,603,129...12,048,930
G
Lipg
lipase G, endothelial type
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of LIPG mRNA
CTD
PMID:16341940
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:68,514,923...68,536,260
G
Lman1
lectin, mannose-binding, 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of LMAN1 mRNA
CTD
PMID:25423262
NCBI chr18:61,778,971...61,800,960
Ensembl chr18:59,508,996...59,530,851
G
Lmo7
LIM domain 7
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of LMO7 mRNA
CTD
PMID:16341940
NCBI chr15:84,981,689...85,184,554
Ensembl chr15:78,567,023...78,769,783
G
Lpl
lipoprotein lipase
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of LPL mRNA
CTD
PMID:25423262
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
G
Magi2
membrane associated guanylate kinase, WW and PDZ domain containing 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of MAGI2 mRNA
CTD
PMID:25423262
NCBI chr 4:15,278,518...16,762,427
Ensembl chr 4:14,386,399...15,870,240
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
EXP
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]
CTD
PMID:35104487
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map2
microtubule-associated protein 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of MAP2 mRNA
CTD
PMID:25423262
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:67,723,371...67,979,809
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
EXP
Venlafaxine Hydrochloride results in increased phosphorylation of MAPK1 protein
CTD
PMID:18511088
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
EXP
Venlafaxine Hydrochloride results in increased phosphorylation of MAPK3 protein
CTD
PMID:18511088
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mfng
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of MFNG mRNA
CTD
PMID:25423262
NCBI chr 7:112,191,288...112,209,129
Ensembl chr 7:110,310,812...110,328,653
G
Mmp9
matrix metallopeptidase 9
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of MMP9 mRNA
CTD
PMID:25423262
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpp2
MAGUK p55 scaffold protein 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of MPP2 mRNA
CTD
PMID:25423262
NCBI chr10:87,511,638...87,544,710
Ensembl chr10:87,011,434...87,043,896
G
Mvp
major vault protein
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of MVP mRNA
CTD
PMID:16341940
NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:181,594,734...181,622,380
G
Myo5a
myosin VA
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of MYO5A mRNA
CTD
PMID:25423262
NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:75,812,412...75,975,918
G
Nasp
nuclear autoantigenic sperm protein
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of NASP mRNA
CTD
PMID:16341940
NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:130,057,363...130,082,928
G
Negr1
neuronal growth regulator 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of NEGR1 mRNA
CTD
PMID:25423262
NCBI chr 2:248,283,164...249,015,538
Ensembl chr 2:245,624,435...246,356,730
G
Nell2
neural EGFL like 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of NELL2 mRNA
CTD
PMID:25423262
NCBI chr 7:128,222,333...128,542,127
Ensembl chr 7:126,198,851...126,733,503
G
Neurod1
neuronal differentiation 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of NEUROD1 mRNA
CTD
PMID:25423262
NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:64,359,395...64,363,649
G
Nfix
nuclear factor I X
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of NFIX mRNA
CTD
PMID:25423262
NCBI chr19:40,259,873...40,356,966
Ensembl chr19:23,355,498...23,448,265
G
Nptxr
neuronal pentraxin receptor
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of NPTXR mRNA
CTD
PMID:25423262
NCBI chr 7:113,217,046...113,235,122
Ensembl chr 7:111,336,664...111,354,802
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of NR3C1 mRNA
CTD
PMID:11406320
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of NR3C2 mRNA
CTD
PMID:11406320
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Nsun2
NOP2/Sun RNA methyltransferase 2
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of NSUN2 mRNA
CTD
PMID:16341940
NCBI chr 1:35,490,583...35,514,839
Ensembl chr 1:33,662,139...33,685,862
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of NTRK2 mRNA
CTD
PMID:25423262
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of NTRK3 mRNA
CTD
PMID:25423262
NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:132,132,849...132,503,286
G
Pdap1
PDGFA associated protein 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of PDAP1 mRNA
CTD
PMID:25423262
NCBI chr12:14,584,414...14,594,641
Ensembl chr12:9,470,574...9,535,374
G
Pde4b
phosphodiesterase 4B
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of PDE4B mRNA
CTD
PMID:25423262
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pde4d
phosphodiesterase 4D
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of PDE4D mRNA
CTD
PMID:25423262
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:40,019,933...41,525,884
G
Pdia3
protein disulfide isomerase family A, member 3
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of PDIA3 mRNA
CTD
PMID:25423262
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:108,388,245...108,413,236
G
Pdpk1
3-phosphoinositide dependent protein kinase-1
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of PDPK1 mRNA
CTD
PMID:25423262
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,105,498...13,174,623
G
Pex2
peroxisomal biogenesis factor 2
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of PEX2 mRNA
CTD
PMID:25423262
NCBI chr 2:97,957,479...97,973,767
Ensembl chr 2:96,045,958...96,073,404
G
Pgrmc1
progesterone receptor membrane component 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of PGRMC1 mRNA
CTD
PMID:25423262
NCBI chr X:120,698,610...120,706,805
Ensembl chr X:115,832,884...115,888,682
G
Pim3
Pim-3 proto-oncogene, serine/threonine kinase
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of PIM3 mRNA
CTD
PMID:25423262
NCBI chr 7:121,822,076...121,836,257
Ensembl chr 7:119,953,175...119,956,587
G
Pou3f2
POU class 3 homeobox 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of POU3F2 mRNA
CTD
PMID:25423262
NCBI chr 5:40,874,631...40,880,539
Ensembl chr 5:36,077,930...36,083,838
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of PPP1CA mRNA
CTD
PMID:25423262
NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:201,485,085...201,497,327
G
Ppp1r3a
protein phosphatase 1, regulatory subunit 3A
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of PPP1R3A mRNA
CTD
PMID:25423262
NCBI chr 4:43,905,648...43,946,236
Ensembl chr 4:42,939,599...42,980,638
G
Ppp1r9b
protein phosphatase 1, regulatory subunit 9B
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of PPP1R9B mRNA
CTD
PMID:25423262
NCBI chr10:80,434,888...80,450,919
Ensembl chr10:79,938,066...79,954,083
G
Ppp3r1
protein phosphatase 3, regulatory subunit B, alpha
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of PPP3R1 mRNA
CTD
PMID:25423262
NCBI chr14:95,758,333...95,808,015
Ensembl chr14:91,604,121...91,606,907
G
Prap1
proline-rich acidic protein 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of PRAP1 mRNA
CTD
PMID:25423262
NCBI chr 1:204,312,723...204,316,519
Ensembl chr 1:194,883,078...194,886,872
G
Prdx1
peroxiredoxin 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of PRDX1 mRNA
CTD
PMID:25423262
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:130,147,204...130,162,856
G
Prex2
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of PREX2 mRNA
CTD
PMID:16341940
NCBI chr 5:12,720,683...13,036,077
Ensembl chr 5:7,942,573...8,253,068
G
Prkce
protein kinase C, epsilon
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of PRKCE mRNA
CTD
PMID:25423262
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Prkg2
protein kinase cGMP-dependent 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of PRKG2 mRNA
CTD
PMID:25423262
NCBI chr14:10,864,020...10,972,617
Ensembl chr14:10,559,882...10,666,888
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
EXP
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of PRKN protein]]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of PRKN protein]
CTD
PMID:35104487
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555
G
Prl
prolactin
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of PRL protein
CTD
PMID:17606668
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Pyy
peptide YY
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of PYY mRNA
CTD
PMID:25423262
NCBI chr10:87,561,347...87,562,470
Ensembl chr10:87,061,161...87,061,815
G
Rab14
RAB14, member RAS oncogene family
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of RAB14 mRNA
CTD
PMID:25423262
NCBI chr 3:38,899,430...38,920,572
Ensembl chr 3:18,501,963...18,523,172
G
Rab4b
RAB4B, member RAS oncogene family
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of RAB4B mRNA
CTD
PMID:25423262
NCBI chr 1:82,461,396...82,472,784
Ensembl chr 1:82,461,396...82,472,763
G
Rcc1
regulator of chromosome condensation 1
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of RCC1 mRNA
CTD
PMID:16341940
NCBI chr 5:149,810,037...149,828,475
Ensembl chr 5:144,526,025...144,544,577
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Venlafaxine Hydrochloride inhibits the reaction [Cisplatin results in increased expression of RELA protein]
CTD
PMID:29852128
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rims1
regulating synaptic membrane exocytosis 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of RIMS1 mRNA
CTD
PMID:25423262
NCBI chr 9:32,193,352...32,692,998
Ensembl chr 9:24,698,854...25,196,631
G
Ring1
ring finger protein 1
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of RING1 mRNA
CTD
PMID:16341940
NCBI chr20:4,832,013...4,835,516
Ensembl chr20:4,830,053...4,833,620
G
Rph3a
rabphilin 3A
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of RPH3A mRNA
CTD
PMID:25423262
NCBI chr12:41,203,004...41,279,536
Ensembl chr12:35,542,728...35,617,592
G
Sall1
spalt-like transcription factor 1
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of SALL1 mRNA
CTD
PMID:16341940
NCBI chr19:34,179,316...34,196,278
Ensembl chr19:18,007,503...18,022,705
G
Serpini1
serpin family I member 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SERPINI1 mRNA
CTD
PMID:16637596
NCBI chr 2:162,645,209...162,731,737
Ensembl chr 2:160,346,758...160,433,135
G
Sgtb
small glutamine rich tetratricopeptide repeat co-chaperone beta
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SGTB mRNA
CTD
PMID:25423262
NCBI chr 2:35,233,045...35,269,527
Ensembl chr 2:35,233,042...35,269,518
G
Shank2
SH3 and multiple ankyrin repeat domains 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SHANK2 mRNA
CTD
PMID:25423262
NCBI chr 1:208,575,144...209,020,300
Ensembl chr 1:199,169,429...199,589,394
G
Sipa1l1
signal-induced proliferation-associated 1 like 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SIPA1L1 mRNA
CTD
PMID:25423262
NCBI chr 6:107,570,569...107,849,613
Ensembl chr 6:101,839,404...102,116,950
G
Slc26a3
solute carrier family 26 member 3
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SLC26A3 mRNA
CTD
PMID:25423262
NCBI chr 6:53,751,415...53,792,300
Ensembl chr 6:48,023,892...48,064,772
G
Slc2a4
solute carrier family 2 member 4
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of SLC2A4 mRNA
CTD
PMID:25423262
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
G
Slc4a4
solute carrier family 4 member 4
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SLC4A4 mRNA
CTD
PMID:25423262
NCBI chr14:19,125,394...19,577,379
Ensembl chr14:18,845,159...19,272,883
G
Slc5a1
solute carrier family 5 member 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SLC5A1 mRNA
CTD
PMID:25423262
NCBI chr14:81,778,495...81,843,084
Ensembl chr14:77,553,843...77,618,547
G
Slc6a4
solute carrier family 6 member 4
affects response to substance
ISO
SLC6A4 gene polymorphism affects the susceptibility to Venlafaxine Hydrochloride
CTD
PMID:17503984
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Slc6a6
solute carrier family 6 member 6
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SLC6A6 mRNA
CTD
PMID:25423262
NCBI chr 4:125,752,340...125,826,033
Ensembl chr 4:124,195,218...124,268,875
G
Sod1
superoxide dismutase 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SOD1 mRNA
CTD
PMID:10721683
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Spn
sialophorin
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SPN mRNA
CTD
PMID:25423262
NCBI chr 1:191,177,449...191,190,115
Ensembl chr 1:181,746,429...181,759,628
G
Sqstm1
sequestosome 1
decreases expression multiple interactions
EXP
Venlafaxine Hydrochloride results in decreased expression of SQSTM1 mRNA Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of SQSTM1 protein]]; Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of SQSTM1 protein]
CTD
PMID:25423262 PMID:35104487
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Stau2
staufen double-stranded RNA binding protein 2
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of STAU2 mRNA
CTD
PMID:25423262
NCBI chr 5:7,623,528...7,868,206
Ensembl chr 5:2,840,765...3,084,929
G
Stk39
serine threonine kinase 39
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of STK39 mRNA
CTD
PMID:25423262
NCBI chr 3:73,321,522...73,588,397
Ensembl chr 3:52,913,585...53,179,060
G
Sv2b
synaptic vesicle glycoprotein 2b
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of SV2B mRNA
CTD
PMID:25423262
NCBI chr 1:128,978,471...129,152,479
Ensembl chr 1:128,978,473...129,152,479
G
Syn2
synapsin II
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of SYN2 mRNA
CTD
PMID:25423262
NCBI chr 4:149,858,919...150,016,845
Ensembl chr 4:148,186,270...148,344,192
G
Synj2
synaptojanin 2
affects expression
EXP
Venlafaxine Hydrochloride affects the expression of SYNJ2 mRNA
CTD
PMID:25423262
NCBI chr 1:48,923,742...49,027,153
Ensembl chr 1:46,518,709...46,633,687
G
Syp
synaptophysin
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of SYP mRNA
CTD
PMID:17950272
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
G
Syt4
synaptotagmin 4
increases expression
ISO
Venlafaxine Hydrochloride results in increased expression of SYT4 mRNA
CTD
PMID:16341940
NCBI chr18:23,311,454...23,320,863
Ensembl chr18:23,038,378...23,046,332
G
Tacr3
tachykinin receptor 3
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of TACR3 mRNA
CTD
PMID:25423262
NCBI chr 2:225,940,497...226,037,756
Ensembl chr 2:223,266,536...223,363,791
G
Tcf12
transcription factor 12
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of TCF12 mRNA
CTD
PMID:16341940
NCBI chr 8:81,371,201...81,682,337
Ensembl chr 8:72,492,567...72,799,201
G
Tcf4
transcription factor 4
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of TCF4 mRNA
CTD
PMID:25423262
NCBI chr18:65,216,840...65,563,186
Ensembl chr18:62,943,782...63,284,425
G
Thbd
thrombomodulin
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of THBD mRNA
CTD
PMID:25423262
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Tp53
tumor protein p53
multiple interactions
EXP
Venlafaxine Hydrochloride inhibits the reaction [Cisplatin results in increased expression of TP53 protein]
CTD
PMID:29852128
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Trim13
tripartite motif-containing 13
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of TRIM13 mRNA
CTD
PMID:16341940
NCBI chr15:39,909,587...39,948,719
Ensembl chr15:35,734,107...35,772,677
G
Tshr
thyroid stimulating hormone receptor
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of TSHR mRNA
CTD
PMID:25423262
NCBI chr 6:116,072,321...116,206,009
Ensembl chr 6:110,341,581...110,474,538
G
Txn2
thioredoxin 2
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of TXN2 mRNA
CTD
PMID:25423262
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:109,496,761...109,510,359
G
Ube2q1
ubiquitin conjugating enzyme E2 Q1
decreases expression
ISO
Venlafaxine Hydrochloride results in decreased expression of UBE2Q1 mRNA
CTD
PMID:16341940
NCBI chr 2:177,496,480...177,505,631
Ensembl chr 2:175,198,873...175,207,942
G
Ucp3
uncoupling protein 3
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of UCP3 mRNA
CTD
PMID:25423262
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:154,815,777...154,828,762
G
Unc13b
unc-13 homolog B
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of UNC13B mRNA
CTD
PMID:25423262
NCBI chr 5:62,084,809...62,299,884
Ensembl chr 5:57,289,227...57,502,926
G
Vamp1
vesicle-associated membrane protein 1
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of VAMP1 mRNA
CTD
PMID:25423262
NCBI chr 4:159,698,894...159,705,582
Ensembl chr 4:158,012,663...158,019,349
G
Vcpip1
valosin containing protein interacting protein 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of VCPIP1 mRNA
CTD
PMID:25423262
NCBI chr 5:14,317,083...14,343,724
Ensembl chr 5:9,534,129...9,562,040
G
Vdac1
voltage-dependent anion channel 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of VDAC1 mRNA
CTD
PMID:25423262
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:36,532,244...36,559,640
G
Vegfb
vascular endothelial growth factor B
decreases expression
EXP
Venlafaxine Hydrochloride results in decreased expression of VEGFB mRNA
CTD
PMID:25423262
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:204,172,225...204,177,944
G
Wdfy1
WD repeat and FYVE domain containing 1
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of WDFY1 mRNA
CTD
PMID:25423262
NCBI chr 9:88,459,613...88,541,215
Ensembl chr 9:81,034,849...81,092,775
G
Zfp24
zinc finger protein 24
increases expression
EXP
Venlafaxine Hydrochloride results in increased expression of ZFP24 mRNA
CTD
PMID:25423262
NCBI chr18:15,573,031...15,583,432
Ensembl chr18:15,298,290...15,306,799
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of ACACA mRNA]
CTD
PMID:33845646
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Ache
acetylcholinesterase
multiple interactions affects activity
EXP
zingerone affects the reaction [Vancomycin affects the activity of ACHE protein] zingerone affects the activity of ACHE protein
CTD
PMID:31454121
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Acox1
acyl-CoA oxidase 1
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in decreased expression of ACOX1 mRNA]
CTD
PMID:33845646
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232
G
Acsl1
acyl-CoA synthetase long-chain family member 1
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of ACSL1 mRNA]
CTD
PMID:33845646
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:45,755,254...45,821,541
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
zingerone results in decreased expression of and results in decreased phosphorylation of AKT1 protein
CTD
PMID:32905641
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
multiple interactions increases expression
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT2 mRNA] zingerone results in increased expression of AKT2 mRNA
CTD
PMID:36822304
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
G
Ar
androgen receptor
multiple interactions
ISO
zingerone binds to and results in decreased activity of AR protein
CTD
PMID:20226658
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
EXP ISO
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAX mRNA]; zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAX protein]; zingerone inhibits the reaction [Ethanol results in increased expression of BAX protein] zingerone results in increased expression of BAX protein
CTD
PMID:28442378 PMID:31476248 PMID:36822304
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bche
butyrylcholinesterase
affects activity multiple interactions
EXP
zingerone affects the activity of BCHE protein zingerone affects the reaction [Vancomycin affects the activity of BCHE protein]
CTD
PMID:31454121
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Bcl2
BCL2, apoptosis regulator
multiple interactions increases expression decreases expression
EXP ISO
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA]; zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 protein]; zingerone inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] zingerone results in increased expression of BCL2 mRNA zingerone results in decreased expression of BCL2 protein
CTD
PMID:28442378 PMID:31476248 PMID:36822304
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Becn1
beclin 1
multiple interactions
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BECN1 mRNA]
CTD
PMID:36822304
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bid
BH3 interacting domain death agonist
increases expression
ISO
zingerone results in increased expression of BID protein
CTD
PMID:31476248
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
G
Casp3
caspase 3
multiple interactions
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CASP3 mRNA]; zingerone inhibits the reaction [Ethanol results in increased expression of CASP3 protein]
CTD
PMID:28442378 PMID:36822304
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
EXP
zingerone inhibits the reaction [Ethanol results in increased expression of CASP9 protein]
CTD
PMID:28442378
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
EXP
zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in decreased activity of CAT protein]; zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of CAT protein]
CTD
PMID:31476248 PMID:33845646 PMID:36822304
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccnd1
cyclin D1
multiple interactions
EXP
zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CCND1]
CTD
PMID:30720227
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ceacam1
CEA cell adhesion molecule 1
multiple interactions
EXP
zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CEACAM5 protein]
CTD
PMID:31476248
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:81,043,595...81,059,992
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in decreased expression of CPT1A mRNA]
CTD
PMID:33845646
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Cyb5a
cytochrome b5 type A
multiple interactions
EXP
zingerone inhibits the reaction [Ethanol results in increased activity of CYB5A protein]
CTD
PMID:28442378
NCBI chr18:80,487,923...80,520,544
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyb5r3
cytochrome b5 reductase 3
multiple interactions
EXP
zingerone inhibits the reaction [Ethanol results in increased activity of CYB5R3 protein]
CTD
PMID:28442378
NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:114,306,685...114,324,298
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CYP2E1 protein]; zingerone inhibits the reaction [Ethanol results in increased activity of CYP2E1 protein]
CTD
PMID:28442378 PMID:30720227
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Fasn
fatty acid synthase
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of FASN mRNA]
CTD
PMID:33845646
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Foxo1
forkhead box O1
multiple interactions increases expression
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FOXO1 mRNA] zingerone results in increased expression of FOXO1 mRNA
CTD
PMID:36822304
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:136,312,168...136,387,790
G
Gsr
glutathione-disulfide reductase
multiple interactions
EXP
zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]
CTD
PMID:31476248
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
EXP
zingerone inhibits the reaction [Ethanol results in increased activity of HMGCR protein]
CTD
PMID:28442378
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Ifng
interferon gamma
multiple interactions
ISO
zingerone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IFNG protein]
CTD
PMID:29289488
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Il1b
interleukin 1 beta
multiple interactions decreases expression
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL1B mRNA] zingerone results in decreased expression of IL1B mRNA; zingerone results in decreased expression of IL1B protein
CTD
PMID:36822304
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO EXP
zingerone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein] zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IL6 protein]; zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL6 mRNA]
CTD
PMID:29289488 PMID:30720227 PMID:36822304
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Irf3
interferon regulatory factor 3
multiple interactions
ISO
zingerone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of IRF3 protein]
CTD
PMID:29289488
NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:95,479,821...95,484,935
G
Lcat
lecithin cholesterol acyltransferase
multiple interactions
EXP
zingerone inhibits the reaction [Ethanol results in decreased activity of LCAT protein]
CTD
PMID:28442378
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:33,834,403...33,838,231
G
Lpl
lipoprotein lipase
multiple interactions
EXP
zingerone inhibits the reaction [Ethanol results in decreased activity of LPL protein]
CTD
PMID:28442378
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
EXP
zingerone results in decreased phosphorylation of MAPK1 protein
CTD
PMID:20211236
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPK14 mRNA]
CTD
PMID:36822304
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk15
mitogen-activated protein kinase 15
multiple interactions
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPK15 mRNA]
CTD
PMID:36822304
NCBI chr 7:109,575,619...109,595,339
Ensembl chr 7:107,694,964...107,714,645
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
EXP
zingerone results in decreased phosphorylation of MAPK3 protein
CTD
PMID:20211236
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases expression
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPK8 mRNA] zingerone results in increased expression of MAPK8 mRNA
CTD
PMID:36822304
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mki67
marker of proliferation Ki-67
multiple interactions
EXP
zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]
CTD
PMID:30720227
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
zingerone results in decreased expression of and results in decreased phosphorylation of MTOR protein
CTD
PMID:32905641
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NFE2L2 protein]
CTD
PMID:30720227
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
affects localization multiple interactions decreases expression
EXP
zingerone affects the localization of NFKB1 protein zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKB1 mRNA] zingerone results in decreased expression of NFKB1 mRNA
CTD
PMID:20211236 PMID:36822304
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
zingerone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of NFKBIA protein]
CTD
PMID:29289488
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
decreases expression multiple interactions
EXP
zingerone results in decreased expression of NOS2 protein zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOS2 protein]; zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOS2 mRNA]
CTD
PMID:20211236 PMID:30720227 PMID:36822304
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
zingerone inhibits the reaction [Ethanol results in decreased activity of NQO1 protein]
CTD
PMID:28442378
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of NR1H3 mRNA]
CTD
PMID:33845646
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Or5d18
olfactory receptor family 5 subfamily D member 18
multiple interactions
ISO
zingerone binds to and results in increased activity of OR5D18 protein
CTD
PMID:21142015
NCBI chr 3:93,972,754...93,973,695
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein]
CTD
PMID:30720227
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pon1
paraoxonase 1
multiple interactions affects activity
EXP
zingerone affects the reaction [Vancomycin results in decreased activity of PON1 protein] zingerone affects the activity of PON1 protein
CTD
PMID:31454121
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Por
cytochrome p450 oxidoreductase
multiple interactions
EXP
zingerone inhibits the reaction [Ethanol results in increased activity of POR protein]
CTD
PMID:28442378
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:20,951,058...20,999,245
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in decreased expression of PPARA mRNA]
CTD
PMID:33845646
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression multiple interactions
EXP
zingerone results in decreased expression of PTGS2 protein zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PTGS2 protein]; zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PTGS2 mRNA]
CTD
PMID:20211236 PMID:30720227 PMID:36822304
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
zingerone affects the localization of and results in increased phosphorylation of RELA protein; zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RELA protein]
CTD
PMID:20211236 PMID:30720227
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Spmip11
sperm microtubule inner protein 11
multiple interactions
EXP
zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NPHS1 protein]
CTD
PMID:36822304
NCBI chr 7:131,599,977...131,621,508
Ensembl chr 7:129,720,950...129,742,485
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of SREBF1 mRNA]
CTD
PMID:33845646
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
EXP
zingerone inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein]
CTD
PMID:28904557
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
zingerone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TLR4 protein]
CTD
PMID:29289488
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions decreases expression
ISO EXP
zingerone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein] zingerone results in decreased expression of TNF mRNA zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TNF protein]; zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNF mRNA]
CTD
PMID:29289488 PMID:30720227 PMID:36822304
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnni3
troponin I3, cardiac type
multiple interactions
EXP
zingerone inhibits the reaction [[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of TNNI3 protein]
CTD
PMID:33845646
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19887
chemical entity
19885
atom
19885
nonmetal atom
19809
oxygen atom
19551
oxygen molecular entity
19551
organooxygen compound
19197
ether
17318
aromatic ether
16609
methoxybenzenes
2948
monomethoxybenzene
1936
(+)-(8R,8'R)-4-hydroxy-5-methoxy-1',2',3',4',5',6'-hexanor-2,7'-cyclolignan-7'-one
0
(+)-catechin-3'-methyl ether
0
(10)-Gingerol
0
(2E)-3-(4-\{[1-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(sulfooxy)propan-2-yl]oxy\}-3-methoxyphenyl)prop-2-enoic acid
0
(2E)-3-[4-(\{1,3-dihydroxy-1-[3-methoxy-4-(sulfooxy)phenyl]propan-2-yl\}oxy)-3-methoxyphenyl]prop-2-enoic acid
0
(4E)-6-hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one
0
(5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)dihydrofuran-2(3H)-one
0
(5R)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one
0
(5R)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradecan-3-one
0
(8)-Gingerol
0
(E)-2-methoxycinnamic acid
0
(E)-4,2',4'-trihydroxy-6'-methoxy-3',5'-dimethylchalcone
0
(R)-N-trans-feruloyloctopamine
0
(S)-[10]-Gingerol
0
(S)-[8]-Gingerol
0
1'-acetoxyeugenol acetate
0
1,7-bis(4-hydroxy-3-methoxyphenyl)hept-1-ene-3,5-dione +
0
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one
0
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)pentan-1-one
0
1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone
10
2',4'-dihydroxy-3'-methyl-6'-methoxychalcone
0
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone
28
2',6'-dihydroxy-4'-methoxyacetophenone
0
2',6'-dihydroxy-4'-methoxydihydrochalcone
0
2'-O-methylisoliquiritigenin
0
2,2',4'-trihydroxy-6'-methoxy-3',5'-dimethylchalcone
0
2,2,4-trimethyl-3-(4-methoxyphenyl)-2H-1-benzopyran-7-ol acetate
0
2,2-dibutyl-3-(4-methoxyphenyl)-4-methyl-2H-1-benzopyran-7-ol acetate
0
2,2-dimethyl-3,4-bis(4-methoxyphenyl)-2H-1-benzopyran-7-ol acetate
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-2H-1-benzopyran-7-ol
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-2H-1-benzopyran-7-ol acetate
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-6-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-ol
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-7-hydroxy-2H-1-benzopyran-8-methanol diacetate
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-8-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-ol
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetate
0
2,4,6-trichloroanisole
0
2-(2-(4-methoxyphenyl)ethyl)chromone
0
2-(2-hydroxy-4-methoxyphenyl)-5-(3-hydroxypropyl)benzofuran
0
2-(4-methoxyphenyl)propan-2-ol
0
2-[3-ethyl-5-(4-methoxyphenyl)-1H-pyrazol-4-yl]phenol
0
2-amino-3-cyano-7-(dimethylamino)-4-(2-methoxyphenyl)-4H-chromene
0
2-amino-5-methoxyphenol
0
2-bromo-1-(4-methoxyphenyl)-3-[(4-methylphenyl)sulfonyl]-1-propanone
0
2-methoxyacetaminophen glucuronide
0
2-methoxyacetaminophen sulfate
0
2-methylanisole
0
3-O-methyldopa
0
3-methoxy-4-hydroxyphenylglycolaldehyde
0
3-methoxybenzaldehyde
0
3-methoxycatechol monosulfate
0
3-methoxyphenol
0
3-methoxytyramine +
2
3-methoxytyramine sulfate
0
4'-O-methyl-(-)-epicatechin
0
4-Gingerol
0
4-O-beta-D-glucosyl-trans-ferulic acid
0
4-O-methyl-L-dopa
0
4-[2-(4-methoxyphenyl)propan-2-yl]phenol
0
4-acetoxy-3-methoxy-trans-cinnamaldehyde
0
4-acetyl-2-methoxyphenyl acetate
0
4-bromoanisole
0
4-ethyl-7-hydroxy-3-(p-methoxyphenyl)coumarin
0
4-formyl-2-methoxyphenyl L-menthyl glutarate
0
4-methoxy-alpha-methylbenzyl alcohol
0
4-methoxyacetophenone
1
4-methoxymagnaldehyde B
0
4-methoxyphenylacetic acid
0
4-methoxytyramine
1
4-vinylguaiacol sulfate
0
5-(3-hydroxypropyl)-2-(2-methoxy-4-hydroxyphenyl)benzofuran
0
5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-(4-methoxyphenyl)pyrazole-3-carboxamide
0
5-(pentadeca-8,11,14-trien-1-yl)resorcinol monomethyl ether
0
5-methoxysalicylaldehyde
0
6-Gingediol
0
6-Hydroxyshogaol
0
6-O-malonyl-trans-rhaponticin
0
7-hydroxy-3-(4-methoxyphenyl)-4-methylcoumarin
0
7-hydroxy-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-2-one
0
8-Gingediol
0
9-cyclopentyl-N(8)-(2-fluorophenyl)-N(2)-(4-methoxyphenyl)-9H-purine-2,8-diamine
0
AOH1996
0
ASP-3026
0
AZD3463
0
BI-2536
3
Cuscuta propenamide 1
0
FPR A14
0
Formyl-N-acetyl-5-methoxykynurenamine
1
GS4012 free base
0
HMN-214
0
HPI-1
0
ICPD-26
0
JWH-201
0
KN-93
69
Ku-0063794
3
ML162
0
ML355
0
Methyl-10-gingerol
0
N(1),N(5),N(10)-tri-(5-hydroxyferuloyl)-spermidine +
0
N(1),N(5),N(10)-triferuloyl spermidine +
0
N(2)-[3-methoxy-4-(morpholin-4-yl)phenyl]-N(4)-(quinolin-3-yl)pyrimidine-2,4-diamine
0
N,N-didesmethylvenlafaxine
0
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide +
2
N-(2,6-dimethylphenyl)-2-\{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl\}acetamide +
3
N-(2-methoxyphenyl)-N'-(2-naphthyl)urea
0
N-(3-methoxyphenyl)quinazolin-4-amine
0
N-desmethylvenlafaxine
0
NK372135A
0
O,2,3-trimethyltyrosine +
0
O-acetylferulic acid
0
O-methyltyrosine +
0
RO0480500-002
0
SGC-CLK-1
0
SKF-96365 free base
0
SNC-80
1
YK-4-279
0
[10]-Gingerdione
0
[10]-Paradol
0
[10]-Shogaol
0
[12]-Gingerdione
0
[12]-Gingerol
0
[12]-Shogaol
0
[6]-Gingerdione
0
[6]-Paradol
0
[6]-Shogaol
54
[7]-Paradol
0
[8]-Gingerdione
0
[8]-Paradol
0
[8]-Shogaol
0
alisertib
0
aliskiren +
11
alpha-(4-methoxyphenyl)-6-methyl-2-pyridineacrylic acid
0
anethole +
37
anisiflupurin
0
anisole +
13
avenanthramide B
0
belladine
0
betrixaban
0
bis(trimethylsilyl)isovanillate
0
candidachalcone
0
capsiate
7
conferol A
0
conferol B
0
coniferaldehyde beta-D-glucoside
0
cvxIAA
0
dicamba-methyl
0
dihydroconiferyl alcohol glucoside
0
diuvaretin
0
elacestrant
0
enitociclib
0
enrasentan
2
epicatechin 3-O-(3'-O-methylgallate)
0
estragole
23
eugenol +
1310
eugenol sulfate
0
ferulic acid 4-sulfate
0
flamenol
0
fluazaindolizine
0
fluopimomide
0
gaboroquinone A
0
gilteritinib
0
glucolimnanthin
0
glycosmisic acid 4'-sulfate
0
griffithane D
0
guaiacol sulfate
0
guaiacols +
1396
guaiacylglycerol beta-coniferyl ether
0
halauxifen +
0
halauxifen-methyl
0
hyperaspidinol A
0
isoeugenol acetate
0
isoeugenol sulfate
0
isovanillin
0
karalicin
0
kuraridinol
0
lespeflorin C3
0
locoracemoside B
0
lonchocarpenin
0
metcamifen
0
methoxyfenozide
2
methyl 4-acetoxy-3-methoxybenzoate
0
methyl 4-acetoxy-3-methoxycinnamate
0
methyl 4-methoxycinnamate
0
methyl p-anisate
0
methylophiopogonone B
0
metoxuron
0
mochimganine
0
nitroanisoles +
13
o-anisidine
96
odoratol +
0
osimertinib
23
oxybenzone
328
pirtobrutinib
0
pisoniamide
0
poacic acid
0
rataniaphenol I
0
rataniaphenol III
0
resiniferatoxin
18
rhaponticin +
10
rocaglamide
8
sappanchalcone
12
satavaptan
1
strobilurin B
0
tert-butyl 4-hydroxy-3-methoxybenzoate
0
tetrahydrodemethoxycurcumin
0
trans-Ned 19
0
trans-coniferyl alcohol diacetate
0
triptobenzene H
0
triptoditerpenic acid B
0
tschimganine
0
vanillin +
56
vanillin acetate
0
vanillyl alcohol diacetate
0
vanilpyruvic acid
0
venlafaxine +
182
verongamine
0
volasertib
0
zingerone
55
Path 2
CHEBI ontology
19887
subatomic particle
19885
composite particle
19885
hadron
19885
baryon
19885
nucleon
19885
atomic nucleus
19885
atom
19885
main group element atom
19824
p-block element atom
19824
carbon group element atom
19763
carbon atom
19760
organic molecular entity
19760
organic molecule
19713
organic cyclic compound
19505
carbocyclic compound
18602
benzenoid aromatic compound
18073
benzenes
17955
methoxybenzenes
2948
monomethoxybenzene
1936
(+)-(8R,8'R)-4-hydroxy-5-methoxy-1',2',3',4',5',6'-hexanor-2,7'-cyclolignan-7'-one
0
(+)-catechin-3'-methyl ether
0
(10)-Gingerol
0
(2E)-3-(4-\{[1-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(sulfooxy)propan-2-yl]oxy\}-3-methoxyphenyl)prop-2-enoic acid
0
(2E)-3-[4-(\{1,3-dihydroxy-1-[3-methoxy-4-(sulfooxy)phenyl]propan-2-yl\}oxy)-3-methoxyphenyl]prop-2-enoic acid
0
(4E)-6-hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one
0
(5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)dihydrofuran-2(3H)-one
0
(5R)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one
0
(5R)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradecan-3-one
0
(8)-Gingerol
0
(E)-2-methoxycinnamic acid
0
(E)-4,2',4'-trihydroxy-6'-methoxy-3',5'-dimethylchalcone
0
(R)-N-trans-feruloyloctopamine
0
(S)-[10]-Gingerol
0
(S)-[8]-Gingerol
0
1'-acetoxyeugenol acetate
0
1,7-bis(4-hydroxy-3-methoxyphenyl)hept-1-ene-3,5-dione +
0
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one
0
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)pentan-1-one
0
1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone
10
2',4'-dihydroxy-3'-methyl-6'-methoxychalcone
0
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone
28
2',6'-dihydroxy-4'-methoxyacetophenone
0
2',6'-dihydroxy-4'-methoxydihydrochalcone
0
2'-O-methylisoliquiritigenin
0
2,2',4'-trihydroxy-6'-methoxy-3',5'-dimethylchalcone
0
2,2,4-trimethyl-3-(4-methoxyphenyl)-2H-1-benzopyran-7-ol acetate
0
2,2-dibutyl-3-(4-methoxyphenyl)-4-methyl-2H-1-benzopyran-7-ol acetate
0
2,2-dimethyl-3,4-bis(4-methoxyphenyl)-2H-1-benzopyran-7-ol acetate
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-2H-1-benzopyran-7-ol
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-2H-1-benzopyran-7-ol acetate
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-6-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-ol
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-7-hydroxy-2H-1-benzopyran-8-methanol diacetate
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-ethyl-8-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-ol
0
2,2-dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetate
0
2,4,6-trichloroanisole
0
2-(2-(4-methoxyphenyl)ethyl)chromone
0
2-(2-hydroxy-4-methoxyphenyl)-5-(3-hydroxypropyl)benzofuran
0
2-(4-methoxyphenyl)propan-2-ol
0
2-[3-ethyl-5-(4-methoxyphenyl)-1H-pyrazol-4-yl]phenol
0
2-amino-3-cyano-7-(dimethylamino)-4-(2-methoxyphenyl)-4H-chromene
0
2-amino-5-methoxyphenol
0
2-bromo-1-(4-methoxyphenyl)-3-[(4-methylphenyl)sulfonyl]-1-propanone
0
2-methoxyacetaminophen glucuronide
0
2-methoxyacetaminophen sulfate
0
2-methylanisole
0
3-O-methyldopa
0
3-methoxy-4-hydroxyphenylglycolaldehyde
0
3-methoxybenzaldehyde
0
3-methoxycatechol monosulfate
0
3-methoxyphenol
0
3-methoxytyramine +
2
3-methoxytyramine sulfate
0
4'-O-methyl-(-)-epicatechin
0
4-Gingerol
0
4-O-beta-D-glucosyl-trans-ferulic acid
0
4-O-methyl-L-dopa
0
4-[2-(4-methoxyphenyl)propan-2-yl]phenol
0
4-acetoxy-3-methoxy-trans-cinnamaldehyde
0
4-acetyl-2-methoxyphenyl acetate
0
4-bromoanisole
0
4-ethyl-7-hydroxy-3-(p-methoxyphenyl)coumarin
0
4-formyl-2-methoxyphenyl L-menthyl glutarate
0
4-methoxy-alpha-methylbenzyl alcohol
0
4-methoxyacetophenone
1
4-methoxymagnaldehyde B
0
4-methoxyphenylacetic acid
0
4-methoxytyramine
1
4-vinylguaiacol sulfate
0
5-(3-hydroxypropyl)-2-(2-methoxy-4-hydroxyphenyl)benzofuran
0
5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-(4-methoxyphenyl)pyrazole-3-carboxamide
0
5-(pentadeca-8,11,14-trien-1-yl)resorcinol monomethyl ether
0
5-methoxysalicylaldehyde
0
6-Gingediol
0
6-Hydroxyshogaol
0
6-O-malonyl-trans-rhaponticin
0
7-hydroxy-3-(4-methoxyphenyl)-4-methylcoumarin
0
7-hydroxy-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-2-one
0
8-Gingediol
0
9-cyclopentyl-N(8)-(2-fluorophenyl)-N(2)-(4-methoxyphenyl)-9H-purine-2,8-diamine
0
AOH1996
0
ASP-3026
0
AZD3463
0
BI-2536
3
Cuscuta propenamide 1
0
FPR A14
0
Formyl-N-acetyl-5-methoxykynurenamine
1
GS4012 free base
0
HMN-214
0
HPI-1
0
ICPD-26
0
JWH-201
0
KN-93
69
Ku-0063794
3
ML162
0
ML355
0
Methyl-10-gingerol
0
N(1),N(5),N(10)-tri-(5-hydroxyferuloyl)-spermidine +
0
N(1),N(5),N(10)-triferuloyl spermidine +
0
N(2)-[3-methoxy-4-(morpholin-4-yl)phenyl]-N(4)-(quinolin-3-yl)pyrimidine-2,4-diamine
0
N,N-didesmethylvenlafaxine
0
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide +
2
N-(2,6-dimethylphenyl)-2-\{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl\}acetamide +
3
N-(2-methoxyphenyl)-N'-(2-naphthyl)urea
0
N-(3-methoxyphenyl)quinazolin-4-amine
0
N-desmethylvenlafaxine
0
NK372135A
0
O,2,3-trimethyltyrosine +
0
O-acetylferulic acid
0
O-methyltyrosine +
0
RO0480500-002
0
SGC-CLK-1
0
SKF-96365 free base
0
SNC-80
1
YK-4-279
0
[10]-Gingerdione
0
[10]-Paradol
0
[10]-Shogaol
0
[12]-Gingerdione
0
[12]-Gingerol
0
[12]-Shogaol
0
[6]-Gingerdione
0
[6]-Paradol
0
[6]-Shogaol
54
[7]-Paradol
0
[8]-Gingerdione
0
[8]-Paradol
0
[8]-Shogaol
0
alisertib
0
aliskiren +
11
alpha-(4-methoxyphenyl)-6-methyl-2-pyridineacrylic acid
0
anethole +
37
anisiflupurin
0
anisole +
13
avenanthramide B
0
belladine
0
betrixaban
0
bis(trimethylsilyl)isovanillate
0
candidachalcone
0
capsiate
7
conferol A
0
conferol B
0
coniferaldehyde beta-D-glucoside
0
cvxIAA
0
dicamba-methyl
0
dihydroconiferyl alcohol glucoside
0
diuvaretin
0
elacestrant
0
enitociclib
0
enrasentan
2
epicatechin 3-O-(3'-O-methylgallate)
0
estragole
23
eugenol +
1310
eugenol sulfate
0
ferulic acid 4-sulfate
0
flamenol
0
fluazaindolizine
0
fluopimomide
0
gaboroquinone A
0
gilteritinib
0
glucolimnanthin
0
glycosmisic acid 4'-sulfate
0
griffithane D
0
guaiacol sulfate
0
guaiacols +
1396
guaiacylglycerol beta-coniferyl ether
0
halauxifen +
0
halauxifen-methyl
0
hyperaspidinol A
0
isoeugenol acetate
0
isoeugenol sulfate
0
isovanillin
0
karalicin
0
kuraridinol
0
lespeflorin C3
0
locoracemoside B
0
lonchocarpenin
0
metcamifen
0
methoxyfenozide
2
methyl 4-acetoxy-3-methoxybenzoate
0
methyl 4-acetoxy-3-methoxycinnamate
0
methyl 4-methoxycinnamate
0
methyl p-anisate
0
methylophiopogonone B
0
metoxuron
0
mochimganine
0
nitroanisoles +
13
o-anisidine
96
odoratol +
0
osimertinib
23
oxybenzone
328
pirtobrutinib
0
pisoniamide
0
poacic acid
0
rataniaphenol I
0
rataniaphenol III
0
resiniferatoxin
18
rhaponticin +
10
rocaglamide
8
sappanchalcone
12
satavaptan
1
strobilurin B
0
tert-butyl 4-hydroxy-3-methoxybenzoate
0
tetrahydrodemethoxycurcumin
0
trans-Ned 19
0
trans-coniferyl alcohol diacetate
0
triptobenzene H
0
triptoditerpenic acid B
0
tschimganine
0
vanillin +
56
vanillin acetate
0
vanillyl alcohol diacetate
0
vanilpyruvic acid
0
venlafaxine +
182
verongamine
0
volasertib
0
zingerone
55